data_5o2q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5o2q _Structure_validation_residue.Date_analyzed 2017-09-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 112.509 0.559 . . . . 50.0 112.509 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 50.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 50.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 50.0 107.46 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 50.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 50.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 50.0 110.258 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 50.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 50.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 50.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 50.0 108.183 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 50.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 50.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 50.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 50.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 50.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 50.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 50.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 50.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 50.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 50.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 50.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 50.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 50.0 108.351 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 50.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 50.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 50.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 50.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 50.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 50.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 50.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 50.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 50.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 50.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 50.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 50.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 75.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 50.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 50.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 50.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG11 ' HD2' ' A' ' 58' ' ' PRO . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' HG11 ' A' ' 57' ' ' VAL . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 50.0 110.803 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 50.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 50.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 50.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 50.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 50.0 109.858 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 50.0 106.991 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 50.0 106.146 178.37 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 C--O 1.241 0.658 0 CA-C-O 120.713 0.214 . . . . 50.0 111.687 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 50.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 50.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 50.0 110.173 175.905 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 50.0 114.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 50.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 50.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 50.0 108.17 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 50.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 50.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 50.0 109.265 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 50.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 50.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 50.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 50.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 50.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 50.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 50.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 50.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 50.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 50.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 50.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 50.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 50.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 50.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 50.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 50.0 108.115 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 50.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 50.0 108.755 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 50.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 50.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 50.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 50.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 50.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 50.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 50.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 50.0 107.536 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 50.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 50.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 50.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 50.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 50.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 50.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 50.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' HD2' ' A' ' 58' ' ' PRO . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 50.0 111.168 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 50.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 50.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 50.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 50.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 50.0 111.348 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 50.0 108.162 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 50.0 109.891 -179.019 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--O 1.241 0.66 0 CA-C-O 120.504 0.127 . . . . 50.0 112.111 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 50.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 50.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 50.0 111.462 177.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.821 -0.807 . . . . 50.0 108.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 50.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 50.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 50.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 50.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 75.0 110.187 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 50.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 50.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 75.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 50.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 50.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 50.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 50.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 50.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 50.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 50.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 50.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 50.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 50.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 50.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 50.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 50.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 50.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 50.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 50.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 50.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 50.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 50.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 50.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 50.0 107.054 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 50.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 50.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 50.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 50.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 50.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 50.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 58' ' ' PRO . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 57' ' ' VAL . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 50.0 110.925 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 50.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 50.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 50.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 75.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 50.0 109.146 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 50.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 50.0 110.297 -179.339 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo . . . . . 0 C--O 1.242 0.715 0 CA-C-O 120.711 0.213 . . . . 50.0 111.703 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 50.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 50.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 50.0 110.294 176.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 112.228 0.455 . . . . 50.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 50.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 50.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 50.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 50.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 50.0 109.841 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 50.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 50.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 50.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 50.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 50.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 50.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 50.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 50.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 50.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 50.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 50.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 50.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 50.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 50.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 50.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 50.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 75.0 108.145 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 50.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 50.0 110.161 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 50.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 50.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 50.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 50.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 50.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 50.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 50.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 50.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 50.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 50.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 50.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 50.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 50.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 50.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 50.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 58' ' ' PRO . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 57' ' ' VAL . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 50.0 111.333 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 50.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 50.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 50.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 50.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 50.0 109.577 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 50.0 107.449 177.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 112.588 0.188 . . . . 50.0 112.588 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 50.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 50.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 50.0 111.143 177.327 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 50.0 116.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 50.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 50.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 50.0 106.465 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 50.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 50.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 50.0 109.776 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 50.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 50.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 50.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 50.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 50.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 50.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 50.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 50.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 50.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 50.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 50.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 50.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 50.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 50.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 50.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 50.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 50.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 50.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 50.0 109.401 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 50.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 50.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 50.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 50.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 50.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 50.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 50.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 50.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 50.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 50.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 50.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 50.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 50.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 50.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 57' ' ' VAL . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 50.0 111.228 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 50.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 50.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 50.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 50.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 50.0 110.783 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 50.0 105.697 177.736 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.572 0.155 . . . . 50.0 111.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 50.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 50.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 50.0 111.109 177.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--O 1.221 -0.432 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 50.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 50.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 50.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 50.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 50.0 110.438 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 50.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 50.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 50.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 50.0 109.624 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 50.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 50.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 50.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 50.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 50.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 50.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 50.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 50.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 50.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 50.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 50.0 108.502 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 50.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 50.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 50.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 50.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 50.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 50.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 50.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 50.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 50.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 50.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 50.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 50.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 50.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 50.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 50.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 50.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 50.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 50.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 50.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 50.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 50.0 111.796 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 50.0 109.344 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 50.0 111.106 -178.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 50.0 110.779 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 50.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 50.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 50.0 110.478 175.62 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 50.0 115.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 50.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 50.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 50.0 106.99 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 50.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 50.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 50.0 109.638 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 50.0 107.736 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 50.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 50.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 50.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 50.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 50.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 50.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 50.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 50.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 50.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 50.0 109.644 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 50.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 50.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 50.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 50.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 50.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 50.0 109.54 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 50.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 50.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 50.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 50.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 50.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 50.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 50.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 50.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 50.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 50.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 50.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 50.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG13 ' HD2' ' A' ' 58' ' ' PRO . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 50.0 111.211 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 50.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 50.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 50.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 50.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 50.0 109.976 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 50.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 50.0 107.502 177.476 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.241 0.673 0 N-CA-C 110.872 -0.472 . . . . 50.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 50.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 50.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 50.0 109.926 175.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.074 0.464 . . . . 50.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 50.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 50.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 50.0 107.155 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 50.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 50.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 50.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 50.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 75.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 50.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 50.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 50.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 50.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 50.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 50.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 50.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 50.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 50.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 50.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 50.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 50.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 50.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 50.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 50.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 50.0 108.33 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 50.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 50.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 50.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 50.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 50.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 50.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 50.0 108.022 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 50.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 50.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 50.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 50.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 50.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 50.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 50.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 50.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 50.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 50.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 50.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 50.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 50.0 109.092 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 50.0 106.674 176.433 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--O 1.241 0.651 0 CA-C-O 120.605 0.169 . . . . 50.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 50.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 50.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 50.0 111.453 177.242 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 50.0 113.99 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 50.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 50.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 50.0 107.66 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 50.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 50.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 50.0 110.258 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 50.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 50.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 50.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 50.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 50.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 50.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 50.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 50.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 50.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 50.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 50.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 50.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 50.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 50.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 50.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 50.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 50.0 108.962 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 50.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 50.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 50.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 50.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 50.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 50.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 50.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 50.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 50.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 50.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 50.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 50.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 50.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 50.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 50.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 50.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 50.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 50.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 50.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 50.0 112.251 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 50.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 50.0 107.839 177.69 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 C--O 1.24 0.608 0 N-CA-C 111.335 -0.294 . . . . 50.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 50.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 50.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 50.0 110.468 176.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 50.0 115.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 50.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 50.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 50.0 107.621 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 50.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 50.0 110.992 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 50.0 110.588 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 50.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 50.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 50.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 50.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 50.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 50.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 50.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 50.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 50.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 50.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 50.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 50.0 107.707 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 50.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 50.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 50.0 108.303 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 50.0 108.392 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 50.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 50.0 109.292 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 50.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 50.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 50.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 50.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 50.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 50.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 50.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 50.0 107.942 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 50.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 50.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 50.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 50.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 50.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 50.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 50.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 50.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 50.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 50.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 50.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 50.0 110.727 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 50.0 108.55 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 50.0 109.492 -178.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 111.403 -0.268 . . . . 50.0 111.403 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 50.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 50.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 50.0 111.019 176.455 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 50.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 50.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 50.0 107.564 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 50.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 50.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 50.0 109.598 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 50.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 50.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 50.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 50.0 108.707 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 50.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 50.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 50.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 50.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 50.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 50.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 50.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 50.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 50.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 50.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 50.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 50.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 50.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 50.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 50.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 50.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 50.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 50.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 50.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 50.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 50.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 50.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 50.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 50.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 50.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 50.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 50.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 50.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 50.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 50.0 109.725 173.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 50.0 108.5 179.053 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.245 0.836 0 N-CA-C 112.67 0.219 . . . . 50.0 112.67 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 50.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 50.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 50.0 109.612 171.287 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 50.0 115.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 50.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 50.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 50.0 106.262 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 50.0 110.681 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 50.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 50.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 50.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 50.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 50.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 50.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 50.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 50.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 50.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 50.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 50.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 50.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 50.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 50.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 50.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 50.0 110.396 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 50.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 50.0 108.624 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 50.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 50.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 50.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 50.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 50.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 50.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 50.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 50.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 50.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 50.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 50.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 50.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 50.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 50.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 50.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 50.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 50.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 50.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 50.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 50.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 50.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 50.0 107.235 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 50.0 107.923 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 CA-C-O 120.634 0.181 . . . . 50.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 50.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 50.0 111.332 178.012 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.907 . . . . 50.0 112.578 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 50.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 50.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 50.0 107.31 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 50.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 50.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 50.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 50.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 50.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 50.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 50.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 50.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 50.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 50.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 50.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 50.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 50.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 50.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 50.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 50.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 50.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 50.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 50.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 50.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 50.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 50.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 50.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 50.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 50.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 50.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 50.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 50.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 50.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 50.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 50.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 50.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 50.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 50.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 50.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 50.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 50.0 111.422 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 50.0 108.74 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.716 0.215 . . . . 50.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 50.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 50.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 50.0 110.617 175.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 50.0 116.134 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 50.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 50.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 50.0 107.389 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 50.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 50.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 75.0 110.055 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 50.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 50.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 75.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 50.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 50.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 50.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 50.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 50.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 50.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 50.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 50.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 50.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 50.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 50.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 50.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 50.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 50.0 108.722 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 50.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 50.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 50.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 50.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 50.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 50.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 50.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 50.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 50.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 50.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 50.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 50.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 50.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 50.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 50.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 50.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.409 HG11 ' HD2' ' A' ' 58' ' ' PRO . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' HG11 ' A' ' 57' ' ' VAL . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 50.0 111.105 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 50.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 50.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 50.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 50.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 50.0 110.242 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--O 1.244 0.812 0 N-CA-C 111.507 -0.228 . . . . 50.0 111.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 50.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 50.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 50.0 111.134 177.426 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.926 0.393 . . . . 50.0 110.669 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 50.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 50.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 50.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 50.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 50.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 75.0 110.504 175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 50.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 50.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 50.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 50.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 50.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 50.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 50.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 50.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 50.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 50.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 50.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 50.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 50.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 50.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 50.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 50.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 50.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 50.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 50.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 50.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 50.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 50.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 50.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 50.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 50.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 50.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 50.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.407 HG13 ' HD2' ' A' ' 58' ' ' PRO . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 50.0 111.851 176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 50.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 50.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 50.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 50.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 50.0 109.793 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 50.0 111.52 -177.254 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.176 -0.355 . . . . 50.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 50.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 50.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 50.0 110.308 176.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 50.0 115.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 50.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 50.0 106.632 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 50.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 50.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 75.0 109.437 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 50.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 50.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 50.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 50.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 50.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 50.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 50.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 50.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 50.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 50.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 50.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 50.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 50.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 50.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 50.0 109.202 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 50.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 50.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 50.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 50.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 50.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 50.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 50.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 50.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 50.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 50.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 50.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 50.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 50.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 50.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 50.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 50.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 50.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 50.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 50.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 50.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 50.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 50.0 111.573 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 50.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 50.0 109.966 -178.067 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.243 0.741 0 N-CA-C 111.408 -0.266 . . . . 50.0 111.408 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 50.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 50.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 50.0 110.197 176.245 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 50.0 116.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 50.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 50.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 50.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 50.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 50.0 109.711 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 50.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 50.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 50.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 50.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 50.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 50.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 50.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 50.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 50.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 50.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 50.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 50.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 50.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 50.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 50.0 108.633 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 50.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 172.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 50.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 50.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 50.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 50.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 50.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 50.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 50.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 75.0 106.95 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 50.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 50.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 50.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 50.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 50.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 50.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 58' ' ' PRO . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 57' ' ' VAL . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 50.0 111.264 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 50.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 50.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 50.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 50.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 50.0 109.298 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 50.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 50.0 107.175 177.757 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 CA-C-O 120.825 0.26 . . . . 50.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 50.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 50.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 50.0 109.477 168.586 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.833 0.349 . . . . 50.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 50.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 50.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 50.0 108.472 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 50.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 50.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 50.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 50.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 50.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 50.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 50.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 50.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 50.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 50.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 50.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 50.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 50.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 50.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 50.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 50.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 50.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 50.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 50.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 50.0 108.192 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 50.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 50.0 109.492 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 50.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 50.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 50.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 50.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 50.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 50.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 50.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 50.0 107.94 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 50.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 50.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 50.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 50.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 50.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 50.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 50.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 50.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 50.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 50.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 50.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 50.0 111.433 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 50.0 107.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 50.0 111.831 -176.275 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.241 0.671 0 CA-C-O 120.704 0.21 . . . . 50.0 112.31 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 50.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 50.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 50.0 110.623 175.48 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 50.0 117.773 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 50.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 50.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 50.0 107.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 50.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 50.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 50.0 109.446 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 50.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 75.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 50.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 50.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 50.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 50.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 50.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 50.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 50.0 112.944 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 50.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 50.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 50.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 50.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 50.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 50.0 108.244 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 50.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 50.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 50.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 50.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 50.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 50.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 50.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 50.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 50.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 50.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 50.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 50.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 50.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 50.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 50.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 HG11 ' HD2' ' A' ' 58' ' ' PRO . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' HG11 ' A' ' 57' ' ' VAL . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 50.0 111.164 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 50.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 50.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 50.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 50.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 50.0 110.635 171.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 50.0 108.679 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 50.0 108.245 178.592 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 50.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 50.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 50.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 50.0 110.384 176.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.422 0.897 . . . . 50.0 113.422 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 50.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 50.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 50.0 108.053 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 50.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 50.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 50.0 109.933 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 50.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 50.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 50.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 50.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 50.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 50.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 50.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 50.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 50.0 107.71 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 50.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 50.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 50.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 50.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 50.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 50.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 50.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 50.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 50.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 50.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 50.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 50.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 50.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 50.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 50.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 50.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 50.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 50.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 50.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 50.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 50.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 50.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 50.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 50.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 50.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 75.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 50.0 109.975 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 50.0 107.442 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 50.0 109.263 -179.174 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.242 0.678 0 N-CA-C 112.665 0.217 . . . . 50.0 112.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 50.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 50.0 110.486 172.644 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 50.0 115.464 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 50.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 50.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 50.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 50.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 50.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 50.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 173.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 50.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 50.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 50.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 50.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 50.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 50.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 50.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 50.0 110.8 177.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 50.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 50.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 50.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 50.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 50.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 50.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 172.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 50.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 50.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 50.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 50.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 50.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 50.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 50.0 107.02 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 50.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 50.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 50.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 50.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 50.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 50.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG11 ' HD2' ' A' ' 58' ' ' PRO . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 50.0 112.115 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 50.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 50.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 50.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 50.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 50.0 108.803 173.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 50.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 50.0 110.858 179.846 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 C--O 1.245 0.84 0 CA-C-O 120.529 0.137 . . . . 50.0 111.765 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 50.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 50.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 50.0 110.805 176.686 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.482 0.919 . . . . 50.0 113.482 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 50.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 50.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 50.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 50.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 75.0 110.391 175.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 50.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 50.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 50.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 50.0 108.545 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 50.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 50.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 50.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 50.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 50.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 50.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 50.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 50.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 50.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 50.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 50.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 50.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 50.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 50.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 50.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 50.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 50.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 50.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 50.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 75.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 50.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 50.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 50.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 50.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 50.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 50.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 50.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 50.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 50.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 50.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 50.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 50.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 50.0 112.284 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 50.0 109.746 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 50.0 110.896 179.848 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 120.667 0.194 . . . . 50.0 112.499 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 50.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 50.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 50.0 109.67 169.334 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 50.0 114.869 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 50.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 50.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 50.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 50.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 50.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 50.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 50.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 50.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 50.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 50.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 50.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 50.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 50.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 50.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 50.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 50.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 50.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 50.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 50.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 50.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 50.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 50.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 50.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 50.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 50.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 50.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 50.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 50.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 50.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 50.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 50.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 50.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 50.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 50.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 50.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG11 ' HD2' ' A' ' 58' ' ' PRO . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 50.0 111.337 176.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 50.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 50.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 50.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 50.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 50.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 50.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 50.0 103.0 172.788 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 50.0 111.1 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 50.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 50.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 50.0 110.528 176.343 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 50.0 115.93 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 50.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 50.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 50.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 50.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 50.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 50.0 110.556 176.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 50.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 50.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 50.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 50.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 50.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 50.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 50.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 50.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 50.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 50.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 50.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 50.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 50.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 50.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 50.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 50.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 50.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 50.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 50.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 50.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 50.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 50.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 50.0 107.33 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 50.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 50.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 50.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 50.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 50.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 50.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 50.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 58' ' ' PRO . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 57' ' ' VAL . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 50.0 111.699 176.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 50.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 50.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 50.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 50.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.299 174.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 50.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 50.0 109.684 -179.007 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 C--O 1.24 0.606 0 N-CA-C 110.802 -0.499 . . . . 50.0 110.802 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 50.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 50.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 50.0 111.331 176.967 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.144 1.164 . . . . 50.0 114.144 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 50.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 50.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 50.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 50.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 50.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 50.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 50.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 50.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 50.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 50.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 50.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 50.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 50.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 50.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 50.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 50.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 50.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 50.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 50.0 108.576 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 50.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 50.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 50.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 50.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 50.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 50.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 50.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 50.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 50.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 50.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 50.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 50.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 50.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 50.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 58' ' ' PRO . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 50.0 111.091 175.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 50.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 50.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 50.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 50.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 50.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 50.0 111.287 -178.667 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--O 1.242 0.692 0 N-CA-C 112.513 0.159 . . . . 50.0 112.513 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 50.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 50.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 50.0 110.019 170.56 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.072 1.508 . . . . 50.0 115.072 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 50.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 50.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 50.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 50.0 109.569 176.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 50.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 50.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 50.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 50.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 50.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 50.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 50.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 50.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 50.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 50.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 50.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 50.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 50.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 50.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 50.0 108.459 178.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 50.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 172.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 50.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 50.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 50.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 50.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 50.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 50.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 50.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 50.0 107.154 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 50.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 50.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 50.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 50.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 50.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 50.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 50.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 50.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 50.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 50.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 50.0 110.156 174.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 50.0 108.515 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 50.0 109.741 179.685 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 C--O 1.243 0.729 0 CA-C-O 120.621 0.175 . . . . 50.0 111.92 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 50.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 50.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 50.0 108.893 167.875 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.456 0.909 . . . . 50.0 113.456 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 50.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 50.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 179.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 50.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 50.0 111.467 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 50.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 50.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 50.0 107.745 -179.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 50.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 50.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 50.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 50.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 50.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 50.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 50.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 50.0 113.274 -177.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 50.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 50.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 50.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 50.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 179.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 50.0 108.445 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 50.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 173.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 50.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 50.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 50.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 50.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 50.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 50.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 50.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 50.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 50.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 50.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 50.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 50.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 50.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 50.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 50.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 50.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 50.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 50.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 50.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 50.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 50.0 106.861 175.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 179.057 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.239 0.554 0 CA-C-O 120.666 0.194 . . . . 50.0 112.197 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 50.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 50.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 50.0 110.531 174.931 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.704 0.288 . . . . 50.0 110.463 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 50.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 50.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 50.0 106.705 179.057 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 50.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 50.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 75.0 109.256 175.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 50.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 50.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 50.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 50.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 50.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 50.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 50.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 50.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 50.0 107.333 177.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 50.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 50.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 50.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 50.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 50.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 50.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 50.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 50.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 50.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 50.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 50.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 50.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 50.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 50.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 50.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 50.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 50.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 50.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 50.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 50.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 50.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 50.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 50.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 50.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 50.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 50.0 111.508 178.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 50.0 108.733 175.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 50.0 108.222 178.618 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 111.666 -0.167 . . . . 50.0 111.666 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 50.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 50.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 50.0 110.695 177.055 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 50.0 114.57 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 50.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 50.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 50.0 106.283 178.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 50.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 50.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 174.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 50.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 50.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 50.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 50.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 50.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 50.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 50.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 50.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 50.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 50.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 50.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 50.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 50.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 50.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 50.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 50.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 50.0 109.706 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 50.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 50.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 50.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 50.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 50.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 50.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 50.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 50.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 50.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 75.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 50.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 50.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 50.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 50.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' HD2' ' A' ' 58' ' ' PRO . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 50.0 110.939 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 50.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 50.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 50.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 50.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 50.0 111.154 178.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 50.0 108.562 176.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 50.0 107.296 178.81 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 50.0 110.955 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 50.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 50.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 50.0 111.521 178.161 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.121 -0.696 . . . . 50.0 109.121 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 50.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 50.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 50.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 50.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 50.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 50.0 110.386 177.042 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 50.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 50.0 109.5 174.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 50.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 50.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 50.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 50.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 50.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 50.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 50.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 50.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 50.0 110.142 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 50.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 50.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 50.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 50.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 50.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 50.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 50.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 50.0 108.437 173.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 50.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 50.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 50.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 50.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 50.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 50.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 50.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 50.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 50.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 50.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 50.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 50.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 50.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 50.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 50.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 50.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 50.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 50.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 50.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 50.0 111.004 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 50.0 110.797 -178.016 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--O 1.243 0.727 0 CA-C-O 120.874 0.281 . . . . 50.0 111.781 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 50.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 50.0 110.657 177.93 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 50.0 115.049 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 50.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 50.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 50.0 106.633 178.125 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 50.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 50.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 50.0 110.158 176.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 50.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 50.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 50.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 50.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 50.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 50.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 50.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 50.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 50.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 50.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 50.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 50.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 50.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 50.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 50.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 50.0 108.606 178.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 50.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 50.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 50.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 50.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 50.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 50.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 50.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 50.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 50.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 50.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 50.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 50.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 50.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 50.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 50.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 50.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 50.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 50.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 50.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 50.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 50.0 111.783 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 50.0 109.171 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 50.0 108.606 179.242 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.887 0.286 . . . . 50.0 112.473 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 50.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 50.0 110.702 176.46 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 50.0 117.069 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 50.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 50.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 50.0 108.563 -177.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 50.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 50.0 111.838 178.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 50.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 50.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 50.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 50.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 50.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 50.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 50.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 50.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 50.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 50.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 50.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 50.0 110.144 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 50.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 50.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 50.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 50.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 178.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 50.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 50.0 109.59 173.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 50.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 50.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 50.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 50.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 50.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 50.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 50.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 50.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 50.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 50.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 50.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 50.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 50.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 58' ' ' PRO . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 57' ' ' VAL . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 50.0 111.633 176.581 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 50.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 50.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 50.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 50.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 50.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 50.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 50.0 109.702 -179.839 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.242 0.725 0 N-CA-C 111.74 -0.138 . . . . 50.0 111.74 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 50.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 50.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 50.0 110.721 177.263 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 113.077 0.769 . . . . 50.0 113.077 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 50.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 50.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 50.0 108.431 -178.389 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 50.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 50.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 176.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 50.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 50.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 50.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 50.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 50.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 50.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 50.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 50.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 50.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 50.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 50.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 50.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 50.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 50.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 50.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 50.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 50.0 108.869 178.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 50.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 173.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 50.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 50.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 50.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 50.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 50.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 50.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 50.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 75.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 50.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 50.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 50.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 50.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 50.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 50.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 50.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 50.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 50.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 50.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 50.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 50.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 50.0 111.388 178.023 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 50.0 108.918 177.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 50.0 107.657 178.722 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 C--O 1.242 0.679 0 CA-C-O 120.697 0.207 . . . . 50.0 111.768 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 50.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 50.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 50.0 110.848 176.989 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.382 1.252 . . . . 50.0 114.382 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 50.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 50.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 50.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 50.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 50.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 176.068 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 50.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 50.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 50.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 50.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 50.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 50.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 50.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 50.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 50.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 50.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 50.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 50.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 50.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 50.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 50.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 50.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 50.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 173.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 50.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 50.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 50.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 50.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 50.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 50.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 50.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 50.0 107.384 179.448 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 50.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 50.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 50.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 50.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 50.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 50.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 50.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 50.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 50.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 50.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 50.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 50.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 50.0 111.294 177.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 50.0 108.141 179.713 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.238 0.503 0 N-CA-C 110.929 -0.451 . . . . 50.0 110.929 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 50.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 50.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 50.0 110.959 177.777 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.225 0.536 . . . . 50.0 112.131 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 50.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 50.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 50.0 108.747 -178.62 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 50.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 50.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 75.0 109.192 174.818 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 50.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 50.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 50.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 50.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 50.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 50.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 50.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 50.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 50.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 50.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 50.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 50.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 50.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 50.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 50.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 50.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 50.0 108.746 173.277 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 50.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 50.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 50.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 50.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 50.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 50.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 50.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 50.0 106.733 178.103 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 50.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 50.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 50.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 50.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 50.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 50.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 50.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 50.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 50.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 50.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 50.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 50.0 109.989 173.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 176.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 50.0 105.398 177.424 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.242 0.705 0 N-CA-C 110.948 -0.443 . . . . 50.0 110.948 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 50.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 50.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 50.0 110.86 177.626 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 50.0 115.144 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 50.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 -178.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 50.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 50.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 50.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 50.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 50.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 50.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 50.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 50.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 50.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 50.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 50.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 50.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 50.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 50.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 50.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 50.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 50.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 50.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 50.0 108.399 178.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 50.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 50.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 50.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 50.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 50.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 50.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 50.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 50.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 50.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 50.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 50.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 50.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 50.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 50.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 50.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 50.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 50.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 50.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 50.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 50.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 50.0 111.669 178.03 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 50.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 50.0 112.221 -177.2 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--O 1.242 0.71 0 CA-C-O 120.727 0.219 . . . . 50.0 111.861 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 50.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 50.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 50.0 109.363 170.328 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 50.0 116.014 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 50.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 50.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 50.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 50.0 111.846 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 50.0 110.531 175.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 50.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 50.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 50.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 50.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 50.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 50.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 50.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 50.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 50.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 50.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 50.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 50.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 50.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 50.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 50.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 50.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 75.0 108.575 179.082 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 50.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 50.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 50.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 50.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 50.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 50.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 50.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 50.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 50.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 50.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 50.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 50.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 75.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 50.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 50.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 50.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 50.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 58' ' ' PRO . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' HG11 ' A' ' 57' ' ' VAL . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 50.0 110.737 175.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 50.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 50.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 50.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 50.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 50.0 110.544 175.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 50.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 50.0 109.849 -179.55 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.245 0.868 0 N-CA-C 111.55 -0.211 . . . . 50.0 111.55 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 50.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 50.0 109.571 169.94 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 50.0 115.554 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 50.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 50.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 50.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 50.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 50.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 50.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 50.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 50.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 50.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 50.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 50.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 50.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 50.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 50.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 50.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 50.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 50.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 50.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 50.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 50.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 50.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 50.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 50.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 50.0 109.599 172.562 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 50.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 50.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 50.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 50.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 50.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 50.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 50.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 50.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 50.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 50.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 50.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 50.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 50.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 50.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 50.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 50.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 50.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 50.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 50.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 50.0 112.503 178.401 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 50.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 50.0 113.006 -176.252 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 50.0 110.857 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 50.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 50.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 50.0 108.943 173.266 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 50.0 115.742 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 50.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 50.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 50.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 50.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 50.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 50.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 50.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 50.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 50.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 50.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 50.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 50.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 50.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 50.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 50.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 50.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 50.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 50.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 50.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 50.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 50.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 50.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 50.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 50.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 50.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 50.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 50.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 50.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 50.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 50.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 50.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 50.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 50.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 50.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 50.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 50.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 50.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 50.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 50.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 50.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 50.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 50.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 50.0 108.402 -179.454 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 CA-C-O 120.625 0.177 . . . . 50.0 112.404 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 50.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 50.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 50.0 109.538 170.684 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 114.489 1.292 . . . . 50.0 114.489 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 50.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 50.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 50.0 107.868 -179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 50.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 50.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 50.0 109.339 174.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 50.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 50.0 110.379 173.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 50.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 50.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 50.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 50.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 50.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 50.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 50.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 50.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 50.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 50.0 108.754 -176.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 50.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 50.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 50.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 50.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 50.0 108.63 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 50.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 50.0 108.436 173.236 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 50.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 50.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 50.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 50.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 50.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 50.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 50.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 178.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 50.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 50.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 50.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 50.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 50.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 50.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 50.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 58' ' ' PRO . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 57' ' ' VAL . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 50.0 111.131 175.101 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 50.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 50.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 50.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 50.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 50.0 109.893 177.578 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 50.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 50.0 106.193 177.65 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.243 0.739 0 CA-C-O 120.812 0.255 . . . . 50.0 111.757 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 50.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 50.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 50.0 110.092 175.623 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 CA-C-O 123.348 1.527 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -65.99 124.28 22.12 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.897 -1.354 . . . . 25.0 109.741 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttp -78.9 79.72 5.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.786 0.803 . . . . 25.0 111.591 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -80.25 -0.97 38.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.735 -0.666 . . . . 50.0 111.238 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.93 163.67 28.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.509 0.559 . . . . 50.0 112.509 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 50.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 50.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 50.0 107.46 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 50.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 50.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 50.0 110.258 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 50.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 50.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 50.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 50.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.482 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 50.0 108.183 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 50.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 50.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 50.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 50.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 50.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 50.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 50.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 50.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 50.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 50.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 50.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 50.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 50.0 108.351 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 50.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 50.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 50.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 50.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 50.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 50.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 50.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 50.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 50.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 50.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 50.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 50.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 75.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 50.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 50.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 50.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG11 ' HD2' ' A' ' 58' ' ' PRO . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' HG11 ' A' ' 57' ' ' VAL . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 50.0 110.803 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 50.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 50.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 50.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 50.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 50.0 109.858 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 50.0 106.991 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt -93.93 92.53 7.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 50.0 106.146 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.15 102.78 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.971 -1.013 . . . . 50.0 109.471 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.67 27.6 2.54 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 115.099 0.8 . . . . 25.0 115.099 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -85.61 -6.49 59.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -134.22 129.77 36.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 25.0 110.721 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.0 138.32 54.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 25.0 110.424 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -144.72 126.67 15.44 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.168 0.509 . . . . 50.0 110.464 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -85.17 147.91 48.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.026 -1.102 . . . . 50.0 108.026 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.86 160.83 40.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 121.975 0.46 . . . . 50.0 113.28 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.96 53.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.143 0.423 . . . . 25.0 112.143 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.45 77.45 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.144 -0.55 . . . . 25.0 114.303 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 p -77.69 50.95 0.87 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.201 1.186 . . . . 25.0 114.201 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.69 -169.09 53.74 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.14 -0.553 . . . . 25.0 112.33 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.5 31.41 0.25 Allowed Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.654 -0.784 . . . . 25.0 114.704 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -29.87 68.19 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.59 68.78 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.181 -0.533 . . . . 25.0 114.322 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 m -73.36 114.55 11.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.21 0.448 . . . . 25.0 112.21 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.49 98.04 2.06 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.316 -1.914 . . . . 25.0 108.316 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.95 -4.71 56.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.956 0.408 . . . . 50.0 111.507 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.22 164.55 31.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.58 127.93 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.476 0.547 . . . . 50.0 112.476 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -125.87 67.93 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.726 -1.212 . . . . 50.0 107.726 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.85 131.36 49.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 50.0 111.235 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.99 151.92 58.17 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.1 -0.955 . . . . 25.0 111.992 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.08 160.87 48.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 117.494 -1.204 . . . . 50.0 111.687 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 50.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 50.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.93 162.73 40.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 50.0 110.173 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.57 175.25 10.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 N-CA-C 113.426 0.51 . . . . 50.0 113.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' CD1' ' HG ' ' A' ' 20' ' ' SER . 20.5 mt -133.72 155.7 80.18 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.598 -0.728 . . . . 50.0 109.181 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.3 176.79 9.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.961 2.44 . . . . 50.0 113.795 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.56 38.07 0.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.38 -0.827 . . . . 50.0 112.722 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.7 166.84 12.99 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 114.399 0.519 . . . . 50.0 114.399 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.35 126.51 30.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.763 0.792 . . . . 50.0 110.998 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 124.154 1.931 . . . . 25.0 113.084 179.31 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 CA-C-O 122.969 1.316 . . . . 25.0 114.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p -150.34 152.05 33.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 120.976 -1.308 . . . . 25.0 107.738 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -81.56 91.65 6.4 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -121.14 126.0 48.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 105.937 -1.875 . . . . 50.0 105.937 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 60.35 172.35 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 50.0 114.947 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 50.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 50.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 50.0 108.17 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 50.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 50.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 50.0 109.265 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 50.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 50.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 50.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 50.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 50.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 50.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 50.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 50.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 50.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 50.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 50.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 50.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 50.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 50.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 50.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 50.0 108.115 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 50.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 50.0 108.755 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 50.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 50.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 50.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 50.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 50.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 50.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 50.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 50.0 107.536 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 50.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 50.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 50.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 50.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 50.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 50.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 50.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' HD2' ' A' ' 58' ' ' PRO . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 50.0 111.168 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 50.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 50.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 50.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 50.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 50.0 111.348 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 50.0 108.162 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.94 82.5 4.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 50.0 109.891 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.33 139.79 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.111 -1.811 . . . . 50.0 106.111 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.23 -122.97 0.47 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.559 -0.616 . . . . 25.0 111.559 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.1 39.72 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.172 -0.605 . . . . 25.0 109.834 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -162.58 -61.46 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.42 0.45 . . . . 25.0 109.888 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.31 -27.42 47.23 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.736 0.779 . . . . 25.0 112.014 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.33 163.85 27.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.906 -0.588 . . . . 50.0 111.09 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.71 149.91 88.1 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.518 -0.764 . . . . 50.0 109.801 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.47 161.21 46.22 Favored 'Trans proline' 0 C--N 1.349 0.58 0 N-CA-C 113.58 0.569 . . . . 50.0 113.58 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.99 173.36 16.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.683 -2.339 . . . . 25.0 104.683 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.06 168.38 37.82 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 109.448 -1.461 . . . . 25.0 109.448 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -130.52 -4.68 4.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.372 1.249 . . . . 25.0 114.372 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.93 -149.83 40.14 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.449 -0.881 . . . . 25.0 111.426 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.62 160.07 20.12 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.867 -1.693 . . . . 25.0 108.867 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.5 t -150.64 161.93 41.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.22 138.17 10.08 Favored Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -150.2 156.97 42.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.83 97.59 2.27 Favored Glycine 0 C--O 1.22 -0.756 0 N-CA-C 109.753 -1.339 . . . . 25.0 109.753 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.54 86.8 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.621 0.724 . . . . 50.0 109.656 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 p -112.7 161.84 16.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.62 9.45 5.14 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 50.0 112.364 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -86.96 85.9 7.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.574 -0.899 . . . . 50.0 108.574 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.0 mt -72.61 139.12 47.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 50.0 111.332 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.78 145.93 71.55 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.76 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.26 164.84 33.25 Favored 'Trans proline' 0 C--O 1.241 0.66 0 O-C-N 121.587 0.256 . . . . 50.0 112.111 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 50.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 50.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.39 161.36 46.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 50.0 111.462 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.28 174.77 12.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 120.386 0.724 . . . . 50.0 113.445 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt -133.9 156.54 79.22 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 50.0 109.316 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.84 171.12 18.56 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.5 1.466 . . . . 50.0 112.6 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -99.53 23.46 9.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.685 . . . . 50.0 111.864 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.47 -172.62 36.13 Favored Glycine 0 N--CA 1.456 -0.024 0 C-N-CA 120.943 -0.646 . . . . 50.0 112.117 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.09 105.52 2.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.02 0.914 . . . . 50.0 109.463 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 123.986 1.851 . . . . 25.0 113.804 -175.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 123.098 1.388 . . . . 25.0 115.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -144.9 133.4 21.96 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.971 -1.311 . . . . 25.0 108.945 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.3 mtp -134.4 154.98 51.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.47 -23.24 13.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.324 0.583 . . . . 50.0 110.845 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -146.95 178.96 7.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.455 -1.248 . . . . 50.0 108.821 -173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 50.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 50.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 50.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 50.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 75.0 110.187 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 50.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 50.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 75.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 50.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 50.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 50.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 50.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 50.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 50.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 50.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 50.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 50.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 50.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 50.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 50.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 50.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 50.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 50.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 50.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 50.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 50.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 50.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 50.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 50.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 50.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 50.0 107.054 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 50.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 50.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 50.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 50.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 50.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 50.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 58' ' ' PRO . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 57' ' ' VAL . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 50.0 110.925 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 50.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 50.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 50.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 75.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 50.0 109.146 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 50.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.0 91.44 6.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 50.0 110.297 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -84.01 0.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.919 0.866 . . . . 50.0 108.815 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 -70.44 3.13 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.979 -0.555 . . . . 25.0 112.359 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.4 ttp -72.3 -32.91 67.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 25.0 110.123 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.59 101.94 13.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -147.43 173.48 12.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.893 -2.632 . . . . 25.0 103.893 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.79 132.79 20.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.891 -0.781 . . . . 50.0 108.891 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.9 149.1 97.91 Favored Pre-proline 0 C--O 1.241 0.631 0 CA-C-N 115.969 -0.559 . . . . 50.0 109.92 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.47 -179.83 4.84 Favored 'Trans proline' 0 C--N 1.349 0.604 0 O-C-N 122.299 0.631 . . . . 50.0 110.851 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.49 68.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.07 45.58 8.87 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.494 -0.86 . . . . 25.0 114.022 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.8 t -59.07 136.81 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.846 -0.427 . . . . 25.0 109.846 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.47 25.32 21.36 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 116.518 -0.31 . . . . 25.0 113.439 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.25 128.84 19.64 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.654 -0.978 . . . . 25.0 110.654 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -72.56 -24.18 61.08 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.541 0.686 . . . . 25.0 111.291 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.62 -177.71 40.3 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.537 -2.225 . . . . 25.0 107.537 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.7 p -68.56 140.05 55.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.533 0.667 . . . . 25.0 109.507 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.96 72.09 0.18 Allowed Glycine 0 C--O 1.22 -0.756 0 N-CA-C 110.876 -0.89 . . . . 25.0 110.876 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.4 mt 56.76 47.27 18.46 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.133 0.968 . . . . 50.0 110.177 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -123.16 129.24 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.616 -1.174 . . . . 25.0 108.188 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.77 150.62 47.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 50.0 111.266 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.93 97.71 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.339 -1.356 . . . . 50.0 107.339 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.27 132.28 46.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 50.0 110.373 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.27 149.56 65.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.604 -0.725 . . . . 25.0 109.98 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.82 158.98 54.08 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 116.75 -1.7 . . . . 50.0 111.703 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 50.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 50.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 161.01 46.55 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 50.0 110.294 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.22 175.48 10.49 Favored 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 113.207 0.426 . . . . 50.0 113.207 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -133.96 155.26 80.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 50.0 109.714 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 178.3 7.76 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.997 2.465 . . . . 50.0 112.846 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 34.04 0.21 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.75 0.82 . . . . 50.0 111.984 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.95 -173.24 27.75 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 122.189 -0.32 . . . . 50.0 113.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -68.51 130.4 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.805 0.812 . . . . 50.0 109.772 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.213 -0.845 0 CA-C-O 125.57 2.605 . . . . 25.0 111.248 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 123.144 1.413 . . . . 25.0 115.588 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -68.43 116.66 9.24 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.173 -1.192 . . . . 25.0 110.908 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -70.89 135.22 47.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 25.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -135.25 11.86 3.54 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.01 -0.541 . . . . 50.0 110.822 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.03 168.64 19.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 50.0 112.228 -172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 50.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 50.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 50.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 50.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 50.0 109.841 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 50.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 50.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 50.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 50.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 50.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 50.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 50.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 50.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 50.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 50.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 50.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 50.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 50.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 50.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 50.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 50.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 75.0 108.145 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 50.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 50.0 110.161 173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 50.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 50.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 50.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 50.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 50.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 50.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 50.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 50.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 50.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 50.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 50.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 50.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 50.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 50.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 50.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 58' ' ' PRO . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 57' ' ' VAL . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 50.0 111.333 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 50.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 50.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 50.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 50.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 50.0 109.577 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 50.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.74 90.15 6.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 50.0 107.449 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.87 -26.08 33.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.261 -0.881 . . . . 50.0 110.578 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.21 -101.73 0.84 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 111.459 -0.657 . . . . 25.0 111.459 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.97 -16.4 62.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.163 0.431 . . . . 25.0 112.163 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -91.08 116.49 28.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 25.0 110.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.88 157.58 45.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -86.52 3.13 45.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 50.0 111.441 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -122.48 138.61 29.5 Favored Pre-proline 0 C--O 1.222 -0.393 0 N-CA-C 107.506 -1.294 . . . . 50.0 107.506 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.79 -1.82 11.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 N-CA-C 114.85 1.058 . . . . 50.0 114.85 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.5 25.48 2.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.99 0.424 . . . . 25.0 110.983 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.41 -161.71 54.41 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.488 -0.863 . . . . 25.0 113.428 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.92 130.38 39.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 25.0 112.276 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.37 60.28 4.85 Favored Glycine 0 C--O 1.224 -0.469 0 CA-C-N 116.235 -0.438 . . . . 25.0 112.237 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -155.36 53.4 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.933 -0.651 . . . . 25.0 111.738 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -153.46 149.28 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.706 -1.22 . . . . 25.0 107.706 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.57 87.57 1.8 Allowed Glycine 0 C--O 1.218 -0.868 0 N-CA-C 111.719 -0.552 . . . . 25.0 111.719 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -87.26 11.46 14.18 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 113.724 1.009 . . . . 25.0 113.724 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.52 -26.46 5.16 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 121.355 -0.45 . . . . 25.0 113.451 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.58 -36.57 78.85 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.283 0.475 . . . . 50.0 112.283 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m 70.59 -25.45 0.16 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.772 1.229 . . . . 25.0 113.935 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.98 155.88 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.212 -1.032 . . . . 50.0 108.212 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -157.59 100.23 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.463 -0.569 . . . . 50.0 109.463 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.02 130.67 43.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.52 0.676 . . . . 50.0 111.111 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.58 150.81 63.9 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.452 -0.795 . . . . 25.0 112.097 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.84 164.06 36.88 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 119.946 0.43 . . . . 50.0 112.588 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 50.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 50.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.08 162.76 40.43 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 50.0 111.143 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.9 172.32 16.56 Favored 'Trans proline' 0 C--N 1.346 0.442 0 N-CA-C 113.619 0.584 . . . . 50.0 113.619 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -133.88 156.11 79.65 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.704 -0.68 . . . . 50.0 110.955 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.85 169.97 18.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.375 2.05 . . . . 50.0 113.527 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -86.0 54.44 3.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.457 -0.792 . . . . 50.0 110.997 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.66 33.94 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 115.074 0.79 . . . . 50.0 115.074 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.47 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 50.0 111.295 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.215 -0.73 0 CA-C-O 124.377 2.037 . . . . 25.0 111.177 -178.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 122.994 1.33 . . . . 25.0 115.312 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -150.93 157.17 42.56 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 89.7 mtp -92.45 137.22 32.55 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.158 -1.052 . . . . 25.0 108.158 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -86.97 152.48 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.739 -1.208 . . . . 50.0 107.739 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 60.0 166.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 50.0 116.518 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 50.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 50.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 50.0 106.465 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 50.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 50.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 50.0 109.776 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 50.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 50.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 50.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 50.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 50.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 50.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 50.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 50.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 50.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 50.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 50.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 50.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 50.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 50.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 50.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 50.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 50.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 50.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 50.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 50.0 109.401 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 50.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 50.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 50.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 50.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 50.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 50.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 50.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 50.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 50.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 50.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 50.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 50.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 50.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 50.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG13 ' HD2' ' A' ' 58' ' ' PRO . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD2' HG13 ' A' ' 57' ' ' VAL . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 50.0 111.228 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 50.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 50.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 50.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 50.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 50.0 110.783 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.57 90.77 7.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 50.0 105.697 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.13 -12.32 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 114.805 1.409 . . . . 50.0 114.805 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.34 -7.79 29.11 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 121.635 -0.317 . . . . 25.0 113.765 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 91.5 mmm -107.24 -54.25 2.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.537 0.94 . . . . 25.0 113.537 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -139.67 32.31 2.04 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.741 1.015 . . . . 25.0 113.741 -171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.29 138.05 58.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 25.0 110.703 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -74.76 108.41 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.819 -0.808 . . . . 50.0 108.819 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.39 143.18 80.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 50.0 110.507 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.48 168.4 23.84 Favored 'Trans proline' 0 C--N 1.347 0.462 0 O-C-N 122.128 0.541 . . . . 50.0 113.065 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.31 33.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.52 177.1 24.97 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.359 -1.096 . . . . 25.0 110.359 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 m -75.64 133.9 40.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.683 -0.488 . . . . 25.0 109.683 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.54 73.21 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.663 -0.78 . . . . 25.0 113.564 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -77.53 -10.0 86.51 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.088 -0.577 . . . . 25.0 112.339 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 m -105.31 35.36 2.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.294 0.568 . . . . 25.0 110.468 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -8.54 66.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.273 0.869 . . . . 25.0 115.273 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.333 0.567 . . . . 25.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.52 179.25 29.67 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 123.524 0.515 . . . . 25.0 113.323 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.26 141.38 33.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.554 -2.017 . . . . 50.0 105.554 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.4 p -126.84 98.64 5.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 60.61 13.66 4.4 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.557 1.143 . . . . 50.0 112.907 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 78.81 9.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 50.0 110.957 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.22 137.06 41.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.145 -0.687 . . . . 50.0 109.145 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.42 145.5 79.59 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 25.0 110.726 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.88 164.66 34.05 Favored 'Trans proline' 0 C--O 1.24 0.586 0 O-C-N 121.78 0.358 . . . . 50.0 111.926 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 50.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 50.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.98 162.99 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 50.0 111.109 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.96 173.92 12.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 O-C-N 122.027 0.488 . . . . 50.0 113.096 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.72 156.97 78.96 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.698 -0.852 . . . . 50.0 108.698 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.38 167.68 26.58 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.836 1.691 . . . . 75.0 112.913 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -117.23 72.11 0.82 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.684 -1.143 . . . . 50.0 110.099 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.53 176.3 47.98 Favored Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 120.756 -0.735 . . . . 50.0 111.426 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -137.7 156.95 47.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 124.312 2.006 . . . . 25.0 113.347 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 122.758 1.199 . . . . 25.0 115.869 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t 58.27 -161.89 0.23 Allowed 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.348 1.059 . . . . 25.0 109.869 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.9 ttp -136.46 65.79 1.51 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 59.84 -107.64 0.34 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.859 -1.064 . . . . 50.0 112.3 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -104.03 169.21 8.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 50.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 50.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 50.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 50.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 50.0 110.438 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 50.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 50.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 50.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.44 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 50.0 109.624 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 50.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 50.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 50.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 50.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 50.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 50.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 50.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 50.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 50.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 50.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 50.0 108.502 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 50.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 50.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 50.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 50.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 50.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 50.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 50.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 50.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 50.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 50.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 50.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 50.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 50.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 50.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 50.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 50.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 50.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 50.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 50.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 50.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 50.0 111.796 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 50.0 109.344 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt -94.43 72.88 3.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 50.0 111.106 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.03 -7.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.84 0.681 . . . . 50.0 112.84 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.89 -113.57 4.55 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.8 mmm -91.96 156.05 17.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 25.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -117.17 26.7 9.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.678 -0.692 . . . . 25.0 112.07 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.05 29.72 16.98 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.133 1.445 . . . . 25.0 109.874 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -154.71 152.3 29.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.69 151.04 73.55 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.696 -1.224 . . . . 50.0 107.696 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.15 156.24 62.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 115.853 -2.298 . . . . 50.0 112.508 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.4 36.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.497 -0.927 . . . . 25.0 108.497 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.8 -30.7 46.93 Favored Glycine 0 C--O 1.221 -0.676 0 N-CA-C 114.947 0.739 . . . . 25.0 114.947 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 m 51.22 30.8 6.11 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.387 1.625 . . . . 25.0 115.387 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.22 161.44 54.33 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 -0.12 71.06 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.233 -0.747 . . . . 25.0 111.233 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 p -82.76 153.56 25.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.92 -0.77 . . . . 25.0 108.92 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.38 170.29 12.67 Favored Glycine 0 C--O 1.227 -0.321 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.9 t -163.75 -58.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.44 0.62 . . . . 25.0 109.921 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.07 -166.82 32.94 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 108.691 -1.764 . . . . 25.0 108.691 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.95 144.11 56.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.979 -0.749 . . . . 50.0 108.979 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -133.36 144.87 49.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -131.17 125.11 32.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.986 -0.746 . . . . 50.0 108.986 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.29 110.73 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.71 141.73 40.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.238 0.542 . . . . 50.0 109.57 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.49 145.86 72.54 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.803 -0.635 . . . . 25.0 112.039 -175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.62 166.12 30.79 Favored 'Trans proline' 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 50.0 110.779 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 50.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 50.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.02 161.25 46.59 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 50.0 110.478 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.1 172.75 15.74 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.549 0.557 . . . . 50.0 113.549 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' CD1' ' HG ' ' A' ' 20' ' ' SER . 25.1 mt -133.99 155.46 80.15 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.837 -0.619 . . . . 75.0 111.294 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.0 172.25 15.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.14 1.893 . . . . 50.0 112.255 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -87.05 48.12 1.6 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.978 -0.555 . . . . 50.0 111.544 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.01 -132.58 11.17 Favored Glycine 0 C--O 1.233 0.085 0 C-N-CA 120.862 -0.685 . . . . 50.0 111.759 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -62.84 114.44 3.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.475 0.655 . . . . 50.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.172 1.789 . . . . 25.0 111.726 -177.254 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 123.266 1.481 . . . . 25.0 115.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 t -76.85 129.39 36.16 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.144 -1.21 . . . . 25.0 109.089 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -97.32 166.21 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.49 -0.559 . . . . 25.0 109.49 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -120.69 122.16 39.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.097 -1.816 . . . . 50.0 106.097 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 59.18 164.53 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 50.0 115.629 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 50.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 50.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 50.0 106.99 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 50.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 50.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 50.0 109.638 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 50.0 107.736 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 50.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 50.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 50.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 50.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 50.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 50.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 50.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 50.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 50.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 50.0 109.644 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 50.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 50.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 50.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 50.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 50.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 50.0 109.54 173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 50.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 50.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 50.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 50.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 50.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 50.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 50.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 50.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 50.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 50.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 50.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 50.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 50.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG13 ' HD2' ' A' ' 58' ' ' PRO . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 50.0 111.211 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 50.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 50.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 50.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 50.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 50.0 109.976 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 50.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt -103.47 101.12 11.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 50.0 107.502 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.49 151.92 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.632 -0.877 . . . . 50.0 108.632 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.04 155.53 27.6 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.497 -1.441 . . . . 25.0 109.497 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.457 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 9.2 ttp 59.7 -162.56 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.271 0.628 . . . . 25.0 111.661 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.457 ' H ' ' HG2' ' A' ' 68' ' ' MET . 29.6 m-85 55.66 -149.48 0.45 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.796 0.838 . . . . 25.0 111.444 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 40.25 37.98 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.952 2.575 . . . . 25.0 117.952 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -76.94 67.91 3.03 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.841 -0.537 . . . . 50.0 111.951 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -138.1 156.19 74.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.25 -1.389 . . . . 50.0 107.25 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.01 -11.08 18.01 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 114.728 1.011 . . . . 50.0 114.728 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.51 142.48 30.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.945 -0.391 . . . . 25.0 109.945 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.6 -156.96 16.44 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.331 -0.462 . . . . 25.0 112.464 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m 55.41 -92.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.948 1.462 . . . . 25.0 114.948 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.85 47.49 3.82 Favored Glycine 0 C--O 1.221 -0.663 0 N-CA-C 114.276 0.471 . . . . 25.0 114.276 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.01 79.31 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.0 t -153.3 142.25 21.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.47 7.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.035 -0.602 . . . . 25.0 114.511 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -143.08 8.11 1.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.78 -74.64 2.44 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 111.363 -0.695 . . . . 25.0 111.363 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 54.22 38.8 29.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.052 0.941 . . . . 50.0 111.55 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.1 t -152.08 167.25 29.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -123.52 120.64 33.49 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 104.886 -2.265 . . . . 50.0 104.886 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -138.77 103.06 4.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.618 -0.882 . . . . 50.0 108.618 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.43 130.72 44.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.738 -0.665 . . . . 50.0 109.276 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.42 147.73 95.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.313 -0.858 . . . . 25.0 112.564 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.31 160.56 49.11 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 118.139 -0.774 . . . . 50.0 110.872 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 50.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 50.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.42 162.6 39.97 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 50.0 109.926 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.79 173.19 14.37 Favored 'Trans proline' 0 C--N 1.346 0.441 0 N-CA-C 113.242 0.439 . . . . 50.0 113.242 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.9 155.69 80.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 50.0 110.101 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 171.89 17.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.605 1.536 . . . . 50.0 112.074 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -90.42 30.36 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.743 0.782 . . . . 50.0 110.397 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.82 10.67 69.28 Favored Glycine 0 CA--C 1.516 0.132 0 CA-C-N 115.905 -0.588 . . . . 50.0 112.495 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -77.08 178.62 6.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.777 0.799 . . . . 50.0 110.335 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.213 -0.844 0 CA-C-O 125.633 2.635 . . . . 25.0 111.996 177.2 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 123.392 1.551 . . . . 25.0 115.383 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 m -84.61 125.17 32.22 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 120.684 -1.48 . . . . 25.0 111.17 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.3 ptp -101.42 108.31 19.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -108.12 16.75 23.03 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.941 -1.133 . . . . 50.0 107.941 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -134.35 164.46 27.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.079 -0.964 . . . . 50.0 110.665 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 50.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 50.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 50.0 107.155 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 50.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 50.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 50.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 50.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 75.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 50.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 50.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 50.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 50.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 50.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 50.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 50.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 50.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 50.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 50.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 50.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 50.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 50.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 50.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 50.0 108.446 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 50.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 50.0 108.33 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 50.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 50.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 50.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 50.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 50.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 50.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 50.0 108.022 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 50.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 50.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 50.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 50.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 50.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 50.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 50.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 50.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 50.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 50.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 50.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 50.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 50.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 50.0 109.092 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.04 94.84 7.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 50.0 106.674 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.17 133.82 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.288 -1.004 . . . . 50.0 108.288 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.8 154.35 26.74 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 109.04 -1.624 . . . . 25.0 109.04 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.0 ttt 70.14 160.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.411 1.084 . . . . 25.0 110.886 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 59.75 -167.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.705 0.802 . . . . 25.0 113.039 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 t0 59.04 177.32 0.07 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.188 1.551 . . . . 25.0 115.188 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.47 113.45 26.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.066 -1.087 . . . . 50.0 108.066 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -60.59 145.14 87.96 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.134 -1.062 . . . . 50.0 108.134 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.16 150.84 66.38 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 117.785 -1.01 . . . . 50.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.9 139.3 20.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.924 -1.509 . . . . 25.0 106.924 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 159.77 26.36 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 111.112 -0.795 . . . . 25.0 111.112 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 m -106.6 1.67 25.43 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.254 0.465 . . . . 25.0 112.254 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.52 -178.77 42.49 Favored Glycine 0 C--O 1.231 -0.047 0 C-N-CA 121.058 -0.591 . . . . 25.0 113.429 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.1 -93.99 0.79 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.618 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.1 p -75.37 -16.51 60.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.7 -0.294 . . . . 25.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.52 36.14 3.58 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 111.792 -0.523 . . . . 25.0 111.792 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -69.0 153.68 43.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.64 152.25 51.42 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 109.674 -1.37 . . . . 25.0 109.674 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.93 150.93 51.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.864 -1.532 . . . . 50.0 106.864 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -109.74 -29.5 8.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -139.73 154.42 47.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.794 -1.558 . . . . 50.0 106.794 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -157.36 96.88 1.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.719 -1.215 . . . . 50.0 107.719 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.17 118.8 31.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.474 0.654 . . . . 50.0 110.08 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.92 142.15 76.05 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.452 -0.794 . . . . 25.0 111.996 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.74 164.99 32.5 Favored 'Trans proline' 0 C--O 1.241 0.651 0 O-C-N 121.597 0.262 . . . . 50.0 112.474 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 50.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 50.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.54 161.95 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 50.0 111.453 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.64 176.96 9.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 120.219 0.613 . . . . 50.0 113.462 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 mt -133.48 153.77 80.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 50.0 109.843 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.5 171.69 15.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.204 2.603 . . . . 50.0 113.773 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -91.57 41.78 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.563 -0.744 . . . . 50.0 111.854 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.15 -175.04 31.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 114.737 0.655 . . . . 50.0 114.737 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.21 124.59 24.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.735 0.778 . . . . 50.0 110.456 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 124.628 2.156 . . . . 25.0 113.068 179.076 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 115.47 0.948 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.11 16.36 4.75 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.137 1.532 . . . . 25.0 115.137 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -108.6 137.4 46.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.741 0.305 . . . . 25.0 110.289 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -146.08 144.29 29.92 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.092 -2.559 . . . . 50.0 104.092 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 56.02 176.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 50.0 113.99 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 50.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 50.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 50.0 107.66 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 50.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 50.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 50.0 110.258 175.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 50.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 50.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 50.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 50.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 50.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 50.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 50.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 50.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 50.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 50.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 50.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 50.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 50.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 50.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 50.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 50.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 50.0 108.962 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 50.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 50.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 50.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 50.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 50.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 50.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 50.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 50.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 50.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 50.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 50.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 50.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 50.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 50.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 50.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 50.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 50.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 50.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 50.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 50.0 112.251 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 50.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -96.85 92.8 6.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 50.0 107.839 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.94 5.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.104 0.779 . . . . 50.0 113.104 -176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.65 -12.61 27.41 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 114.732 0.653 . . . . 25.0 114.732 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.35 -5.33 57.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.186 0.81 . . . . 25.0 113.186 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -142.34 151.72 42.21 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.977 -0.452 . . . . 25.0 112.156 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.17 157.5 45.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 172.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -160.37 106.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.349 -0.611 . . . . 50.0 109.349 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.63 140.92 68.37 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.26 108.94 2.71 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.269 -0.687 . . . . 50.0 112.648 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.07 154.62 31.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.792 -1.188 . . . . 25.0 107.792 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.35 174.22 20.62 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 112.032 -0.427 . . . . 25.0 112.032 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 p -80.0 164.99 23.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.97 3.13 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 121.33 -0.462 . . . . 25.0 112.704 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.59 10.3 8.94 Favored Glycine 0 C--O 1.219 -0.839 0 CA-C-O 121.439 0.466 . . . . 25.0 112.939 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m -88.6 -9.47 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.07 0.548 . . . . 25.0 110.415 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.26 157.92 24.33 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.544 -1.022 . . . . 25.0 110.544 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -68.79 -26.58 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.227 0.513 . . . . 25.0 111.815 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.69 151.96 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.889 -2.485 . . . . 25.0 106.889 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.9 mt -153.36 -47.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.799 0.799 . . . . 50.0 110.609 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -136.99 165.97 24.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.611 -1.625 . . . . 25.0 106.611 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.26 156.39 44.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.502 0.501 . . . . 50.0 109.798 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -121.07 93.62 4.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.35 135.66 53.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.487 0.661 . . . . 50.0 109.272 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.82 149.13 87.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.472 -0.785 . . . . 25.0 112.749 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -69.56 164.97 32.32 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 121.761 0.348 . . . . 50.0 111.335 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 50.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 50.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.35 161.34 45.19 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 50.0 110.468 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.03 174.9 11.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 N-CA-C 113.328 0.472 . . . . 50.0 113.328 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -133.92 153.46 79.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 50.0 111.025 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.49 177.37 8.2 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.957 2.438 . . . . 50.0 111.293 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -91.3 27.02 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.427 0.632 . . . . 50.0 110.622 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.44 177.54 16.92 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 111.423 -0.671 . . . . 50.0 111.423 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.44 142.25 51.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.373 -0.973 . . . . 50.0 108.373 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 124.159 1.933 . . . . 25.0 113.057 -176.407 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 CA-C-O 123.243 1.468 . . . . 25.0 115.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 p -65.06 129.1 38.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.071 -1.252 . . . . 25.0 111.149 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ttt 52.54 52.76 13.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.007 0.817 . . . . 25.0 112.735 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -116.55 140.55 49.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.635 -0.876 . . . . 50.0 108.635 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 61.38 168.44 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 50.0 115.209 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 50.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 50.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 50.0 107.621 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 50.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 50.0 110.992 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 50.0 110.588 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 50.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 50.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 50.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 50.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 50.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 50.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 50.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 50.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 50.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 50.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 50.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HZ3' ' CD ' ' A' ' 86' ' ' GLU . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 50.0 107.707 170.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 50.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 50.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 50.0 108.303 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 50.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 50.0 108.392 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 50.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 50.0 109.292 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 50.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 50.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 50.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 50.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 50.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 50.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 50.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 50.0 107.942 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 50.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 50.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 50.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 50.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 50.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 50.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 50.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 50.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 50.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 50.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 50.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 50.0 110.727 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 50.0 108.55 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.31 75.25 3.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 50.0 109.492 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.31 -26.9 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.407 0.623 . . . . 50.0 110.142 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.66 -28.03 6.13 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.145 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.5 ttm -74.33 30.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.612 1.165 . . . . 25.0 113.479 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -140.26 127.18 20.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.851 -0.531 . . . . 25.0 109.977 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -71.45 -29.56 65.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 25.0 111.96 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -76.16 59.52 1.36 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.196 0.998 . . . . 50.0 112.002 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -78.15 147.25 72.7 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 106.788 -1.56 . . . . 50.0 106.788 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.21 -15.34 35.37 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 118.103 -0.798 . . . . 50.0 113.976 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.89 -24.33 67.7 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.21 -0.306 . . . . 25.0 111.194 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.28 -1.86 90.23 Favored Glycine 0 C--O 1.219 -0.785 0 C-N-CA 121.008 -0.615 . . . . 25.0 113.284 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 t -86.67 -11.54 50.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.251 0.525 . . . . 25.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.79 -155.07 52.72 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.195 -0.762 . . . . 25.0 111.195 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.64 148.9 20.28 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 106.141 -2.783 . . . . 25.0 106.141 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 t -158.62 170.58 21.86 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.22 151.54 8.44 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.66 -0.976 . . . . 25.0 110.66 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.04 29.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.863 0.84 . . . . 25.0 109.661 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.81 -176.93 39.34 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 106.782 -2.527 . . . . 25.0 106.782 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.77 -45.2 90.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.911 0.855 . . . . 50.0 110.871 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.17 171.23 0.15 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.101 0.96 . . . . 25.0 111.501 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -130.64 139.1 50.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.984 -0.746 . . . . 50.0 108.984 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 38.6 tt0 -150.16 91.39 1.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.874 -1.158 . . . . 50.0 107.874 176.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.346 0.593 . . . . 50.0 110.419 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.67 149.53 80.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.351 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.95 161.66 45.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 117.166 -1.422 . . . . 50.0 111.403 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 50.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 50.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.68 160.59 49.17 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 50.0 111.019 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.41 175.28 11.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 N-CA-C 113.672 0.605 . . . . 50.0 113.672 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.1 mt -133.88 155.47 80.24 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 50.0 110.724 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.03 168.36 23.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.272 1.981 . . . . 50.0 113.323 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.22 43.24 1.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.97 -1.014 . . . . 50.0 112.11 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.54 -159.3 14.97 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.274 -0.489 . . . . 50.0 113.324 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.479 ' C ' ' HXT' ' A' ' 99' ' ' VAL . 52.7 mt-10 -67.11 115.16 6.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.008 0.909 . . . . 50.0 110.093 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' HXT' ' C ' ' A' ' 98' ' ' GLU . 34.9 m . . . . . 0 CA--C 1.557 1.246 0 CA-C-O 124.57 2.128 . . . . 25.0 114.513 -176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 CA-C-O 124.58 2.211 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.95 150.45 48.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.975 -1.612 . . . . 25.0 110.171 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpt 52.96 38.62 27.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.026 0.75 . . . . 25.0 113.026 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -89.51 14.67 10.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.635 -0.666 . . . . 50.0 110.981 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.0 161.14 35.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.454 -0.943 . . . . 50.0 108.454 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 50.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 50.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 50.0 107.564 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 50.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 50.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 50.0 109.598 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 50.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 50.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 50.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.5 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 50.0 108.707 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 50.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 50.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 50.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 50.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 50.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 50.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 50.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 50.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 50.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 50.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 50.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 50.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 50.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 50.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 50.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 50.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 50.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 50.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 50.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 50.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 50.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 50.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 50.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 50.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 50.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 50.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 50.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 50.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 50.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 50.0 109.725 173.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 50.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.23 91.65 7.35 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 50.0 108.5 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.4 130.13 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.994 -0.743 . . . . 50.0 108.994 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 173.05 43.42 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.895 -0.669 . . . . 25.0 112.066 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 74.23 -44.4 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.253 1.421 . . . . 25.0 112.474 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.3 -179.32 7.05 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.269 0.628 . . . . 25.0 110.159 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 53.91 33.79 18.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.67 1.224 . . . . 25.0 112.708 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -73.4 99.75 3.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.929 -1.032 . . . . 50.0 110.088 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 74.26 158.08 0.16 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 125.715 1.606 . . . . 50.0 108.311 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.46 48.0 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 N-CA-C 115.188 1.188 . . . . 50.0 115.188 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 137.73 52.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.23 -49.14 3.94 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.201 -0.523 . . . . 25.0 113.546 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -75.08 -24.37 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.704 0.752 . . . . 25.0 111.578 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.74 -40.6 2.78 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 113.886 0.314 . . . . 25.0 113.886 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.62 -131.32 1.76 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.207 -1.157 . . . . 25.0 110.207 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.9 m -142.34 146.43 34.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.89 151.49 16.97 Favored Glycine 0 C--O 1.23 -0.126 0 C-N-CA 121.149 -0.548 . . . . 25.0 111.889 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 64.84 0.94 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.06 -0.719 . . . . 25.0 109.06 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.83 94.98 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 120.744 -0.741 . . . . 25.0 113.035 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 mt 52.3 35.9 18.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.366 0.876 . . . . 50.0 113.366 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.44 -60.67 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.812 0.339 . . . . 25.0 110.449 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.5 149.02 20.13 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.728 -2.323 . . . . 50.0 104.728 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.69 111.99 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.609 -0.515 . . . . 50.0 109.609 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.19 119.76 31.55 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.166 0.507 . . . . 50.0 110.452 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.19 145.63 86.03 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.089 -0.505 . . . . 25.0 109.994 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.73 160.98 40.21 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 118.662 -0.426 . . . . 50.0 112.67 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 50.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 50.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.14 161.52 45.53 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 50.0 109.612 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.91 174.79 11.35 Favored 'Trans proline' 0 C--N 1.35 0.632 0 N-CA-C 113.524 0.548 . . . . 50.0 113.524 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' A' ' 20' ' ' SER . 16.5 mt -133.96 156.69 79.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.613 -0.721 . . . . 50.0 109.267 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.04 -163.19 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.561 2.84 . . . . 50.0 113.37 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 75.98 -1.62 2.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.293 1.837 . . . . 50.0 113.669 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.72 85.17 0.07 OUTLIER Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.545 -1.207 . . . . 50.0 115.912 171.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.35 129.25 37.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.752 0.787 . . . . 50.0 109.587 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.213 -0.862 0 CA-C-O 124.478 2.085 . . . . 25.0 113.201 -179.334 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 CA-C-O 124.868 2.371 . . . . 25.0 113.246 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -77.34 166.49 23.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.725 -1.738 . . . . 25.0 109.98 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.2 tpp 58.06 48.46 13.09 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -65.63 134.64 53.7 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.232 -1.395 . . . . 50.0 107.232 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 63.26 161.22 0.09 Allowed 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 50.0 115.276 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 50.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 50.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 50.0 106.262 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 50.0 110.681 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 50.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 50.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 50.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 50.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 50.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 50.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 50.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 50.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 50.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 50.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 50.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 50.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 50.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 50.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 50.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 50.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 50.0 110.396 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 50.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 50.0 108.624 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 50.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 50.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 50.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 50.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.43 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 50.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 50.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 50.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 50.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 50.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 50.0 107.773 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 50.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 50.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 50.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 50.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 50.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 50.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 50.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 50.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 50.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 50.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 50.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 50.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 50.0 107.235 176.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.39 88.54 7.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 50.0 107.923 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.0 114.12 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.282 -0.872 . . . . 50.0 109.179 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.96 -175.31 46.77 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 110.07 -1.212 . . . . 25.0 110.07 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ptp 65.37 -6.22 0.4 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.765 1.765 . . . . 25.0 115.765 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -105.32 -4.91 20.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.365 0.602 . . . . 25.0 109.873 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.85 154.86 25.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.49 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -144.08 -33.35 0.41 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.337 1.236 . . . . 50.0 114.337 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.73 145.79 32.71 Favored Pre-proline 0 C--O 1.22 -0.494 0 N-CA-C 107.508 -1.293 . . . . 50.0 107.508 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 7.51 3.94 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 113.941 0.708 . . . . 50.0 113.941 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.14 132.47 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.053 -0.351 . . . . 25.0 110.053 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.13 164.83 37.2 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 121.036 -0.602 . . . . 25.0 112.191 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -70.2 -24.79 63.17 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.919 0.711 . . . . 25.0 112.919 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.04 -171.27 50.43 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.894 -0.669 . . . . 25.0 112.974 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.49 146.25 5.61 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 109.493 -1.443 . . . . 25.0 109.493 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -73.61 -42.68 61.18 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.3 3.92 27.36 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.958 1.143 . . . . 25.0 115.958 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -84.95 3.96 35.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.89 1.441 . . . . 25.0 114.89 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.18 23.29 71.69 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.892 -0.671 . . . . 25.0 113.657 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.7 124.03 19.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.583 -0.525 . . . . 50.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.32 11.13 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.212 1.19 . . . . 25.0 114.212 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.88 -178.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 50.0 111.568 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -152.87 99.92 2.47 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.362 -0.836 . . . . 50.0 111.591 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.58 142.82 44.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.287 0.565 . . . . 50.0 110.517 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.61 148.21 41.36 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 113.528 0.936 . . . . 25.0 113.528 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.59 167.12 27.84 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.175 1.25 . . . . 50.0 112.214 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 50.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 50.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.95 162.27 42.81 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 50.0 111.332 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.23 174.59 12.54 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 120.341 0.694 . . . . 50.0 113.66 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -134.01 155.84 79.77 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 123.07 0.548 . . . . 50.0 111.081 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.66 177.15 8.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.1 2.534 . . . . 50.0 112.043 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.08 32.89 3.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 50.0 111.798 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.55 171.08 44.26 Favored Glycine 0 C--O 1.229 -0.218 0 C-N-CA 120.511 -0.852 . . . . 50.0 113.798 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -75.82 106.81 7.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.454 0.645 . . . . 50.0 109.346 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.213 -0.866 0 CA-C-O 123.404 1.573 . . . . 25.0 112.042 -178.571 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 CA-C-O 122.775 1.208 . . . . 25.0 115.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -135.77 162.05 33.86 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.492 -1.005 . . . . 25.0 108.667 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.2 ttt -172.27 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.549 0.69 . . . . 25.0 110.25 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.84 136.22 34.7 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 102.541 -3.133 . . . . 50.0 102.541 173.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 62.54 161.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.428 1.705 . . . . 50.0 112.578 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 50.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 50.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 50.0 107.31 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 50.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 50.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 50.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 50.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 50.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 50.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 50.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 50.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 50.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 50.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 50.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 50.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 50.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 50.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 50.0 109.045 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 50.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 50.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 50.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 50.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 50.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 50.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 50.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 50.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 50.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 50.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 50.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 50.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 50.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 50.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 50.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 50.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 50.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 50.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 50.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 50.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 50.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 50.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 50.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 50.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 50.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 50.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 50.0 111.422 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 50.0 108.74 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.44 94.55 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 50.0 108.762 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -81.37 4.88 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.424 -0.807 . . . . 50.0 112.283 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.8 -40.8 2.81 Favored Glycine 0 N--CA 1.46 0.296 0 CA-C-O 121.585 0.547 . . . . 25.0 112.133 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.3 164.49 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 62.93 -166.91 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.035 0.934 . . . . 25.0 111.596 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 59.39 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -73.97 90.83 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 50.0 114.254 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -138.27 153.8 73.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 104.88 -2.267 . . . . 50.0 104.88 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.9 -23.04 22.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 116.899 -1.601 . . . . 50.0 113.01 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.53 156.89 34.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.433 -2.062 . . . . 25.0 105.433 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.87 -26.87 43.67 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.552 -0.832 . . . . 25.0 111.952 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 t 65.36 175.68 0.21 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.446 1.099 . . . . 25.0 110.332 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.8 31.62 78.86 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 121.092 -0.575 . . . . 25.0 113.126 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.69 -155.21 11.51 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.803 -1.319 . . . . 25.0 109.803 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.9 m 59.47 31.61 21.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.466 0.706 . . . . 25.0 112.063 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.4 -127.14 2.87 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 108.421 -1.871 . . . . 25.0 108.421 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 m -143.61 160.44 40.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.23 -1.026 . . . . 25.0 108.23 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.68 168.71 38.39 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 107.813 -2.115 . . . . 25.0 107.813 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.91 -23.48 16.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.548 0.674 . . . . 50.0 111.844 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.0 p -88.5 125.26 34.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -79.98 154.95 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.043 -0.725 . . . . 50.0 109.043 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 28' ' ' LYS . 7.9 pt-20 -84.25 67.64 9.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.2 1.0 . . . . 50.0 109.144 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.88 138.53 58.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.604 -1.18 . . . . 50.0 111.182 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.16 150.51 68.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.265 1.209 . . . . 25.0 114.265 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.65 166.61 28.91 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 120.24 0.626 . . . . 50.0 111.874 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 50.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 50.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.99 164.22 22.84 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 50.0 110.617 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.76 171.83 15.68 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 117.37 -1.287 . . . . 50.0 111.72 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -133.98 156.51 79.18 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.645 -0.707 . . . . 50.0 110.813 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.04 -175.22 2.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.434 2.09 . . . . 50.0 112.686 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 66.37 8.91 6.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.394 1.478 . . . . 50.0 113.353 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.58 161.73 27.5 Favored Glycine 0 C--N 1.32 -0.327 0 N-CA-C 107.957 -2.057 . . . . 50.0 107.957 169.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -68.75 136.13 52.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.774 1.273 . . . . 50.0 111.045 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.217 -0.62 0 CA-C-O 125.209 2.433 . . . . 25.0 110.519 -178.358 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 123.363 1.535 . . . . 25.0 115.656 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -90.0 146.28 24.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.037 -1.272 . . . . 25.0 109.227 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -77.12 88.45 3.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 25.0 110.311 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.71 140.07 53.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 105.405 -2.072 . . . . 50.0 105.405 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 60.63 165.63 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 50.0 116.134 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 50.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 50.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 50.0 107.389 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 50.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 50.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 75.0 110.055 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 50.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 50.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 75.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 50.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 50.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 50.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 50.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 50.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 50.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 50.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 50.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 50.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 50.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 50.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 50.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 50.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 50.0 108.722 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 50.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 50.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 50.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 50.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 50.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 50.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 50.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 50.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 50.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 50.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 50.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 50.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 50.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 50.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 50.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 50.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG11 ' HD2' ' A' ' 58' ' ' PRO . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' HG11 ' A' ' 57' ' ' VAL . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 50.0 111.105 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 50.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 50.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 50.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 50.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 50.0 110.242 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -94.71 89.75 5.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.23 -35.36 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.209 -0.905 . . . . 50.0 111.383 -174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.9 2.39 70.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.047 -0.597 . . . . 25.0 114.03 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -97.53 -48.18 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.409 -0.589 . . . . 25.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -72.97 -38.85 66.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.617 0.722 . . . . 25.0 109.217 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -83.95 112.03 19.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -66.77 -13.74 61.79 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.686 1.365 . . . . 50.0 114.686 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -161.1 156.21 20.61 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.849 -0.797 . . . . 50.0 108.849 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.53 163.88 37.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.092 -1.472 . . . . 50.0 111.142 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.81 74.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.742 0.645 . . . . 25.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.07 75.98 Favored Glycine 0 C--O 1.221 -0.657 0 N-CA-C 115.641 1.016 . . . . 25.0 115.641 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.2 p -114.67 -94.96 0.47 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.699 0.75 . . . . 25.0 112.451 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.29 -171.92 37.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.751 -1.34 . . . . 25.0 109.751 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.86 -172.51 51.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.11 -0.567 . . . . 25.0 111.851 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -150.63 165.89 31.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.56 32.49 Favored Glycine 0 C--O 1.224 -0.481 0 CA-C-O 121.377 0.432 . . . . 25.0 112.559 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.7 m -145.73 163.73 34.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.856 -1.905 . . . . 25.0 105.856 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.82 41.95 2.38 Favored Glycine 0 N--CA 1.461 0.352 0 C-N-CA 121.03 -0.605 . . . . 25.0 112.176 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.59 175.31 0.07 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.026 1.491 . . . . 50.0 115.026 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 p -133.86 174.88 9.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.653 -1.61 . . . . 25.0 106.653 -175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 61.74 15.42 6.97 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.687 1.736 . . . . 50.0 115.687 170.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -84.96 89.47 7.6 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.11 -1.441 . . . . 50.0 107.11 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.68 144.71 50.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.939 -1.028 . . . . 50.0 112.198 -171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.35 144.8 50.61 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 113.652 0.982 . . . . 25.0 113.652 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.5 167.7 25.12 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 120.248 0.632 . . . . 50.0 111.507 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 50.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 50.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.32 159.97 51.02 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 50.0 111.134 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.37 177.55 7.77 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 120.241 0.627 . . . . 50.0 112.857 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.94 156.3 79.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.574 -1.269 . . . . 50.0 107.574 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.2 -170.97 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.352 2.035 . . . . 50.0 114.076 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 76.91 -5.16 2.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.73 2.012 . . . . 50.0 112.973 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.86 140.65 6.35 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 107.868 -2.093 . . . . 50.0 107.868 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.16 147.79 24.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.191 -1.781 . . . . 50.0 106.191 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.215 -0.762 0 CA-C-O 124.255 1.979 . . . . 25.0 112.609 -178.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 CA-C-O 125.135 2.52 . . . . 25.0 112.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 t -71.19 -29.59 65.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 112.327 -1.937 . . . . 25.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtt 55.79 47.87 19.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.755 0.822 . . . . 25.0 112.066 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -113.57 24.2 12.4 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.709 0.766 . . . . 50.0 109.269 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -135.29 165.58 25.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.8 -1.091 . . . . 50.0 110.669 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 50.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 50.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 50.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 50.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 50.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 75.0 110.504 175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 50.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 50.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 50.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 50.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 50.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 50.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 50.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 50.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 50.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 50.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 50.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 50.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 50.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 50.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 50.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 50.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 50.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 50.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 50.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 50.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 50.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 50.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 50.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 50.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 50.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 50.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 50.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 50.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 50.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 50.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 50.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 50.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.407 HG13 ' HD2' ' A' ' 58' ' ' PRO . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 50.0 111.851 176.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 50.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 50.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 50.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 50.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 50.0 109.793 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 50.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -89.3 70.7 8.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 50.0 111.52 -177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.38 -24.16 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.897 -1.52 . . . . 50.0 106.897 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.82 -81.23 1.11 Allowed Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 114.975 -1.012 . . . . 25.0 111.43 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.86 163.0 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -159.6 45.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 57.48 6.39 0.4 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 117.888 2.551 . . . . 25.0 117.888 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -69.43 111.72 5.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.352 -0.842 . . . . 50.0 110.175 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -63.13 149.42 90.94 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.144 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.94 152.98 63.7 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 118.256 -0.696 . . . . 50.0 112.851 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -114.75 -9.3 12.56 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.661 0.615 . . . . 25.0 112.661 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.6 10.8 71.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 115.351 0.9 . . . . 25.0 115.351 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 t -77.23 67.2 3.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.83 -40.81 2.1 Favored Glycine 0 C--O 1.218 -0.846 0 N-CA-C 116.874 1.51 . . . . 25.0 116.874 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.25 0.84 79.7 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 117.466 0.633 . . . . 25.0 113.48 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m 57.25 36.83 27.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.75 153.48 23.75 Favored Glycine 0 C--O 1.23 -0.1 0 N-CA-C 109.105 -1.598 . . . . 25.0 109.105 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -152.93 -28.32 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.754 1.39 . . . . 25.0 114.754 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.02 24.48 77.08 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.874 -0.679 . . . . 25.0 114.151 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.56 115.83 21.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.892 -0.781 . . . . 50.0 108.892 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 p 46.62 70.81 0.35 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.262 0.977 . . . . 25.0 113.273 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t0 69.01 175.27 0.28 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.921 -1.49 . . . . 50.0 111.458 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.43 63.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.006 -1.109 . . . . 50.0 108.006 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.96 133.98 55.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.55 -1.204 . . . . 50.0 109.895 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.21 149.67 69.81 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 113.61 0.967 . . . . 25.0 113.61 -172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -69.78 165.57 30.55 Favored 'Trans proline' 0 C--N 1.35 0.619 0 O-C-N 121.831 0.385 . . . . 50.0 111.176 174.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 50.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 50.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.96 162.7 38.68 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 50.0 110.308 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.16 171.98 16.49 Favored 'Trans proline' 0 C--N 1.346 0.443 0 N-CA-C 113.52 0.546 . . . . 50.0 113.52 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.93 158.42 75.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 50.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -78.36 -160.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.565 2.843 . . . . 50.0 109.973 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 66.94 20.7 10.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.45 1.1 . . . . 50.0 111.449 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.91 156.21 26.64 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 108.073 -2.011 . . . . 50.0 108.073 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -80.07 135.45 36.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.666 0.746 . . . . 50.0 110.617 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 125.474 2.559 . . . . 25.0 110.978 179.332 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.012 0 CA-C-O 124.941 2.412 . . . . 25.0 113.409 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -84.78 -21.04 30.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 112.825 -1.687 . . . . 25.0 109.695 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.8 ttt -86.92 148.95 25.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.412 -0.958 . . . . 25.0 108.412 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -77.55 122.97 25.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 103.313 -2.847 . . . . 50.0 103.313 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 61.25 165.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 50.0 115.186 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 50.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 50.0 106.632 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 50.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 50.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 75.0 109.437 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 50.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 50.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 50.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 50.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 50.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 50.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 50.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 50.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 50.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 50.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 50.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 50.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 50.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 50.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 50.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 50.0 109.202 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 50.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 50.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 50.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 50.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 50.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 50.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 50.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 50.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 50.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 50.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 50.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 50.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 50.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 50.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 50.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 50.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 50.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 50.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 50.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 50.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 50.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 50.0 111.573 176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 50.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -91.48 79.21 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 50.0 109.966 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -67.59 129.92 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.492 -1.67 . . . . 50.0 106.492 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.32 41.29 1.12 Allowed Glycine 0 C--O 1.221 -0.667 0 CA-C-O 121.621 0.567 . . . . 25.0 114.391 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -153.33 -37.58 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.947 0.899 . . . . 25.0 108.726 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -114.67 -0.24 13.67 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 116.673 2.101 . . . . 25.0 116.673 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.36 -47.97 83.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.41 1.005 . . . . 25.0 111.491 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -166.91 -58.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.82 -0.627 . . . . 50.0 111.447 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -151.64 157.4 34.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 106.212 -1.773 . . . . 50.0 106.212 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.61 -7.06 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 117.929 -0.914 . . . . 50.0 112.898 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.05 110.2 20.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.691 0.281 . . . . 25.0 110.304 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.0 162.85 11.49 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 p -116.3 -45.11 2.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.217 0.508 . . . . 25.0 112.055 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.2 93.56 0.55 Allowed Glycine 0 C--O 1.224 -0.478 0 C-N-CA 121.0 -0.619 . . . . 25.0 112.229 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.34 -164.76 31.13 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.943 -0.646 . . . . 25.0 113.016 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.0 p -92.33 -178.92 5.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.95 -1.13 . . . . 25.0 107.95 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.24 171.33 38.95 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.456 -1.857 . . . . 25.0 108.456 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.3 t -79.06 147.72 32.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.652 0.726 . . . . 25.0 109.33 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.27 156.22 23.33 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.6 mt -126.05 -7.19 6.59 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.421 0.611 . . . . 50.0 111.1 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.8 p -142.6 161.25 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -80.62 153.6 27.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.601 -0.888 . . . . 50.0 108.601 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.65 118.37 8.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.912 -1.514 . . . . 50.0 106.912 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.4 mt -79.17 131.63 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.252 0.549 . . . . 50.0 111.225 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.62 146.07 56.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.706 -0.679 . . . . 25.0 111.825 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.89 166.04 31.1 Favored 'Trans proline' 0 C--O 1.243 0.741 0 O-C-N 121.736 0.335 . . . . 50.0 111.408 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 50.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 50.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.45 162.95 38.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 50.0 110.197 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.73 170.11 20.79 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 118.245 -0.703 . . . . 50.0 113.366 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -133.95 159.14 73.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.235 -0.893 . . . . 50.0 110.665 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.82 177.31 8.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 109.783 -0.891 . . . . 50.0 109.783 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 63.62 5.99 2.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.624 1.342 . . . . 50.0 114.624 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.7 -8.18 60.97 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.878 -1.056 . . . . 50.0 111.427 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.422 ' C ' ' HXT' ' A' ' 99' ' ' VAL . 66.4 mt-10 27.66 58.14 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.906 1.817 . . . . 50.0 115.906 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.422 ' HXT' ' C ' ' A' ' 98' ' ' GLU . 7.8 p . . . . . 0 CA--C 1.563 1.48 0 CA-C-O 125.945 2.783 . . . . 25.0 113.389 -176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.844 0 CA-C-O 124.562 2.201 . . . . 25.0 112.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t 58.05 14.41 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 111.161 -2.519 . . . . 25.0 114.122 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.9 ttt -81.66 64.24 6.28 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.66 133.3 35.69 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.57 -1.27 . . . . 50.0 107.57 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 63.57 163.81 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 50.0 116.22 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 50.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 50.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 50.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 50.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 50.0 109.711 176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 50.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 50.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 50.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 50.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 50.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 50.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 50.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 50.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 50.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 50.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 50.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 50.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 50.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 50.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 50.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 50.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 50.0 108.633 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 50.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 50.0 109.173 172.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 50.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 50.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 50.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 50.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 50.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 50.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 50.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 75.0 106.95 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 50.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 50.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 50.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 50.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 50.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 50.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 58' ' ' PRO . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 57' ' ' VAL . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 50.0 111.264 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 50.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 50.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 50.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 50.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 50.0 109.298 172.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 50.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt -93.87 84.57 4.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 50.0 107.175 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -68.49 -36.74 76.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.656 -0.702 . . . . 50.0 110.321 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -40.27 2.81 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 116.435 -0.348 . . . . 25.0 112.612 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mtp -69.78 -24.97 63.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.977 0.418 . . . . 25.0 111.112 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -159.11 164.97 34.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -142.28 164.43 30.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.298 -1.371 . . . . 25.0 107.298 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -113.97 25.69 10.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.394 0.516 . . . . 50.0 112.394 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -136.41 147.87 61.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 105.04 -2.207 . . . . 50.0 105.04 173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.06 -10.99 19.65 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 N-CA-C 114.242 0.824 . . . . 50.0 114.242 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.15 -157.67 11.58 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.288 -1.925 . . . . 25.0 108.288 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 p -74.26 146.98 42.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.28 -48.5 0.39 Allowed Glycine 0 C--O 1.222 -0.624 0 N-CA-C 109.685 -1.366 . . . . 25.0 109.685 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.74 -176.84 49.39 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 108.436 -1.865 . . . . 25.0 108.436 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m -60.13 140.49 56.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.891 0.346 . . . . 25.0 110.637 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.91 15.28 59.69 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.416 -0.421 . . . . 25.0 112.275 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -85.61 150.78 24.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.805 0.442 . . . . 25.0 109.894 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.38 -164.19 23.49 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 108.72 -1.752 . . . . 25.0 108.72 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.12 148.21 52.13 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.349 -1.722 . . . . 50.0 106.349 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 149.87 38.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -99.37 109.67 22.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.347 -0.612 . . . . 50.0 109.347 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -144.01 98.71 3.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.407 -1.331 . . . . 50.0 107.407 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.3 140.95 58.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.409 -0.589 . . . . 50.0 109.409 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.55 148.67 42.59 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 114.085 1.142 . . . . 25.0 114.085 -172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.71 165.84 31.27 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 121.751 0.342 . . . . 50.0 112.128 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 50.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 50.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.59 160.49 49.57 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 50.0 109.477 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.54 175.77 10.21 Favored 'Trans proline' 0 C--N 1.347 0.449 0 N-CA-C 113.222 0.432 . . . . 50.0 113.222 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -132.8 153.61 81.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.2 179.32 6.28 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.826 2.351 . . . . 50.0 112.339 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -88.55 11.25 17.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.668 0.747 . . . . 50.0 111.021 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.09 176.81 25.51 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.285 -0.871 . . . . 50.0 112.59 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -137.83 165.43 26.48 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.61 -0.885 . . . . 50.0 108.61 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.213 -0.857 0 CA-C-O 124.233 1.968 . . . . 25.0 112.667 176.648 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.888 0 CA-C-O 125.245 2.581 . . . . 25.0 113.23 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -88.04 57.13 4.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 112.626 -1.787 . . . . 25.0 111.629 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.574 0.702 . . . . 25.0 109.598 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -105.81 7.07 32.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.656 -0.702 . . . . 50.0 109.144 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.94 171.51 14.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.936 -1.029 . . . . 50.0 111.061 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 50.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 50.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 50.0 108.472 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 50.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 50.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 50.0 109.426 176.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 50.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 50.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 50.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 50.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 50.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 50.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 50.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 50.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 50.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 50.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 50.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 50.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 50.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 50.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 50.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 50.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 50.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 50.0 108.192 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 50.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 50.0 109.492 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 50.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 50.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 50.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 50.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 50.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 50.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 50.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 50.0 107.94 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 50.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 50.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 50.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 50.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 50.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 50.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 50.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 50.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 50.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 50.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 50.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 50.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 50.0 111.433 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 50.0 107.074 175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.4 17.52 12.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 50.0 111.831 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t 68.05 -44.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.653 1.581 . . . . 50.0 115.015 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.53 -129.04 6.1 Favored Glycine 0 C--O 1.219 -0.787 0 N-CA-C 111.308 -0.717 . . . . 25.0 111.308 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 ptm -75.13 3.12 9.18 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -94.64 117.44 30.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.19 0.441 . . . . 25.0 112.19 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.39 169.7 17.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -136.11 -27.03 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.391 0.515 . . . . 50.0 112.391 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -158.61 144.92 12.59 Favored Pre-proline 0 N--CA 1.472 0.675 0 N-CA-C 109.099 -0.704 . . . . 50.0 109.099 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.34 8.55 4.1 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 120.91 1.073 . . . . 50.0 114.146 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.99 35.24 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.209 -0.663 . . . . 25.0 109.209 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.53 -171.37 39.37 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 115.908 -0.587 . . . . 25.0 111.681 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -147.08 158.62 43.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.73 -3.74 86.78 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 121.171 -0.537 . . . . 25.0 114.182 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 51.5 4.31 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 114.302 0.481 . . . . 25.0 114.302 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -79.46 152.94 29.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.94 -152.54 27.24 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.8 m -148.74 158.59 44.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.85 -178.86 39.14 Favored Glycine 0 C--O 1.229 -0.182 0 N-CA-C 110.292 -1.123 . . . . 25.0 110.292 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.63 163.7 16.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.771 -0.826 . . . . 50.0 108.771 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -72.8 -28.06 62.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.57 90.31 3.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.588 -1.187 . . . . 50.0 110.835 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -133.89 111.13 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.039 -1.097 . . . . 50.0 108.039 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.8 126.32 33.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 50.0 110.208 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 144.5 78.9 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 25.0 110.26 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.14 165.04 32.9 Favored 'Trans proline' 0 C--O 1.241 0.671 0 CA-C-N 117.917 0.292 . . . . 50.0 112.31 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 50.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 50.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.28 161.19 46.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 50.0 110.623 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.74 173.38 14.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 N-CA-C 113.693 0.613 . . . . 50.0 113.693 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 mt -133.84 155.86 79.91 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.994 -0.548 . . . . 50.0 111.787 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -79.76 171.4 15.63 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.182 2.588 . . . . 50.0 114.091 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.94 30.78 0.73 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.479 0.918 . . . . 50.0 113.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.14 158.96 17.5 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 117.455 1.742 . . . . 50.0 117.455 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -96.84 46.71 1.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 122.226 1.012 . . . . 50.0 109.836 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 124.495 2.093 . . . . 25.0 113.397 -176.322 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.118 0 CA-C-O 123.486 1.603 . . . . 25.0 113.334 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 t 75.05 147.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 111.061 -2.57 . . . . 25.0 111.713 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.7 mmt -120.23 24.41 10.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.935 -1.505 . . . . 25.0 106.935 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -146.32 150.06 35.02 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.392 -1.336 . . . . 50.0 107.392 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 62.89 166.24 0.12 Allowed 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 50.0 117.773 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 50.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 50.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 50.0 107.709 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 50.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 50.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 50.0 109.446 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 50.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 75.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 50.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 50.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 50.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 50.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 50.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 50.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 50.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 50.0 112.944 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 50.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 50.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 50.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 50.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 50.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 50.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 50.0 108.244 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 50.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 50.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 50.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 50.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 50.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 50.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 50.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 50.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 50.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 50.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 50.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 50.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 50.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 50.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 50.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 50.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 HG11 ' HD2' ' A' ' 58' ' ' PRO . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' HG11 ' A' ' 57' ' ' VAL . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 50.0 111.164 175.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 50.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 50.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 50.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 50.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 50.0 110.635 171.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 50.0 108.679 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.1 98.55 10.14 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 50.0 108.245 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.65 -31.24 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.33 -0.85 . . . . 50.0 110.784 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 166.33 41.93 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 6.5 tmm? 69.36 -54.26 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.254 1.422 . . . . 25.0 111.082 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -74.93 170.3 16.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 170.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 56.4 34.08 23.57 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.825 0.821 . . . . 25.0 112.158 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -65.42 -23.35 66.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.299 0.571 . . . . 50.0 110.728 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -89.92 146.7 35.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.069 -1.456 . . . . 50.0 107.069 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.01 153.57 63.11 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 116.766 -1.689 . . . . 50.0 110.969 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.54 141.99 33.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 -171.76 54.2 Favored Glycine 0 C--O 1.23 -0.132 0 N-CA-C 111.741 -0.544 . . . . 25.0 111.741 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.9 p -138.25 112.18 8.43 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.61 -12.73 60.43 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.247 -0.501 . . . . 25.0 113.693 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 -168.43 37.54 Favored Glycine 0 C--O 1.219 -0.781 0 N-CA-C 110.347 -1.101 . . . . 25.0 110.347 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.9 p -89.05 -4.96 58.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.32 -168.37 54.42 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.446 -0.883 . . . . 25.0 111.611 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -126.99 22.14 6.74 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.337 0.589 . . . . 25.0 110.796 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.13 174.36 41.02 Favored Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 103.489 -3.844 . . . . 25.0 103.489 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt 52.14 51.95 15.33 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.695 1.248 . . . . 50.0 109.608 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -66.26 123.3 19.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -140.96 -178.16 5.43 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.425 -0.583 . . . . 50.0 109.425 -174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 68.89 82.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.637 1.575 . . . . 50.0 110.274 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -66.63 147.28 53.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.012 -1.449 . . . . 50.0 111.771 -175.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.94 53.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.82 166.71 29.04 Favored 'Trans proline' 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 50.0 110.928 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 50.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 50.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 163.26 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 50.0 110.384 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.26 174.72 11.61 Favored 'Trans proline' 0 C--N 1.347 0.451 0 CA-C-O 121.255 0.44 . . . . 50.0 113.214 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.7 mt -133.99 159.61 71.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.475 -0.784 . . . . 50.0 109.198 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 97' ' ' GLY . 85.7 Cg_endo -71.79 -176.78 2.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 120.822 1.014 . . . . 50.0 111.36 175.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 72.23 -11.3 0.81 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.594 1.558 . . . . 50.0 114.251 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -105.63 6.43 41.43 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 113.195 -1.82 . . . . 50.0 109.982 172.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.89 134.2 44.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.056 0.932 . . . . 50.0 110.191 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 125.114 2.388 . . . . 25.0 111.182 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 CA-C-O 124.392 2.107 . . . . 25.0 114.015 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -62.2 119.57 9.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.036 -1.582 . . . . 25.0 110.796 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.71 -8.04 38.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.944 0.402 . . . . 25.0 111.788 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -146.01 129.41 16.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.599 -2.741 . . . . 50.0 103.599 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 56.48 179.81 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 O-C-N 124.268 0.98 . . . . 50.0 113.422 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 50.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 50.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 50.0 108.053 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 50.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 50.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 50.0 109.933 176.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 50.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 50.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 50.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 50.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 50.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 50.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 50.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 50.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 50.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 50.0 107.71 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 50.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 50.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 50.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 50.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 50.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 50.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 50.0 108.322 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 50.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 50.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 50.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 50.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 50.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 50.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 50.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 50.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 50.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 50.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 50.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 50.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 50.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 50.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 50.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 50.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 50.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 50.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 50.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 50.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 50.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 75.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 50.0 109.975 174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 50.0 107.442 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.54 81.31 3.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 50.0 109.263 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.09 105.67 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 50.0 109.401 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.22 2.58 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 114.972 0.749 . . . . 25.0 114.972 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.9 ttm -80.29 -22.07 41.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.503 0.668 . . . . 25.0 109.307 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -128.25 145.85 50.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.289 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.583 ' CG ' ' H ' ' A' ' 71' ' ' LYS . 23.1 t0 -103.5 -163.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.583 ' H ' ' CG ' ' A' ' 70' ' ' ASP . 69.3 tttt 57.31 38.93 28.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.297 1.046 . . . . 50.0 110.357 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -60.71 144.13 89.9 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 50.0 106.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.5 -18.48 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 114.957 1.099 . . . . 50.0 114.957 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 54.72 -149.48 0.44 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.076 0.55 . . . . 25.0 111.571 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.54 174.33 45.45 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.708 -2.557 . . . . 25.0 106.708 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 t -156.46 174.71 15.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.64 -39.62 2.01 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 113.941 0.336 . . . . 25.0 113.941 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.08 179.42 45.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.403 -0.904 . . . . 25.0 112.365 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.7 p -128.43 59.6 1.52 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.778 0.431 . . . . 25.0 111.179 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.97 9.41 32.37 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 121.009 -0.615 . . . . 25.0 114.304 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -80.67 150.87 29.22 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.389 -1.708 . . . . 25.0 106.389 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.31 134.93 8.71 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.92 -0.872 . . . . 25.0 110.92 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -150.98 167.56 27.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.798 -1.556 . . . . 50.0 106.798 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.09 28.06 14.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.098 1.147 . . . . 25.0 114.098 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -151.57 170.29 20.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.288 -1.745 . . . . 50.0 106.288 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 55.12 63.78 2.0 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.481 1.134 . . . . 50.0 112.08 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.17 137.17 58.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.753 -1.112 . . . . 50.0 111.21 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 149.55 65.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.28 -0.873 . . . . 25.0 113.151 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.87 163.95 36.94 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 120.608 0.872 . . . . 50.0 112.665 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 50.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 50.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.41 159.5 52.71 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 50.0 110.486 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.96 161.48 13.04 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 N-CA-C 115.434 1.282 . . . . 50.0 115.434 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.79 156.39 79.45 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 113.103 -1.862 . . . . 50.0 110.536 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.94 -167.06 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.479 2.786 . . . . 50.0 110.945 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 64.89 14.33 9.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.159 . . . . 50.0 112.067 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -144.88 152.14 24.2 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 106.337 -2.705 . . . . 50.0 106.337 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.77 83.2 7.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.19 0.995 . . . . 50.0 110.192 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.213 -0.854 0 CA-C-O 125.313 2.482 . . . . 25.0 110.865 -179.485 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 115.469 0.947 . . . . 25.0 115.469 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m 60.7 -168.63 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.809 1.244 . . . . 25.0 110.906 -177.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -135.35 89.98 2.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.685 0.755 . . . . 25.0 110.131 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -134.87 132.45 38.57 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.787 -1.931 . . . . 50.0 105.787 177.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 58.17 167.37 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 50.0 115.464 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 50.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 50.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 50.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 50.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 50.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 50.0 109.057 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 50.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 50.0 108.063 173.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 50.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 50.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 50.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 50.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 50.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 50.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 50.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 50.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 50.0 110.8 177.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 50.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 50.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 50.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 50.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 50.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 50.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 172.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 50.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 50.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 50.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 50.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 50.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 50.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 50.0 107.02 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 50.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 50.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 50.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 50.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 50.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 50.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG11 ' HD2' ' A' ' 58' ' ' PRO . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 50.0 112.115 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 50.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 50.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 50.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 50.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 70' ' ' ASP . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 50.0 108.803 173.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 50.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.85 65.42 5.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 50.0 110.858 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -9.11 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.379 0.609 . . . . 50.0 110.733 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.66 176.61 46.68 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 106.876 -2.489 . . . . 25.0 106.876 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.0 tpt -80.56 78.55 7.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.767 0.784 . . . . 25.0 109.572 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -135.1 148.19 49.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -140.64 152.74 45.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 177.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 10.81 71.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.218 1.932 . . . . 50.0 116.218 -178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.01 149.63 85.58 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 107.565 -1.272 . . . . 50.0 107.565 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.46 139.96 55.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 116.63 -1.78 . . . . 50.0 114.666 -172.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.32 -50.58 0.05 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.438 -1.256 . . . . 25.0 108.286 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.3 -10.76 84.43 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 114.752 0.661 . . . . 25.0 114.752 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m 55.41 19.54 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.051 1.871 . . . . 25.0 116.051 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.38 179.49 43.13 Favored Glycine 0 CA--C 1.508 -0.353 0 N-CA-C 107.685 -2.166 . . . . 25.0 107.685 178.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.84 39.47 96.59 Favored Glycine 0 C--O 1.223 -0.552 0 CA-C-N 118.006 0.903 . . . . 25.0 113.769 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.4 t -54.29 -45.93 72.63 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.53 0.937 . . . . 25.0 113.53 -175.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.47 88.23 0.43 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.058 -0.591 . . . . 25.0 114.043 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -127.06 80.82 1.98 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 122.35 -0.5 . . . . 25.0 110.11 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.49 178.95 45.72 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 108.41 -1.876 . . . . 25.0 108.41 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -123.37 106.97 11.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.629 -0.878 . . . . 50.0 108.629 178.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.9 p -142.46 168.75 18.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.93 146.06 55.48 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.179 -1.045 . . . . 50.0 108.179 174.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -138.88 105.13 5.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.019 -1.474 . . . . 50.0 107.019 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.8 mt -67.09 140.55 57.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.431 0.634 . . . . 50.0 110.439 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.4 146.69 70.71 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 113.366 0.876 . . . . 25.0 113.366 -174.21 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.69 164.77 33.0 Favored 'Trans proline' 0 C--O 1.245 0.84 0 O-C-N 121.895 0.419 . . . . 50.0 111.765 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 50.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 50.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.46 160.92 47.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 50.0 110.805 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.46 176.11 10.13 Favored 'Trans proline' 0 C--N 1.347 0.476 0 N-CA-C 113.249 0.442 . . . . 50.0 113.249 -177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.8 156.17 79.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.58 -0.526 . . . . 50.0 109.58 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.89 170.94 18.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 50.0 113.392 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.42 46.23 0.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.13 -0.941 . . . . 50.0 110.612 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.7 145.6 10.64 Favored Glycine 0 C--O 1.225 -0.444 0 N-CA-C 111.171 -0.771 . . . . 50.0 111.171 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -138.39 30.2 2.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.485 1.135 . . . . 50.0 111.947 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.214 -0.765 0 CA-C-O 125.554 2.597 . . . . 25.0 112.891 -177.662 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 CA-C-O 124.271 2.039 . . . . 25.0 115.454 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -77.48 148.7 35.23 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 121.431 -1.041 . . . . 25.0 108.623 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -131.38 163.9 26.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.549 -0.537 . . . . 25.0 109.549 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -140.34 130.97 25.61 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.077 -2.564 . . . . 50.0 104.077 173.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 59.91 173.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 124.573 1.171 . . . . 50.0 113.482 -177.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 50.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 50.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 50.0 108.729 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 50.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 50.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 75.0 110.391 175.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 50.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 50.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 50.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 50.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.464 ' HG ' ' CD1' ' A' ' 94' ' ' LEU . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 50.0 108.545 176.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 50.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 50.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 50.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 50.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 50.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 50.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 50.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 50.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 50.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 50.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 50.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 50.0 108.234 178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 50.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 50.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 50.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 50.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 50.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 50.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 50.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 50.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 50.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 75.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 50.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 50.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 50.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 50.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 50.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 50.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 50.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 50.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 50.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 50.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 50.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 50.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 50.0 112.284 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 50.0 109.746 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt -107.09 0.8 23.77 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 50.0 110.896 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t 64.86 -87.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.567 -1.651 . . . . 50.0 110.127 -172.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.68 174.03 13.19 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 106.103 -2.799 . . . . 25.0 106.103 -177.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 29.3 ttp 52.41 42.95 31.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.281 1.041 . . . . 25.0 110.374 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -121.82 90.32 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.154 -0.93 . . . . 25.0 111.346 -173.256 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.98 36.6 0.41 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.167 0.984 . . . . 25.0 110.387 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 69' ' ' TYR . 28.7 tttm -67.45 -21.35 65.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 50.0 112.598 -173.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -151.89 147.47 20.0 Favored Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 105.097 -2.186 . . . . 50.0 105.097 172.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.68 -6.0 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 115.124 1.163 . . . . 50.0 115.124 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.47 -51.67 0.58 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.23 -148.38 20.07 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.306 -0.949 . . . . 25.0 113.119 -179.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -100.88 -2.08 32.96 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.668 0.618 . . . . 25.0 112.668 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -171.19 14.39 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 109.599 -1.4 . . . . 25.0 109.599 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.86 -157.63 19.08 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -177.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m 57.34 33.96 24.03 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.792 1.404 . . . . 25.0 114.792 177.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.78 134.04 9.41 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 110.23 -1.148 . . . . 25.0 110.23 176.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.5 p -156.77 163.49 39.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.555 -1.646 . . . . 25.0 106.555 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 158.64 -169.24 35.02 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 107.54 -2.224 . . . . 25.0 107.54 -178.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.24 128.35 33.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.104 -1.814 . . . . 50.0 106.104 175.264 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.6 p -134.31 123.51 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.0 88.98 7.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.327 -1.36 . . . . 50.0 107.327 178.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.17 113.26 9.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.945 -1.025 . . . . 50.0 109.028 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.12 123.42 33.95 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.23 0.538 . . . . 50.0 109.97 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.4 147.66 68.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.771 -0.649 . . . . 25.0 109.879 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.96 162.6 41.39 Favored 'Trans proline' 0 C--O 1.244 0.807 0 CA-C-N 117.991 0.318 . . . . 50.0 112.499 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 50.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 50.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.5 160.96 47.02 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 50.0 109.67 169.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.59 172.03 16.99 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 113.577 0.568 . . . . 50.0 113.577 -176.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.464 ' CD1' ' HG ' ' A' ' 20' ' ' SER . 19.7 mt -134.02 155.78 79.83 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 50.0 111.084 178.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.75 176.21 10.3 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.913 2.409 . . . . 50.0 112.081 174.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.18 35.83 0.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.169 0.803 . . . . 50.0 113.169 -179.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.66 -177.06 21.11 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 111.738 -0.545 . . . . 50.0 111.738 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -116.62 149.66 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.823 0.82 . . . . 50.0 111.54 -178.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 123.719 1.723 . . . . 25.0 112.732 -179.399 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.576 0 CA-C-O 124.611 2.228 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -149.61 153.95 37.88 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 113.056 -1.572 . . . . 25.0 107.399 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.5 mtt 59.26 15.97 4.63 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 tttp 67.19 167.33 0.23 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.781 1.232 . . . . 50.0 109.872 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 57.15 178.01 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 50.0 114.869 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 50.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 50.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 50.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 50.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 50.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 50.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 50.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 50.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 50.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 50.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 50.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 50.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 50.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 50.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 50.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 50.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 50.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 50.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 50.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 50.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 50.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 50.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 50.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 50.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 50.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 50.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 50.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 50.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 50.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 50.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 50.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 50.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 50.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 50.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 50.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 50.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 50.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 50.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 50.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG11 ' HD2' ' A' ' 58' ' ' PRO . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 50.0 111.337 176.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 50.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 50.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 50.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 50.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 50.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 50.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt -103.68 107.89 18.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 50.0 103.0 172.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -56.18 117.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 50.0 110.905 -171.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.1 178.5 50.88 Favored Glycine 0 C--O 1.225 -0.441 0 CA-C-N 115.582 -0.735 . . . . 25.0 111.952 -176.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.59 5.81 1.81 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.504 1.668 . . . . 25.0 115.504 177.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.55 -67.34 0.83 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 173.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.91 -174.99 4.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 178.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -145.6 34.51 1.05 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.703 0.631 . . . . 50.0 112.703 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -80.25 146.97 63.6 Favored Pre-proline 0 N--CA 1.471 0.596 0 N-CA-C 108.393 -0.966 . . . . 50.0 108.393 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.9 133.56 20.18 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 116.27 -2.02 . . . . 50.0 111.638 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.03 141.39 16.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.317 -0.623 . . . . 25.0 109.317 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.29 -139.29 45.79 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.793 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t 57.32 28.95 16.04 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.686 1.365 . . . . 25.0 114.686 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 166.12 51.2 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.13 -1.188 . . . . 25.0 110.13 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.28 175.83 45.73 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 108.29 -1.924 . . . . 25.0 108.29 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.5 m -102.13 130.17 48.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.643 0.722 . . . . 25.0 110.85 -178.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.75 43.05 3.19 Favored Glycine 0 C--O 1.221 -0.699 0 C-N-CA 121.643 -0.313 . . . . 25.0 112.979 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -65.54 -27.33 68.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -175.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.08 -7.85 58.98 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.351 -0.452 . . . . 25.0 113.826 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.41 157.39 34.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 50.0 110.604 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -95.65 124.57 39.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 173.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -155.57 169.37 24.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.094 -1.076 . . . . 50.0 108.094 -177.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 60.62 85.88 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.093 1.357 . . . . 50.0 112.789 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.56 142.41 58.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.962 -1.017 . . . . 50.0 111.071 -177.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.91 148.35 56.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 113.758 1.021 . . . . 25.0 113.758 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 167.18 27.98 Favored 'Trans proline' 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 50.0 111.1 173.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 50.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 50.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.69 162.28 42.66 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 50.0 110.528 176.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.16 174.43 12.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.326 0.471 . . . . 50.0 113.326 -177.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.86 162.03 60.17 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.551 -0.75 . . . . 50.0 110.866 -179.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.82 178.68 5.53 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.114 1.209 . . . . 50.0 111.454 175.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 68.75 7.85 6.39 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.332 1.453 . . . . 50.0 111.429 -174.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.16 -169.09 51.28 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 114.113 -1.403 . . . . 50.0 111.926 175.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -85.64 57.14 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.368 1.08 . . . . 50.0 108.468 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.211 -0.974 0 CA-C-O 125.283 2.468 . . . . 25.0 110.541 -176.16 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 CA-C-O 124.709 2.283 . . . . 25.0 113.281 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 m -139.0 8.15 2.49 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 112.851 -1.675 . . . . 25.0 112.327 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.33 -24.03 27.81 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 -176.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -145.59 136.6 24.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.678 -1.601 . . . . 50.0 106.678 178.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.5 167.38 0.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 50.0 115.93 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 50.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 50.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 50.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 50.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 50.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 50.0 110.556 176.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 50.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 50.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 50.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 50.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 50.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 50.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 50.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 50.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 50.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 50.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 50.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 50.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 50.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 50.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 50.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 50.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 50.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 50.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 50.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 50.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 50.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 50.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 50.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 50.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 50.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 50.0 107.33 177.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 50.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 50.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 50.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 50.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 50.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 50.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 50.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 HG13 ' HD2' ' A' ' 58' ' ' PRO . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' HG13 ' A' ' 57' ' ' VAL . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 50.0 111.699 176.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 50.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 50.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 50.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 50.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 50.0 111.299 174.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 50.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt -100.09 74.4 1.78 Allowed 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 50.0 109.684 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -12.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.408 1.262 . . . . 50.0 114.408 -177.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.71 2.33 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 121.297 -0.478 . . . . 25.0 113.753 -177.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -51.61 -30.7 22.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.925 0.89 . . . . 25.0 113.335 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -100.46 75.35 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.189 0.44 . . . . 25.0 112.189 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -110.93 99.11 8.06 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.872 0.844 . . . . 25.0 110.034 175.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -139.16 1.73 2.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.583 0.706 . . . . 50.0 111.359 -177.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -133.12 148.73 70.42 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 102.344 -3.206 . . . . 50.0 102.344 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.12 152.54 80.98 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.361 -1.959 . . . . 50.0 111.514 -175.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 38.06 0.12 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.618 0.969 . . . . 25.0 113.618 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.7 129.31 4.49 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 109.724 -1.35 . . . . 25.0 109.724 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.4 m -157.28 150.73 24.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.61 -165.6 54.77 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.882 -0.675 . . . . 25.0 112.367 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.04 152.65 22.41 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 109.176 -1.569 . . . . 25.0 109.176 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 t -68.74 -21.88 64.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 25.0 112.341 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.99 -175.67 40.87 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.952 -0.859 . . . . 25.0 110.952 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.0 t -153.91 149.81 27.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 177.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.04 -149.68 49.45 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.142 -1.028 . . . . 25.0 110.954 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.54 -5.35 59.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.562 0.578 . . . . 50.0 112.562 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.5 p 42.88 72.07 0.2 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.22 1.193 . . . . 25.0 114.22 -178.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.25 97.31 0.12 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.026 -0.988 . . . . 50.0 113.175 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -141.13 115.77 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.32 139.28 31.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.474 0.654 . . . . 50.0 111.981 -176.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 148.45 54.64 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.628 -0.715 . . . . 25.0 111.028 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.92 163.9 37.07 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 118.497 -0.535 . . . . 50.0 110.802 175.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 50.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 50.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.61 164.15 35.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 50.0 111.331 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.23 179.2 6.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 120.421 0.748 . . . . 50.0 113.542 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -133.73 157.76 77.11 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.985 -0.552 . . . . 50.0 109.631 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.21 -171.7 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.943 3.095 . . . . 50.0 114.09 -178.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 68.53 8.06 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.401 1.48 . . . . 50.0 111.454 -177.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.65 99.58 2.3 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.116 -1.402 . . . . 50.0 110.378 175.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.01 64.25 1.88 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.527 1.156 . . . . 50.0 111.164 177.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.553 1.073 0 CA-C-O 123.548 1.642 . . . . 25.0 113.048 -179.92 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.145 0 CA-C-O 124.453 2.14 . . . . 25.0 115.505 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -87.89 120.8 29.58 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.885 -1.362 . . . . 25.0 110.58 -179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -71.39 103.31 2.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.574 -0.528 . . . . 25.0 109.574 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -113.21 139.06 49.1 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 104.109 -2.552 . . . . 50.0 104.109 176.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 61.73 164.71 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.961 1.413 . . . . 50.0 114.144 -174.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 50.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 50.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 50.0 107.352 179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 50.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 50.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 50.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 50.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 50.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 50.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 50.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 50.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 50.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 50.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 50.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 50.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 50.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 50.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 50.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 50.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 50.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 50.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 50.0 108.576 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 50.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 50.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 50.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 50.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 50.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 50.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 50.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 50.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 50.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 50.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 50.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 50.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 50.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 50.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 50.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 50.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 50.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 58' ' ' PRO . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 57' ' ' VAL . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 50.0 111.091 175.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 50.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 50.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 50.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 50.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 50.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.82 70.05 4.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 50.0 111.287 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.93 -33.44 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.43 -0.952 . . . . 50.0 108.43 176.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.15 -3.55 61.54 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 115.838 -0.619 . . . . 25.0 113.825 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.0 ttp -134.74 75.58 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.591 0.71 . . . . 25.0 111.04 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -161.12 145.99 13.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 176.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.52 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 55.88 40.13 30.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.085 -0.961 . . . . 50.0 113.222 176.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -111.51 146.55 34.87 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 107.117 -1.438 . . . . 50.0 107.117 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 124.06 9.72 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 116.232 -2.045 . . . . 50.0 112.685 -178.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.22 6.86 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.318 1.229 . . . . 25.0 114.318 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.15 176.53 41.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.384 -0.913 . . . . 25.0 112.989 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 p -144.45 162.63 36.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.06 -1.459 . . . . 25.0 107.06 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.48 153.32 13.23 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.642 -1.266 . . . . 25.0 115.55 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.0 -153.76 24.39 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 178.525 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.0 p -135.34 154.54 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.52 -166.55 37.84 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 110.826 -0.909 . . . . 25.0 110.826 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.7 p -148.96 159.61 44.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.03 171.9 41.26 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 107.621 -2.191 . . . . 25.0 107.621 178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 mt 59.64 176.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.116 0.966 . . . . 50.0 112.361 -175.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 t -123.05 -12.43 7.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 177.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 116.99 33.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.694 -1.224 . . . . 50.0 107.694 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.68 126.69 14.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.712 -1.958 . . . . 50.0 105.712 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.3 mt -106.26 142.15 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 50.0 110.895 -176.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.3 146.18 39.41 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.735 -0.666 . . . . 25.0 111.625 -177.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.82 165.39 31.55 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 119.859 0.373 . . . . 50.0 112.513 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 50.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 50.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.85 162.57 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 50.0 110.019 170.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.77 172.22 16.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.85 0.673 . . . . 50.0 113.85 -176.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.97 153.36 79.75 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.776 -0.647 . . . . 50.0 110.743 177.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.64 173.29 11.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.608 2.872 . . . . 50.0 113.933 176.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.75 57.64 4.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.402 175.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.33 -161.97 47.38 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.599 0.599 . . . . 50.0 114.599 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.09 141.69 51.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.574 -0.899 . . . . 50.0 108.574 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.212 -0.875 0 CA-C-O 125.348 2.499 . . . . 25.0 110.644 178.103 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.912 0 CA-C-O 124.033 1.907 . . . . 25.0 115.46 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -73.97 30.23 0.08 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.146 1.378 . . . . 25.0 114.149 -179.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.36 9.41 20.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 25.0 111.096 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.17 130.38 52.04 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.403 -0.962 . . . . 50.0 108.403 178.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 58.78 172.94 0.07 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 125.212 1.57 . . . . 50.0 115.072 176.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 50.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 50.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 50.0 107.781 -179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 50.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 50.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 50.0 109.569 176.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 50.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 50.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 50.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 50.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 50.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 50.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 50.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 50.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 50.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 50.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 50.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 50.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 50.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 50.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 50.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 50.0 108.459 178.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 50.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 172.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 50.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 50.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 50.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 50.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 50.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 50.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 50.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 50.0 107.154 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 50.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 50.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 50.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 50.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 50.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 50.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 50.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 50.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 50.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 50.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 50.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 50.0 110.156 174.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 50.0 108.515 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt -100.5 85.77 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 50.0 109.741 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.39 107.33 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.745 -0.465 . . . . 50.0 109.745 -178.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.32 47.53 1.02 Allowed Glycine 0 C--O 1.215 -1.055 0 CA-C-N 116.427 -0.351 . . . . 25.0 113.217 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.0 ptp -130.86 18.82 5.07 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -132.17 94.78 3.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.04 6.42 1.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.74 0.816 . . . . 25.0 112.98 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -63.36 -16.8 61.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.13 0.789 . . . . 50.0 113.13 -176.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -159.08 157.67 28.12 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 107.692 -1.225 . . . . 50.0 107.692 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.34 160.83 47.61 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 116.612 -1.792 . . . . 50.0 112.379 175.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.55 24.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.62 145.97 7.99 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 176.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 t -163.45 150.38 12.39 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.49 174.07 46.61 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 107.984 -2.046 . . . . 25.0 107.984 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.31 18.5 0.1 Allowed Glycine 0 C--O 1.221 -0.712 0 CA-C-N 117.944 0.872 . . . . 25.0 115.262 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.2 m 52.46 27.86 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.24 1.941 . . . . 25.0 116.24 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.76 138.81 32.12 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.425 -0.893 . . . . 25.0 111.005 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -99.69 -11.45 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.453 1.279 . . . . 25.0 114.453 -174.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.48 -174.15 44.47 Favored Glycine 0 C--O 1.228 -0.25 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.6 mp -122.0 93.25 3.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -155.23 155.29 33.58 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 50.85 34.11 9.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.202 1.927 . . . . 50.0 116.202 171.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -105.74 81.87 1.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.817 0.818 . . . . 50.0 110.617 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.93 151.89 35.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.543 -0.753 . . . . 50.0 111.903 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 148.73 52.92 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -175.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.19 165.1 33.57 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 120.512 0.808 . . . . 50.0 111.92 175.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 50.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 50.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.85 159.37 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 50.0 108.893 167.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.57 174.99 11.68 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 118.586 -0.476 . . . . 50.0 113.062 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.91 152.66 79.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.111 -0.7 . . . . 50.0 109.111 176.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.57 171.44 9.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.68 2.253 . . . . 50.0 113.739 175.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -92.75 86.83 5.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.236 -0.893 . . . . 50.0 109.031 173.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.4 169.02 36.12 Favored Glycine 0 C--O 1.225 -0.407 0 C-N-CA 120.92 -0.657 . . . . 50.0 111.931 178.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 162.89 40.69 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.819 -1.549 . . . . 50.0 106.819 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.887 0 CA-C-O 126.324 2.964 . . . . 25.0 112.587 -179.042 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 0 CA-C-O 124.123 1.957 . . . . 25.0 113.251 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m 56.89 26.52 11.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.118 -2.041 . . . . 25.0 112.604 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 tpt -81.42 47.82 1.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.887 0.475 . . . . 25.0 112.196 -177.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 63.56 105.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.135 1.374 . . . . 50.0 113.267 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 61.11 174.76 0.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.023 -0.99 . . . . 50.0 113.456 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 50.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 50.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 179.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 50.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 50.0 111.467 179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 50.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 50.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 50.0 107.745 -179.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 50.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 50.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 50.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 50.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 50.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 50.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 50.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 50.0 113.274 -177.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 50.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 50.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 50.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 50.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 179.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 50.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 50.0 108.445 178.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 50.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 173.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 50.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 50.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 50.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 50.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 50.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 50.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 50.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 50.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 50.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 50.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 50.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 50.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 50.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 50.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 50.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 50.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 50.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 50.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 50.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 50.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 50.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 50.0 106.861 175.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.17 85.68 4.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 179.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.8 130.13 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.295 -1.002 . . . . 50.0 108.295 -178.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 146.33 24.1 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.761 -1.336 . . . . 25.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.4 ttt 62.33 -174.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 25.0 112.205 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 67.23 -38.42 0.34 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.098 2.258 . . . . 25.0 117.098 178.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -66.65 135.08 53.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.86 33.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.802 0.81 . . . . 50.0 109.517 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.45 158.99 62.51 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.482 -0.932 . . . . 50.0 108.482 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.95 154.4 72.89 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 115.702 -2.399 . . . . 50.0 111.261 174.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.21 166.88 23.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.307 -1.368 . . . . 25.0 107.307 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.37 -170.74 37.27 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.445 -1.462 . . . . 25.0 109.445 -179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 m -65.91 153.16 42.78 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.641 0.608 . . . . 25.0 112.641 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.22 -146.62 21.18 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 110.151 -1.18 . . . . 25.0 110.151 175.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.4 22.07 17.9 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.969 -0.634 . . . . 25.0 114.134 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -70.28 159.0 34.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 176.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.59 -143.92 5.62 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.25 -0.432 . . . . 25.0 113.236 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 m 57.93 31.32 20.42 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.41 -11.79 84.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.129 178.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.9 mt -129.87 79.78 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.1 t -152.35 168.97 23.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -77.5 141.08 39.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.878 -0.786 . . . . 50.0 108.878 176.087 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.56 97.39 2.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.219 -1.03 . . . . 50.0 108.219 177.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.9 mt -80.44 130.52 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.569 0.699 . . . . 50.0 110.855 -177.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.48 151.46 59.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.362 -0.836 . . . . 25.0 110.984 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.91 159.51 53.03 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 117.213 -1.391 . . . . 50.0 112.197 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 50.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 50.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.06 162.67 40.77 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 50.0 110.531 174.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.15 175.51 10.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 O-C-N 121.921 0.432 . . . . 50.0 112.981 -177.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.1 mt -133.91 157.67 77.23 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.573 -0.739 . . . . 75.0 109.235 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.26 172.68 15.88 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.203 1.935 . . . . 50.0 113.208 178.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.3 56.77 1.77 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.976 0.894 . . . . 50.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.57 -116.49 4.31 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.852 -0.69 . . . . 50.0 112.974 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.6 123.69 18.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.212 1.006 . . . . 50.0 110.414 -177.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 125.798 2.713 . . . . 25.0 111.946 -175.173 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.805 0 CA-C-O 124.458 2.143 . . . . 25.0 114.162 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -146.72 158.1 43.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.833 -1.183 . . . . 25.0 109.258 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -75.49 165.14 25.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -84.23 20.64 1.56 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 120.799 0.333 . . . . 50.0 111.773 176.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -134.89 158.6 43.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.955 -0.566 . . . . 50.0 110.463 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 50.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 50.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 50.0 106.705 179.057 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 50.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 50.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 75.0 109.256 175.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 50.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 50.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 50.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 50.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 50.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 50.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 50.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 50.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 50.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 50.0 107.333 177.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 50.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 50.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 50.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 50.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 50.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 50.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 50.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 50.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 50.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 50.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 50.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 50.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 50.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 50.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 50.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 50.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 50.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 50.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 50.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 50.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 50.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 50.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 50.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 50.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 50.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 50.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 50.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 50.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 50.0 111.508 178.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 50.0 108.733 175.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.09 85.45 6.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 50.0 108.222 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.83 162.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.86 -1.064 . . . . 50.0 110.153 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.8 170.94 35.49 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.786 -0.721 . . . . 25.0 111.393 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ttm 71.79 -39.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.317 1.447 . . . . 25.0 113.903 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.69 68.91 10.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.05 1.13 . . . . 25.0 114.05 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -93.8 -72.86 0.59 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.493 -0.776 . . . . 25.0 109.201 173.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt 54.32 64.99 1.63 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.098 0.777 . . . . 50.0 113.098 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -59.24 145.6 80.73 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.545 -0.752 . . . . 50.0 110.469 177.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.74 175.43 11.01 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 120.661 0.908 . . . . 50.0 114.216 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.79 168.13 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 175.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 34.87 9.9 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.308 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m 60.79 -161.71 0.28 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.626 0.77 . . . . 25.0 111.651 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.71 -176.89 41.71 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 108.681 -1.768 . . . . 25.0 108.681 -177.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.14 -179.07 48.66 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 109.134 -1.586 . . . . 25.0 109.134 178.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.7 m -107.17 123.84 48.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.86 52.09 0.32 Allowed Glycine 0 C--O 1.217 -0.925 0 N-CA-C 111.361 -0.696 . . . . 25.0 111.361 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -65.06 -22.51 66.98 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 114.614 1.338 . . . . 25.0 114.614 -175.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.31 -153.69 29.31 Favored Glycine 0 CA--C 1.516 0.103 0 C-N-CA 120.609 -0.805 . . . . 25.0 111.93 -178.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.4 mp -82.63 170.27 15.33 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.7 p -66.67 128.76 37.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.294 -0.632 . . . . 25.0 109.294 176.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.27 -172.95 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.195 -0.668 . . . . 50.0 109.195 -176.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 59.19 95.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.141 1.534 . . . . 50.0 115.141 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.84 129.5 40.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 50.0 109.265 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 153.03 83.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.512 -0.767 . . . . 25.0 112.344 -175.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.43 164.41 32.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 O-C-N 121.801 0.369 . . . . 50.0 111.666 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 50.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 50.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.17 163.37 36.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 50.0 110.695 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.09 174.43 12.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 N-CA-C 113.438 0.515 . . . . 50.0 113.438 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.97 157.25 78.16 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 50.0 110.337 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 97' ' ' GLY . 67.5 Cg_endo -74.99 -177.96 3.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.59 1.527 . . . . 50.0 110.636 174.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 68.88 -6.7 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.364 1.465 . . . . 50.0 114.204 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -98.86 14.9 61.33 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 113.587 -1.642 . . . . 50.0 109.421 172.223 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -137.57 147.21 44.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.434 -1.321 . . . . 50.0 107.434 -178.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.483 1.211 0 C-N-CA 125.346 1.459 . . . . 25.0 113.646 179.555 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 124.568 2.204 . . . . 25.0 113.707 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 t -68.47 -19.03 64.53 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.276 -1.132 . . . . 25.0 111.86 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ptm -147.59 28.28 0.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.557 0.694 . . . . 25.0 110.536 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.4 153.32 42.56 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 105.131 -2.174 . . . . 50.0 105.131 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 59.74 168.06 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 50.0 114.57 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 50.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 50.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 50.0 106.283 178.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 50.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 50.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 174.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 50.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 50.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 50.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 50.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 50.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 50.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 50.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 50.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 50.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 50.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 50.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 50.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 50.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 50.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 50.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 50.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 50.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 50.0 109.706 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 50.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 50.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 50.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 50.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 50.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 50.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 50.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 50.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 50.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 75.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 50.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 50.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 50.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 50.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 50.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 50.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' HD2' ' A' ' 58' ' ' PRO . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HD2' HG11 ' A' ' 57' ' ' VAL . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 50.0 110.939 175.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 50.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 50.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 50.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 50.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 50.0 111.154 178.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 50.0 108.562 176.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.38 89.7 5.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 50.0 107.296 178.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.19 108.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.428 -0.805 . . . . 50.0 109.642 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.38 46.24 3.63 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 112.013 -0.435 . . . . 25.0 112.013 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.51 151.03 32.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 25.0 107.863 -175.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 63.43 10.22 4.68 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.858 1.799 . . . . 25.0 115.858 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.62 125.55 30.68 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.592 -0.693 . . . . 25.0 111.705 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -150.04 29.44 0.73 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.91 -1.144 . . . . 50.0 107.91 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.17 155.74 79.51 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.428 -0.805 . . . . 50.0 111.191 -174.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.51 160.21 44.81 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.692 -1.072 . . . . 50.0 112.324 178.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.05 -170.71 0.16 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.307 1.043 . . . . 25.0 112.2 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.52 166.15 20.58 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.074 -0.81 . . . . 25.0 111.074 -178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 p -66.13 -23.71 66.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.46 167.43 43.24 Favored Glycine 0 CA--C 1.517 0.199 0 CA-C-O 121.493 0.496 . . . . 25.0 113.625 177.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.28 130.22 10.18 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 110.035 -1.226 . . . . 25.0 110.035 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.6 p -152.38 152.86 32.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.52 -2.67 30.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 121.47 -0.395 . . . . 25.0 113.543 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -65.09 153.08 41.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 175.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.77 60.23 3.38 Favored Glycine 0 C--O 1.218 -0.9 0 CA-C-N 116.647 -0.251 . . . . 25.0 113.601 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -73.47 -17.04 61.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.893 0.477 . . . . 50.0 111.362 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -163.57 0.24 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.103 0.877 . . . . 25.0 109.497 -177.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 55.49 -176.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.98 1.474 . . . . 50.0 114.98 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.7 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.713 1.605 . . . . 50.0 112.156 -173.576 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.59 130.5 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.739 . . . . 50.0 111.573 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.57 140.96 72.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.383 -0.826 . . . . 25.0 112.033 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.74 165.95 30.97 Favored 'Trans proline' 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 50.0 110.955 175.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 50.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 50.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.64 159.44 52.74 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 50.0 111.521 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.75 169.01 7.66 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 N-CA-C 114.768 1.026 . . . . 50.0 114.768 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -133.95 154.62 80.41 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 113.275 -1.784 . . . . 50.0 110.274 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.89 169.81 20.99 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.143 1.895 . . . . 50.0 112.892 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -93.67 34.06 1.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.437 -0.801 . . . . 50.0 111.927 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.49 -171.16 20.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.449 -0.405 . . . . 50.0 113.825 178.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.78 149.06 25.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.021 0.915 . . . . 50.0 111.76 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 124.061 1.886 . . . . 25.0 112.503 177.151 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.258 0 CA-C-O 123.46 1.589 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 54.76 22.02 3.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 113.245 -1.478 . . . . 25.0 114.567 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -63.95 126.8 28.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.988 -0.745 . . . . 25.0 108.988 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -125.36 3.11 7.75 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.606 -0.725 . . . . 50.0 110.003 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.81 168.96 18.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.767 -1.106 . . . . 50.0 109.121 -176.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 50.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 50.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 50.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 50.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 50.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 50.0 110.386 177.042 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 50.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 50.0 109.5 174.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 50.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 50.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 50.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 50.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 50.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 50.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 50.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 50.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 50.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 50.0 110.142 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 50.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 50.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 50.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 50.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 50.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 50.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 50.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 50.0 108.437 173.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 50.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 50.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 50.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 50.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 50.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 50.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 50.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 50.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 50.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 50.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 50.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 50.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 50.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 50.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 50.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 50.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 50.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 50.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 50.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 50.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 50.0 111.004 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 50.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt -93.84 74.19 4.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 50.0 110.797 -178.016 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.53 -31.78 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.342 -0.845 . . . . 50.0 110.278 178.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.24 115.95 0.68 Allowed Glycine 0 C--O 1.221 -0.716 0 CA-C-N 116.278 -0.419 . . . . 25.0 113.333 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mtm 62.07 -49.54 0.16 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.622 2.453 . . . . 25.0 117.622 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -53.34 144.6 16.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.04 0.536 . . . . 25.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t0 56.16 69.69 0.71 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.681 0.993 . . . . 25.0 113.681 177.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm 54.2 29.2 10.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.909 1.818 . . . . 50.0 115.909 168.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -85.01 143.34 39.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.849 -1.167 . . . . 50.0 107.849 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.38 149.16 50.15 Favored 'Trans proline' 0 C--N 1.344 0.33 0 N-CA-C 114.553 0.944 . . . . 50.0 114.553 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.92 161.15 27.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.523 -0.762 . . . . 25.0 109.254 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.36 -87.7 1.01 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.2 m 52.6 31.44 10.09 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.933 1.457 . . . . 25.0 114.933 177.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.72 87.0 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 120.673 -0.775 . . . . 25.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.39 152.99 8.65 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 109.967 -1.253 . . . . 25.0 109.967 176.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.2 t -167.0 153.66 8.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 154.95 12.0 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.235 -1.546 . . . . 25.0 109.235 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.5 m -131.22 19.36 4.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.407 0.604 . . . . 25.0 109.959 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.43 -173.95 15.79 Favored Glycine 0 CA--C 1.51 -0.28 0 N-CA-C 107.361 -2.296 . . . . 25.0 107.361 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.32 -41.77 47.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.56 0.68 . . . . 50.0 110.187 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 70.15 139.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 125.155 1.535 . . . . 25.0 112.367 -177.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 121.8 26.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.769 -1.937 . . . . 50.0 105.769 175.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -147.81 117.37 7.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.314 -0.624 . . . . 50.0 109.314 -173.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.51 111.54 19.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.672 0.749 . . . . 50.0 109.381 178.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.54 148.28 98.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.324 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.92 160.58 49.14 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 117.868 -0.955 . . . . 50.0 111.781 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 50.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 50.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.17 163.29 38.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 50.0 110.657 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.28 176.47 7.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 CA-C-O 121.335 0.473 . . . . 50.0 112.88 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.99 159.63 71.64 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.63 -0.878 . . . . 50.0 108.63 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.29 -175.96 2.24 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.605 1.537 . . . . 50.0 111.349 178.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.3 14.95 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 115.403 1.631 . . . . 50.0 115.403 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.59 12.63 67.89 Favored Glycine 0 C--O 1.229 -0.169 0 N-CA-C 110.47 -1.052 . . . . 50.0 110.47 172.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.09 118.75 14.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.034 0.921 . . . . 50.0 109.037 -177.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.209 -1.04 0 CA-C-O 124.512 2.101 . . . . 25.0 112.712 -177.126 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.956 0 CA-C-O 124.615 2.231 . . . . 25.0 113.628 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 t -75.31 128.04 34.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.149 -1.526 . . . . 25.0 108.993 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -144.59 122.3 11.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 67.1 158.75 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.727 1.267 . . . . 50.0 108.417 -171.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 58.76 179.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 50.0 115.049 176.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 50.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 50.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 50.0 106.633 178.125 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 50.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 50.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 50.0 110.158 176.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 50.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 50.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 50.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 50.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 50.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 50.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 50.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 50.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 50.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 50.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 50.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 50.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 50.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 50.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 50.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 50.0 108.606 178.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 50.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 50.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 50.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 50.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 50.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 50.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 50.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 50.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 50.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 50.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 50.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 50.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 50.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 50.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 50.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 50.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 50.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 50.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 50.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 50.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 50.0 111.783 179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 50.0 109.171 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.77 85.86 4.95 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 50.0 108.606 179.242 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.97 -27.51 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.361 -0.836 . . . . 50.0 109.693 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.44 -52.81 4.78 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.473 -1.051 . . . . 25.0 110.473 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.6 mtm -72.13 157.48 37.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.25 11.16 6.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.864 1.431 . . . . 25.0 114.864 175.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 177.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -139.59 43.11 2.0 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.396 0.517 . . . . 50.0 112.396 -173.606 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -65.7 152.0 93.69 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 109.291 -0.633 . . . . 50.0 109.291 176.219 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.86 -15.15 16.92 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.267 -0.689 . . . . 50.0 112.553 173.874 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.28 -105.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 25.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.5 -52.0 0.01 OUTLIER Glycine 0 C--O 1.235 0.162 0 N-CA-C 111.194 -0.762 . . . . 25.0 111.194 178.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 p -90.67 -179.85 5.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 176.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.08 -48.79 4.11 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.65 0.62 . . . . 25.0 114.65 176.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.18 40.41 1.48 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 115.537 0.975 . . . . 25.0 115.537 -178.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 m -96.0 -37.78 10.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.233 0.517 . . . . 25.0 111.412 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.63 173.68 37.73 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.923 -0.871 . . . . 25.0 110.923 -175.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -122.3 -1.13 9.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.69 0.626 . . . . 25.0 112.69 -179.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.9 -21.55 45.48 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 119.329 -0.706 . . . . 25.0 113.937 -179.354 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.5 mt 54.97 -147.34 0.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.356 0.662 . . . . 50.0 109.731 -179.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 p -135.27 166.23 23.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.128 -1.805 . . . . 25.0 106.128 179.142 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 59.19 15.53 4.25 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.421 1.638 . . . . 50.0 115.421 171.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.23 88.51 6.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.953 0.883 . . . . 50.0 109.644 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.4 123.5 26.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.607 0.717 . . . . 50.0 110.101 -178.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.96 149.59 85.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.284 -0.871 . . . . 25.0 112.195 -176.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.45 163.99 36.95 Favored 'Trans proline' 0 C--O 1.241 0.65 0 O-C-N 121.758 0.347 . . . . 50.0 112.473 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 50.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 50.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.94 162.69 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 50.0 110.702 176.46 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.23 172.47 15.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 113.467 0.526 . . . . 50.0 113.467 -176.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -133.97 154.84 80.51 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 50.0 110.854 178.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.19 174.7 12.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.53 2.153 . . . . 50.0 112.468 176.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -82.4 38.33 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.013 -0.539 . . . . 50.0 112.143 179.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.34 -146.86 19.22 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 121.144 -0.551 . . . . 50.0 111.802 -178.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -77.15 87.05 3.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.183 0.992 . . . . 50.0 109.996 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 125.662 2.649 . . . . 25.0 111.812 -179.651 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 CA-C-O 122.582 1.101 . . . . 25.0 115.221 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -68.28 141.11 55.96 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.403 -1.057 . . . . 25.0 108.351 177.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -111.45 159.07 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 25.0 112.39 -175.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -147.73 148.08 30.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 103.659 -2.719 . . . . 50.0 103.659 172.423 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 58.35 167.48 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 50.0 117.069 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 50.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 50.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 50.0 108.563 -177.864 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 50.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 50.0 111.838 178.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 50.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 50.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 50.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 50.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 50.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 50.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 50.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 50.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 50.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 50.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 50.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 50.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 50.0 110.144 -179.812 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 50.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 50.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 50.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 50.0 109.491 -179.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 50.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 50.0 108.815 178.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 50.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 50.0 109.59 173.029 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 50.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 50.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 50.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 50.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 50.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 50.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 50.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 50.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 50.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 50.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 50.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 50.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 50.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG13 ' HD2' ' A' ' 58' ' ' PRO . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 57' ' ' VAL . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 50.0 111.633 176.581 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 50.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 50.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 50.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 50.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 50.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 50.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.13 73.59 7.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 50.0 109.702 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.02 -33.78 64.42 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.527 -0.76 . . . . 50.0 110.202 -179.149 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.6 -1.8 56.24 Favored Glycine 0 C--O 1.218 -0.862 0 N-CA-C 115.032 0.773 . . . . 25.0 115.032 178.189 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -132.27 -36.83 1.12 Allowed 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 -176.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -5.92 49.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 -172.294 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 t0 13.34 73.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.573 2.434 . . . . 25.0 117.573 -172.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -65.87 -26.66 67.74 Favored 'General case' 0 C--O 1.239 0.537 0 O-C-N 121.586 -0.696 . . . . 50.0 110.138 179.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.3 133.64 0.76 Allowed Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 106.517 -1.66 . . . . 50.0 106.517 174.379 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.79 -14.38 17.41 Favored 'Trans proline' 0 C--N 1.344 0.317 0 N-CA-C 114.338 0.861 . . . . 50.0 114.338 -174.532 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.24 -96.96 0.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.045 0.938 . . . . 25.0 110.84 -176.508 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 -161.38 45.59 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 p -94.7 155.67 16.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.69 173.93 40.64 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.174 -1.571 . . . . 25.0 109.174 176.629 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.48 87.77 0.23 Allowed Glycine 0 C--O 1.223 -0.532 0 N-CA-C 111.179 -0.768 . . . . 25.0 111.179 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -125.34 21.14 7.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.345 0.498 . . . . 25.0 112.345 -175.829 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.69 38.13 1.25 Allowed Glycine 0 C--O 1.223 -0.569 0 N-CA-C 115.45 0.94 . . . . 25.0 115.45 -177.321 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 m -64.73 -25.18 67.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.203 0.501 . . . . 25.0 111.631 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.84 46.34 3.59 Favored Glycine 0 C--O 1.22 -0.779 0 N-CA-C 111.894 -0.482 . . . . 25.0 111.894 176.127 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.63 32.91 15.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.748 0.785 . . . . 50.0 112.021 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.48 17.49 9.59 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 179.104 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -73.87 127.31 32.52 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 122.104 -0.373 . . . . 50.0 110.539 176.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -122.41 75.49 1.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.795 0.807 . . . . 50.0 110.466 177.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.73 141.89 56.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.898 -1.046 . . . . 50.0 110.803 179.433 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 149.0 60.26 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.398 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.45 163.22 39.22 Favored 'Trans proline' 0 C--O 1.242 0.725 0 O-C-N 121.637 0.283 . . . . 50.0 111.74 176.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 50.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 50.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 161.22 45.91 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 50.0 110.721 177.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.59 174.74 12.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 120.167 0.578 . . . . 50.0 113.397 -177.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 156.21 79.52 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 50.0 109.9 179.016 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.89 173.37 14.58 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 50.0 112.357 176.51 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.52 52.26 2.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.488 0.661 . . . . 50.0 111.163 178.682 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.57 173.6 32.28 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 121.788 0.66 . . . . 50.0 114.194 178.426 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -106.56 122.55 46.53 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 122.145 0.974 . . . . 50.0 111.345 -174.057 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 124.087 1.899 . . . . 25.0 113.536 179.603 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 CA-C-O 124.383 2.102 . . . . 25.0 115.161 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -77.96 140.08 39.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.356 -1.085 . . . . 25.0 110.039 179.228 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -63.42 142.83 58.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -135.66 145.19 46.52 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.563 -2.755 . . . . 50.0 103.563 175.786 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 61.49 169.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.892 1.37 . . . . 50.0 113.077 -174.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 50.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 50.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 50.0 108.431 -178.389 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 50.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 50.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 50.0 109.758 176.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 50.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 50.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 50.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 50.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 50.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 50.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 50.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 50.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 50.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 50.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 50.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 50.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 50.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 50.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 50.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 50.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 50.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 50.0 108.869 178.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 50.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 50.0 108.945 173.673 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 50.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 50.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 50.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 50.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 50.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 50.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 50.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 75.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 50.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 50.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 50.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 50.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 50.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 50.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 50.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 50.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 50.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 50.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 50.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 50.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 50.0 111.388 178.023 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 50.0 108.918 177.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.28 79.55 5.04 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 50.0 107.657 178.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.4 120.91 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 50.0 111.27 -177.14 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 6.95 74.34 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 114.436 0.534 . . . . 25.0 114.436 -178.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.2 ptp -80.54 0.76 32.41 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.303 -0.528 . . . . 25.0 111.733 -179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.06 9.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.957 0.408 . . . . 25.0 110.882 179.351 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.82 -33.02 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.031 0.92 . . . . 25.0 109.022 175.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -106.34 135.31 48.06 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.804 -1.089 . . . . 50.0 112.586 -171.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -158.26 158.28 29.68 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 103.887 -2.634 . . . . 50.0 103.887 176.098 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.59 144.84 36.41 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 114.567 -3.155 . . . . 50.0 111.372 174.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.29 -170.6 0.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 176.254 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 177.89 47.35 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 107.639 -2.185 . . . . 25.0 107.639 -178.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 56.44 17.4 2.93 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.193 1.924 . . . . 25.0 116.193 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.79 159.21 34.31 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.567 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 175.25 41.41 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 106.262 -2.735 . . . . 25.0 106.262 178.452 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m -149.73 -87.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.467 1.133 . . . . 25.0 111.765 -179.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.99 157.08 48.22 Favored Glycine 0 N--CA 1.455 -0.077 0 C-N-CA 120.753 -0.737 . . . . 25.0 111.543 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.6 t -147.06 -79.19 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.581 0.215 . . . . 25.0 111.581 178.418 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.23 2.12 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 115.088 0.795 . . . . 25.0 115.088 -177.747 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.54 152.03 27.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.019 0.409 . . . . 50.0 109.949 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.2 p -116.73 87.01 2.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.561 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -154.14 -174.4 4.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 103.484 -2.784 . . . . 50.0 103.484 -177.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 68.26 86.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.595 1.158 . . . . 50.0 111.332 179.227 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.55 130.7 47.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.191 -0.913 . . . . 50.0 111.269 -177.278 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.74 148.38 68.91 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.247 -0.888 . . . . 25.0 110.929 -178.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.29 164.52 35.46 Favored 'Trans proline' 0 C--O 1.242 0.679 0 O-C-N 121.681 0.306 . . . . 50.0 111.768 176.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 50.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 50.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.58 161.16 46.33 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 50.0 110.848 176.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.75 177.66 7.78 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 120.125 0.55 . . . . 50.0 113.338 -177.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -132.68 156.52 79.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.907 -0.588 . . . . 50.0 109.482 178.558 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.9 -169.82 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.331 3.354 . . . . 50.0 113.544 179.401 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 63.69 26.09 14.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.933 1.293 . . . . 50.0 109.207 -174.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.26 131.77 3.71 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.232 -1.547 . . . . 50.0 109.232 173.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -114.02 150.39 33.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.962 0.887 . . . . 50.0 110.282 -178.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.214 -0.77 0 CA-C-O 125.468 2.556 . . . . 25.0 111.828 178.629 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 123.047 1.359 . . . . 25.0 115.555 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -79.0 136.6 37.25 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.22 -1.165 . . . . 25.0 110.494 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -106.91 -3.09 20.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.505 0.669 . . . . 25.0 111.545 177.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -97.2 135.24 39.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 104.054 -2.573 . . . . 50.0 104.054 172.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 63.82 162.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.321 1.638 . . . . 50.0 114.382 -177.381 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 50.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 50.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 50.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 50.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 50.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 176.068 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 50.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 50.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 50.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 50.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 50.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 50.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 50.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 50.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 50.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 50.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 50.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 50.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 50.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 50.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 50.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 50.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 50.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 50.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 173.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 50.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 50.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 50.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 50.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 50.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 50.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 50.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 50.0 107.384 179.448 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 50.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 50.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 50.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 50.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 50.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 50.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 50.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 50.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 50.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 50.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 50.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 50.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 50.0 111.294 177.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 50.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -97.7 72.03 2.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 50.0 108.141 179.713 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.3 143.99 7.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 115.063 -0.971 . . . . 50.0 112.903 -176.245 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 -175.32 50.69 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 108.408 -1.877 . . . . 25.0 108.408 174.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 tmm? 55.39 45.38 25.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.315 1.055 . . . . 25.0 109.902 -178.553 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.97 138.06 48.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 -179.596 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.15 118.72 8.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.835 0.826 . . . . 25.0 110.365 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -143.74 160.98 39.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.385 -2.08 . . . . 50.0 105.385 -177.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -133.91 156.4 79.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 50.0 108.422 178.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.51 170.44 19.3 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 117.2 -1.4 . . . . 50.0 112.245 175.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.67 178.22 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.491 1.663 . . . . 25.0 115.491 173.634 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.25 -177.73 22.41 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 108.885 -1.686 . . . . 25.0 108.885 -175.183 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 t 59.8 -166.88 0.18 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.299 0.64 . . . . 25.0 110.223 -176.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.25 -37.63 2.57 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 115.604 1.002 . . . . 25.0 115.604 178.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.94 -33.75 88.0 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 117.492 0.646 . . . . 25.0 114.413 -176.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.3 p -157.61 167.91 28.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 178.426 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.33 154.81 29.07 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.297 -1.521 . . . . 25.0 109.297 175.005 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.5 p -89.72 8.61 30.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.093 0.473 . . . . 25.0 110.417 179.311 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.86 156.01 8.61 Favored Glycine 0 C--O 1.236 0.24 0 N-CA-C 107.595 -2.202 . . . . 25.0 107.595 -176.127 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.96 141.22 32.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.526 -1.657 . . . . 50.0 106.526 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.1 p 46.8 -156.32 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.364 1.04 . . . . 25.0 111.916 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 54.19 18.42 1.79 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.896 1.813 . . . . 50.0 115.896 177.069 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -128.38 103.46 7.16 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 -179.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.78 147.37 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.43 -0.805 . . . . 50.0 111.707 -175.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.33 146.39 61.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 -177.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.79 168.73 22.99 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 120.149 0.566 . . . . 50.0 110.929 172.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 50.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 50.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.67 162.66 40.17 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 50.0 110.959 177.777 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.97 173.13 15.02 Favored 'Trans proline' 0 C--N 1.351 0.688 0 N-CA-C 113.158 0.407 . . . . 50.0 113.158 -177.063 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 154.84 80.58 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 177.567 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.42 169.63 18.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 120.839 1.026 . . . . 50.0 112.938 175.28 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -98.46 65.73 1.66 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.249 -0.887 . . . . 50.0 108.779 175.66 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.29 174.79 32.72 Favored Glycine 0 C--O 1.229 -0.172 0 CA-C-N 115.766 -0.652 . . . . 50.0 112.358 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.65 137.16 53.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.257 -1.016 . . . . 50.0 108.257 176.526 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 126.259 2.933 . . . . 25.0 111.959 -177.499 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 122.463 1.035 . . . . 25.0 114.577 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p 61.12 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 118.092 2.627 . . . . 25.0 118.092 179.323 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -45.76 -63.43 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.834 1.79 . . . . 25.0 115.834 -176.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 55.86 19.34 3.46 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.738 1.755 . . . . 50.0 115.738 -178.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -135.93 169.91 16.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 50.0 112.131 -177.525 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 50.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 50.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 50.0 108.747 -178.62 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 50.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 50.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 75.0 109.192 174.818 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 50.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 50.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 50.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 50.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 50.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 50.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 50.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 50.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 50.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 50.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 50.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 50.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 50.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 50.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 50.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 178.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 50.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 50.0 108.746 173.277 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 50.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 50.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 50.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 50.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 50.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 50.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 50.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 50.0 106.733 178.103 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 50.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 50.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 50.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 50.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 50.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 50.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 50.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 50.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 50.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 50.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 50.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 50.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 50.0 109.989 173.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 50.0 108.264 176.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -95.78 94.14 7.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 50.0 105.398 177.424 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.96 123.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 -175.478 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.61 163.62 53.23 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 111.038 -0.825 . . . . 25.0 111.038 -178.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 ttp 69.87 -38.19 0.4 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.112 1.365 . . . . 25.0 114.347 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -90.33 119.85 30.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.582 0.956 . . . . 25.0 113.582 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.93 155.43 22.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 165.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.78 38.04 2.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 50.0 109.64 -178.489 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt 77.33 151.12 0.13 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.773 2.029 . . . . 50.0 110.014 -178.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.86 140.81 62.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 116.403 -1.931 . . . . 50.0 112.266 -178.537 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.81 141.06 17.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.702 -1.222 . . . . 25.0 107.702 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.73 174.29 46.92 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 107.882 -2.087 . . . . 25.0 107.882 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -161.36 163.8 30.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.051 -2.203 . . . . 25.0 105.051 179.055 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.78 169.07 41.06 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 107.98 -2.048 . . . . 25.0 107.98 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.44 -67.84 0.3 Allowed Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 178.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m 53.53 28.57 7.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.491 0.923 . . . . 25.0 113.491 176.859 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.62 -169.12 37.59 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.513 -1.835 . . . . 25.0 108.513 -177.249 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -76.62 60.87 1.72 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.881 1.067 . . . . 25.0 113.881 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.01 78.01 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.915 -0.66 . . . . 25.0 111.476 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.3 mt 49.49 37.22 11.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.066 1.135 . . . . 50.0 114.066 173.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -100.55 -47.71 4.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.957 0.408 . . . . 25.0 111.364 -178.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 57.29 179.82 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -1.151 . . . . 50.0 112.648 -176.698 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.97 134.5 8.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.437 -1.32 . . . . 50.0 107.437 -176.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.37 130.61 36.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.425 0.631 . . . . 50.0 109.634 -178.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.15 77.08 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 25.0 112.074 -177.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.48 162.81 41.1 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 118.136 -0.776 . . . . 50.0 110.948 174.607 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 50.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 50.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.13 160.06 51.41 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 50.0 110.86 177.626 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.86 179.8 5.33 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 119.926 0.417 . . . . 50.0 112.675 -178.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.6 mt -127.88 155.83 76.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 50.0 109.628 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.1 -173.4 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.343 2.695 . . . . 50.0 112.865 179.366 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.75 11.31 1.3 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 118.187 2.662 . . . . 50.0 118.187 173.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.38 -155.55 16.27 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 115.801 -0.636 . . . . 50.0 112.796 176.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 50.41 38.54 18.39 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.836 1.779 . . . . 50.0 113.049 -177.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 125.308 2.48 . . . . 25.0 111.138 177.784 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 122.632 1.129 . . . . 25.0 115.192 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -67.01 112.03 4.15 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.458 -1.025 . . . . 25.0 110.288 179.596 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -81.19 72.29 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 tptm 65.41 -177.09 0.18 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.103 -1.073 . . . . 50.0 108.103 -172.101 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 54.79 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 50.0 115.144 175.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 50.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 50.0 108.167 -178.814 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 50.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 50.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 50.0 110.387 175.13 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 50.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 50.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 50.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 50.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 50.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 50.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 50.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 50.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 50.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 50.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 50.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 50.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 50.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 50.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 50.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 50.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 50.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 50.0 108.399 178.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 50.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 50.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 50.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 50.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 50.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 50.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 50.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 50.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 50.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 50.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 50.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 50.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 50.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 50.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 50.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 50.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 50.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 50.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 50.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 50.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 50.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 50.0 111.669 178.03 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 50.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.99 72.06 3.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 50.0 112.221 -177.2 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.2 m -75.26 -11.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.073 0.463 . . . . 50.0 110.984 176.071 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.22 177.59 48.27 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 110.585 -1.006 . . . . 25.0 110.585 -178.137 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.5 mtm 55.02 15.29 1.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 177.418 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -131.94 172.27 12.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -178.387 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t0 60.4 43.31 13.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.789 0.836 . . . . 25.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -77.23 60.71 1.99 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.686 0.755 . . . . 50.0 111.536 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -70.08 154.55 94.52 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.661 -0.699 . . . . 50.0 110.228 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.59 -16.64 18.84 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 114.599 0.961 . . . . 50.0 114.599 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.93 98.64 9.32 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.911 -0.493 . . . . 25.0 110.894 -179.098 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.17 -14.64 58.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.871 1.108 . . . . 25.0 115.871 -178.626 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -93.14 149.22 21.38 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.867 . . . . 25.0 111.175 -177.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.73 -170.7 18.48 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.724 -0.216 . . . . 25.0 112.917 177.253 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 -59.03 3.27 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-O 120.085 -0.286 . . . . 25.0 113.745 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.2 m -134.46 146.5 49.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.401 -0.963 . . . . 25.0 108.401 178.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.87 9.14 86.72 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.885 -0.674 . . . . 25.0 112.225 -178.295 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.7 p -120.01 160.63 22.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.26 174.88 49.31 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.418 -1.073 . . . . 25.0 110.418 176.182 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.55 160.18 31.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 179.53 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 t -139.66 163.58 32.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.023 -2.214 . . . . 25.0 105.023 177.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.74 151.21 42.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.679 -0.86 . . . . 50.0 108.679 176.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.59 99.79 2.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.02 -1.474 . . . . 50.0 107.02 179.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.55 139.18 58.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 50.0 111.367 -173.825 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.16 148.96 40.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.23 -0.895 . . . . 25.0 113.283 -174.212 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.84 164.76 34.65 Favored 'Trans proline' 0 C--O 1.242 0.71 0 O-C-N 121.836 0.387 . . . . 50.0 111.861 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 50.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 50.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.51 159.72 51.18 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 50.0 109.363 170.328 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.8 170.85 19.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 118.402 -0.599 . . . . 50.0 113.482 -175.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.1 mt -133.94 155.94 79.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.51 -0.768 . . . . 50.0 108.943 178.297 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.6 167.68 25.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.222 1.282 . . . . 50.0 113.156 176.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.02 28.48 4.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 50.0 110.401 -178.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 -157.8 27.55 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.144 -0.782 . . . . 50.0 111.144 -176.009 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.13 149.88 40.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.265 1.031 . . . . 50.0 110.797 -179.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 124.785 2.231 . . . . 25.0 111.504 178.99 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 122.348 0.971 . . . . 25.0 114.379 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t 54.82 37.2 28.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.887 0.875 . . . . 25.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.6 ttt 54.29 64.75 1.71 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.899 0.857 . . . . 25.0 112.484 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -134.27 148.31 50.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.507 -2.034 . . . . 50.0 105.507 176.292 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 56.93 170.94 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 50.0 116.014 179.482 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 50.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 50.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 50.0 106.97 178.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 50.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 50.0 111.846 179.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 50.0 110.531 175.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 50.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 50.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 50.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 50.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 50.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 50.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 50.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 50.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 50.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 50.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 50.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 50.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 50.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 50.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 50.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 50.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 50.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 75.0 108.575 179.082 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 50.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 50.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 50.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 50.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 50.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 50.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 50.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 50.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 50.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 50.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 50.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 50.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 75.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 50.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 50.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 50.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 50.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' A' ' 58' ' ' PRO . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD2' HG11 ' A' ' 57' ' ' VAL . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 50.0 110.737 175.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 50.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 50.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 50.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 50.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 50.0 110.544 175.657 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 50.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.1 mt -106.55 83.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 50.0 109.849 -179.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.84 146.87 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.208 0.528 . . . . 50.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.21 -171.8 40.01 Favored Glycine 0 C--O 1.217 -0.919 0 N-CA-C 109.451 -1.46 . . . . 25.0 109.451 176.709 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.9 mtm 62.23 8.82 2.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 178.04 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -127.9 26.66 5.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.219 -0.289 . . . . 25.0 110.219 177.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 47.09 50.3 14.2 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.73 0.776 . . . . 25.0 111.82 -179.147 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -70.89 83.43 0.66 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.188 0.994 . . . . 50.0 113.283 -174.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -75.23 151.38 85.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 50.0 109.353 176.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.62 -15.73 21.61 Favored 'Trans proline' 0 C--N 1.35 0.638 0 N-CA-C 115.219 1.2 . . . . 50.0 115.219 -176.503 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.22 22.77 13.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.56 178.0 15.34 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.493 -0.384 . . . . 25.0 112.307 176.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 p -161.24 167.55 25.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.417 -2.438 . . . . 25.0 104.417 177.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.62 19.66 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 111.595 -0.602 . . . . 25.0 111.595 179.422 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.1 -41.31 1.17 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 179.44 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 t 54.59 24.08 5.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.104 1.89 . . . . 25.0 116.104 174.451 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.3 153.43 22.41 Favored Glycine 0 CA--C 1.512 -0.099 0 N-CA-C 111.565 -0.614 . . . . 25.0 111.565 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.8 m -97.01 177.22 5.68 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.644 0.377 . . . . 25.0 110.203 -178.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.99 -125.56 15.89 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.55 -20.71 58.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.157 0.428 . . . . 50.0 112.157 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m 62.21 36.84 14.66 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 -169.618 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 50.78 -159.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 112.878 -1.965 . . . . 50.0 115.549 173.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 67.01 97.38 0.05 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.769 1.228 . . . . 50.0 109.98 -173.39 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.69 135.34 56.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 50.0 111.479 -173.422 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.7 146.66 53.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.019 -0.992 . . . . 25.0 112.511 -175.334 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.25 165.58 31.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 O-C-N 121.793 0.365 . . . . 50.0 111.55 174.464 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 50.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.06 162.91 39.76 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 50.0 109.571 169.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.93 172.4 16.41 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 113.813 0.659 . . . . 50.0 113.813 -175.634 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.9 mt -133.87 156.48 79.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 50.0 110.251 177.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.24 -162.04 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.963 3.109 . . . . 50.0 112.41 177.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 67.51 13.36 9.28 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.065 1.346 . . . . 50.0 113.129 178.532 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.41 -85.47 1.37 Allowed Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.347 -1.101 . . . . 50.0 110.347 172.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -113.24 124.09 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.914 -0.773 . . . . 50.0 108.914 177.072 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 126.257 2.932 . . . . 25.0 111.683 -178.507 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 CA-C-O 124.84 2.355 . . . . 25.0 113.452 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m -147.38 162.8 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.223 -1.489 . . . . 25.0 109.357 -179.35 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.3 ttp -132.67 153.26 51.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 -179.045 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -121.83 142.4 50.27 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 103.555 -2.757 . . . . 50.0 103.555 174.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.53 165.67 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 50.0 115.554 -176.392 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 50.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 50.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 50.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 50.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 50.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 50.0 109.715 175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 50.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 50.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 50.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 50.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 50.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 50.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 50.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 50.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 50.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 50.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 50.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 50.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 50.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 50.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 50.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 50.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 50.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 50.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 50.0 109.599 172.562 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 50.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 50.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 50.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 50.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 50.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 50.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 50.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 50.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 50.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 50.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 50.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 50.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 50.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 50.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 50.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 50.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 50.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 50.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 50.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 50.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 50.0 112.503 178.401 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 50.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -96.49 41.35 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 50.0 113.006 -176.252 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.6 t -106.61 -57.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.014 0.376 . . . . 50.0 112.014 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.42 -97.95 1.61 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 106.909 -2.476 . . . . 25.0 106.909 -170.726 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.33 108.92 3.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.655 0.727 . . . . 25.0 110.478 176.236 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -146.83 149.24 32.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.906 -0.776 . . . . 25.0 108.906 176.132 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -87.19 -25.64 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.971 0.891 . . . . 25.0 109.464 172.01 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -109.84 160.23 16.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.83 -0.623 . . . . 50.0 110.759 -176.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -80.06 157.85 73.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.638 -1.245 . . . . 50.0 107.638 178.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.89 -13.7 37.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 N-CA-C 114.713 1.005 . . . . 50.0 114.713 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.33 35.97 21.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.433 0.901 . . . . 25.0 113.433 176.703 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.3 -178.06 36.73 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.704 -1.758 . . . . 25.0 108.704 179.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.6 m -145.58 165.53 28.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.254 -0.647 . . . . 25.0 109.254 -178.503 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 172.75 40.55 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 107.827 -2.109 . . . . 25.0 107.827 178.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.18 -151.02 7.44 Favored Glycine 0 C--O 1.239 0.431 0 CA-C-N 117.79 0.795 . . . . 25.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 m -143.42 162.34 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.67 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -139.57 109.09 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 109.282 -1.527 . . . . 25.0 109.282 175.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 p -155.27 141.64 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.362 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.1 -3.64 19.3 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.293 -0.48 . . . . 25.0 113.324 -179.427 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.73 150.48 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.493 -0.929 . . . . 50.0 108.493 -177.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 p -141.52 67.47 1.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.749 0.785 . . . . 25.0 110.062 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.6 53.46 2.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.007 -0.997 . . . . 50.0 112.299 -174.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 140.38 15.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.125 -1.805 . . . . 50.0 106.125 -179.28 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.48 146.16 23.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.284 -0.871 . . . . 50.0 110.424 -177.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.67 146.23 46.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.107 -0.497 . . . . 25.0 112.141 -177.2 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.57 167.15 26.33 Favored 'Trans proline' 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 50.0 110.857 174.358 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 50.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 50.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.51 155.88 67.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 50.0 108.943 173.266 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.65 174.76 12.11 Favored 'Trans proline' 0 C--O 1.239 0.572 0 O-C-N 121.878 0.409 . . . . 50.0 112.907 -176.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.3 mt -130.61 161.55 60.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 50.0 111.659 -179.37 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.4 -164.01 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.06 1.84 . . . . 50.0 112.692 177.16 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 62.57 12.26 5.35 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.024 1.329 . . . . 50.0 114.412 178.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.78 6.91 48.87 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.601 -0.727 . . . . 50.0 113.689 176.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 143.68 57.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.604 -1.628 . . . . 50.0 106.604 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 116.549 2.055 . . . . 25.0 116.549 -170.847 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.839 0 CA-C-O 124.34 2.078 . . . . 25.0 115.075 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 150.03 33.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 176.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.34 136.27 39.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 25.0 109.975 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -158.11 140.7 14.57 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 103.421 -2.807 . . . . 50.0 103.421 175.82 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 58.42 175.33 0.06 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 50.0 115.742 177.711 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 50.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 50.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 50.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 50.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 50.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 50.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 50.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 50.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 50.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 50.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 50.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 50.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 50.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 50.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 50.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 50.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 50.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 50.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 50.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 50.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 50.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 50.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 50.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 50.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 50.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 50.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 50.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 50.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 50.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 50.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 50.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 50.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 50.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 50.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 50.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 50.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 50.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 50.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 50.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 50.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 50.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 50.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 50.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 50.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 50.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.56 68.84 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 50.0 108.402 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -27.88 43.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 115.089 1.515 . . . . 50.0 115.089 -173.167 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.1 2.99 67.67 Favored Glycine 0 C--O 1.218 -0.873 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.879 -177.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.8 mmm -88.57 -9.58 51.78 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.133 1.16 . . . . 25.0 114.133 -176.275 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.59 133.22 25.25 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.351 -0.218 . . . . 25.0 110.747 -175.823 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -120.74 179.09 4.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.147 1.166 . . . . 25.0 114.147 -173.789 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 55.08 42.37 30.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.408 1.632 . . . . 50.0 115.408 171.062 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.68 149.31 50.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 105.465 -2.05 . . . . 50.0 105.465 171.038 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 151.79 73.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 117.314 -1.324 . . . . 50.0 111.225 -178.767 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.75 -30.71 0.16 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -176.513 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.28 134.25 12.28 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.305 -0.95 . . . . 25.0 111.588 -178.011 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -100.35 -15.47 17.98 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 117.347 0.573 . . . . 25.0 111.803 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.83 -146.2 14.49 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.565 -1.414 . . . . 25.0 109.565 -175.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.46 175.03 40.88 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 121.697 0.609 . . . . 25.0 114.006 179.099 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -94.4 152.93 18.24 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 122.659 -0.318 . . . . 25.0 110.232 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.35 86.89 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 114.845 0.698 . . . . 25.0 114.845 176.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -58.17 150.99 20.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.802 0.667 . . . . 25.0 112.802 -178.003 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.97 48.86 0.54 Allowed Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.706 -0.958 . . . . 25.0 110.706 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.41 -174.42 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.637 -0.505 . . . . 50.0 109.637 -178.533 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -74.15 -178.77 3.51 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.42 0.688 . . . . 25.0 109.923 177.099 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 62.12 -158.57 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.009 0.924 . . . . 50.0 112.251 175.178 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 48.5 42.22 18.32 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.837 0.827 . . . . 50.0 111.755 -176.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.09 134.86 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.324 -0.853 . . . . 50.0 111.226 -175.324 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.93 148.27 67.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.101 -0.954 . . . . 25.0 112.35 -175.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.05 164.1 36.71 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 O-C-N 121.902 0.422 . . . . 50.0 112.404 175.551 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 50.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 50.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.65 162.21 42.9 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 50.0 109.538 170.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.51 172.77 15.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 N-CA-C 113.566 0.564 . . . . 50.0 113.566 -175.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.09 156.59 79.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.854 -0.795 . . . . 50.0 108.854 178.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.49 -176.59 3.03 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.622 2.214 . . . . 50.0 112.581 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.54 11.91 6.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.835 1.254 . . . . 50.0 113.136 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.78 160.55 41.29 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.427 -1.069 . . . . 50.0 110.427 175.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.79 161.86 18.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.645 0.736 . . . . 50.0 110.982 -178.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 126.171 2.891 . . . . 25.0 112.204 -179.836 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.607 0 CA-C-O 122.895 1.275 . . . . 25.0 115.84 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t 59.2 -155.02 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.726 1.21 . . . . 25.0 108.902 -175.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 42.75 55.23 4.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.456 1.102 . . . . 25.0 113.748 177.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -73.55 132.63 43.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.151 -1.796 . . . . 50.0 106.151 175.038 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 62.63 161.38 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.919 1.387 . . . . 50.0 114.489 -176.401 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 50.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 50.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 50.0 107.868 -179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 50.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 50.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 50.0 109.339 174.879 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 50.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 50.0 110.379 173.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 50.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 50.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 50.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 50.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 50.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 50.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 50.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 50.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 50.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 50.0 108.754 -176.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 50.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 50.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 50.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 50.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 50.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 50.0 108.63 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 50.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 50.0 108.436 173.236 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 50.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 50.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 50.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 50.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 50.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 50.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 50.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 50.0 107.083 178.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 50.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 50.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 50.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 50.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 50.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 50.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 50.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 58' ' ' PRO . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 57' ' ' VAL . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 50.0 111.131 175.101 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 50.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 50.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 50.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 50.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 50.0 109.893 177.578 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 50.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -93.98 97.22 10.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 50.0 106.193 177.65 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.81 -38.24 18.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.899 -0.408 . . . . 50.0 109.899 -174.659 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.91 31.17 62.43 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 110.01 -1.236 . . . . 25.0 110.01 -179.374 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.5 ttm -139.46 -85.24 0.24 Allowed 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.095 0.406 . . . . 25.0 112.095 -176.569 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -90.19 -17.2 27.98 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.666 -0.646 . . . . 25.0 111.392 -177.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 15.93 59.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.657 2.465 . . . . 25.0 117.657 179.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -74.54 -6.88 50.97 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.115 0.783 . . . . 50.0 113.115 -176.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -89.33 137.13 29.3 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 104.973 -2.232 . . . . 50.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.33 161.43 44.42 Favored 'Trans proline' 0 C--O 1.237 0.459 0 N-CA-C 115.682 1.378 . . . . 50.0 115.682 -169.214 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.3 161.68 41.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 102.658 -3.09 . . . . 25.0 102.658 175.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.51 -151.28 22.89 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 107.311 -2.316 . . . . 25.0 107.311 -175.534 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -19.09 64.92 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 112.904 0.705 . . . . 25.0 112.904 178.133 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.61 -43.05 2.5 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 112.179 -0.368 . . . . 25.0 112.179 178.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.64 -173.05 22.52 Favored Glycine 0 C--O 1.225 -0.423 0 N-CA-C 106.84 -2.504 . . . . 25.0 106.84 179.502 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -158.56 144.81 17.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.741 -1.948 . . . . 25.0 105.741 176.072 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.4 69.05 1.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 115.062 0.785 . . . . 25.0 115.062 178.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -143.06 151.63 40.99 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.219 -0.66 . . . . 25.0 109.219 178.267 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.47 28.17 43.56 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.5 1.36 . . . . 25.0 116.5 176.272 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 55.91 34.59 23.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.102 0.561 . . . . 50.0 110.85 -176.187 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 88.12 -6.71 0.55 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.994 2.118 . . . . 25.0 112.852 177.142 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -100.41 153.34 19.42 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.861 -0.792 . . . . 50.0 108.861 174.045 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.59 72.48 1.48 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.953 0.882 . . . . 50.0 108.656 179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.99 142.8 56.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.25 -1.341 . . . . 50.0 111.222 -177.005 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.81 150.04 43.15 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.593 -1.185 . . . . 25.0 113.658 -173.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.53 166.29 30.25 Favored 'Trans proline' 0 C--O 1.243 0.739 0 O-C-N 121.696 0.314 . . . . 50.0 111.757 174.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 50.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 50.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.21 161.84 42.85 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 50.0 110.092 175.623 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.31 175.68 9.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 CA-C-O 121.075 0.365 . . . . 50.0 112.514 -178.002 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.6 mt -131.33 153.42 81.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.6 -1.259 . . . . 75.0 107.6 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.44 167.67 22.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 121.97 1.78 . . . . 50.0 114.273 -178.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.89 90.42 4.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.441 -1.254 . . . . 50.0 107.767 178.393 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.76 -173.3 39.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.23 -0.51 . . . . 50.0 111.869 -177.783 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.92 30.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.405 -1.332 . . . . 50.0 107.405 178.955 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 124.638 2.161 . . . . 25.0 111.253 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 112.509 0.559 . . . . 25.0 112.509 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 25.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 25.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 25.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 25.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 25.0 110.258 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 25.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 25.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 25.0 108.183 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 25.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 25.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 25.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 25.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 25.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 25.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 25.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 25.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 25.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 25.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 25.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 25.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 25.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 25.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 25.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 25.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 25.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 25.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 25.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 25.0 110.803 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 25.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 25.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 25.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 13' ' ' LEU . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 25.0 109.858 173.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 8' ' ' VAL . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 25.0 106.991 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 25.0 106.146 178.37 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 C--O 1.241 0.658 0 CA-C-O 120.713 0.214 . . . . 25.0 111.687 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 25.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 25.0 110.173 175.905 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 25.0 114.947 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 25.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 64' ' ' ILE . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 25.0 108.17 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 25.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 25.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 175.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 25.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 25.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 25.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 25.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 25.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 25.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 25.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 25.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 25.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 25.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 25.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 25.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 25.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 25.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 25.0 108.755 172.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 25.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 25.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 25.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 25.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 25.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 25.0 107.536 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 25.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 25.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 25.0 111.168 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 25.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 25.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 25.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 25.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 25.0 111.348 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 8' ' ' VAL . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 25.0 108.162 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 25.0 109.891 -179.019 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--O 1.241 0.66 0 CA-C-O 120.504 0.127 . . . . 25.0 112.111 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 25.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 25.0 111.462 177.884 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.821 -0.807 . . . . 25.0 108.821 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 25.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 25.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 25.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 25.0 110.187 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 25.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 25.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 25.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 25.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 25.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 25.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 25.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 25.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 25.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 25.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 25.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 25.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 25.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 25.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 25.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 25.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 25.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 25.0 107.054 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 25.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 25.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 25.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 25.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 25.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.925 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 25.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 25.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 25.0 109.146 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 25.0 110.297 -179.339 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo . . . . . 0 C--O 1.242 0.715 0 CA-C-O 120.711 0.213 . . . . 25.0 111.703 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 25.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 25.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 25.0 110.294 176.149 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 112.228 0.455 . . . . 25.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 25.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 25.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 25.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 25.0 109.841 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 25.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 25.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 25.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 25.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 25.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 25.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 25.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 25.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 25.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 25.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 25.0 108.145 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 25.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 25.0 110.161 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 25.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 25.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 25.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 25.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 25.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 25.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 25.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 25.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 25.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 25.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 25.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 25.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 25.0 111.333 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 25.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 25.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 25.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 25.0 109.577 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 25.0 107.449 177.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 112.588 0.188 . . . . 25.0 112.588 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 25.0 111.143 177.327 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 25.0 116.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 25.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 25.0 106.465 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 25.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 25.0 109.776 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 25.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 25.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 25.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 25.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 25.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 25.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 25.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 25.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 25.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 25.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 25.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 25.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 25.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 25.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 25.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 25.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 25.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 25.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 25.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 25.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 25.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 25.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 25.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 25.0 111.228 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 25.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 25.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 25.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 25.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 25.0 110.783 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 8' ' ' VAL . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 177.736 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.572 0.155 . . . . 25.0 111.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 25.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 25.0 111.109 177.569 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--O 1.221 -0.432 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 25.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 25.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 25.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 25.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 25.0 110.438 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 25.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 25.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 25.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 25.0 109.624 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 25.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 25.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 25.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 25.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 25.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 25.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 25.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 25.0 108.502 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 25.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 25.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 25.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 25.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 25.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 25.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 25.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 25.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 25.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 25.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 25.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 25.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 25.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 25.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 25.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 25.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 25.0 111.796 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 HG21 ' A' ' 8' ' ' VAL . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 25.0 109.344 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 25.0 111.106 -178.653 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 25.0 110.779 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 25.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 25.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 25.0 110.478 175.62 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 25.0 115.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 25.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 25.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 25.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 25.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 173.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 25.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 25.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 25.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 25.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 25.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 25.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 25.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 25.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 25.0 109.644 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 25.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 25.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 25.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 25.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 25.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 25.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 25.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 25.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 25.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 25.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 25.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 25.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 25.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 25.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 25.0 111.211 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 25.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 25.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 25.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 25.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 25.0 109.976 174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 25.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 25.0 107.502 177.476 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.241 0.673 0 N-CA-C 110.872 -0.472 . . . . 25.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 25.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 25.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 25.0 109.926 175.839 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.074 0.464 . . . . 25.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 25.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 25.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 25.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 25.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 25.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 25.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 25.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 25.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 25.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 25.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 25.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 25.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 25.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 25.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 25.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 25.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 25.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 25.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 25.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 25.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 25.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 25.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 25.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 25.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 25.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 25.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 25.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 25.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 25.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 25.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 25.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.092 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 25.0 106.674 176.433 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--O 1.241 0.651 0 CA-C-O 120.605 0.169 . . . . 25.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 25.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 25.0 111.453 177.242 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 25.0 113.99 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 25.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 25.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 25.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 25.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 25.0 110.258 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 25.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 25.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 25.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 25.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 25.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 25.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 25.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 25.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 25.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 25.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 25.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 25.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 25.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 25.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 25.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 25.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 25.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 25.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 25.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 25.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 25.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 25.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 25.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 25.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 25.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 25.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 25.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 25.0 112.251 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 25.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.69 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 C--O 1.24 0.608 0 N-CA-C 111.335 -0.294 . . . . 25.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 25.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 25.0 110.468 176.558 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 25.0 115.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 25.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 25.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 25.0 107.621 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 25.0 110.992 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 25.0 110.588 175.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 25.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 25.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 25.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 25.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 25.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 25.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 25.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 25.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 25.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.501 HD11 ' HE2' ' A' ' 11' ' ' LYS . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 25.0 108.303 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 25.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 25.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 25.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 25.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 25.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 25.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 25.0 107.942 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 25.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 25.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 25.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 25.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 25.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 25.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 25.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.727 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 111.403 -0.268 . . . . 25.0 111.403 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 25.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 25.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 25.0 111.019 176.455 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 25.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 25.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 25.0 107.564 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 25.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 25.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 25.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 25.0 108.707 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 25.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 25.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 25.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 25.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 25.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 25.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 25.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 25.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 25.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 25.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 25.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 25.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 25.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 25.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 25.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 25.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 25.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 25.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 25.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 25.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 25.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 25.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 25.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 25.0 109.725 173.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 179.053 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.245 0.836 0 N-CA-C 112.67 0.219 . . . . 25.0 112.67 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 25.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 25.0 109.612 171.287 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 25.0 115.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 25.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 25.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 177.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 25.0 110.681 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 25.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 25.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 25.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 25.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 25.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 25.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 25.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 25.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 25.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 25.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 25.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 25.0 110.396 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 25.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 25.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 25.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 25.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 25.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 25.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 25.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 25.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 25.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 25.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 25.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 25.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 25.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 25.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 25.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 25.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 25.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 25.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 25.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 25.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 25.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 25.0 107.235 176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 CA-C-O 120.634 0.181 . . . . 25.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 25.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 25.0 111.332 178.012 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.907 . . . . 25.0 112.578 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 25.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 25.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 25.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 25.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 25.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 25.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 25.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 25.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 25.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 25.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 25.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 25.0 109.045 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 25.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 25.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 25.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 25.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 25.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 25.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 25.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 25.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 25.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 25.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 25.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 25.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 25.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 25.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 25.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 25.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 25.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 25.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 25.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 25.0 111.422 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 8' ' ' VAL . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.74 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.716 0.215 . . . . 25.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 25.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 25.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 25.0 110.617 175.352 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 25.0 116.134 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 25.0 107.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 25.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 25.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 25.0 110.055 176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 25.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 25.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 25.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 25.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 25.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 25.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 25.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 25.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 25.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 25.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 25.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 25.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 25.0 108.722 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 25.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 25.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 25.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 25.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 25.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 25.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 25.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 25.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 25.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 25.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 25.0 111.105 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 25.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 25.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 25.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 25.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 25.0 110.242 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--O 1.244 0.812 0 N-CA-C 111.507 -0.228 . . . . 25.0 111.507 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 25.0 111.134 177.426 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.926 0.393 . . . . 25.0 110.669 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 25.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 25.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 25.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 25.0 110.504 175.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 25.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 25.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 25.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 25.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 25.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 25.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 25.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 25.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 25.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 25.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 25.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 25.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 25.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 25.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 25.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 25.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 25.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 25.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 25.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 25.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 25.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 25.0 111.851 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 25.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 25.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 25.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 25.0 109.793 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 25.0 111.52 -177.254 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.176 -0.355 . . . . 25.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 25.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 25.0 110.308 176.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 25.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 25.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 25.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 25.0 109.437 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 25.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 25.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 25.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 25.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 25.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 25.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 25.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 25.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 25.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 25.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 25.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 8' ' ' VAL . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 25.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 25.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 25.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 25.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 25.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 25.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 25.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 25.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 25.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 25.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 25.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 25.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 25.0 111.573 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 25.0 109.966 -178.067 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.243 0.741 0 N-CA-C 111.408 -0.266 . . . . 25.0 111.408 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 25.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 25.0 110.197 176.245 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 25.0 116.22 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 25.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 25.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 25.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 25.0 109.711 176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 25.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 25.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 25.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 25.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 25.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 25.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 25.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 25.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 25.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 25.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 172.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 25.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 25.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 25.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 25.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 25.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 25.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 25.0 106.95 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 25.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 25.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 25.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 25.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 25.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 25.0 111.264 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 25.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 25.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 25.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.298 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 177.757 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 CA-C-O 120.825 0.26 . . . . 25.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 25.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 25.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 25.0 109.477 168.586 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.833 0.349 . . . . 25.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 25.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 25.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 25.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 25.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 176.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 25.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 25.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 25.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 25.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 25.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 25.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 25.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 25.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 25.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 25.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 25.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 25.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 25.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 25.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 25.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 25.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 25.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 25.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 25.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 25.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 25.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 25.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 25.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 25.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 25.0 111.433 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 25.0 107.074 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 25.0 111.831 -176.275 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.241 0.671 0 CA-C-O 120.704 0.21 . . . . 25.0 112.31 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 25.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 25.0 110.623 175.48 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 25.0 117.773 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 25.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 25.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 25.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 25.0 109.446 175.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 25.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 25.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 25.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 25.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 25.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 25.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 25.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 25.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' HG13 ' A' ' 57' ' ' VAL . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 25.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 25.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 25.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 25.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 25.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 25.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 8' ' ' VAL . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 25.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 25.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 25.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 25.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 25.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 25.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 25.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 25.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 25.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 26' ' ' PHE . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 25.0 111.164 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 25.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 25.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 25.0 110.635 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG23 HG21 ' A' ' 8' ' ' VAL . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 25.0 108.245 178.592 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 25.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 25.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 25.0 110.384 176.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 25.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 25.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 25.0 108.053 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 25.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 25.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 25.0 109.933 176.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 25.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 25.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 25.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 25.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 25.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 25.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 25.0 107.71 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 25.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 25.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 25.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 25.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 25.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 25.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 25.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 25.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 25.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 25.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 25.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 25.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 25.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 25.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 25.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 25.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 25.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 25.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 25.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 25.0 109.975 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 8' ' ' VAL . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 25.0 109.263 -179.174 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.242 0.678 0 N-CA-C 112.665 0.217 . . . . 25.0 112.665 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 25.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 25.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 25.0 110.486 172.644 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 25.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 25.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 25.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 25.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 175.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 25.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 173.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 25.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 25.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 25.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 25.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 25.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 25.0 110.8 177.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 25.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 25.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 25.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 25.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 25.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 172.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 25.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 25.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 25.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 25.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 25.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 25.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 25.0 112.115 176.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 25.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 25.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 25.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 25.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 25.0 108.803 173.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 25.0 110.858 179.846 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 C--O 1.245 0.84 0 CA-C-O 120.529 0.137 . . . . 25.0 111.765 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 25.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 25.0 110.805 176.686 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 25.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 HG23 ' A' ' 64' ' ' ILE . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 25.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 25.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 25.0 110.391 175.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 25.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 25.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 25.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 25.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 25.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 25.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 25.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 25.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 25.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 25.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 178.594 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 25.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 25.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 25.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 25.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 25.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 25.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 25.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 25.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 25.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 25.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 25.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 25.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 25.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 25.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 25.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 25.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 25.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 25.0 112.284 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.429 HG23 HG21 ' A' ' 8' ' ' VAL . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.746 178.187 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 25.0 110.896 179.848 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 120.667 0.194 . . . . 25.0 112.499 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 25.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 25.0 109.67 169.334 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 25.0 114.869 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 25.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 25.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 25.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 25.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 25.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 25.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 25.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 25.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 25.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 25.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 25.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 25.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 25.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 25.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 25.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 25.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 25.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 25.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 25.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 25.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 25.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 25.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 25.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 25.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 25.0 111.337 176.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 25.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 25.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 25.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 25.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 25.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 25.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 172.788 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 25.0 111.1 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 25.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 25.0 110.528 176.343 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 25.0 115.93 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 25.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 25.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 25.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 25.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 25.0 110.556 176.815 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 25.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 25.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 25.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 25.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 25.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 25.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 25.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 25.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 25.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 25.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 25.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 25.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 25.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 25.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 25.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 25.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 25.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 25.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 25.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 25.0 111.699 176.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 25.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 25.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 25.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 25.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 25.0 111.299 174.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 -179.007 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 C--O 1.24 0.606 0 N-CA-C 110.802 -0.499 . . . . 25.0 110.802 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 25.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 25.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 25.0 111.331 176.967 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.144 1.164 . . . . 25.0 114.144 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 25.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 25.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 179.29 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 25.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 25.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 25.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 25.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 25.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 25.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 25.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 25.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 25.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 25.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 25.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 25.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 25.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 25.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 25.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 25.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 25.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 25.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 25.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 25.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 25.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 25.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 25.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 25.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 25.0 111.091 175.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 25.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 25.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 25.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 25.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 25.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 25.0 111.287 -178.667 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--O 1.242 0.692 0 N-CA-C 112.513 0.159 . . . . 25.0 112.513 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 25.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 25.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 25.0 110.019 170.56 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 25.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 25.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 25.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 176.25 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 25.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 25.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 25.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 25.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 25.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 25.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 25.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 25.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 8' ' ' VAL . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 178.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 25.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 172.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 25.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 25.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 25.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 25.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 25.0 107.154 178.141 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 25.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 25.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 25.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 25.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 25.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 25.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 25.0 110.156 174.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.488 HG23 HG21 ' A' ' 8' ' ' VAL . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 25.0 109.741 179.685 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 C--O 1.243 0.729 0 CA-C-O 120.621 0.175 . . . . 25.0 111.92 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 25.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 25.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 25.0 108.893 167.875 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.456 0.909 . . . . 25.0 113.456 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 25.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 25.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.143 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 25.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 25.0 111.467 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 25.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 25.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.423 ' ND2' ' CE1' ' A' ' 26' ' ' PHE . 21.3 t30 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 -179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 25.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 25.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 25.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 25.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 25.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' ' ND2' ' A' ' 16' ' ' ASN . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -177.034 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 25.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 25.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 25.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 25.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 25.0 108.445 178.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 25.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.394 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 25.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 25.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 25.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 25.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 25.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 25.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 25.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 25.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 25.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 25.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 25.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 25.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 25.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 25.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 25.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 8' ' ' VAL . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 179.057 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.239 0.554 0 CA-C-O 120.666 0.194 . . . . 25.0 112.197 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 25.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 25.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.531 174.931 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.704 0.288 . . . . 25.0 110.463 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 25.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 25.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.057 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 25.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 25.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 175.244 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 25.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 25.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 25.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 25.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 25.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 25.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 25.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 25.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 177.355 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 25.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 25.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 25.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 25.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 25.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 25.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 25.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 25.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 25.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 25.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 25.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 25.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 25.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 25.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 25.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 25.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 25.0 111.508 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 8' ' ' VAL . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 25.0 108.733 175.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 178.618 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 111.666 -0.167 . . . . 25.0 111.666 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 25.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 25.0 110.695 177.055 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 25.0 114.57 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 25.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 178.315 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 25.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 25.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 174.585 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 25.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 25.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 25.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 25.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 25.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 25.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 25.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 25.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 25.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 25.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 25.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 8' ' ' VAL . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 25.0 109.706 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 25.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 25.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 25.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 25.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 25.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 25.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 25.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 25.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 25.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 25.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 25.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 25.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 25.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 25.0 110.939 175.281 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 25.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 25.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 25.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.154 178.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 8' ' ' VAL . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 176.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 178.81 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 25.0 110.955 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 25.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 25.0 111.521 178.161 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 25.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 25.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 25.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 25.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 25.0 110.386 177.042 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 25.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 25.0 109.5 174.487 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 25.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 25.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 25.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 25.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 25.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 25.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 15' ' ' ASP . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 25.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 25.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 25.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 25.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 25.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 173.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 25.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 25.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 25.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 25.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 25.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 25.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 25.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 25.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 25.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 25.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 25.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 25.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 25.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 25.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 25.0 111.004 176.73 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 25.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 25.0 110.797 -178.016 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--O 1.243 0.727 0 CA-C-O 120.874 0.281 . . . . 25.0 111.781 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 25.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 25.0 110.657 177.93 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 25.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 178.125 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 25.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 25.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 176.69 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 25.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 25.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 25.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 25.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 25.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 25.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 25.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 25.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 25.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 25.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 25.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 25.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 25.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 25.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 25.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 25.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 25.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 25.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 25.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 25.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 25.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 25.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 25.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 25.0 111.783 179.521 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.402 HG23 HG21 ' A' ' 8' ' ' VAL . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 25.0 109.171 177.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 179.242 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.887 0.286 . . . . 25.0 112.473 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 25.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 25.0 110.702 176.46 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 25.0 117.069 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 25.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 25.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 25.0 108.563 -177.864 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 25.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 25.0 111.838 178.773 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 25.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 25.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 25.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 25.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 25.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 25.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 25.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 25.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 25.0 110.144 -179.812 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 25.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 25.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 11' ' ' LYS . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 178.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 173.029 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 25.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 25.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 25.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 25.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 25.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 25.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 25.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 25.0 111.633 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 25.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 25.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 25.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 25.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 25.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 25.0 109.702 -179.839 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.242 0.725 0 N-CA-C 111.74 -0.138 . . . . 25.0 111.74 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 25.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 25.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 25.0 110.721 177.263 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 113.077 0.769 . . . . 25.0 113.077 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 25.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 25.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 25.0 108.431 -178.389 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 25.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 176.372 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 25.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 25.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 25.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 25.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 25.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 25.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 25.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 25.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 25.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 25.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 25.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 25.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 8' ' ' VAL . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 178.994 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 25.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.673 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 25.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 25.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 25.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 25.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 25.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 25.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 25.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 25.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 25.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 25.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 25.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 25.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 25.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 25.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 25.0 111.388 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 8' ' ' VAL . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 25.0 108.918 177.249 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 25.0 107.657 178.722 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 C--O 1.242 0.679 0 CA-C-O 120.697 0.207 . . . . 25.0 111.768 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 25.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 25.0 110.848 176.989 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.382 1.252 . . . . 25.0 114.382 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 25.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 25.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 25.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 25.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 176.068 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 25.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 25.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 25.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 25.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 25.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 25.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 25.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 25.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 25.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 25.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 25.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 25.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 25.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 25.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 25.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 25.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 173.668 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 25.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 25.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 25.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 25.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 25.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 25.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 25.0 107.384 179.448 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 25.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 25.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 25.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 25.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 25.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 25.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 25.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 25.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 25.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.294 177.619 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 25.0 108.141 179.713 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.238 0.503 0 N-CA-C 110.929 -0.451 . . . . 25.0 110.929 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 25.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 25.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 25.0 110.959 177.777 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.225 0.536 . . . . 25.0 112.131 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 25.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 25.0 108.747 -178.62 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 25.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 25.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 174.818 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 25.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 25.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 25.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 25.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 25.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 25.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 25.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 25.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 25.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 25.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 25.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 8' ' ' VAL . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.472 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 173.277 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 25.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 25.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 25.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 25.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 25.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 178.103 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 25.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 25.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 25.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 25.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 25.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 25.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 25.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 25.0 109.989 173.815 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.445 HG23 HG21 ' A' ' 8' ' ' VAL . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 176.956 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 177.424 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.242 0.705 0 N-CA-C 110.948 -0.443 . . . . 25.0 110.948 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 25.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 25.0 110.86 177.626 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 25.0 115.144 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 25.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -178.814 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 25.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 25.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 25.0 110.387 175.13 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 25.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 25.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 25.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 25.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 25.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 25.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 25.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 25.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 25.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 178.913 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 25.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 25.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 25.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 25.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 25.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 25.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 25.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 25.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 25.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 25.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 25.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 25.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 25.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 25.0 111.669 178.03 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 25.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -177.2 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--O 1.242 0.71 0 CA-C-O 120.727 0.219 . . . . 25.0 111.861 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 25.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 25.0 109.363 170.328 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 25.0 116.014 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 25.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.793 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 25.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 65' ' ' LEU . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 25.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 25.0 110.531 175.777 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 25.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 25.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 25.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 25.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 25.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 25.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 25.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 25.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 25.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 25.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 25.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 25.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 25.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 179.082 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 25.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 25.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 25.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 25.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 25.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 25.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 25.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 25.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 25.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 25.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 25.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 25.0 110.737 175.658 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 25.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 25.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 25.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 25.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' HB2' HD21 ' A' ' 13' ' ' LEU . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 25.0 110.544 175.657 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 11' ' ' LYS . 56.1 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 25.0 109.849 -179.55 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.245 0.868 0 N-CA-C 111.55 -0.211 . . . . 25.0 111.55 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 25.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 25.0 109.571 169.94 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 25.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 25.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 25.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 25.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 25.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 25.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 25.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 25.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 25.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 25.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 25.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 25.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 25.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 25.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 25.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 25.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 25.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 25.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 25.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 25.0 109.599 172.562 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 25.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 25.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 25.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 25.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 25.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 25.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 25.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 25.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 25.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 25.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 25.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 25.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 25.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 25.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 25.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 25.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 25.0 112.503 178.401 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 25.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -176.252 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 25.0 110.857 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 25.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 25.0 108.943 173.266 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 25.0 115.742 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 25.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 25.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 25.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 25.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 25.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 25.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 25.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 25.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 25.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 25.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 25.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 25.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 25.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 25.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 25.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 25.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 25.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 25.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 25.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 25.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 25.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 25.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 25.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 25.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 25.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 25.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 25.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 25.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 25.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 25.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 25.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 25.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 25.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 25.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 25.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 25.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 -179.454 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 CA-C-O 120.625 0.177 . . . . 25.0 112.404 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 25.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 25.0 109.538 170.684 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 114.489 1.292 . . . . 25.0 114.489 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 25.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -179.82 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 25.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 25.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 25.0 109.339 174.879 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 25.0 110.379 173.846 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 25.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 25.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 25.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 25.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 25.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 25.0 108.754 -176.206 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 25.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 25.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 25.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 178.863 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 173.236 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 25.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 25.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 25.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 25.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.616 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 25.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 25.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 25.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 25.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 25.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 25.0 111.131 175.101 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 25.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 25.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 25.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 25.0 109.893 177.578 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 177.65 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.243 0.739 0 CA-C-O 120.812 0.255 . . . . 25.0 111.757 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 25.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 25.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 25.0 110.092 175.623 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 CA-C-O 123.348 1.527 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -65.99 124.28 22.12 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.897 -1.354 . . . . 25.0 109.741 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttp -78.9 79.72 5.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.786 0.803 . . . . 25.0 111.591 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -80.25 -0.97 38.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.735 -0.666 . . . . 25.0 111.238 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.93 163.67 28.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.509 0.559 . . . . 25.0 112.509 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 25.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 25.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 25.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 25.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 25.0 110.258 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 25.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 25.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 25.0 108.183 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 25.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 25.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 25.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 25.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 25.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 25.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 25.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 25.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 25.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 25.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 25.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 25.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 25.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 25.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 25.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 25.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 25.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 25.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 25.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 25.0 110.803 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 25.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 25.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 25.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 13' ' ' LEU . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 25.0 109.858 173.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 8' ' ' VAL . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 25.0 106.991 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt -93.93 92.53 7.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 25.0 106.146 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.15 102.78 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.471 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.67 27.6 2.54 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 115.099 0.8 . . . . 25.0 115.099 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -85.61 -6.49 59.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -134.22 129.77 36.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 25.0 110.721 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.0 138.32 54.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 25.0 110.424 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -144.72 126.67 15.44 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.168 0.509 . . . . 25.0 110.464 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -85.17 147.91 48.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.026 -1.102 . . . . 25.0 108.026 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.86 160.83 40.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 121.975 0.46 . . . . 25.0 113.28 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.96 53.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.143 0.423 . . . . 25.0 112.143 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.45 77.45 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.144 -0.55 . . . . 25.0 114.303 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 p -77.69 50.95 0.87 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.201 1.186 . . . . 25.0 114.201 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.69 -169.09 53.74 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.14 -0.553 . . . . 25.0 112.33 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.5 31.41 0.25 Allowed Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.654 -0.784 . . . . 25.0 114.704 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -29.87 68.19 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.59 68.78 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.181 -0.533 . . . . 25.0 114.322 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 m -73.36 114.55 11.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.21 0.448 . . . . 25.0 112.21 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.49 98.04 2.06 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.316 -1.914 . . . . 25.0 108.316 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.95 -4.71 56.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.956 0.408 . . . . 25.0 111.507 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.22 164.55 31.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.58 127.93 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -125.87 67.93 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.726 -1.212 . . . . 25.0 107.726 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.85 131.36 49.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 25.0 111.235 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.99 151.92 58.17 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.1 -0.955 . . . . 25.0 111.992 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.08 160.87 48.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 117.494 -1.204 . . . . 25.0 111.687 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 25.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.93 162.73 40.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 25.0 110.173 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.57 175.25 10.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 N-CA-C 113.426 0.51 . . . . 25.0 113.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 mt -133.72 155.7 80.18 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.598 -0.728 . . . . 25.0 109.181 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.3 176.79 9.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.961 2.44 . . . . 25.0 113.795 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.56 38.07 0.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.722 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.7 166.84 12.99 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 114.399 0.519 . . . . 25.0 114.399 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.35 126.51 30.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.763 0.792 . . . . 25.0 110.998 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 124.154 1.931 . . . . 25.0 113.084 179.31 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 CA-C-O 122.969 1.316 . . . . 25.0 114.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p -150.34 152.05 33.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 120.976 -1.308 . . . . 25.0 107.738 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -81.56 91.65 6.4 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -121.14 126.0 48.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 105.937 -1.875 . . . . 25.0 105.937 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 60.35 172.35 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 25.0 114.947 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 25.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 64' ' ' ILE . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 25.0 108.17 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 25.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 25.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 175.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 25.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 25.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 25.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 25.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 25.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 25.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 25.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 25.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 25.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 25.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 25.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 25.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 25.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 25.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 25.0 108.755 172.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 25.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 25.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 25.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 25.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 25.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 25.0 107.536 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 25.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 25.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 25.0 111.168 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 25.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 25.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 25.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 25.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 25.0 111.348 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 8' ' ' VAL . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 25.0 108.162 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.94 82.5 4.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 25.0 109.891 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.33 139.79 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.23 -122.97 0.47 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.559 -0.616 . . . . 25.0 111.559 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.1 39.72 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.172 -0.605 . . . . 25.0 109.834 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -162.58 -61.46 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.42 0.45 . . . . 25.0 109.888 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.31 -27.42 47.23 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.736 0.779 . . . . 25.0 112.014 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.33 163.85 27.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.906 -0.588 . . . . 25.0 111.09 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.71 149.91 88.1 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.801 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.47 161.21 46.22 Favored 'Trans proline' 0 C--N 1.349 0.58 0 N-CA-C 113.58 0.569 . . . . 25.0 113.58 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.99 173.36 16.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.683 -2.339 . . . . 25.0 104.683 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.06 168.38 37.82 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 109.448 -1.461 . . . . 25.0 109.448 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -130.52 -4.68 4.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.372 1.249 . . . . 25.0 114.372 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.93 -149.83 40.14 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.449 -0.881 . . . . 25.0 111.426 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.62 160.07 20.12 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.867 -1.693 . . . . 25.0 108.867 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.5 t -150.64 161.93 41.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.22 138.17 10.08 Favored Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -150.2 156.97 42.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.83 97.59 2.27 Favored Glycine 0 C--O 1.22 -0.756 0 N-CA-C 109.753 -1.339 . . . . 25.0 109.753 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.54 86.8 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.621 0.724 . . . . 25.0 109.656 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 p -112.7 161.84 16.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.62 9.45 5.14 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 25.0 112.364 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -86.96 85.9 7.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.0 mt -72.61 139.12 47.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 25.0 111.332 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.78 145.93 71.55 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.76 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.26 164.84 33.25 Favored 'Trans proline' 0 C--O 1.241 0.66 0 O-C-N 121.587 0.256 . . . . 25.0 112.111 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 25.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.39 161.36 46.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 25.0 111.462 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.28 174.77 12.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 120.386 0.724 . . . . 25.0 113.445 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt -133.9 156.54 79.22 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.84 171.12 18.56 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.5 1.466 . . . . 25.0 112.6 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -99.53 23.46 9.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.685 . . . . 25.0 111.864 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.47 -172.62 36.13 Favored Glycine 0 N--CA 1.456 -0.024 0 C-N-CA 120.943 -0.646 . . . . 25.0 112.117 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.09 105.52 2.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.02 0.914 . . . . 25.0 109.463 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 123.986 1.851 . . . . 25.0 113.804 -175.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 123.098 1.388 . . . . 25.0 115.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -144.9 133.4 21.96 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.971 -1.311 . . . . 25.0 108.945 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.3 mtp -134.4 154.98 51.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.47 -23.24 13.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.324 0.583 . . . . 25.0 110.845 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -146.95 178.96 7.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.455 -1.248 . . . . 25.0 108.821 -173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 25.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 25.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 25.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 25.0 110.187 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 25.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 25.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 25.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 25.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 25.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 25.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 25.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 25.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 25.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 25.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 25.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 25.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 25.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 25.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 25.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 25.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 25.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 25.0 107.054 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 25.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 25.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 25.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 25.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 25.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.925 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 25.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 25.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 25.0 109.146 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.0 91.44 6.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 25.0 110.297 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -84.01 0.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.919 0.866 . . . . 25.0 108.815 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 -70.44 3.13 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.979 -0.555 . . . . 25.0 112.359 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.4 ttp -72.3 -32.91 67.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 25.0 110.123 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.59 101.94 13.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -147.43 173.48 12.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.893 -2.632 . . . . 25.0 103.893 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.79 132.79 20.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.891 -0.781 . . . . 25.0 108.891 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.9 149.1 97.91 Favored Pre-proline 0 C--O 1.241 0.631 0 CA-C-N 115.969 -0.559 . . . . 25.0 109.92 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.47 -179.83 4.84 Favored 'Trans proline' 0 C--N 1.349 0.604 0 O-C-N 122.299 0.631 . . . . 25.0 110.851 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.49 68.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.07 45.58 8.87 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.494 -0.86 . . . . 25.0 114.022 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.8 t -59.07 136.81 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.846 -0.427 . . . . 25.0 109.846 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.47 25.32 21.36 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 116.518 -0.31 . . . . 25.0 113.439 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.25 128.84 19.64 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.654 -0.978 . . . . 25.0 110.654 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -72.56 -24.18 61.08 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.541 0.686 . . . . 25.0 111.291 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.62 -177.71 40.3 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.537 -2.225 . . . . 25.0 107.537 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.7 p -68.56 140.05 55.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.533 0.667 . . . . 25.0 109.507 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.96 72.09 0.18 Allowed Glycine 0 C--O 1.22 -0.756 0 N-CA-C 110.876 -0.89 . . . . 25.0 110.876 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.4 mt 56.76 47.27 18.46 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.133 0.968 . . . . 25.0 110.177 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -123.16 129.24 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.616 -1.174 . . . . 25.0 108.188 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.77 150.62 47.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 25.0 111.266 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.93 97.71 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.27 132.28 46.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 25.0 110.373 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.27 149.56 65.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.604 -0.725 . . . . 25.0 109.98 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.82 158.98 54.08 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 116.75 -1.7 . . . . 25.0 111.703 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 25.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 25.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 161.01 46.55 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 25.0 110.294 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.22 175.48 10.49 Favored 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 113.207 0.426 . . . . 25.0 113.207 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -133.96 155.26 80.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.714 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 178.3 7.76 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.997 2.465 . . . . 25.0 112.846 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 34.04 0.21 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.75 0.82 . . . . 25.0 111.984 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.95 -173.24 27.75 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 122.189 -0.32 . . . . 25.0 113.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -68.51 130.4 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.805 0.812 . . . . 25.0 109.772 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.213 -0.845 0 CA-C-O 125.57 2.605 . . . . 25.0 111.248 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 123.144 1.413 . . . . 25.0 115.588 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -68.43 116.66 9.24 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.173 -1.192 . . . . 25.0 110.908 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -70.89 135.22 47.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 25.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -135.25 11.86 3.54 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.01 -0.541 . . . . 25.0 110.822 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.03 168.64 19.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.228 -172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 25.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 25.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 25.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 25.0 109.841 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 25.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 25.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 25.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 25.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 25.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 25.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 25.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 25.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 25.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 25.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 25.0 108.145 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 25.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 25.0 110.161 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 25.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 25.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 25.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 25.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 25.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 25.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 25.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 25.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 25.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 25.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 25.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 25.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 25.0 111.333 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 25.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 25.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 25.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 25.0 109.577 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.74 90.15 6.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 25.0 107.449 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.87 -26.08 33.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.261 -0.881 . . . . 25.0 110.578 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.21 -101.73 0.84 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 111.459 -0.657 . . . . 25.0 111.459 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.97 -16.4 62.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.163 0.431 . . . . 25.0 112.163 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -91.08 116.49 28.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 25.0 110.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.88 157.58 45.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -86.52 3.13 45.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 25.0 111.441 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -122.48 138.61 29.5 Favored Pre-proline 0 C--O 1.222 -0.393 0 N-CA-C 107.506 -1.294 . . . . 25.0 107.506 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.79 -1.82 11.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 N-CA-C 114.85 1.058 . . . . 25.0 114.85 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.5 25.48 2.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.99 0.424 . . . . 25.0 110.983 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.41 -161.71 54.41 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.488 -0.863 . . . . 25.0 113.428 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.92 130.38 39.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 25.0 112.276 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.37 60.28 4.85 Favored Glycine 0 C--O 1.224 -0.469 0 CA-C-N 116.235 -0.438 . . . . 25.0 112.237 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -155.36 53.4 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.933 -0.651 . . . . 25.0 111.738 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -153.46 149.28 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.706 -1.22 . . . . 25.0 107.706 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.57 87.57 1.8 Allowed Glycine 0 C--O 1.218 -0.868 0 N-CA-C 111.719 -0.552 . . . . 25.0 111.719 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -87.26 11.46 14.18 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 113.724 1.009 . . . . 25.0 113.724 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.52 -26.46 5.16 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 121.355 -0.45 . . . . 25.0 113.451 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.58 -36.57 78.85 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.283 0.475 . . . . 25.0 112.283 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m 70.59 -25.45 0.16 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.772 1.229 . . . . 25.0 113.935 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.98 155.88 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.212 -1.032 . . . . 25.0 108.212 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -157.59 100.23 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.02 130.67 43.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.52 0.676 . . . . 25.0 111.111 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.58 150.81 63.9 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.452 -0.795 . . . . 25.0 112.097 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.84 164.06 36.88 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 119.946 0.43 . . . . 25.0 112.588 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.08 162.76 40.43 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 25.0 111.143 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.9 172.32 16.56 Favored 'Trans proline' 0 C--N 1.346 0.442 0 N-CA-C 113.619 0.584 . . . . 25.0 113.619 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -133.88 156.11 79.65 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.704 -0.68 . . . . 25.0 110.955 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.85 169.97 18.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.375 2.05 . . . . 25.0 113.527 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -86.0 54.44 3.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.997 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.66 33.94 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 115.074 0.79 . . . . 25.0 115.074 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.47 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 25.0 111.295 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.215 -0.73 0 CA-C-O 124.377 2.037 . . . . 25.0 111.177 -178.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 122.994 1.33 . . . . 25.0 115.312 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -150.93 157.17 42.56 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 89.7 mtp -92.45 137.22 32.55 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.158 -1.052 . . . . 25.0 108.158 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -86.97 152.48 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 60.0 166.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 25.0 116.518 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 25.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 25.0 106.465 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 25.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 25.0 109.776 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 25.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 25.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 25.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 25.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 25.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 25.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 25.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 25.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 25.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 25.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 25.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 25.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 25.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 25.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 25.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 25.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 25.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 25.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 25.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 25.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 25.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 25.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 25.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 25.0 111.228 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 25.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 25.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 25.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 25.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 25.0 110.783 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 8' ' ' VAL . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.57 90.77 7.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 68' ' ' MET . 16.8 m -63.13 -12.32 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 114.805 1.409 . . . . 25.0 114.805 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.34 -7.79 29.11 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 121.635 -0.317 . . . . 25.0 113.765 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.447 ' H ' HG23 ' A' ' 66' ' ' VAL . 91.5 mmm -107.24 -54.25 2.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.537 0.94 . . . . 25.0 113.537 -175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -139.67 32.31 2.04 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.741 1.015 . . . . 25.0 113.741 -171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.29 138.05 58.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 25.0 110.703 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -74.76 108.41 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.39 143.18 80.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 25.0 110.507 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.48 168.4 23.84 Favored 'Trans proline' 0 C--N 1.347 0.462 0 O-C-N 122.128 0.541 . . . . 25.0 113.065 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.31 33.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.52 177.1 24.97 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.359 -1.096 . . . . 25.0 110.359 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 m -75.64 133.9 40.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.683 -0.488 . . . . 25.0 109.683 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.54 73.21 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.663 -0.78 . . . . 25.0 113.564 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -77.53 -10.0 86.51 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.088 -0.577 . . . . 25.0 112.339 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 m -105.31 35.36 2.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.294 0.568 . . . . 25.0 110.468 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -8.54 66.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.273 0.869 . . . . 25.0 115.273 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.333 0.567 . . . . 25.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.52 179.25 29.67 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 123.524 0.515 . . . . 25.0 113.323 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.26 141.38 33.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.554 -2.017 . . . . 25.0 105.554 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.4 p -126.84 98.64 5.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 60.61 13.66 4.4 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.557 1.143 . . . . 25.0 112.907 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 78.81 9.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 25.0 110.957 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.22 137.06 41.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.42 145.5 79.59 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 25.0 110.726 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.88 164.66 34.05 Favored 'Trans proline' 0 C--O 1.24 0.586 0 O-C-N 121.78 0.358 . . . . 25.0 111.926 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 25.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.98 162.99 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 25.0 111.109 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.96 173.92 12.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 O-C-N 122.027 0.488 . . . . 25.0 113.096 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.72 156.97 78.96 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.38 167.68 26.58 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.836 1.691 . . . . 25.0 112.913 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -117.23 72.11 0.82 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.684 -1.143 . . . . 25.0 110.099 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.53 176.3 47.98 Favored Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 120.756 -0.735 . . . . 25.0 111.426 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -137.7 156.95 47.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 124.312 2.006 . . . . 25.0 113.347 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 122.758 1.199 . . . . 25.0 115.869 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t 58.27 -161.89 0.23 Allowed 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.348 1.059 . . . . 25.0 109.869 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.9 ttp -136.46 65.79 1.51 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 59.84 -107.64 0.34 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.3 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -104.03 169.21 8.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 25.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 25.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 25.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 25.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 25.0 110.438 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 25.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 25.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 25.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 25.0 109.624 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 25.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 25.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 25.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 25.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 25.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 25.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 25.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 25.0 108.502 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 25.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 25.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 25.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 25.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 25.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 25.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 25.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 25.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 25.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 25.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 25.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 25.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 25.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 25.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 25.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 25.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 25.0 111.796 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 HG21 ' A' ' 8' ' ' VAL . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 25.0 109.344 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt -94.43 72.88 3.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 25.0 111.106 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.2 m -72.03 -7.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.89 -113.57 4.55 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.8 mmm -91.96 156.05 17.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 25.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -117.17 26.7 9.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.678 -0.692 . . . . 25.0 112.07 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.05 29.72 16.98 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.133 1.445 . . . . 25.0 109.874 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -154.71 152.3 29.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.69 151.04 73.55 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.696 -1.224 . . . . 25.0 107.696 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.15 156.24 62.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 115.853 -2.298 . . . . 25.0 112.508 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.4 36.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.497 -0.927 . . . . 25.0 108.497 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.8 -30.7 46.93 Favored Glycine 0 C--O 1.221 -0.676 0 N-CA-C 114.947 0.739 . . . . 25.0 114.947 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 m 51.22 30.8 6.11 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.387 1.625 . . . . 25.0 115.387 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.22 161.44 54.33 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 -0.12 71.06 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.233 -0.747 . . . . 25.0 111.233 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 p -82.76 153.56 25.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.92 -0.77 . . . . 25.0 108.92 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.38 170.29 12.67 Favored Glycine 0 C--O 1.227 -0.321 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.9 t -163.75 -58.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.44 0.62 . . . . 25.0 109.921 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.07 -166.82 32.94 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 108.691 -1.764 . . . . 25.0 108.691 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.95 144.11 56.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -133.36 144.87 49.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -131.17 125.11 32.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.986 -0.746 . . . . 25.0 108.986 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.29 110.73 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.71 141.73 40.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.238 0.542 . . . . 25.0 109.57 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.49 145.86 72.54 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.803 -0.635 . . . . 25.0 112.039 -175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.62 166.12 30.79 Favored 'Trans proline' 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 25.0 110.779 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 25.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 25.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.02 161.25 46.59 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 25.0 110.478 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.1 172.75 15.74 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.549 0.557 . . . . 25.0 113.549 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.1 mt -133.99 155.46 80.15 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.837 -0.619 . . . . 25.0 111.294 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.0 172.25 15.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.14 1.893 . . . . 25.0 112.255 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -87.05 48.12 1.6 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.978 -0.555 . . . . 25.0 111.544 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.01 -132.58 11.17 Favored Glycine 0 C--O 1.233 0.085 0 C-N-CA 120.862 -0.685 . . . . 25.0 111.759 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -62.84 114.44 3.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.475 0.655 . . . . 25.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.172 1.789 . . . . 25.0 111.726 -177.254 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 123.266 1.481 . . . . 25.0 115.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 t -76.85 129.39 36.16 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.144 -1.21 . . . . 25.0 109.089 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -97.32 166.21 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.49 -0.559 . . . . 25.0 109.49 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -120.69 122.16 39.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 59.18 164.53 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 25.0 115.629 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 25.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 25.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 25.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 25.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 173.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 25.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 25.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 25.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 25.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 25.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 25.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 25.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 25.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 25.0 109.644 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 25.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 25.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 25.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 25.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 25.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 25.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 25.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 25.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 25.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 25.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 25.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 25.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 25.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 25.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 25.0 111.211 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 25.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 25.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 25.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 25.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 25.0 109.976 174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 25.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt -103.47 101.12 11.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 25.0 107.502 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.49 151.92 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.04 155.53 27.6 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.497 -1.441 . . . . 25.0 109.497 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 9.2 ttp 59.7 -162.56 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.271 0.628 . . . . 25.0 111.661 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 68' ' ' MET . 29.6 m-85 55.66 -149.48 0.45 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.796 0.838 . . . . 25.0 111.444 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 40.25 37.98 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.952 2.575 . . . . 25.0 117.952 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -76.94 67.91 3.03 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.841 -0.537 . . . . 25.0 111.951 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -138.1 156.19 74.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.01 -11.08 18.01 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 114.728 1.011 . . . . 25.0 114.728 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.51 142.48 30.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.945 -0.391 . . . . 25.0 109.945 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.6 -156.96 16.44 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.331 -0.462 . . . . 25.0 112.464 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m 55.41 -92.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.948 1.462 . . . . 25.0 114.948 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.85 47.49 3.82 Favored Glycine 0 C--O 1.221 -0.663 0 N-CA-C 114.276 0.471 . . . . 25.0 114.276 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.01 79.31 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.0 t -153.3 142.25 21.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.47 7.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.035 -0.602 . . . . 25.0 114.511 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -143.08 8.11 1.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.78 -74.64 2.44 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 111.363 -0.695 . . . . 25.0 111.363 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 54.22 38.8 29.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.052 0.941 . . . . 25.0 111.55 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.1 t -152.08 167.25 29.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -123.52 120.64 33.49 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 104.886 -2.265 . . . . 25.0 104.886 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -138.77 103.06 4.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.43 130.72 44.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.738 -0.665 . . . . 25.0 109.276 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.42 147.73 95.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.313 -0.858 . . . . 25.0 112.564 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.31 160.56 49.11 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 118.139 -0.774 . . . . 25.0 110.872 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 25.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 25.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.42 162.6 39.97 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 25.0 109.926 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.79 173.19 14.37 Favored 'Trans proline' 0 C--N 1.346 0.441 0 N-CA-C 113.242 0.439 . . . . 25.0 113.242 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.9 155.69 80.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 25.0 110.101 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 171.89 17.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.605 1.536 . . . . 25.0 112.074 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -90.42 30.36 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.743 0.782 . . . . 25.0 110.397 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.82 10.67 69.28 Favored Glycine 0 CA--C 1.516 0.132 0 CA-C-N 115.905 -0.588 . . . . 25.0 112.495 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -77.08 178.62 6.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.777 0.799 . . . . 25.0 110.335 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.213 -0.844 0 CA-C-O 125.633 2.635 . . . . 25.0 111.996 177.2 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 123.392 1.551 . . . . 25.0 115.383 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 m -84.61 125.17 32.22 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 120.684 -1.48 . . . . 25.0 111.17 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.3 ptp -101.42 108.31 19.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -108.12 16.75 23.03 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -134.35 164.46 27.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.079 -0.964 . . . . 25.0 110.665 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 25.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 25.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 25.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 25.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 25.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 25.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 25.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 25.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 25.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 25.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 25.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 25.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 25.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 25.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 25.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 25.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 25.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 25.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 25.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 25.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 25.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 25.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 25.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 25.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 25.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 25.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 25.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 25.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 25.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 25.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 25.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.092 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.04 94.84 7.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 25.0 106.674 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.17 133.82 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.288 -1.004 . . . . 25.0 108.288 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.8 154.35 26.74 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 109.04 -1.624 . . . . 25.0 109.04 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.0 ttt 70.14 160.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.411 1.084 . . . . 25.0 110.886 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 59.75 -167.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.705 0.802 . . . . 25.0 113.039 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 t0 59.04 177.32 0.07 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.188 1.551 . . . . 25.0 115.188 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.47 113.45 26.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -60.59 145.14 87.96 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.16 150.84 66.38 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 117.785 -1.01 . . . . 25.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.9 139.3 20.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.924 -1.509 . . . . 25.0 106.924 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 159.77 26.36 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 111.112 -0.795 . . . . 25.0 111.112 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 m -106.6 1.67 25.43 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.254 0.465 . . . . 25.0 112.254 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.52 -178.77 42.49 Favored Glycine 0 C--O 1.231 -0.047 0 C-N-CA 121.058 -0.591 . . . . 25.0 113.429 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.1 -93.99 0.79 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.618 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.1 p -75.37 -16.51 60.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.7 -0.294 . . . . 25.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.52 36.14 3.58 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 111.792 -0.523 . . . . 25.0 111.792 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -69.0 153.68 43.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.64 152.25 51.42 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 109.674 -1.37 . . . . 25.0 109.674 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.93 150.93 51.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -109.74 -29.5 8.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -139.73 154.42 47.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -157.36 96.88 1.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.719 -1.215 . . . . 25.0 107.719 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.17 118.8 31.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.474 0.654 . . . . 25.0 110.08 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.92 142.15 76.05 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.452 -0.794 . . . . 25.0 111.996 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.74 164.99 32.5 Favored 'Trans proline' 0 C--O 1.241 0.651 0 O-C-N 121.597 0.262 . . . . 25.0 112.474 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 25.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.54 161.95 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 25.0 111.453 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.64 176.96 9.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 120.219 0.613 . . . . 25.0 113.462 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 mt -133.48 153.77 80.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 25.0 109.843 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.5 171.69 15.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.204 2.603 . . . . 25.0 113.773 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -91.57 41.78 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.563 -0.744 . . . . 25.0 111.854 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.15 -175.04 31.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 114.737 0.655 . . . . 25.0 114.737 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.21 124.59 24.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.735 0.778 . . . . 25.0 110.456 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 124.628 2.156 . . . . 25.0 113.068 179.076 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 115.47 0.948 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.11 16.36 4.75 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.137 1.532 . . . . 25.0 115.137 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -108.6 137.4 46.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.741 0.305 . . . . 25.0 110.289 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -146.08 144.29 29.92 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.092 -2.559 . . . . 25.0 104.092 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 56.02 176.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 25.0 113.99 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 25.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 25.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 25.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 25.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 25.0 110.258 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 25.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 25.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 25.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 25.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 25.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 25.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 25.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 25.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 25.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 25.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 25.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 25.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 25.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 25.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 25.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 25.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 25.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 25.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 25.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 25.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 25.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 25.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 25.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 25.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 25.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 25.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 25.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 25.0 112.251 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 25.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -96.85 92.8 6.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.94 5.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.104 0.779 . . . . 25.0 113.104 -176.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.65 -12.61 27.41 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 114.732 0.653 . . . . 25.0 114.732 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.35 -5.33 57.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.186 0.81 . . . . 25.0 113.186 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -142.34 151.72 42.21 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.977 -0.452 . . . . 25.0 112.156 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.17 157.5 45.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 172.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -160.37 106.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.349 -0.611 . . . . 25.0 109.349 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.63 140.92 68.37 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.26 108.94 2.71 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.269 -0.687 . . . . 25.0 112.648 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.07 154.62 31.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.792 -1.188 . . . . 25.0 107.792 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.35 174.22 20.62 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 112.032 -0.427 . . . . 25.0 112.032 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 p -80.0 164.99 23.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.97 3.13 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 121.33 -0.462 . . . . 25.0 112.704 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.59 10.3 8.94 Favored Glycine 0 C--O 1.219 -0.839 0 CA-C-O 121.439 0.466 . . . . 25.0 112.939 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m -88.6 -9.47 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.07 0.548 . . . . 25.0 110.415 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.26 157.92 24.33 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.544 -1.022 . . . . 25.0 110.544 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -68.79 -26.58 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.227 0.513 . . . . 25.0 111.815 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.69 151.96 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.889 -2.485 . . . . 25.0 106.889 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.9 mt -153.36 -47.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.799 0.799 . . . . 25.0 110.609 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -136.99 165.97 24.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.611 -1.625 . . . . 25.0 106.611 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.26 156.39 44.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.502 0.501 . . . . 25.0 109.798 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -121.07 93.62 4.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.35 135.66 53.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.487 0.661 . . . . 25.0 109.272 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.82 149.13 87.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.472 -0.785 . . . . 25.0 112.749 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -69.56 164.97 32.32 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 121.761 0.348 . . . . 25.0 111.335 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 25.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.35 161.34 45.19 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 25.0 110.468 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.03 174.9 11.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 N-CA-C 113.328 0.472 . . . . 25.0 113.328 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -133.92 153.46 79.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.025 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.49 177.37 8.2 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.957 2.438 . . . . 25.0 111.293 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -91.3 27.02 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.427 0.632 . . . . 25.0 110.622 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.44 177.54 16.92 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 111.423 -0.671 . . . . 25.0 111.423 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.44 142.25 51.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 124.159 1.933 . . . . 25.0 113.057 -176.407 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 CA-C-O 123.243 1.468 . . . . 25.0 115.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 p -65.06 129.1 38.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.071 -1.252 . . . . 25.0 111.149 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ttt 52.54 52.76 13.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.007 0.817 . . . . 25.0 112.735 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -116.55 140.55 49.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 61.38 168.44 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 25.0 115.209 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 25.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 25.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 25.0 107.621 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 25.0 110.992 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 25.0 110.588 175.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 25.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 25.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 25.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 25.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 25.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 25.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 25.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 25.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 25.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD11 ' HE2' ' A' ' 11' ' ' LYS . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 25.0 108.303 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 25.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 25.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 25.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 25.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 25.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 25.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 25.0 107.942 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 25.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 25.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 25.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 25.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 25.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 25.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 25.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.727 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.31 75.25 3.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.31 -26.9 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.407 0.623 . . . . 25.0 110.142 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.66 -28.03 6.13 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.145 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.5 ttm -74.33 30.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.612 1.165 . . . . 25.0 113.479 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -140.26 127.18 20.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.851 -0.531 . . . . 25.0 109.977 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -71.45 -29.56 65.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 25.0 111.96 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -76.16 59.52 1.36 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.196 0.998 . . . . 25.0 112.002 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -78.15 147.25 72.7 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 106.788 -1.56 . . . . 25.0 106.788 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.21 -15.34 35.37 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 118.103 -0.798 . . . . 25.0 113.976 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.89 -24.33 67.7 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.21 -0.306 . . . . 25.0 111.194 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.28 -1.86 90.23 Favored Glycine 0 C--O 1.219 -0.785 0 C-N-CA 121.008 -0.615 . . . . 25.0 113.284 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 t -86.67 -11.54 50.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.251 0.525 . . . . 25.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.79 -155.07 52.72 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.195 -0.762 . . . . 25.0 111.195 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.64 148.9 20.28 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 106.141 -2.783 . . . . 25.0 106.141 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 t -158.62 170.58 21.86 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.22 151.54 8.44 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.66 -0.976 . . . . 25.0 110.66 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.04 29.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.863 0.84 . . . . 25.0 109.661 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.81 -176.93 39.34 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 106.782 -2.527 . . . . 25.0 106.782 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.77 -45.2 90.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.911 0.855 . . . . 25.0 110.871 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.17 171.23 0.15 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.101 0.96 . . . . 25.0 111.501 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -130.64 139.1 50.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.984 -0.746 . . . . 25.0 108.984 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -150.16 91.39 1.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.874 -1.158 . . . . 25.0 107.874 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.346 0.593 . . . . 25.0 110.419 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.67 149.53 80.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.351 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.95 161.66 45.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 117.166 -1.422 . . . . 25.0 111.403 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 25.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 25.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.68 160.59 49.17 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 25.0 111.019 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.41 175.28 11.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 N-CA-C 113.672 0.605 . . . . 25.0 113.672 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.1 mt -133.88 155.47 80.24 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 25.0 110.724 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.03 168.36 23.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.272 1.981 . . . . 25.0 113.323 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.22 43.24 1.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.97 -1.014 . . . . 25.0 112.11 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.54 -159.3 14.97 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.274 -0.489 . . . . 25.0 113.324 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.11 115.16 6.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.008 0.909 . . . . 25.0 110.093 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.557 1.246 0 CA-C-O 124.57 2.128 . . . . 25.0 114.513 -176.759 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 CA-C-O 124.58 2.211 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.95 150.45 48.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.975 -1.612 . . . . 25.0 110.171 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpt 52.96 38.62 27.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.026 0.75 . . . . 25.0 113.026 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -89.51 14.67 10.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.635 -0.666 . . . . 25.0 110.981 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.0 161.14 35.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 25.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 25.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 25.0 107.564 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 25.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 25.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 25.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 25.0 108.707 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 25.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 25.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 25.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 25.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 25.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 25.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 25.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 25.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 25.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 25.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 25.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 25.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 25.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 25.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 25.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 25.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 25.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 25.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 25.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 25.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 25.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 25.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 25.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 25.0 109.725 173.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.23 91.65 7.35 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.4 130.13 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 173.05 43.42 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.895 -0.669 . . . . 25.0 112.066 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 74.23 -44.4 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.253 1.421 . . . . 25.0 112.474 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.3 -179.32 7.05 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.269 0.628 . . . . 25.0 110.159 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 53.91 33.79 18.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.67 1.224 . . . . 25.0 112.708 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -73.4 99.75 3.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.088 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 74.26 158.08 0.16 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 125.715 1.606 . . . . 25.0 108.311 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.46 48.0 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 N-CA-C 115.188 1.188 . . . . 25.0 115.188 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 137.73 52.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.23 -49.14 3.94 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.201 -0.523 . . . . 25.0 113.546 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -75.08 -24.37 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.704 0.752 . . . . 25.0 111.578 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.74 -40.6 2.78 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 113.886 0.314 . . . . 25.0 113.886 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.62 -131.32 1.76 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.207 -1.157 . . . . 25.0 110.207 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.9 m -142.34 146.43 34.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.89 151.49 16.97 Favored Glycine 0 C--O 1.23 -0.126 0 C-N-CA 121.149 -0.548 . . . . 25.0 111.889 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 64.84 0.94 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.06 -0.719 . . . . 25.0 109.06 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.83 94.98 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 120.744 -0.741 . . . . 25.0 113.035 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 mt 52.3 35.9 18.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.366 0.876 . . . . 25.0 113.366 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.44 -60.67 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.812 0.339 . . . . 25.0 110.449 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.5 149.02 20.13 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.728 -2.323 . . . . 25.0 104.728 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.69 111.99 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.19 119.76 31.55 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.166 0.507 . . . . 25.0 110.452 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.19 145.63 86.03 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.089 -0.505 . . . . 25.0 109.994 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.73 160.98 40.21 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 118.662 -0.426 . . . . 25.0 112.67 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 25.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.14 161.52 45.53 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 25.0 109.612 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.91 174.79 11.35 Favored 'Trans proline' 0 C--N 1.35 0.632 0 N-CA-C 113.524 0.548 . . . . 25.0 113.524 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.96 156.69 79.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.613 -0.721 . . . . 25.0 109.267 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.04 -163.19 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.561 2.84 . . . . 25.0 113.37 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 75.98 -1.62 2.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.293 1.837 . . . . 25.0 113.669 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.72 85.17 0.07 OUTLIER Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.545 -1.207 . . . . 25.0 115.912 171.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.35 129.25 37.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.752 0.787 . . . . 25.0 109.587 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.213 -0.862 0 CA-C-O 124.478 2.085 . . . . 25.0 113.201 -179.334 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 CA-C-O 124.868 2.371 . . . . 25.0 113.246 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -77.34 166.49 23.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.725 -1.738 . . . . 25.0 109.98 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.2 tpp 58.06 48.46 13.09 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -65.63 134.64 53.7 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.232 -1.395 . . . . 25.0 107.232 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 63.26 161.22 0.09 Allowed 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 25.0 115.276 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 25.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 25.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 177.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 25.0 110.681 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 25.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 25.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 25.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 25.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 25.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 25.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 25.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 25.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 25.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 25.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 25.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 25.0 110.396 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 25.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 25.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 25.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 25.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 25.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 25.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 25.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 25.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 25.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 25.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 25.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 25.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 25.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 25.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 25.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 25.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 25.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 25.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 25.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 25.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 25.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 25.0 107.235 176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.39 88.54 7.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.0 114.12 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.282 -0.872 . . . . 25.0 109.179 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.96 -175.31 46.77 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 110.07 -1.212 . . . . 25.0 110.07 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ptp 65.37 -6.22 0.4 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.765 1.765 . . . . 25.0 115.765 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -105.32 -4.91 20.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.365 0.602 . . . . 25.0 109.873 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.85 154.86 25.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.49 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -144.08 -33.35 0.41 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.337 1.236 . . . . 25.0 114.337 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.73 145.79 32.71 Favored Pre-proline 0 C--O 1.22 -0.494 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 7.51 3.94 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 113.941 0.708 . . . . 25.0 113.941 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.14 132.47 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.053 -0.351 . . . . 25.0 110.053 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.13 164.83 37.2 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 121.036 -0.602 . . . . 25.0 112.191 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -70.2 -24.79 63.17 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.919 0.711 . . . . 25.0 112.919 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.04 -171.27 50.43 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.894 -0.669 . . . . 25.0 112.974 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.49 146.25 5.61 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 109.493 -1.443 . . . . 25.0 109.493 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -73.61 -42.68 61.18 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.3 3.92 27.36 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.958 1.143 . . . . 25.0 115.958 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -84.95 3.96 35.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.89 1.441 . . . . 25.0 114.89 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.18 23.29 71.69 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.892 -0.671 . . . . 25.0 113.657 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.7 124.03 19.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.32 11.13 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.212 1.19 . . . . 25.0 114.212 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.88 -178.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 25.0 111.568 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -152.87 99.92 2.47 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.362 -0.836 . . . . 25.0 111.591 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.58 142.82 44.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.287 0.565 . . . . 25.0 110.517 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.61 148.21 41.36 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 113.528 0.936 . . . . 25.0 113.528 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.59 167.12 27.84 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.175 1.25 . . . . 25.0 112.214 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 25.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.95 162.27 42.81 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 25.0 111.332 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.23 174.59 12.54 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 120.341 0.694 . . . . 25.0 113.66 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -134.01 155.84 79.77 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 123.07 0.548 . . . . 25.0 111.081 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.66 177.15 8.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.1 2.534 . . . . 25.0 112.043 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.08 32.89 3.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.798 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.55 171.08 44.26 Favored Glycine 0 C--O 1.229 -0.218 0 C-N-CA 120.511 -0.852 . . . . 25.0 113.798 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -75.82 106.81 7.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.454 0.645 . . . . 25.0 109.346 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.213 -0.866 0 CA-C-O 123.404 1.573 . . . . 25.0 112.042 -178.571 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 CA-C-O 122.775 1.208 . . . . 25.0 115.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -135.77 162.05 33.86 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.492 -1.005 . . . . 25.0 108.667 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.2 ttt -172.27 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.549 0.69 . . . . 25.0 110.25 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.84 136.22 34.7 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 102.541 -3.133 . . . . 25.0 102.541 173.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 62.54 161.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.428 1.705 . . . . 25.0 112.578 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 25.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 25.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 25.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 25.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 25.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 25.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 25.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 25.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 25.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 25.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 25.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 25.0 109.045 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 25.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 25.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 25.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 25.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 25.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 25.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 25.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 25.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 25.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 25.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 25.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 25.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 25.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 25.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 25.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 25.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 25.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 25.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 25.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 25.0 111.422 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 8' ' ' VAL . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.74 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.44 94.55 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -81.37 4.88 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.424 -0.807 . . . . 25.0 112.283 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.8 -40.8 2.81 Favored Glycine 0 N--CA 1.46 0.296 0 CA-C-O 121.585 0.547 . . . . 25.0 112.133 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.3 164.49 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 62.93 -166.91 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.035 0.934 . . . . 25.0 111.596 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 59.39 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -73.97 90.83 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -138.27 153.8 73.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 104.88 -2.267 . . . . 25.0 104.88 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.9 -23.04 22.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 116.899 -1.601 . . . . 25.0 113.01 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.53 156.89 34.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.433 -2.062 . . . . 25.0 105.433 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.87 -26.87 43.67 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.552 -0.832 . . . . 25.0 111.952 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 t 65.36 175.68 0.21 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.446 1.099 . . . . 25.0 110.332 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.8 31.62 78.86 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 121.092 -0.575 . . . . 25.0 113.126 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.69 -155.21 11.51 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.803 -1.319 . . . . 25.0 109.803 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.9 m 59.47 31.61 21.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.466 0.706 . . . . 25.0 112.063 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.4 -127.14 2.87 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 108.421 -1.871 . . . . 25.0 108.421 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 m -143.61 160.44 40.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.23 -1.026 . . . . 25.0 108.23 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.68 168.71 38.39 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 107.813 -2.115 . . . . 25.0 107.813 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.91 -23.48 16.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.548 0.674 . . . . 25.0 111.844 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.0 p -88.5 125.26 34.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -79.98 154.95 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.25 67.64 9.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.2 1.0 . . . . 25.0 109.144 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.88 138.53 58.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.604 -1.18 . . . . 25.0 111.182 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.16 150.51 68.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.265 1.209 . . . . 25.0 114.265 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.65 166.61 28.91 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 120.24 0.626 . . . . 25.0 111.874 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 25.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 25.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.99 164.22 22.84 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 25.0 110.617 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.76 171.83 15.68 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 117.37 -1.287 . . . . 25.0 111.72 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -133.98 156.51 79.18 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.645 -0.707 . . . . 25.0 110.813 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.04 -175.22 2.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.434 2.09 . . . . 25.0 112.686 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 66.37 8.91 6.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.394 1.478 . . . . 25.0 113.353 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.58 161.73 27.5 Favored Glycine 0 C--N 1.32 -0.327 0 N-CA-C 107.957 -2.057 . . . . 25.0 107.957 169.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -68.75 136.13 52.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.774 1.273 . . . . 25.0 111.045 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.217 -0.62 0 CA-C-O 125.209 2.433 . . . . 25.0 110.519 -178.358 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 123.363 1.535 . . . . 25.0 115.656 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -90.0 146.28 24.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.037 -1.272 . . . . 25.0 109.227 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -77.12 88.45 3.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 25.0 110.311 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.71 140.07 53.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 105.405 -2.072 . . . . 25.0 105.405 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 60.63 165.63 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 25.0 116.134 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 25.0 107.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 25.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 25.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 25.0 110.055 176.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 25.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 25.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 25.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 25.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 25.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 25.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 25.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 25.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 25.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 25.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 25.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 25.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 25.0 108.722 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 25.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 25.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 25.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 25.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 25.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 25.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 25.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 25.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 25.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 25.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 25.0 111.105 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 25.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 25.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 25.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 25.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 25.0 110.242 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -94.71 89.75 5.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.23 -35.36 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.209 -0.905 . . . . 25.0 111.383 -174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.9 2.39 70.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.047 -0.597 . . . . 25.0 114.03 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -97.53 -48.18 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.409 -0.589 . . . . 25.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -72.97 -38.85 66.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.617 0.722 . . . . 25.0 109.217 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -83.95 112.03 19.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -66.77 -13.74 61.79 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.686 1.365 . . . . 25.0 114.686 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -161.1 156.21 20.61 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.53 163.88 37.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.092 -1.472 . . . . 25.0 111.142 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.81 74.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.742 0.645 . . . . 25.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.07 75.98 Favored Glycine 0 C--O 1.221 -0.657 0 N-CA-C 115.641 1.016 . . . . 25.0 115.641 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.2 p -114.67 -94.96 0.47 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.699 0.75 . . . . 25.0 112.451 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.29 -171.92 37.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.751 -1.34 . . . . 25.0 109.751 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.86 -172.51 51.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.11 -0.567 . . . . 25.0 111.851 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -150.63 165.89 31.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.56 32.49 Favored Glycine 0 C--O 1.224 -0.481 0 CA-C-O 121.377 0.432 . . . . 25.0 112.559 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.7 m -145.73 163.73 34.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.856 -1.905 . . . . 25.0 105.856 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.82 41.95 2.38 Favored Glycine 0 N--CA 1.461 0.352 0 C-N-CA 121.03 -0.605 . . . . 25.0 112.176 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.59 175.31 0.07 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.026 1.491 . . . . 25.0 115.026 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 p -133.86 174.88 9.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.653 -1.61 . . . . 25.0 106.653 -175.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 61.74 15.42 6.97 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.687 1.736 . . . . 25.0 115.687 170.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -84.96 89.47 7.6 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.11 -1.441 . . . . 25.0 107.11 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.68 144.71 50.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.939 -1.028 . . . . 25.0 112.198 -171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.35 144.8 50.61 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 113.652 0.982 . . . . 25.0 113.652 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.5 167.7 25.12 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 120.248 0.632 . . . . 25.0 111.507 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.32 159.97 51.02 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 25.0 111.134 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.37 177.55 7.77 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 120.241 0.627 . . . . 25.0 112.857 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.94 156.3 79.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.2 -170.97 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.352 2.035 . . . . 25.0 114.076 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 76.91 -5.16 2.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.73 2.012 . . . . 25.0 112.973 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.86 140.65 6.35 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 107.868 -2.093 . . . . 25.0 107.868 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.16 147.79 24.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.191 -1.781 . . . . 25.0 106.191 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.215 -0.762 0 CA-C-O 124.255 1.979 . . . . 25.0 112.609 -178.9 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 CA-C-O 125.135 2.52 . . . . 25.0 112.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 t -71.19 -29.59 65.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 112.327 -1.937 . . . . 25.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtt 55.79 47.87 19.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.755 0.822 . . . . 25.0 112.066 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -113.57 24.2 12.4 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.709 0.766 . . . . 25.0 109.269 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -135.29 165.58 25.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.8 -1.091 . . . . 25.0 110.669 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 25.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 25.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 25.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 25.0 110.504 175.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 25.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 25.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 25.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 25.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 25.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 25.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 25.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 25.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 25.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 25.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 25.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 25.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 25.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 25.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 25.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 25.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 25.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 25.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 25.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 25.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 25.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 25.0 111.851 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 25.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 25.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 25.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 25.0 109.793 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -89.3 70.7 8.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 25.0 111.52 -177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.38 -24.16 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.82 -81.23 1.11 Allowed Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 114.975 -1.012 . . . . 25.0 111.43 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.86 163.0 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -159.6 45.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 57.48 6.39 0.4 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 117.888 2.551 . . . . 25.0 117.888 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -69.43 111.72 5.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.352 -0.842 . . . . 25.0 110.175 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -63.13 149.42 90.94 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.144 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.94 152.98 63.7 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 118.256 -0.696 . . . . 25.0 112.851 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -114.75 -9.3 12.56 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.661 0.615 . . . . 25.0 112.661 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.6 10.8 71.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 115.351 0.9 . . . . 25.0 115.351 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 t -77.23 67.2 3.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.83 -40.81 2.1 Favored Glycine 0 C--O 1.218 -0.846 0 N-CA-C 116.874 1.51 . . . . 25.0 116.874 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.25 0.84 79.7 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 117.466 0.633 . . . . 25.0 113.48 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m 57.25 36.83 27.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.75 153.48 23.75 Favored Glycine 0 C--O 1.23 -0.1 0 N-CA-C 109.105 -1.598 . . . . 25.0 109.105 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -152.93 -28.32 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.754 1.39 . . . . 25.0 114.754 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.02 24.48 77.08 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.874 -0.679 . . . . 25.0 114.151 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.56 115.83 21.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 p 46.62 70.81 0.35 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.262 0.977 . . . . 25.0 113.273 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t0 69.01 175.27 0.28 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.921 -1.49 . . . . 25.0 111.458 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.43 63.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.006 -1.109 . . . . 25.0 108.006 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.96 133.98 55.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.55 -1.204 . . . . 25.0 109.895 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.21 149.67 69.81 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 113.61 0.967 . . . . 25.0 113.61 -172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -69.78 165.57 30.55 Favored 'Trans proline' 0 C--N 1.35 0.619 0 O-C-N 121.831 0.385 . . . . 25.0 111.176 174.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 25.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.96 162.7 38.68 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 25.0 110.308 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.16 171.98 16.49 Favored 'Trans proline' 0 C--N 1.346 0.443 0 N-CA-C 113.52 0.546 . . . . 25.0 113.52 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.93 158.42 75.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 25.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -78.36 -160.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.565 2.843 . . . . 25.0 109.973 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 66.94 20.7 10.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.45 1.1 . . . . 25.0 111.449 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.91 156.21 26.64 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 108.073 -2.011 . . . . 25.0 108.073 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -80.07 135.45 36.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.666 0.746 . . . . 25.0 110.617 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 125.474 2.559 . . . . 25.0 110.978 179.332 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.012 0 CA-C-O 124.941 2.412 . . . . 25.0 113.409 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -84.78 -21.04 30.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 112.825 -1.687 . . . . 25.0 109.695 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.8 ttt -86.92 148.95 25.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.412 -0.958 . . . . 25.0 108.412 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -77.55 122.97 25.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 61.25 165.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 25.0 115.186 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 25.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 25.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 25.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 25.0 109.437 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 25.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 25.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 25.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 25.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 25.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 25.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 25.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 25.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 25.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 25.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 25.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 8' ' ' VAL . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 25.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 25.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 25.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 25.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 25.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 25.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 25.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 25.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 25.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 25.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 25.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 25.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 25.0 111.573 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -91.48 79.21 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 25.0 109.966 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -67.59 129.92 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.492 -1.67 . . . . 25.0 106.492 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.32 41.29 1.12 Allowed Glycine 0 C--O 1.221 -0.667 0 CA-C-O 121.621 0.567 . . . . 25.0 114.391 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -153.33 -37.58 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.947 0.899 . . . . 25.0 108.726 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -114.67 -0.24 13.67 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 116.673 2.101 . . . . 25.0 116.673 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.36 -47.97 83.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.41 1.005 . . . . 25.0 111.491 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -166.91 -58.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.82 -0.627 . . . . 25.0 111.447 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -151.64 157.4 34.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 106.212 -1.773 . . . . 25.0 106.212 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.61 -7.06 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 117.929 -0.914 . . . . 25.0 112.898 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.05 110.2 20.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.691 0.281 . . . . 25.0 110.304 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.0 162.85 11.49 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 p -116.3 -45.11 2.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.217 0.508 . . . . 25.0 112.055 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.2 93.56 0.55 Allowed Glycine 0 C--O 1.224 -0.478 0 C-N-CA 121.0 -0.619 . . . . 25.0 112.229 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.34 -164.76 31.13 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.943 -0.646 . . . . 25.0 113.016 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.0 p -92.33 -178.92 5.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.95 -1.13 . . . . 25.0 107.95 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.24 171.33 38.95 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.456 -1.857 . . . . 25.0 108.456 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.3 t -79.06 147.72 32.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.652 0.726 . . . . 25.0 109.33 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.27 156.22 23.33 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.6 mt -126.05 -7.19 6.59 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.421 0.611 . . . . 25.0 111.1 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.8 p -142.6 161.25 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -80.62 153.6 27.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.601 -0.888 . . . . 25.0 108.601 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.65 118.37 8.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.4 mt -79.17 131.63 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.252 0.549 . . . . 25.0 111.225 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.62 146.07 56.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.706 -0.679 . . . . 25.0 111.825 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.89 166.04 31.1 Favored 'Trans proline' 0 C--O 1.243 0.741 0 O-C-N 121.736 0.335 . . . . 25.0 111.408 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 25.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.45 162.95 38.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 25.0 110.197 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.73 170.11 20.79 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 118.245 -0.703 . . . . 25.0 113.366 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -133.95 159.14 73.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.665 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.82 177.31 8.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 109.783 -0.891 . . . . 25.0 109.783 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 63.62 5.99 2.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.624 1.342 . . . . 25.0 114.624 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.7 -8.18 60.97 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.878 -1.056 . . . . 25.0 111.427 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 27.66 58.14 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.906 1.817 . . . . 25.0 115.906 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.563 1.48 0 CA-C-O 125.945 2.783 . . . . 25.0 113.389 -176.989 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.844 0 CA-C-O 124.562 2.201 . . . . 25.0 112.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t 58.05 14.41 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 111.161 -2.519 . . . . 25.0 114.122 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.9 ttt -81.66 64.24 6.28 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.66 133.3 35.69 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.57 -1.27 . . . . 25.0 107.57 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 63.57 163.81 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 25.0 116.22 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 25.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 25.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 25.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 25.0 109.711 176.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 25.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 25.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 25.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 25.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 25.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 25.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 25.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 25.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 25.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 25.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 172.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 25.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 25.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 25.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 25.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 25.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 25.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 25.0 106.95 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 25.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 25.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 25.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 25.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 25.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 25.0 111.264 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 25.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 25.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 25.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.298 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt -93.87 84.57 4.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -68.49 -36.74 76.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.656 -0.702 . . . . 25.0 110.321 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -40.27 2.81 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 116.435 -0.348 . . . . 25.0 112.612 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mtp -69.78 -24.97 63.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.977 0.418 . . . . 25.0 111.112 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -159.11 164.97 34.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -142.28 164.43 30.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.298 -1.371 . . . . 25.0 107.298 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -113.97 25.69 10.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -136.41 147.87 61.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 173.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.06 -10.99 19.65 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 N-CA-C 114.242 0.824 . . . . 25.0 114.242 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.15 -157.67 11.58 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.288 -1.925 . . . . 25.0 108.288 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 p -74.26 146.98 42.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.28 -48.5 0.39 Allowed Glycine 0 C--O 1.222 -0.624 0 N-CA-C 109.685 -1.366 . . . . 25.0 109.685 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.74 -176.84 49.39 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 108.436 -1.865 . . . . 25.0 108.436 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m -60.13 140.49 56.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.891 0.346 . . . . 25.0 110.637 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.91 15.28 59.69 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.416 -0.421 . . . . 25.0 112.275 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -85.61 150.78 24.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.805 0.442 . . . . 25.0 109.894 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.38 -164.19 23.49 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 108.72 -1.752 . . . . 25.0 108.72 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.12 148.21 52.13 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.349 -1.722 . . . . 25.0 106.349 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 149.87 38.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -99.37 109.67 22.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -144.01 98.71 3.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.3 140.95 58.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.409 -0.589 . . . . 25.0 109.409 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.55 148.67 42.59 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 114.085 1.142 . . . . 25.0 114.085 -172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.71 165.84 31.27 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 121.751 0.342 . . . . 25.0 112.128 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 25.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 25.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.59 160.49 49.57 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 25.0 109.477 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.54 175.77 10.21 Favored 'Trans proline' 0 C--N 1.347 0.449 0 N-CA-C 113.222 0.432 . . . . 25.0 113.222 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -132.8 153.61 81.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.2 179.32 6.28 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.826 2.351 . . . . 25.0 112.339 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -88.55 11.25 17.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.668 0.747 . . . . 25.0 111.021 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.09 176.81 25.51 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.285 -0.871 . . . . 25.0 112.59 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -137.83 165.43 26.48 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.213 -0.857 0 CA-C-O 124.233 1.968 . . . . 25.0 112.667 176.648 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.888 0 CA-C-O 125.245 2.581 . . . . 25.0 113.23 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -88.04 57.13 4.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 112.626 -1.787 . . . . 25.0 111.629 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.574 0.702 . . . . 25.0 109.598 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -105.81 7.07 32.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.656 -0.702 . . . . 25.0 109.144 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.94 171.51 14.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.936 -1.029 . . . . 25.0 111.061 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 25.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 25.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 25.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 25.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 176.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 25.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 25.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 25.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 25.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 25.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 25.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 25.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 25.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 25.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 25.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 25.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 25.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 25.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 25.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 25.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 25.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 25.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 25.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 25.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 25.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 25.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 25.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 25.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 25.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 25.0 111.433 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 66' ' ' VAL . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 25.0 107.074 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.4 17.52 12.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 25.0 111.831 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' H ' HG22 ' A' ' 64' ' ' ILE . 9.8 t 68.05 -44.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.653 1.581 . . . . 25.0 115.015 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.53 -129.04 6.1 Favored Glycine 0 C--O 1.219 -0.787 0 N-CA-C 111.308 -0.717 . . . . 25.0 111.308 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 ptm -75.13 3.12 9.18 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -94.64 117.44 30.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.19 0.441 . . . . 25.0 112.19 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.39 169.7 17.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -136.11 -27.03 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.391 0.515 . . . . 25.0 112.391 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -158.61 144.92 12.59 Favored Pre-proline 0 N--CA 1.472 0.675 0 N-CA-C 109.099 -0.704 . . . . 25.0 109.099 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.34 8.55 4.1 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 120.91 1.073 . . . . 25.0 114.146 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.99 35.24 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.209 -0.663 . . . . 25.0 109.209 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.53 -171.37 39.37 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 115.908 -0.587 . . . . 25.0 111.681 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -147.08 158.62 43.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.73 -3.74 86.78 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 121.171 -0.537 . . . . 25.0 114.182 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 51.5 4.31 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 114.302 0.481 . . . . 25.0 114.302 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -79.46 152.94 29.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.94 -152.54 27.24 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.8 m -148.74 158.59 44.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.85 -178.86 39.14 Favored Glycine 0 C--O 1.229 -0.182 0 N-CA-C 110.292 -1.123 . . . . 25.0 110.292 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.63 163.7 16.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -72.8 -28.06 62.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.57 90.31 3.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.588 -1.187 . . . . 25.0 110.835 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -133.89 111.13 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.8 126.32 33.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 25.0 110.208 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 144.5 78.9 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 25.0 110.26 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.14 165.04 32.9 Favored 'Trans proline' 0 C--O 1.241 0.671 0 CA-C-N 117.917 0.292 . . . . 25.0 112.31 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 25.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.28 161.19 46.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 25.0 110.623 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.74 173.38 14.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 N-CA-C 113.693 0.613 . . . . 25.0 113.693 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 mt -133.84 155.86 79.91 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.787 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -79.76 171.4 15.63 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.182 2.588 . . . . 25.0 114.091 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.94 30.78 0.73 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.479 0.918 . . . . 25.0 113.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.14 158.96 17.5 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 117.455 1.742 . . . . 25.0 117.455 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -96.84 46.71 1.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 122.226 1.012 . . . . 25.0 109.836 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 124.495 2.093 . . . . 25.0 113.397 -176.322 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.118 0 CA-C-O 123.486 1.603 . . . . 25.0 113.334 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 t 75.05 147.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 111.061 -2.57 . . . . 25.0 111.713 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.7 mmt -120.23 24.41 10.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.935 -1.505 . . . . 25.0 106.935 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -146.32 150.06 35.02 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 62.89 166.24 0.12 Allowed 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 25.0 117.773 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 25.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 25.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 25.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 25.0 109.446 175.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 25.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 25.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 25.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 25.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 25.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 25.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 25.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 25.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' HG13 ' A' ' 57' ' ' VAL . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 25.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 25.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 25.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 25.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 25.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 25.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 8' ' ' VAL . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 25.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 25.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 25.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 25.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 25.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 25.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 25.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 25.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 25.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 26' ' ' PHE . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 25.0 111.164 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 25.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 25.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 25.0 110.635 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG23 HG21 ' A' ' 8' ' ' VAL . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.1 98.55 10.14 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 25.0 108.245 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.65 -31.24 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.33 -0.85 . . . . 25.0 110.784 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 166.33 41.93 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 6.5 tmm? 69.36 -54.26 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.254 1.422 . . . . 25.0 111.082 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -74.93 170.3 16.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 170.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 56.4 34.08 23.57 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.825 0.821 . . . . 25.0 112.158 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -65.42 -23.35 66.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.299 0.571 . . . . 25.0 110.728 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -89.92 146.7 35.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.069 -1.456 . . . . 25.0 107.069 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.01 153.57 63.11 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 116.766 -1.689 . . . . 25.0 110.969 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.54 141.99 33.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 -171.76 54.2 Favored Glycine 0 C--O 1.23 -0.132 0 N-CA-C 111.741 -0.544 . . . . 25.0 111.741 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.9 p -138.25 112.18 8.43 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.61 -12.73 60.43 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.247 -0.501 . . . . 25.0 113.693 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 -168.43 37.54 Favored Glycine 0 C--O 1.219 -0.781 0 N-CA-C 110.347 -1.101 . . . . 25.0 110.347 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.9 p -89.05 -4.96 58.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.32 -168.37 54.42 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.446 -0.883 . . . . 25.0 111.611 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -126.99 22.14 6.74 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.337 0.589 . . . . 25.0 110.796 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.13 174.36 41.02 Favored Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 103.489 -3.844 . . . . 25.0 103.489 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt 52.14 51.95 15.33 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.695 1.248 . . . . 25.0 109.608 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -66.26 123.3 19.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -140.96 -178.16 5.43 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.425 -0.583 . . . . 25.0 109.425 -174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 68.89 82.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.637 1.575 . . . . 25.0 110.274 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -66.63 147.28 53.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.012 -1.449 . . . . 25.0 111.771 -175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.94 53.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.82 166.71 29.04 Favored 'Trans proline' 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 25.0 110.928 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 25.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 163.26 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 25.0 110.384 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.26 174.72 11.61 Favored 'Trans proline' 0 C--N 1.347 0.451 0 CA-C-O 121.255 0.44 . . . . 25.0 113.214 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.7 mt -133.99 159.61 71.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.475 -0.784 . . . . 25.0 109.198 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 97' ' ' GLY . 85.7 Cg_endo -71.79 -176.78 2.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 120.822 1.014 . . . . 25.0 111.36 175.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 72.23 -11.3 0.81 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.594 1.558 . . . . 25.0 114.251 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -105.63 6.43 41.43 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 113.195 -1.82 . . . . 25.0 109.982 172.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.89 134.2 44.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.056 0.932 . . . . 25.0 110.191 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 125.114 2.388 . . . . 25.0 111.182 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 CA-C-O 124.392 2.107 . . . . 25.0 114.015 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -62.2 119.57 9.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.036 -1.582 . . . . 25.0 110.796 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.71 -8.04 38.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.944 0.402 . . . . 25.0 111.788 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -146.01 129.41 16.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.599 -2.741 . . . . 25.0 103.599 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 56.48 179.81 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 O-C-N 124.268 0.98 . . . . 25.0 113.422 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 25.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 25.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 25.0 108.053 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 25.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 25.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 25.0 109.933 176.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 25.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 25.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 25.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 25.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 25.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 25.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 25.0 107.71 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 25.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 25.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 25.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 25.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 25.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 25.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 25.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 25.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 25.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 25.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 25.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 25.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 25.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 25.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 25.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 25.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 25.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 25.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 25.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 25.0 109.975 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 8' ' ' VAL . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.54 81.31 3.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 25.0 109.263 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.09 105.67 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 25.0 109.401 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.22 2.58 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 114.972 0.749 . . . . 25.0 114.972 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.9 ttm -80.29 -22.07 41.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.503 0.668 . . . . 25.0 109.307 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -128.25 145.85 50.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.289 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 71' ' ' LYS . 23.1 t0 -103.5 -163.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 70' ' ' ASP . 69.3 tttt 57.31 38.93 28.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.297 1.046 . . . . 25.0 110.357 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -60.71 144.13 89.9 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.5 -18.48 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 114.957 1.099 . . . . 25.0 114.957 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 54.72 -149.48 0.44 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.076 0.55 . . . . 25.0 111.571 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.54 174.33 45.45 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.708 -2.557 . . . . 25.0 106.708 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 t -156.46 174.71 15.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.64 -39.62 2.01 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 113.941 0.336 . . . . 25.0 113.941 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.08 179.42 45.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.403 -0.904 . . . . 25.0 112.365 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.7 p -128.43 59.6 1.52 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.778 0.431 . . . . 25.0 111.179 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.97 9.41 32.37 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 121.009 -0.615 . . . . 25.0 114.304 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -80.67 150.87 29.22 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.389 -1.708 . . . . 25.0 106.389 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.31 134.93 8.71 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.92 -0.872 . . . . 25.0 110.92 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -150.98 167.56 27.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.09 28.06 14.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.098 1.147 . . . . 25.0 114.098 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -151.57 170.29 20.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.288 -1.745 . . . . 25.0 106.288 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 55.12 63.78 2.0 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.481 1.134 . . . . 25.0 112.08 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.17 137.17 58.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.753 -1.112 . . . . 25.0 111.21 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 149.55 65.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.28 -0.873 . . . . 25.0 113.151 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.87 163.95 36.94 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 120.608 0.872 . . . . 25.0 112.665 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 25.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 25.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.41 159.5 52.71 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 25.0 110.486 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.96 161.48 13.04 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 N-CA-C 115.434 1.282 . . . . 25.0 115.434 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.79 156.39 79.45 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 113.103 -1.862 . . . . 25.0 110.536 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.94 -167.06 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.479 2.786 . . . . 25.0 110.945 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 64.89 14.33 9.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.159 . . . . 25.0 112.067 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -144.88 152.14 24.2 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 106.337 -2.705 . . . . 25.0 106.337 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.77 83.2 7.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.19 0.995 . . . . 25.0 110.192 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.213 -0.854 0 CA-C-O 125.313 2.482 . . . . 25.0 110.865 -179.485 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 115.469 0.947 . . . . 25.0 115.469 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m 60.7 -168.63 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.809 1.244 . . . . 25.0 110.906 -177.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -135.35 89.98 2.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.685 0.755 . . . . 25.0 110.131 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -134.87 132.45 38.57 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 177.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 58.17 167.37 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 25.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 25.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 25.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 25.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 175.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 25.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 173.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 25.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 25.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 25.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 25.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 25.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 25.0 110.8 177.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 25.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 25.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 25.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 25.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 25.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 172.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 25.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 25.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 25.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 25.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 25.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 25.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 25.0 112.115 176.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 25.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 25.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 25.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 25.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 25.0 108.803 173.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.85 65.42 5.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 25.0 110.858 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -72.96 -9.11 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.379 0.609 . . . . 25.0 110.733 176.603 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.66 176.61 46.68 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 106.876 -2.489 . . . . 25.0 106.876 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.0 tpt -80.56 78.55 7.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.767 0.784 . . . . 25.0 109.572 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -135.1 148.19 49.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.64 152.74 45.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 10.81 71.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.218 1.932 . . . . 25.0 116.218 -178.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.01 149.63 85.58 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.46 139.96 55.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 116.63 -1.78 . . . . 25.0 114.666 -172.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.32 -50.58 0.05 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.438 -1.256 . . . . 25.0 108.286 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.3 -10.76 84.43 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 114.752 0.661 . . . . 25.0 114.752 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m 55.41 19.54 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.051 1.871 . . . . 25.0 116.051 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.38 179.49 43.13 Favored Glycine 0 CA--C 1.508 -0.353 0 N-CA-C 107.685 -2.166 . . . . 25.0 107.685 178.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.84 39.47 96.59 Favored Glycine 0 C--O 1.223 -0.552 0 CA-C-N 118.006 0.903 . . . . 25.0 113.769 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.4 t -54.29 -45.93 72.63 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.53 0.937 . . . . 25.0 113.53 -175.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.47 88.23 0.43 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.058 -0.591 . . . . 25.0 114.043 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -127.06 80.82 1.98 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 122.35 -0.5 . . . . 25.0 110.11 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.49 178.95 45.72 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 108.41 -1.876 . . . . 25.0 108.41 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -123.37 106.97 11.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 178.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.9 p -142.46 168.75 18.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.93 146.06 55.48 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 174.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -138.88 105.13 5.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.8 mt -67.09 140.55 57.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.431 0.634 . . . . 25.0 110.439 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.4 146.69 70.71 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 113.366 0.876 . . . . 25.0 113.366 -174.21 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.69 164.77 33.0 Favored 'Trans proline' 0 C--O 1.245 0.84 0 O-C-N 121.895 0.419 . . . . 25.0 111.765 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 25.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.46 160.92 47.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 25.0 110.805 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.46 176.11 10.13 Favored 'Trans proline' 0 C--N 1.347 0.476 0 N-CA-C 113.249 0.442 . . . . 25.0 113.249 -177.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.8 156.17 79.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.58 -0.526 . . . . 25.0 109.58 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.89 170.94 18.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 25.0 113.392 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.42 46.23 0.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.612 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.7 145.6 10.64 Favored Glycine 0 C--O 1.225 -0.444 0 N-CA-C 111.171 -0.771 . . . . 25.0 111.171 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -138.39 30.2 2.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.485 1.135 . . . . 25.0 111.947 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.214 -0.765 0 CA-C-O 125.554 2.597 . . . . 25.0 112.891 -177.662 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 CA-C-O 124.271 2.039 . . . . 25.0 115.454 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -77.48 148.7 35.23 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 121.431 -1.041 . . . . 25.0 108.623 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -131.38 163.9 26.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.549 -0.537 . . . . 25.0 109.549 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -140.34 130.97 25.61 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.077 -2.564 . . . . 25.0 104.077 173.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 59.91 173.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 124.573 1.171 . . . . 25.0 113.482 -177.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 25.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 HG23 ' A' ' 64' ' ' ILE . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 25.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 25.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 25.0 110.391 175.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 25.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 25.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 25.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 25.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 25.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 25.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 25.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 25.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 25.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 25.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 178.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 25.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 25.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 25.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 25.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 25.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 25.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 25.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 25.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 25.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 25.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 25.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 25.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 25.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 25.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 25.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 25.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 25.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 25.0 112.284 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.429 HG23 HG21 ' A' ' 8' ' ' VAL . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.746 178.187 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt -107.09 0.8 23.77 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 25.0 110.896 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t 64.86 -87.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.567 -1.651 . . . . 25.0 110.127 -172.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.68 174.03 13.19 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 106.103 -2.799 . . . . 25.0 106.103 -177.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 29.3 ttp 52.41 42.95 31.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.281 1.041 . . . . 25.0 110.374 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 90.32 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.154 -0.93 . . . . 25.0 111.346 -173.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.98 36.6 0.41 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.167 0.984 . . . . 25.0 110.387 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -67.45 -21.35 65.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.598 -173.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -151.89 147.47 20.0 Favored Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 172.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.68 -6.0 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 115.124 1.163 . . . . 25.0 115.124 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.47 -51.67 0.58 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.23 -148.38 20.07 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.306 -0.949 . . . . 25.0 113.119 -179.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -100.88 -2.08 32.96 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.668 0.618 . . . . 25.0 112.668 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -171.19 14.39 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 109.599 -1.4 . . . . 25.0 109.599 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.86 -157.63 19.08 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -177.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m 57.34 33.96 24.03 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.792 1.404 . . . . 25.0 114.792 177.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.78 134.04 9.41 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 110.23 -1.148 . . . . 25.0 110.23 176.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.5 p -156.77 163.49 39.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.555 -1.646 . . . . 25.0 106.555 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 158.64 -169.24 35.02 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 107.54 -2.224 . . . . 25.0 107.54 -178.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.24 128.35 33.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.104 -1.814 . . . . 25.0 106.104 175.264 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.6 p -134.31 123.51 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.0 88.98 7.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.17 113.26 9.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.945 -1.025 . . . . 25.0 109.028 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.12 123.42 33.95 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.23 0.538 . . . . 25.0 109.97 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.4 147.66 68.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.771 -0.649 . . . . 25.0 109.879 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.96 162.6 41.39 Favored 'Trans proline' 0 C--O 1.244 0.807 0 CA-C-N 117.991 0.318 . . . . 25.0 112.499 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 25.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.5 160.96 47.02 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 25.0 109.67 169.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.59 172.03 16.99 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 113.577 0.568 . . . . 25.0 113.577 -176.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 mt -134.02 155.78 79.83 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 25.0 111.084 178.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.75 176.21 10.3 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.913 2.409 . . . . 25.0 112.081 174.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.18 35.83 0.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.169 0.803 . . . . 25.0 113.169 -179.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.66 -177.06 21.11 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 111.738 -0.545 . . . . 25.0 111.738 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -116.62 149.66 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.823 0.82 . . . . 25.0 111.54 -178.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 123.719 1.723 . . . . 25.0 112.732 -179.399 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.576 0 CA-C-O 124.611 2.228 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -149.61 153.95 37.88 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 113.056 -1.572 . . . . 25.0 107.399 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.5 mtt 59.26 15.97 4.63 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 tttp 67.19 167.33 0.23 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.781 1.232 . . . . 25.0 109.872 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 57.15 178.01 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 25.0 114.869 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 25.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 25.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 25.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 25.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 25.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 25.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 25.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 25.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 25.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 25.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 25.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 25.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 25.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 25.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 25.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 25.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 25.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 25.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 25.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 25.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 25.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 25.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 25.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 25.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 25.0 111.337 176.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 25.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 25.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 25.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 25.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 25.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 25.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt -103.68 107.89 18.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 172.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -56.18 117.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 25.0 110.905 -171.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.1 178.5 50.88 Favored Glycine 0 C--O 1.225 -0.441 0 CA-C-N 115.582 -0.735 . . . . 25.0 111.952 -176.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.59 5.81 1.81 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.504 1.668 . . . . 25.0 115.504 177.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.55 -67.34 0.83 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 173.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.91 -174.99 4.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 178.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -145.6 34.51 1.05 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -80.25 146.97 63.6 Favored Pre-proline 0 N--CA 1.471 0.596 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.9 133.56 20.18 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 116.27 -2.02 . . . . 25.0 111.638 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.03 141.39 16.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.317 -0.623 . . . . 25.0 109.317 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.29 -139.29 45.79 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.793 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t 57.32 28.95 16.04 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.686 1.365 . . . . 25.0 114.686 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 166.12 51.2 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.13 -1.188 . . . . 25.0 110.13 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.28 175.83 45.73 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 108.29 -1.924 . . . . 25.0 108.29 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.5 m -102.13 130.17 48.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.643 0.722 . . . . 25.0 110.85 -178.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.75 43.05 3.19 Favored Glycine 0 C--O 1.221 -0.699 0 C-N-CA 121.643 -0.313 . . . . 25.0 112.979 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -65.54 -27.33 68.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -175.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.08 -7.85 58.98 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.351 -0.452 . . . . 25.0 113.826 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.41 157.39 34.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 25.0 110.604 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -95.65 124.57 39.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 173.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -155.57 169.37 24.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -177.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 60.62 85.88 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.093 1.357 . . . . 25.0 112.789 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.56 142.41 58.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.962 -1.017 . . . . 25.0 111.071 -177.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.91 148.35 56.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 113.758 1.021 . . . . 25.0 113.758 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 167.18 27.98 Favored 'Trans proline' 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 25.0 111.1 173.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 25.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.69 162.28 42.66 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 25.0 110.528 176.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.16 174.43 12.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.326 0.471 . . . . 25.0 113.326 -177.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.86 162.03 60.17 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.551 -0.75 . . . . 25.0 110.866 -179.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.82 178.68 5.53 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.114 1.209 . . . . 25.0 111.454 175.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 68.75 7.85 6.39 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.332 1.453 . . . . 25.0 111.429 -174.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.16 -169.09 51.28 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 114.113 -1.403 . . . . 25.0 111.926 175.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -85.64 57.14 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.368 1.08 . . . . 25.0 108.468 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.211 -0.974 0 CA-C-O 125.283 2.468 . . . . 25.0 110.541 -176.16 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 CA-C-O 124.709 2.283 . . . . 25.0 113.281 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 m -139.0 8.15 2.49 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 112.851 -1.675 . . . . 25.0 112.327 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.33 -24.03 27.81 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 -176.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -145.59 136.6 24.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 178.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.5 167.38 0.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 25.0 115.93 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 25.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 25.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 25.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 25.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 25.0 110.556 176.815 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 25.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 25.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 25.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 25.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 25.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 25.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 25.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 25.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 25.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 25.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 25.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 25.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 25.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 25.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 25.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 25.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 25.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 25.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 25.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 25.0 111.699 176.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 25.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 25.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 25.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 25.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 25.0 111.299 174.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt -100.09 74.4 1.78 Allowed 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -70.89 -12.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.408 1.262 . . . . 25.0 114.408 -177.697 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.71 2.33 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 121.297 -0.478 . . . . 25.0 113.753 -177.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -51.61 -30.7 22.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.925 0.89 . . . . 25.0 113.335 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -100.46 75.35 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.189 0.44 . . . . 25.0 112.189 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -110.93 99.11 8.06 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.872 0.844 . . . . 25.0 110.034 175.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -139.16 1.73 2.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.583 0.706 . . . . 25.0 111.359 -177.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -133.12 148.73 70.42 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 102.344 -3.206 . . . . 25.0 102.344 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.12 152.54 80.98 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.361 -1.959 . . . . 25.0 111.514 -175.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 38.06 0.12 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.618 0.969 . . . . 25.0 113.618 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.7 129.31 4.49 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 109.724 -1.35 . . . . 25.0 109.724 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.4 m -157.28 150.73 24.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.61 -165.6 54.77 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.882 -0.675 . . . . 25.0 112.367 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.04 152.65 22.41 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 109.176 -1.569 . . . . 25.0 109.176 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 t -68.74 -21.88 64.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 25.0 112.341 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.99 -175.67 40.87 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.952 -0.859 . . . . 25.0 110.952 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.0 t -153.91 149.81 27.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 177.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.04 -149.68 49.45 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.142 -1.028 . . . . 25.0 110.954 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.54 -5.35 59.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.5 p 42.88 72.07 0.2 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.22 1.193 . . . . 25.0 114.22 -178.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.25 97.31 0.12 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.026 -0.988 . . . . 25.0 113.175 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -141.13 115.77 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.32 139.28 31.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.474 0.654 . . . . 25.0 111.981 -176.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 148.45 54.64 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.628 -0.715 . . . . 25.0 111.028 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.92 163.9 37.07 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 118.497 -0.535 . . . . 25.0 110.802 175.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 25.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 25.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.61 164.15 35.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 25.0 111.331 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.23 179.2 6.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 120.421 0.748 . . . . 25.0 113.542 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -133.73 157.76 77.11 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.985 -0.552 . . . . 25.0 109.631 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.21 -171.7 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.943 3.095 . . . . 25.0 114.09 -178.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 68.53 8.06 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.401 1.48 . . . . 25.0 111.454 -177.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.65 99.58 2.3 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.116 -1.402 . . . . 25.0 110.378 175.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.01 64.25 1.88 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.527 1.156 . . . . 25.0 111.164 177.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.553 1.073 0 CA-C-O 123.548 1.642 . . . . 25.0 113.048 -179.92 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.145 0 CA-C-O 124.453 2.14 . . . . 25.0 115.505 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -87.89 120.8 29.58 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.885 -1.362 . . . . 25.0 110.58 -179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -71.39 103.31 2.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.574 -0.528 . . . . 25.0 109.574 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -113.21 139.06 49.1 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 104.109 -2.552 . . . . 25.0 104.109 176.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 61.73 164.71 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.961 1.413 . . . . 25.0 114.144 -174.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 25.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 25.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 179.29 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 25.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 25.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 25.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 25.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 25.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 25.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 25.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 25.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 25.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 25.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 25.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 25.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 25.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 25.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 25.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 25.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 25.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 25.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 25.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 25.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 25.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 25.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 25.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 25.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 25.0 111.091 175.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 25.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 25.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 25.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 25.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 25.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.82 70.05 4.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 25.0 111.287 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.93 -33.44 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 176.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.15 -3.55 61.54 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 115.838 -0.619 . . . . 25.0 113.825 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.0 ttp -134.74 75.58 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.591 0.71 . . . . 25.0 111.04 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -161.12 145.99 13.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 176.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.52 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 55.88 40.13 30.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.085 -0.961 . . . . 25.0 113.222 176.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -111.51 146.55 34.87 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 124.06 9.72 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 116.232 -2.045 . . . . 25.0 112.685 -178.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.22 6.86 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.318 1.229 . . . . 25.0 114.318 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.15 176.53 41.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.384 -0.913 . . . . 25.0 112.989 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 p -144.45 162.63 36.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.06 -1.459 . . . . 25.0 107.06 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.48 153.32 13.23 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.642 -1.266 . . . . 25.0 115.55 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.0 -153.76 24.39 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 178.525 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.0 p -135.34 154.54 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.52 -166.55 37.84 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 110.826 -0.909 . . . . 25.0 110.826 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.7 p -148.96 159.61 44.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.03 171.9 41.26 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 107.621 -2.191 . . . . 25.0 107.621 178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 mt 59.64 176.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.116 0.966 . . . . 25.0 112.361 -175.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 t -123.05 -12.43 7.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 177.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 116.99 33.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.68 126.69 14.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.712 -1.958 . . . . 25.0 105.712 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.3 mt -106.26 142.15 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 25.0 110.895 -176.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.3 146.18 39.41 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.735 -0.666 . . . . 25.0 111.625 -177.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.82 165.39 31.55 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 119.859 0.373 . . . . 25.0 112.513 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 25.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 25.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.85 162.57 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 25.0 110.019 170.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.77 172.22 16.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.85 0.673 . . . . 25.0 113.85 -176.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.97 153.36 79.75 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.743 177.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.64 173.29 11.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.608 2.872 . . . . 25.0 113.933 176.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.75 57.64 4.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.402 175.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.33 -161.97 47.38 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.599 0.599 . . . . 25.0 114.599 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.09 141.69 51.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.212 -0.875 0 CA-C-O 125.348 2.499 . . . . 25.0 110.644 178.103 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.912 0 CA-C-O 124.033 1.907 . . . . 25.0 115.46 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -73.97 30.23 0.08 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.146 1.378 . . . . 25.0 114.149 -179.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.36 9.41 20.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 25.0 111.096 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.17 130.38 52.04 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 178.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 58.78 172.94 0.07 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 125.212 1.57 . . . . 25.0 115.072 176.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 25.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 25.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 25.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 176.25 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 25.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 25.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 25.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 25.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 25.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 25.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 25.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 25.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 8' ' ' VAL . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 178.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 25.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 172.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 25.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 25.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 25.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 25.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 25.0 107.154 178.141 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 25.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 25.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 25.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 25.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 25.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 25.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 25.0 110.156 174.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.488 HG23 HG21 ' A' ' 8' ' ' VAL . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt -100.5 85.77 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 25.0 109.741 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.39 107.33 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 -178.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.32 47.53 1.02 Allowed Glycine 0 C--O 1.215 -1.055 0 CA-C-N 116.427 -0.351 . . . . 25.0 113.217 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.0 ptp -130.86 18.82 5.07 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -132.17 94.78 3.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.04 6.42 1.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.74 0.816 . . . . 25.0 112.98 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -63.36 -16.8 61.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.13 0.789 . . . . 25.0 113.13 -176.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -159.08 157.67 28.12 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.34 160.83 47.61 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 116.612 -1.792 . . . . 25.0 112.379 175.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.55 24.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.62 145.97 7.99 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 176.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 t -163.45 150.38 12.39 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.49 174.07 46.61 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 107.984 -2.046 . . . . 25.0 107.984 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.31 18.5 0.1 Allowed Glycine 0 C--O 1.221 -0.712 0 CA-C-N 117.944 0.872 . . . . 25.0 115.262 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.2 m 52.46 27.86 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.24 1.941 . . . . 25.0 116.24 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.76 138.81 32.12 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.425 -0.893 . . . . 25.0 111.005 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -99.69 -11.45 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.453 1.279 . . . . 25.0 114.453 -174.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.48 -174.15 44.47 Favored Glycine 0 C--O 1.228 -0.25 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.6 mp -122.0 93.25 3.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -155.23 155.29 33.58 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 50.85 34.11 9.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.202 1.927 . . . . 25.0 116.202 171.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -105.74 81.87 1.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.817 0.818 . . . . 25.0 110.617 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.93 151.89 35.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.543 -0.753 . . . . 25.0 111.903 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 148.73 52.92 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -175.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.19 165.1 33.57 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 120.512 0.808 . . . . 25.0 111.92 175.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 25.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 25.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.85 159.37 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 25.0 108.893 167.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.57 174.99 11.68 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 118.586 -0.476 . . . . 25.0 113.062 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.91 152.66 79.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.111 -0.7 . . . . 25.0 109.111 176.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.57 171.44 9.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.68 2.253 . . . . 25.0 113.739 175.471 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -92.75 86.83 5.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.031 173.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.4 169.02 36.12 Favored Glycine 0 C--O 1.225 -0.407 0 C-N-CA 120.92 -0.657 . . . . 25.0 111.931 178.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 162.89 40.69 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.819 -1.549 . . . . 25.0 106.819 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.887 0 CA-C-O 126.324 2.964 . . . . 25.0 112.587 -179.042 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 0 CA-C-O 124.123 1.957 . . . . 25.0 113.251 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m 56.89 26.52 11.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.118 -2.041 . . . . 25.0 112.604 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 tpt -81.42 47.82 1.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.887 0.475 . . . . 25.0 112.196 -177.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 63.56 105.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.135 1.374 . . . . 25.0 113.267 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 61.11 174.76 0.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.023 -0.99 . . . . 25.0 113.456 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 25.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 25.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.143 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 25.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 25.0 111.467 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 25.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 25.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' ND2' ' CE1' ' A' ' 26' ' ' PHE . 21.3 t30 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 -179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 25.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 25.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 25.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 25.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 25.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.423 ' CE1' ' ND2' ' A' ' 16' ' ' ASN . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -177.034 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 25.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 25.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 25.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 25.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 25.0 108.445 178.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 25.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 25.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 25.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 25.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 25.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 25.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 25.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 25.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 25.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 25.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 25.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 25.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 25.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 25.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 25.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 25.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 8' ' ' VAL . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.17 85.68 4.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 179.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.8 130.13 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 -178.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 146.33 24.1 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.761 -1.336 . . . . 25.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.4 ttt 62.33 -174.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 25.0 112.205 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 67.23 -38.42 0.34 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.098 2.258 . . . . 25.0 117.098 178.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -66.65 135.08 53.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.86 33.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.802 0.81 . . . . 25.0 109.517 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.45 158.99 62.51 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.482 -0.932 . . . . 25.0 108.482 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.95 154.4 72.89 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 115.702 -2.399 . . . . 25.0 111.261 174.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.21 166.88 23.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.307 -1.368 . . . . 25.0 107.307 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.37 -170.74 37.27 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.445 -1.462 . . . . 25.0 109.445 -179.055 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 m -65.91 153.16 42.78 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.641 0.608 . . . . 25.0 112.641 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.22 -146.62 21.18 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 110.151 -1.18 . . . . 25.0 110.151 175.487 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.4 22.07 17.9 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.969 -0.634 . . . . 25.0 114.134 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -70.28 159.0 34.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 176.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.59 -143.92 5.62 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.25 -0.432 . . . . 25.0 113.236 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 m 57.93 31.32 20.42 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.41 -11.79 84.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.129 178.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.9 mt -129.87 79.78 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.1 t -152.35 168.97 23.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -77.5 141.08 39.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 176.087 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.56 97.39 2.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 177.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.9 mt -80.44 130.52 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.569 0.699 . . . . 25.0 110.855 -177.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.48 151.46 59.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.362 -0.836 . . . . 25.0 110.984 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.91 159.51 53.03 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 117.213 -1.391 . . . . 25.0 112.197 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 25.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 25.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.06 162.67 40.77 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.531 174.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.15 175.51 10.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 O-C-N 121.921 0.432 . . . . 25.0 112.981 -177.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.1 mt -133.91 157.67 77.23 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.235 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.26 172.68 15.88 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.203 1.935 . . . . 25.0 113.208 178.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.3 56.77 1.77 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.976 0.894 . . . . 25.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.57 -116.49 4.31 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.852 -0.69 . . . . 25.0 112.974 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.6 123.69 18.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.212 1.006 . . . . 25.0 110.414 -177.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 125.798 2.713 . . . . 25.0 111.946 -175.173 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.805 0 CA-C-O 124.458 2.143 . . . . 25.0 114.162 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -146.72 158.1 43.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.833 -1.183 . . . . 25.0 109.258 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -75.49 165.14 25.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -84.23 20.64 1.56 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 120.799 0.333 . . . . 25.0 111.773 176.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -134.89 158.6 43.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.955 -0.566 . . . . 25.0 110.463 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 25.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 25.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.057 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 25.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 25.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 175.244 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 25.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 25.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 25.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 25.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 25.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 25.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 25.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 25.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 177.355 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 25.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 25.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 25.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 25.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 25.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 25.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 25.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 25.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 25.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 25.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 25.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 25.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 25.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 25.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 25.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 25.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 25.0 111.508 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 8' ' ' VAL . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 25.0 108.733 175.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.09 85.45 6.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.83 162.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.86 -1.064 . . . . 25.0 110.153 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.8 170.94 35.49 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.786 -0.721 . . . . 25.0 111.393 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ttm 71.79 -39.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.317 1.447 . . . . 25.0 113.903 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.69 68.91 10.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.05 1.13 . . . . 25.0 114.05 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -93.8 -72.86 0.59 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.493 -0.776 . . . . 25.0 109.201 173.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt 54.32 64.99 1.63 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.098 0.777 . . . . 25.0 113.098 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -59.24 145.6 80.73 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.545 -0.752 . . . . 25.0 110.469 177.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.74 175.43 11.01 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 120.661 0.908 . . . . 25.0 114.216 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.79 168.13 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 175.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 34.87 9.9 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.308 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m 60.79 -161.71 0.28 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.626 0.77 . . . . 25.0 111.651 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.71 -176.89 41.71 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 108.681 -1.768 . . . . 25.0 108.681 -177.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.14 -179.07 48.66 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 109.134 -1.586 . . . . 25.0 109.134 178.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.7 m -107.17 123.84 48.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.86 52.09 0.32 Allowed Glycine 0 C--O 1.217 -0.925 0 N-CA-C 111.361 -0.696 . . . . 25.0 111.361 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -65.06 -22.51 66.98 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 114.614 1.338 . . . . 25.0 114.614 -175.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.31 -153.69 29.31 Favored Glycine 0 CA--C 1.516 0.103 0 C-N-CA 120.609 -0.805 . . . . 25.0 111.93 -178.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.4 mp -82.63 170.27 15.33 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.7 p -66.67 128.76 37.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.294 -0.632 . . . . 25.0 109.294 176.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.27 -172.95 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.195 -0.668 . . . . 25.0 109.195 -176.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 59.19 95.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.141 1.534 . . . . 25.0 115.141 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.84 129.5 40.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 25.0 109.265 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 153.03 83.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.512 -0.767 . . . . 25.0 112.344 -175.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.43 164.41 32.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 O-C-N 121.801 0.369 . . . . 25.0 111.666 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 25.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.17 163.37 36.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 25.0 110.695 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.09 174.43 12.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 N-CA-C 113.438 0.515 . . . . 25.0 113.438 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.97 157.25 78.16 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 25.0 110.337 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 97' ' ' GLY . 67.5 Cg_endo -74.99 -177.96 3.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.59 1.527 . . . . 25.0 110.636 174.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 68.88 -6.7 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.364 1.465 . . . . 25.0 114.204 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -98.86 14.9 61.33 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 113.587 -1.642 . . . . 25.0 109.421 172.223 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -137.57 147.21 44.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.483 1.211 0 C-N-CA 125.346 1.459 . . . . 25.0 113.646 179.555 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 124.568 2.204 . . . . 25.0 113.707 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 t -68.47 -19.03 64.53 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.276 -1.132 . . . . 25.0 111.86 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ptm -147.59 28.28 0.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.557 0.694 . . . . 25.0 110.536 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.4 153.32 42.56 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 105.131 -2.174 . . . . 25.0 105.131 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 59.74 168.06 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 25.0 114.57 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 25.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 178.315 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 25.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 25.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 174.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 25.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 25.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 25.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 25.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 25.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 25.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 25.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 25.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 25.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 25.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 25.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 8' ' ' VAL . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 25.0 109.706 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 25.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 25.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 25.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 25.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 25.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 25.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 25.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 25.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 25.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 25.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 25.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 25.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 25.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 25.0 110.939 175.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 25.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 25.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 25.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.154 178.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 8' ' ' VAL . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 176.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.38 89.7 5.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 178.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.19 108.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.428 -0.805 . . . . 25.0 109.642 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.38 46.24 3.63 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 112.013 -0.435 . . . . 25.0 112.013 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.51 151.03 32.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 25.0 107.863 -175.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 63.43 10.22 4.68 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.858 1.799 . . . . 25.0 115.858 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.62 125.55 30.68 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.592 -0.693 . . . . 25.0 111.705 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -150.04 29.44 0.73 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.91 -1.144 . . . . 25.0 107.91 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.17 155.74 79.51 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.428 -0.805 . . . . 25.0 111.191 -174.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.51 160.21 44.81 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.692 -1.072 . . . . 25.0 112.324 178.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.05 -170.71 0.16 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.307 1.043 . . . . 25.0 112.2 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.52 166.15 20.58 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.074 -0.81 . . . . 25.0 111.074 -178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 p -66.13 -23.71 66.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.46 167.43 43.24 Favored Glycine 0 CA--C 1.517 0.199 0 CA-C-O 121.493 0.496 . . . . 25.0 113.625 177.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.28 130.22 10.18 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 110.035 -1.226 . . . . 25.0 110.035 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.6 p -152.38 152.86 32.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.52 -2.67 30.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 121.47 -0.395 . . . . 25.0 113.543 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -65.09 153.08 41.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 175.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.77 60.23 3.38 Favored Glycine 0 C--O 1.218 -0.9 0 CA-C-N 116.647 -0.251 . . . . 25.0 113.601 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -73.47 -17.04 61.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.893 0.477 . . . . 25.0 111.362 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -163.57 0.24 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.103 0.877 . . . . 25.0 109.497 -177.643 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 55.49 -176.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.98 1.474 . . . . 25.0 114.98 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.7 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.713 1.605 . . . . 25.0 112.156 -173.576 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.59 130.5 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.739 . . . . 25.0 111.573 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.57 140.96 72.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.383 -0.826 . . . . 25.0 112.033 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.74 165.95 30.97 Favored 'Trans proline' 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 25.0 110.955 175.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 25.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.64 159.44 52.74 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 25.0 111.521 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.75 169.01 7.66 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 N-CA-C 114.768 1.026 . . . . 25.0 114.768 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -133.95 154.62 80.41 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 113.275 -1.784 . . . . 25.0 110.274 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.89 169.81 20.99 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.143 1.895 . . . . 25.0 112.892 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -93.67 34.06 1.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.437 -0.801 . . . . 25.0 111.927 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.49 -171.16 20.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.449 -0.405 . . . . 25.0 113.825 178.543 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.78 149.06 25.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.021 0.915 . . . . 25.0 111.76 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 124.061 1.886 . . . . 25.0 112.503 177.151 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.258 0 CA-C-O 123.46 1.589 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 54.76 22.02 3.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 113.245 -1.478 . . . . 25.0 114.567 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -63.95 126.8 28.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.988 -0.745 . . . . 25.0 108.988 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -125.36 3.11 7.75 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.606 -0.725 . . . . 25.0 110.003 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.81 168.96 18.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.767 -1.106 . . . . 25.0 109.121 -176.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 25.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 25.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 25.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 25.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 25.0 110.386 177.042 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 25.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 25.0 109.5 174.487 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 25.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 25.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 25.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 25.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 25.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 25.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 15' ' ' ASP . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 25.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 25.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 25.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 25.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 25.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 173.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 25.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 25.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 25.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 25.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 25.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 25.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 25.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 25.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 25.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 25.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 25.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 25.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 25.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 25.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 25.0 111.004 176.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 25.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt -93.84 74.19 4.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 25.0 110.797 -178.016 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.53 -31.78 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.342 -0.845 . . . . 25.0 110.278 178.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.24 115.95 0.68 Allowed Glycine 0 C--O 1.221 -0.716 0 CA-C-N 116.278 -0.419 . . . . 25.0 113.333 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mtm 62.07 -49.54 0.16 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.622 2.453 . . . . 25.0 117.622 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -53.34 144.6 16.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.04 0.536 . . . . 25.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t0 56.16 69.69 0.71 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.681 0.993 . . . . 25.0 113.681 177.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm 54.2 29.2 10.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.909 1.818 . . . . 25.0 115.909 168.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -85.01 143.34 39.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.38 149.16 50.15 Favored 'Trans proline' 0 C--N 1.344 0.33 0 N-CA-C 114.553 0.944 . . . . 25.0 114.553 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.92 161.15 27.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.523 -0.762 . . . . 25.0 109.254 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.36 -87.7 1.01 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.2 m 52.6 31.44 10.09 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.933 1.457 . . . . 25.0 114.933 177.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.72 87.0 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 120.673 -0.775 . . . . 25.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.39 152.99 8.65 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 109.967 -1.253 . . . . 25.0 109.967 176.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.2 t -167.0 153.66 8.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 154.95 12.0 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.235 -1.546 . . . . 25.0 109.235 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.5 m -131.22 19.36 4.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.407 0.604 . . . . 25.0 109.959 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.43 -173.95 15.79 Favored Glycine 0 CA--C 1.51 -0.28 0 N-CA-C 107.361 -2.296 . . . . 25.0 107.361 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.32 -41.77 47.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.56 0.68 . . . . 25.0 110.187 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 70.15 139.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 125.155 1.535 . . . . 25.0 112.367 -177.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 121.8 26.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.769 -1.937 . . . . 25.0 105.769 175.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -147.81 117.37 7.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.314 -0.624 . . . . 25.0 109.314 -173.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.51 111.54 19.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.672 0.749 . . . . 25.0 109.381 178.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.54 148.28 98.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.324 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.92 160.58 49.14 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 117.868 -0.955 . . . . 25.0 111.781 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 25.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.17 163.29 38.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 25.0 110.657 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.28 176.47 7.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 CA-C-O 121.335 0.473 . . . . 25.0 112.88 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.99 159.63 71.64 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.29 -175.96 2.24 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.605 1.537 . . . . 25.0 111.349 178.063 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.3 14.95 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 115.403 1.631 . . . . 25.0 115.403 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.59 12.63 67.89 Favored Glycine 0 C--O 1.229 -0.169 0 N-CA-C 110.47 -1.052 . . . . 25.0 110.47 172.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.09 118.75 14.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.034 0.921 . . . . 25.0 109.037 -177.631 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.209 -1.04 0 CA-C-O 124.512 2.101 . . . . 25.0 112.712 -177.126 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.956 0 CA-C-O 124.615 2.231 . . . . 25.0 113.628 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 t -75.31 128.04 34.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.149 -1.526 . . . . 25.0 108.993 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -144.59 122.3 11.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 67.1 158.75 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.727 1.267 . . . . 25.0 108.417 -171.48 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 58.76 179.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 25.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 178.125 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 25.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 25.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 176.69 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 25.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 25.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 25.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 25.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 25.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 25.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 25.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 25.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 25.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 25.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 25.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 25.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 25.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 25.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 25.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 25.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 25.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 25.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 25.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 25.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 25.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 25.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 25.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 25.0 111.783 179.521 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.402 HG23 HG21 ' A' ' 8' ' ' VAL . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 25.0 109.171 177.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.77 85.86 4.95 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 179.242 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.97 -27.51 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.693 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.44 -52.81 4.78 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.473 -1.051 . . . . 25.0 110.473 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.6 mtm -72.13 157.48 37.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.25 11.16 6.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.864 1.431 . . . . 25.0 114.864 175.726 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 177.405 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -139.59 43.11 2.0 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.396 0.517 . . . . 25.0 112.396 -173.606 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -65.7 152.0 93.69 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 176.219 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.86 -15.15 16.92 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.267 -0.689 . . . . 25.0 112.553 173.874 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.28 -105.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 25.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.5 -52.0 0.01 OUTLIER Glycine 0 C--O 1.235 0.162 0 N-CA-C 111.194 -0.762 . . . . 25.0 111.194 178.386 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 p -90.67 -179.85 5.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 176.274 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.08 -48.79 4.11 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.65 0.62 . . . . 25.0 114.65 176.725 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.18 40.41 1.48 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 115.537 0.975 . . . . 25.0 115.537 -178.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 m -96.0 -37.78 10.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.233 0.517 . . . . 25.0 111.412 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.63 173.68 37.73 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.923 -0.871 . . . . 25.0 110.923 -175.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -122.3 -1.13 9.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.69 0.626 . . . . 25.0 112.69 -179.528 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.9 -21.55 45.48 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 119.329 -0.706 . . . . 25.0 113.937 -179.354 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.5 mt 54.97 -147.34 0.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.356 0.662 . . . . 25.0 109.731 -179.334 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 p -135.27 166.23 23.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.128 -1.805 . . . . 25.0 106.128 179.142 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 59.19 15.53 4.25 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.421 1.638 . . . . 25.0 115.421 171.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.23 88.51 6.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.953 0.883 . . . . 25.0 109.644 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.4 123.5 26.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.607 0.717 . . . . 25.0 110.101 -178.263 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.96 149.59 85.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.284 -0.871 . . . . 25.0 112.195 -176.375 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.45 163.99 36.95 Favored 'Trans proline' 0 C--O 1.241 0.65 0 O-C-N 121.758 0.347 . . . . 25.0 112.473 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 25.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.94 162.69 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 25.0 110.702 176.46 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.23 172.47 15.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 113.467 0.526 . . . . 25.0 113.467 -176.299 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -133.97 154.84 80.51 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 25.0 110.854 178.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.19 174.7 12.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.53 2.153 . . . . 25.0 112.468 176.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -82.4 38.33 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.013 -0.539 . . . . 25.0 112.143 179.442 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.34 -146.86 19.22 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 121.144 -0.551 . . . . 25.0 111.802 -178.626 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -77.15 87.05 3.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.183 0.992 . . . . 25.0 109.996 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 125.662 2.649 . . . . 25.0 111.812 -179.651 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 CA-C-O 122.582 1.101 . . . . 25.0 115.221 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -68.28 141.11 55.96 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.403 -1.057 . . . . 25.0 108.351 177.492 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -111.45 159.07 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 25.0 112.39 -175.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -147.73 148.08 30.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 103.659 -2.719 . . . . 25.0 103.659 172.423 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 58.35 167.48 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 25.0 117.069 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 25.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 25.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 25.0 108.563 -177.864 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 25.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 25.0 111.838 178.773 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 25.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 25.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 25.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 25.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 25.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 25.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 25.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 25.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 25.0 110.144 -179.812 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 25.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 25.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 11' ' ' LYS . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 178.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 173.029 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 25.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 25.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 25.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 25.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 25.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 25.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 25.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 25.0 111.633 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 25.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 25.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 25.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 25.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 25.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.13 73.59 7.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 25.0 109.702 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.02 -33.78 64.42 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.527 -0.76 . . . . 25.0 110.202 -179.149 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.6 -1.8 56.24 Favored Glycine 0 C--O 1.218 -0.862 0 N-CA-C 115.032 0.773 . . . . 25.0 115.032 178.189 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -132.27 -36.83 1.12 Allowed 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 -176.45 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -5.92 49.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 -172.294 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 t0 13.34 73.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.573 2.434 . . . . 25.0 117.573 -172.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -65.87 -26.66 67.74 Favored 'General case' 0 C--O 1.239 0.537 0 O-C-N 121.586 -0.696 . . . . 25.0 110.138 179.45 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.3 133.64 0.76 Allowed Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 174.379 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.79 -14.38 17.41 Favored 'Trans proline' 0 C--N 1.344 0.317 0 N-CA-C 114.338 0.861 . . . . 25.0 114.338 -174.532 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.24 -96.96 0.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.045 0.938 . . . . 25.0 110.84 -176.508 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 -161.38 45.59 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 p -94.7 155.67 16.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.04 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.69 173.93 40.64 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.174 -1.571 . . . . 25.0 109.174 176.629 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.48 87.77 0.23 Allowed Glycine 0 C--O 1.223 -0.532 0 N-CA-C 111.179 -0.768 . . . . 25.0 111.179 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -125.34 21.14 7.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.345 0.498 . . . . 25.0 112.345 -175.829 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.69 38.13 1.25 Allowed Glycine 0 C--O 1.223 -0.569 0 N-CA-C 115.45 0.94 . . . . 25.0 115.45 -177.321 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 m -64.73 -25.18 67.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.203 0.501 . . . . 25.0 111.631 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.84 46.34 3.59 Favored Glycine 0 C--O 1.22 -0.779 0 N-CA-C 111.894 -0.482 . . . . 25.0 111.894 176.127 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.63 32.91 15.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.748 0.785 . . . . 25.0 112.021 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.48 17.49 9.59 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 179.104 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -73.87 127.31 32.52 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 122.104 -0.373 . . . . 25.0 110.539 176.514 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -122.41 75.49 1.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.795 0.807 . . . . 25.0 110.466 177.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.73 141.89 56.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.898 -1.046 . . . . 25.0 110.803 179.433 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 149.0 60.26 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.398 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.45 163.22 39.22 Favored 'Trans proline' 0 C--O 1.242 0.725 0 O-C-N 121.637 0.283 . . . . 25.0 111.74 176.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 25.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 25.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 161.22 45.91 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 25.0 110.721 177.263 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.59 174.74 12.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 120.167 0.578 . . . . 25.0 113.397 -177.694 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 156.21 79.52 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 25.0 109.9 179.016 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.89 173.37 14.58 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 25.0 112.357 176.51 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.52 52.26 2.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.488 0.661 . . . . 25.0 111.163 178.682 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.57 173.6 32.28 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 121.788 0.66 . . . . 25.0 114.194 178.426 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -106.56 122.55 46.53 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 122.145 0.974 . . . . 25.0 111.345 -174.057 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 124.087 1.899 . . . . 25.0 113.536 179.603 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 CA-C-O 124.383 2.102 . . . . 25.0 115.161 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -77.96 140.08 39.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.356 -1.085 . . . . 25.0 110.039 179.228 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -63.42 142.83 58.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -135.66 145.19 46.52 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.563 -2.755 . . . . 25.0 103.563 175.786 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 61.49 169.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.892 1.37 . . . . 25.0 113.077 -174.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 25.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 25.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 25.0 108.431 -178.389 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 25.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 176.372 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 25.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 25.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 25.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 25.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 25.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 25.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 25.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 25.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 25.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 25.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 25.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 25.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 8' ' ' VAL . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 178.994 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 25.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.673 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 25.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 25.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 25.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 25.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 25.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 25.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 25.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 25.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 25.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 25.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 25.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 25.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 25.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 25.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 25.0 111.388 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 8' ' ' VAL . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 25.0 108.918 177.249 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.28 79.55 5.04 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 25.0 107.657 178.722 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -64.4 120.91 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.27 -177.14 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 6.95 74.34 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 114.436 0.534 . . . . 25.0 114.436 -178.223 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.2 ptp -80.54 0.76 32.41 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.303 -0.528 . . . . 25.0 111.733 -179.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.06 9.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.957 0.408 . . . . 25.0 110.882 179.351 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.82 -33.02 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.031 0.92 . . . . 25.0 109.022 175.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -106.34 135.31 48.06 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.804 -1.089 . . . . 25.0 112.586 -171.902 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -158.26 158.28 29.68 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 103.887 -2.634 . . . . 25.0 103.887 176.098 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.59 144.84 36.41 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 114.567 -3.155 . . . . 25.0 111.372 174.315 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.29 -170.6 0.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 176.254 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 177.89 47.35 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 107.639 -2.185 . . . . 25.0 107.639 -178.885 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 56.44 17.4 2.93 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.193 1.924 . . . . 25.0 116.193 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.79 159.21 34.31 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.567 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 175.25 41.41 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 106.262 -2.735 . . . . 25.0 106.262 178.452 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m -149.73 -87.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.467 1.133 . . . . 25.0 111.765 -179.103 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.99 157.08 48.22 Favored Glycine 0 N--CA 1.455 -0.077 0 C-N-CA 120.753 -0.737 . . . . 25.0 111.543 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.6 t -147.06 -79.19 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.581 0.215 . . . . 25.0 111.581 178.418 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.23 2.12 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 115.088 0.795 . . . . 25.0 115.088 -177.747 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.54 152.03 27.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.019 0.409 . . . . 25.0 109.949 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.2 p -116.73 87.01 2.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.561 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -154.14 -174.4 4.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 103.484 -2.784 . . . . 25.0 103.484 -177.723 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 68.26 86.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.595 1.158 . . . . 25.0 111.332 179.227 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.55 130.7 47.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.191 -0.913 . . . . 25.0 111.269 -177.278 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.74 148.38 68.91 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.247 -0.888 . . . . 25.0 110.929 -178.245 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.29 164.52 35.46 Favored 'Trans proline' 0 C--O 1.242 0.679 0 O-C-N 121.681 0.306 . . . . 25.0 111.768 176.734 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 25.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.58 161.16 46.33 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 25.0 110.848 176.989 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.75 177.66 7.78 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 120.125 0.55 . . . . 25.0 113.338 -177.444 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -132.68 156.52 79.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.907 -0.588 . . . . 25.0 109.482 178.558 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.9 -169.82 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.331 3.354 . . . . 25.0 113.544 179.401 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 63.69 26.09 14.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.933 1.293 . . . . 25.0 109.207 -174.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.26 131.77 3.71 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.232 -1.547 . . . . 25.0 109.232 173.934 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -114.02 150.39 33.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.962 0.887 . . . . 25.0 110.282 -178.838 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.214 -0.77 0 CA-C-O 125.468 2.556 . . . . 25.0 111.828 178.629 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 123.047 1.359 . . . . 25.0 115.555 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -79.0 136.6 37.25 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.22 -1.165 . . . . 25.0 110.494 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -106.91 -3.09 20.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.505 0.669 . . . . 25.0 111.545 177.635 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -97.2 135.24 39.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.184 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 63.82 162.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.321 1.638 . . . . 25.0 114.382 -177.381 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 25.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 25.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 25.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 25.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 176.068 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 25.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 25.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 25.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 25.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 25.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 25.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 25.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 25.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 25.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 25.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 25.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 25.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 25.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 25.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 25.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 25.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 173.668 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 25.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 25.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 25.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 25.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 25.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 25.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 25.0 107.384 179.448 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 25.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 25.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 25.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 25.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 25.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 25.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 25.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 25.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 25.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.294 177.619 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -97.7 72.03 2.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 25.0 108.141 179.713 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.3 143.99 7.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 115.063 -0.971 . . . . 25.0 112.903 -176.245 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 -175.32 50.69 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 108.408 -1.877 . . . . 25.0 108.408 174.862 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 tmm? 55.39 45.38 25.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.315 1.055 . . . . 25.0 109.902 -178.553 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.97 138.06 48.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 -179.596 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.15 118.72 8.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.835 0.826 . . . . 25.0 110.365 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -143.74 160.98 39.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.385 -2.08 . . . . 25.0 105.385 -177.324 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -133.91 156.4 79.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 25.0 108.422 178.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.51 170.44 19.3 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 117.2 -1.4 . . . . 25.0 112.245 175.153 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.67 178.22 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.491 1.663 . . . . 25.0 115.491 173.634 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.25 -177.73 22.41 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 108.885 -1.686 . . . . 25.0 108.885 -175.183 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 t 59.8 -166.88 0.18 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.299 0.64 . . . . 25.0 110.223 -176.635 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.25 -37.63 2.57 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 115.604 1.002 . . . . 25.0 115.604 178.771 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.94 -33.75 88.0 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 117.492 0.646 . . . . 25.0 114.413 -176.889 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.3 p -157.61 167.91 28.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 178.426 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.33 154.81 29.07 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.297 -1.521 . . . . 25.0 109.297 175.005 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.5 p -89.72 8.61 30.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.093 0.473 . . . . 25.0 110.417 179.311 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.86 156.01 8.61 Favored Glycine 0 C--O 1.236 0.24 0 N-CA-C 107.595 -2.202 . . . . 25.0 107.595 -176.127 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.96 141.22 32.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.1 p 46.8 -156.32 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.364 1.04 . . . . 25.0 111.916 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 54.19 18.42 1.79 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 177.069 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -128.38 103.46 7.16 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.04 -0.726 . . . . 25.0 109.04 -179.583 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.78 147.37 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.43 -0.805 . . . . 25.0 111.707 -175.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.33 146.39 61.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 -177.371 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.79 168.73 22.99 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 120.149 0.566 . . . . 25.0 110.929 172.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 25.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 25.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.67 162.66 40.17 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 25.0 110.959 177.777 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.97 173.13 15.02 Favored 'Trans proline' 0 C--N 1.351 0.688 0 N-CA-C 113.158 0.407 . . . . 25.0 113.158 -177.063 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 154.84 80.58 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.567 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.42 169.63 18.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 120.839 1.026 . . . . 25.0 112.938 175.28 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -98.46 65.73 1.66 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.249 -0.887 . . . . 25.0 108.779 175.66 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.29 174.79 32.72 Favored Glycine 0 C--O 1.229 -0.172 0 CA-C-N 115.766 -0.652 . . . . 25.0 112.358 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.65 137.16 53.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 176.526 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 126.259 2.933 . . . . 25.0 111.959 -177.499 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 122.463 1.035 . . . . 25.0 114.577 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p 61.12 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 118.092 2.627 . . . . 25.0 118.092 179.323 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -45.76 -63.43 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.834 1.79 . . . . 25.0 115.834 -176.679 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 55.86 19.34 3.46 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.738 1.755 . . . . 25.0 115.738 -178.749 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -135.93 169.91 16.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 25.0 112.131 -177.525 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 25.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 25.0 108.747 -178.62 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 25.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 25.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 174.818 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 25.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 25.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 25.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 25.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 25.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 25.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 25.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 25.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 25.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 25.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 25.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 8' ' ' VAL . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.472 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 173.277 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 25.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 25.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 25.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 25.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 25.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 178.103 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 25.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 25.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 25.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 25.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 25.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 25.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 25.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 25.0 109.989 173.815 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.445 HG23 HG21 ' A' ' 8' ' ' VAL . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 176.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -95.78 94.14 7.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 177.424 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.96 123.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -175.478 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.61 163.62 53.23 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 111.038 -0.825 . . . . 25.0 111.038 -178.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 ttp 69.87 -38.19 0.4 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.112 1.365 . . . . 25.0 114.347 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -90.33 119.85 30.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.582 0.956 . . . . 25.0 113.582 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.93 155.43 22.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 165.409 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.78 38.04 2.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 25.0 109.64 -178.489 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt 77.33 151.12 0.13 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.773 2.029 . . . . 25.0 110.014 -178.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.86 140.81 62.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 116.403 -1.931 . . . . 25.0 112.266 -178.537 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.81 141.06 17.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.702 -1.222 . . . . 25.0 107.702 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.73 174.29 46.92 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 107.882 -2.087 . . . . 25.0 107.882 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -161.36 163.8 30.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.051 -2.203 . . . . 25.0 105.051 179.055 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.78 169.07 41.06 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 107.98 -2.048 . . . . 25.0 107.98 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.44 -67.84 0.3 Allowed Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 178.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m 53.53 28.57 7.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.491 0.923 . . . . 25.0 113.491 176.859 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.62 -169.12 37.59 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.513 -1.835 . . . . 25.0 108.513 -177.249 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -76.62 60.87 1.72 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.881 1.067 . . . . 25.0 113.881 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.01 78.01 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.915 -0.66 . . . . 25.0 111.476 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.3 mt 49.49 37.22 11.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.066 1.135 . . . . 25.0 114.066 173.749 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -100.55 -47.71 4.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.957 0.408 . . . . 25.0 111.364 -178.049 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 57.29 179.82 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -1.151 . . . . 25.0 112.648 -176.698 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.97 134.5 8.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -176.836 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.37 130.61 36.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.425 0.631 . . . . 25.0 109.634 -178.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.15 77.08 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 25.0 112.074 -177.367 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.48 162.81 41.1 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 118.136 -0.776 . . . . 25.0 110.948 174.607 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 25.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.13 160.06 51.41 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 25.0 110.86 177.626 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.86 179.8 5.33 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 119.926 0.417 . . . . 25.0 112.675 -178.828 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.6 mt -127.88 155.83 76.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 25.0 109.628 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.1 -173.4 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.343 2.695 . . . . 25.0 112.865 179.366 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.75 11.31 1.3 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 118.187 2.662 . . . . 25.0 118.187 173.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.38 -155.55 16.27 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.796 176.287 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 50.41 38.54 18.39 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.836 1.779 . . . . 25.0 113.049 -177.339 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 125.308 2.48 . . . . 25.0 111.138 177.784 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 122.632 1.129 . . . . 25.0 115.192 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -67.01 112.03 4.15 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.458 -1.025 . . . . 25.0 110.288 179.596 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -81.19 72.29 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.522 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 tptm 65.41 -177.09 0.18 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -172.101 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 54.79 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 25.0 115.144 175.598 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 25.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -178.814 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 25.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 25.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 25.0 110.387 175.13 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 25.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 25.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 25.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 25.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 25.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 25.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 25.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 25.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 25.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 178.913 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 25.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 25.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 25.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 25.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 25.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 25.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 25.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 25.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 25.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 25.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 25.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 25.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 25.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 25.0 111.669 178.03 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 25.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.99 72.06 3.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -177.2 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.2 m -75.26 -11.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.073 0.463 . . . . 25.0 110.984 176.071 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.22 177.59 48.27 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 110.585 -1.006 . . . . 25.0 110.585 -178.137 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.5 mtm 55.02 15.29 1.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 177.418 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -131.94 172.27 12.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -178.387 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t0 60.4 43.31 13.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.789 0.836 . . . . 25.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -77.23 60.71 1.99 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.686 0.755 . . . . 25.0 111.536 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -70.08 154.55 94.52 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.661 -0.699 . . . . 25.0 110.228 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.59 -16.64 18.84 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 114.599 0.961 . . . . 25.0 114.599 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.93 98.64 9.32 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.911 -0.493 . . . . 25.0 110.894 -179.098 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.17 -14.64 58.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.871 1.108 . . . . 25.0 115.871 -178.626 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -93.14 149.22 21.38 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.867 . . . . 25.0 111.175 -177.503 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.73 -170.7 18.48 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.724 -0.216 . . . . 25.0 112.917 177.253 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 -59.03 3.27 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-O 120.085 -0.286 . . . . 25.0 113.745 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.2 m -134.46 146.5 49.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.401 -0.963 . . . . 25.0 108.401 178.918 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.87 9.14 86.72 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.885 -0.674 . . . . 25.0 112.225 -178.295 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.7 p -120.01 160.63 22.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.26 174.88 49.31 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.418 -1.073 . . . . 25.0 110.418 176.182 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.55 160.18 31.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 179.53 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 t -139.66 163.58 32.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.023 -2.214 . . . . 25.0 105.023 177.886 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.74 151.21 42.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 176.962 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.59 99.79 2.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.962 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.55 139.18 58.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 25.0 111.367 -173.825 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.16 148.96 40.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.23 -0.895 . . . . 25.0 113.283 -174.212 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.84 164.76 34.65 Favored 'Trans proline' 0 C--O 1.242 0.71 0 O-C-N 121.836 0.387 . . . . 25.0 111.861 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 25.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.51 159.72 51.18 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 25.0 109.363 170.328 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.8 170.85 19.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 118.402 -0.599 . . . . 25.0 113.482 -175.815 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.1 mt -133.94 155.94 79.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.51 -0.768 . . . . 25.0 108.943 178.297 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.6 167.68 25.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.222 1.282 . . . . 25.0 113.156 176.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.02 28.48 4.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 25.0 110.401 -178.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 -157.8 27.55 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.144 -0.782 . . . . 25.0 111.144 -176.009 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.13 149.88 40.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.265 1.031 . . . . 25.0 110.797 -179.648 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 124.785 2.231 . . . . 25.0 111.504 178.99 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 122.348 0.971 . . . . 25.0 114.379 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t 54.82 37.2 28.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.887 0.875 . . . . 25.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.6 ttt 54.29 64.75 1.71 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.899 0.857 . . . . 25.0 112.484 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -134.27 148.31 50.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 176.292 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 56.93 170.94 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 25.0 116.014 179.482 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 25.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.793 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 25.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 65' ' ' LEU . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 25.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 25.0 110.531 175.777 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 25.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 25.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 25.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 25.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 25.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 25.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 25.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 25.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 25.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 25.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 25.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 25.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 25.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 179.082 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 25.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 25.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 25.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 25.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 25.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 25.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 25.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 25.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 25.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 25.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 25.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 25.0 110.737 175.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 25.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 25.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 25.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 25.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' HB2' HD21 ' A' ' 13' ' ' LEU . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 25.0 110.544 175.657 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 11' ' ' LYS . 56.1 mt -106.55 83.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 25.0 109.849 -179.55 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.84 146.87 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.208 0.528 . . . . 25.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.21 -171.8 40.01 Favored Glycine 0 C--O 1.217 -0.919 0 N-CA-C 109.451 -1.46 . . . . 25.0 109.451 176.709 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.9 mtm 62.23 8.82 2.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 178.04 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -127.9 26.66 5.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.219 -0.289 . . . . 25.0 110.219 177.596 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 47.09 50.3 14.2 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.73 0.776 . . . . 25.0 111.82 -179.147 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -70.89 83.43 0.66 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.188 0.994 . . . . 25.0 113.283 -174.885 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -75.23 151.38 85.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 25.0 109.353 176.705 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.62 -15.73 21.61 Favored 'Trans proline' 0 C--N 1.35 0.638 0 N-CA-C 115.219 1.2 . . . . 25.0 115.219 -176.503 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.22 22.77 13.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.56 178.0 15.34 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.493 -0.384 . . . . 25.0 112.307 176.59 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 p -161.24 167.55 25.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.417 -2.438 . . . . 25.0 104.417 177.536 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.62 19.66 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 111.595 -0.602 . . . . 25.0 111.595 179.422 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.1 -41.31 1.17 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 179.44 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 t 54.59 24.08 5.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.104 1.89 . . . . 25.0 116.104 174.451 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.3 153.43 22.41 Favored Glycine 0 CA--C 1.512 -0.099 0 N-CA-C 111.565 -0.614 . . . . 25.0 111.565 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.8 m -97.01 177.22 5.68 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.644 0.377 . . . . 25.0 110.203 -178.775 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.99 -125.56 15.89 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.55 -20.71 58.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.157 0.428 . . . . 25.0 112.157 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m 62.21 36.84 14.66 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 -169.618 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 50.78 -159.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 112.878 -1.965 . . . . 25.0 115.549 173.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 67.01 97.38 0.05 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.769 1.228 . . . . 25.0 109.98 -173.39 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.69 135.34 56.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 25.0 111.479 -173.422 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.7 146.66 53.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.019 -0.992 . . . . 25.0 112.511 -175.334 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.25 165.58 31.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 O-C-N 121.793 0.365 . . . . 25.0 111.55 174.464 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 25.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.06 162.91 39.76 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 25.0 109.571 169.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.93 172.4 16.41 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 113.813 0.659 . . . . 25.0 113.813 -175.634 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.9 mt -133.87 156.48 79.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 25.0 110.251 177.799 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.24 -162.04 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.963 3.109 . . . . 25.0 112.41 177.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 67.51 13.36 9.28 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.065 1.346 . . . . 25.0 113.129 178.532 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.41 -85.47 1.37 Allowed Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.347 -1.101 . . . . 25.0 110.347 172.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -113.24 124.09 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.914 -0.773 . . . . 25.0 108.914 177.072 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 126.257 2.932 . . . . 25.0 111.683 -178.507 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 CA-C-O 124.84 2.355 . . . . 25.0 113.452 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m -147.38 162.8 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.223 -1.489 . . . . 25.0 109.357 -179.35 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.3 ttp -132.67 153.26 51.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 -179.045 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -121.83 142.4 50.27 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 174.101 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.53 165.67 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 -176.392 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 25.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 25.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 25.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 25.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 25.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 25.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 25.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 25.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 25.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 25.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 25.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 25.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 25.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 25.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 25.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 25.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 25.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 25.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 25.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 25.0 109.599 172.562 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 25.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 25.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 25.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 25.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 25.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 25.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 25.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 25.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 25.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 25.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 25.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 25.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 25.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 25.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 25.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 25.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 25.0 112.503 178.401 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 25.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -96.49 41.35 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -176.252 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.6 t -106.61 -57.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.014 0.376 . . . . 25.0 112.014 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.42 -97.95 1.61 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 106.909 -2.476 . . . . 25.0 106.909 -170.726 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.33 108.92 3.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.655 0.727 . . . . 25.0 110.478 176.236 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -146.83 149.24 32.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.906 -0.776 . . . . 25.0 108.906 176.132 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -87.19 -25.64 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.971 0.891 . . . . 25.0 109.464 172.01 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -109.84 160.23 16.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.83 -0.623 . . . . 25.0 110.759 -176.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -80.06 157.85 73.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.149 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.89 -13.7 37.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 N-CA-C 114.713 1.005 . . . . 25.0 114.713 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.33 35.97 21.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.433 0.901 . . . . 25.0 113.433 176.703 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.3 -178.06 36.73 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.704 -1.758 . . . . 25.0 108.704 179.874 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.6 m -145.58 165.53 28.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.254 -0.647 . . . . 25.0 109.254 -178.503 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 172.75 40.55 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 107.827 -2.109 . . . . 25.0 107.827 178.808 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.18 -151.02 7.44 Favored Glycine 0 C--O 1.239 0.431 0 CA-C-N 117.79 0.795 . . . . 25.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 m -143.42 162.34 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.67 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -139.57 109.09 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 109.282 -1.527 . . . . 25.0 109.282 175.275 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 p -155.27 141.64 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.362 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.1 -3.64 19.3 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.293 -0.48 . . . . 25.0 113.324 -179.427 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.73 150.48 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -177.661 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 p -141.52 67.47 1.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.749 0.785 . . . . 25.0 110.062 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.6 53.46 2.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.007 -0.997 . . . . 25.0 112.299 -174.725 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 140.38 15.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.125 -1.805 . . . . 25.0 106.125 -179.28 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.48 146.16 23.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.284 -0.871 . . . . 25.0 110.424 -177.507 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.67 146.23 46.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.107 -0.497 . . . . 25.0 112.141 -177.2 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.57 167.15 26.33 Favored 'Trans proline' 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 25.0 110.857 174.358 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 25.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.51 155.88 67.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 25.0 108.943 173.266 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.65 174.76 12.11 Favored 'Trans proline' 0 C--O 1.239 0.572 0 O-C-N 121.878 0.409 . . . . 25.0 112.907 -176.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.3 mt -130.61 161.55 60.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 25.0 111.659 -179.37 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.4 -164.01 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.06 1.84 . . . . 25.0 112.692 177.16 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 62.57 12.26 5.35 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.024 1.329 . . . . 25.0 114.412 178.613 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.78 6.91 48.87 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.601 -0.727 . . . . 25.0 113.689 176.088 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 143.68 57.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 116.549 2.055 . . . . 25.0 116.549 -170.847 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.839 0 CA-C-O 124.34 2.078 . . . . 25.0 115.075 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 150.03 33.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 176.569 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.34 136.27 39.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 25.0 109.975 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -158.11 140.7 14.57 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 103.421 -2.807 . . . . 25.0 103.421 175.82 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 58.42 175.33 0.06 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 25.0 115.742 177.711 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 25.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 25.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 25.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 25.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 25.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 25.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 25.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 25.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 25.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 25.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 25.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 25.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 25.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 25.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 25.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 25.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 25.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 25.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 25.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 25.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 25.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 25.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 25.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 25.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 25.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 25.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 25.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 25.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 25.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 25.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 25.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 25.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 25.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 25.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 25.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 25.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.56 68.84 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -27.88 43.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 115.089 1.515 . . . . 25.0 115.089 -173.167 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.1 2.99 67.67 Favored Glycine 0 C--O 1.218 -0.873 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.879 -177.599 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.8 mmm -88.57 -9.58 51.78 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.133 1.16 . . . . 25.0 114.133 -176.275 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.59 133.22 25.25 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.351 -0.218 . . . . 25.0 110.747 -175.823 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -120.74 179.09 4.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.147 1.166 . . . . 25.0 114.147 -173.789 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 55.08 42.37 30.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.408 1.632 . . . . 25.0 115.408 171.062 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.68 149.31 50.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 171.038 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 151.79 73.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.225 -178.767 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.75 -30.71 0.16 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -176.513 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.28 134.25 12.28 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.305 -0.95 . . . . 25.0 111.588 -178.011 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -100.35 -15.47 17.98 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 117.347 0.573 . . . . 25.0 111.803 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.83 -146.2 14.49 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.565 -1.414 . . . . 25.0 109.565 -175.8 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.46 175.03 40.88 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 121.697 0.609 . . . . 25.0 114.006 179.099 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -94.4 152.93 18.24 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 122.659 -0.318 . . . . 25.0 110.232 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.35 86.89 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 114.845 0.698 . . . . 25.0 114.845 176.791 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -58.17 150.99 20.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.802 0.667 . . . . 25.0 112.802 -178.003 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.97 48.86 0.54 Allowed Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.706 -0.958 . . . . 25.0 110.706 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.41 -174.42 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.637 -0.505 . . . . 25.0 109.637 -178.533 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -74.15 -178.77 3.51 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.42 0.688 . . . . 25.0 109.923 177.099 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 62.12 -158.57 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.009 0.924 . . . . 25.0 112.251 175.178 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 48.5 42.22 18.32 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.837 0.827 . . . . 25.0 111.755 -176.819 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.09 134.86 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.324 -0.853 . . . . 25.0 111.226 -175.324 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.93 148.27 67.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.101 -0.954 . . . . 25.0 112.35 -175.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.05 164.1 36.71 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 O-C-N 121.902 0.422 . . . . 25.0 112.404 175.551 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 25.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.65 162.21 42.9 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 25.0 109.538 170.684 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.51 172.77 15.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 N-CA-C 113.566 0.564 . . . . 25.0 113.566 -175.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.09 156.59 79.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 178.576 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.49 -176.59 3.03 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.622 2.214 . . . . 25.0 112.581 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.54 11.91 6.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.835 1.254 . . . . 25.0 113.136 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.78 160.55 41.29 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.427 -1.069 . . . . 25.0 110.427 175.235 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.79 161.86 18.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.645 0.736 . . . . 25.0 110.982 -178.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 126.171 2.891 . . . . 25.0 112.204 -179.836 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.607 0 CA-C-O 122.895 1.275 . . . . 25.0 115.84 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t 59.2 -155.02 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.726 1.21 . . . . 25.0 108.902 -175.899 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 42.75 55.23 4.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.456 1.102 . . . . 25.0 113.748 177.816 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -73.55 132.63 43.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 175.038 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 62.63 161.38 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.919 1.387 . . . . 25.0 114.489 -176.401 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 25.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -179.82 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 25.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 25.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 25.0 109.339 174.879 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 25.0 110.379 173.846 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 25.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 25.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 25.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 25.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 25.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 25.0 108.754 -176.206 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 25.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 25.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 25.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 178.863 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 173.236 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 25.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 25.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 25.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 25.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.616 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 25.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 25.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 25.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 25.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 25.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 25.0 111.131 175.101 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 25.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 25.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 25.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 25.0 109.893 177.578 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -93.98 97.22 10.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 177.65 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.81 -38.24 18.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 -174.659 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.91 31.17 62.43 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 110.01 -1.236 . . . . 25.0 110.01 -179.374 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.5 ttm -139.46 -85.24 0.24 Allowed 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.095 0.406 . . . . 25.0 112.095 -176.569 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -90.19 -17.2 27.98 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.666 -0.646 . . . . 25.0 111.392 -177.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 15.93 59.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.657 2.465 . . . . 25.0 117.657 179.264 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -74.54 -6.88 50.97 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.115 0.783 . . . . 25.0 113.115 -176.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -89.33 137.13 29.3 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 104.973 -2.232 . . . . 25.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.33 161.43 44.42 Favored 'Trans proline' 0 C--O 1.237 0.459 0 N-CA-C 115.682 1.378 . . . . 25.0 115.682 -169.214 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.3 161.68 41.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 102.658 -3.09 . . . . 25.0 102.658 175.973 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.51 -151.28 22.89 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 107.311 -2.316 . . . . 25.0 107.311 -175.534 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -19.09 64.92 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 112.904 0.705 . . . . 25.0 112.904 178.133 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.61 -43.05 2.5 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 112.179 -0.368 . . . . 25.0 112.179 178.872 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.64 -173.05 22.52 Favored Glycine 0 C--O 1.225 -0.423 0 N-CA-C 106.84 -2.504 . . . . 25.0 106.84 179.502 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -158.56 144.81 17.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.741 -1.948 . . . . 25.0 105.741 176.072 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.4 69.05 1.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 115.062 0.785 . . . . 25.0 115.062 178.477 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -143.06 151.63 40.99 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.219 -0.66 . . . . 25.0 109.219 178.267 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.47 28.17 43.56 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.5 1.36 . . . . 25.0 116.5 176.272 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 55.91 34.59 23.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.102 0.561 . . . . 25.0 110.85 -176.187 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 88.12 -6.71 0.55 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.994 2.118 . . . . 25.0 112.852 177.142 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -100.41 153.34 19.42 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 174.045 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.59 72.48 1.48 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.953 0.882 . . . . 25.0 108.656 179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.99 142.8 56.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.25 -1.341 . . . . 25.0 111.222 -177.005 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.81 150.04 43.15 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.593 -1.185 . . . . 25.0 113.658 -173.103 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.53 166.29 30.25 Favored 'Trans proline' 0 C--O 1.243 0.739 0 O-C-N 121.696 0.314 . . . . 25.0 111.757 174.356 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 25.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 25.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.21 161.84 42.85 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 25.0 110.092 175.623 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.31 175.68 9.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 CA-C-O 121.075 0.365 . . . . 25.0 112.514 -178.002 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.6 mt -131.33 153.42 81.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.44 167.67 22.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 121.97 1.78 . . . . 25.0 114.273 -178.333 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.89 90.42 4.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.441 -1.254 . . . . 25.0 107.767 178.393 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.76 -173.3 39.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.23 -0.51 . . . . 25.0 111.869 -177.783 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.92 30.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.405 -1.332 . . . . 25.0 107.405 178.955 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 124.638 2.161 . . . . 25.0 111.253 179.701 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 112.509 0.559 . . . . 25.0 112.509 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 25.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 25.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 25.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 25.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 25.0 110.258 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 25.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 25.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 25.0 108.183 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 25.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 25.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 25.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 25.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 25.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 25.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 25.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 25.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 25.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 25.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 25.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 25.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 25.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 25.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 25.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 25.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 25.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 25.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 25.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 25.0 110.803 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 25.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 25.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 25.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 13' ' ' LEU . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 25.0 109.858 173.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 8' ' ' VAL . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 25.0 106.991 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 25.0 106.146 178.37 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 C--O 1.241 0.658 0 CA-C-O 120.713 0.214 . . . . 25.0 111.687 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 25.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 25.0 110.173 175.905 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 25.0 114.947 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 25.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 64' ' ' ILE . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 25.0 108.17 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 25.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 25.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 175.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 25.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 25.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 25.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 25.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 25.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 25.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 25.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 25.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 25.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 25.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 25.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 25.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 25.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 25.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 25.0 108.755 172.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 25.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 25.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 25.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 25.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 25.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 25.0 107.536 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 25.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 25.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 25.0 111.168 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 25.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 25.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 25.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 25.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 25.0 111.348 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 8' ' ' VAL . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 25.0 108.162 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 25.0 109.891 -179.019 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--O 1.241 0.66 0 CA-C-O 120.504 0.127 . . . . 25.0 112.111 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 25.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 25.0 111.462 177.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.821 -0.807 . . . . 25.0 108.821 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 25.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 25.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 25.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 25.0 110.187 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 25.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 25.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 25.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 25.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 25.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 25.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 25.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 25.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 25.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 25.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 25.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 25.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 25.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 25.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 25.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 25.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 25.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 25.0 107.054 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 25.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 25.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 25.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 25.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 25.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.925 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 25.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 25.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 25.0 109.146 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 25.0 110.297 -179.339 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo . . . . . 0 C--O 1.242 0.715 0 CA-C-O 120.711 0.213 . . . . 25.0 111.703 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 25.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 25.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 25.0 110.294 176.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 112.228 0.455 . . . . 25.0 112.228 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 25.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 25.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 25.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 25.0 109.841 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 25.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 25.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 25.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 25.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 25.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 25.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 25.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 25.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 25.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 25.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 25.0 108.145 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 25.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 25.0 110.161 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 25.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 25.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 25.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 25.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 25.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 25.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 25.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 25.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 25.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 25.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 25.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 25.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 25.0 111.333 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 25.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 25.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 25.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 25.0 109.577 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 25.0 107.449 177.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.239 0.564 0 N-CA-C 112.588 0.188 . . . . 25.0 112.588 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 25.0 111.143 177.327 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 25.0 116.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 25.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 25.0 106.465 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 25.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 25.0 109.776 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 25.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 25.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 25.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 25.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 25.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 25.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 25.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 25.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 25.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 25.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 25.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 25.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 25.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 25.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 25.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 25.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 25.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 25.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 25.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 25.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 25.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 25.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 25.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 25.0 111.228 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 25.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 25.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 25.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 25.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 25.0 110.783 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 8' ' ' VAL . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 177.736 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.24 0.586 0 CA-C-O 120.572 0.155 . . . . 25.0 111.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 25.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 25.0 111.109 177.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 . . . . . 0 C--O 1.221 -0.432 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 25.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 25.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 25.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 25.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 25.0 110.438 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 25.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 25.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 25.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 25.0 109.624 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 25.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 25.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 25.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 25.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 25.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 25.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 25.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 25.0 108.502 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 25.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 25.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 25.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 25.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 25.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 25.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 25.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 25.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 25.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 25.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 25.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 25.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 25.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 25.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 25.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 25.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 25.0 111.796 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 HG21 ' A' ' 8' ' ' VAL . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 25.0 109.344 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 25.0 111.106 -178.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 25.0 110.779 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 25.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 25.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 25.0 110.478 175.62 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 25.0 115.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 25.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 25.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 25.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 25.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 173.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 25.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 25.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 25.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 25.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 25.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 25.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 25.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 25.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 25.0 109.644 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 25.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 25.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 25.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 25.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 25.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 25.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 25.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 25.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 25.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 25.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 25.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 25.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 25.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 25.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 25.0 111.211 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 25.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 25.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 25.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 25.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 25.0 109.976 174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 25.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 25.0 107.502 177.476 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.241 0.673 0 N-CA-C 110.872 -0.472 . . . . 25.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 25.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 25.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 25.0 109.926 175.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 . . . . . 0 N--CA 1.443 -0.824 0 CA-C-O 121.074 0.464 . . . . 25.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 25.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 25.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 25.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 25.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 25.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 25.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 25.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 25.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 25.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 25.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 25.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 25.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 25.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 25.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 25.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 25.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 25.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 25.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 25.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 25.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 25.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 25.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 25.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 25.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 25.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 25.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 25.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 25.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 25.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 25.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 25.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.092 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 25.0 106.674 176.433 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 C--O 1.241 0.651 0 CA-C-O 120.605 0.169 . . . . 25.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 25.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 25.0 111.453 177.242 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 25.0 113.99 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 25.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 25.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 25.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 25.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 25.0 110.258 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 25.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 25.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 25.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 25.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 25.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 25.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 25.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 25.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 25.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 25.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 25.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 25.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 25.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 25.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 25.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 25.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 25.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 25.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 25.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 25.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 25.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 25.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 25.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 25.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 25.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 25.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 25.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 25.0 112.251 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 25.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.69 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo . . . . . 0 C--O 1.24 0.608 0 N-CA-C 111.335 -0.294 . . . . 25.0 111.335 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 25.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 25.0 110.468 176.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 25.0 115.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 25.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 25.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 25.0 107.621 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 25.0 110.992 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 25.0 110.588 175.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 25.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 25.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 25.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 25.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 25.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 25.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 25.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 25.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 25.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.501 HD11 ' HE2' ' A' ' 11' ' ' LYS . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 25.0 108.303 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 25.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 25.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 25.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 25.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 25.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 25.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 25.0 107.942 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 25.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 25.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 25.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 25.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 25.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 25.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 25.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.727 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 C--O 1.237 0.465 0 N-CA-C 111.403 -0.268 . . . . 25.0 111.403 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 25.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 25.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 25.0 111.019 176.455 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 CA--C 1.52 -0.209 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 25.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 25.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 25.0 107.564 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 25.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 25.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 25.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 25.0 108.707 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 25.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 25.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 25.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 25.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 25.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 25.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 25.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 25.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 25.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 25.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 25.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 25.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 25.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 25.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 25.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 25.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 25.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 25.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 25.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 25.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 25.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 25.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 25.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 25.0 109.725 173.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 179.053 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--O 1.245 0.836 0 N-CA-C 112.67 0.219 . . . . 25.0 112.67 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 25.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo . . . . . 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 25.0 109.612 171.287 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 25.0 115.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 25.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 25.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 177.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 25.0 110.681 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 25.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 25.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 25.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 25.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 25.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 25.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 25.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 25.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 25.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 25.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 25.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 25.0 110.396 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 25.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 25.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 25.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 25.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 25.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 25.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 25.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 25.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 25.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 25.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 25.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 25.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 25.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 25.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 25.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 25.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 25.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 25.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 25.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 25.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 25.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 25.0 107.235 176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 CA--C 1.537 0.646 0 CA-C-O 120.634 0.181 . . . . 25.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 25.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 25.0 111.332 178.012 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 122.006 0.907 . . . . 25.0 112.578 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 25.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 25.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 25.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 25.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 25.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 25.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 25.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 25.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 25.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 25.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 25.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 25.0 109.045 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 25.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 25.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 25.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 25.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 25.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 25.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 25.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 25.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 25.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 25.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 25.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 25.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 25.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 25.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 25.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 25.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 25.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 25.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 25.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 25.0 111.422 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 8' ' ' VAL . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.74 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 -179.611 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.716 0.215 . . . . 25.0 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 25.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 25.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 25.0 110.617 175.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 25.0 116.134 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 25.0 107.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 25.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 25.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 25.0 110.055 176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 25.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 25.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 25.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 25.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 25.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 25.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 25.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 25.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 25.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 25.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 25.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 25.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 25.0 108.722 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 25.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 25.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 25.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 25.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 25.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 25.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 25.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 25.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 25.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 25.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 25.0 111.105 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 25.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 25.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 25.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 25.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 25.0 110.242 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 179.27 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--O 1.244 0.812 0 N-CA-C 111.507 -0.228 . . . . 25.0 111.507 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 25.0 111.134 177.426 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.926 0.393 . . . . 25.0 110.669 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 25.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 25.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 25.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 25.0 110.504 175.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 25.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 25.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 25.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 25.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 25.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 25.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 25.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 25.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 25.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 25.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 25.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 25.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 25.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 25.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 25.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 25.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 25.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 25.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 25.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 25.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 25.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 25.0 111.851 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 25.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 25.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 25.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 25.0 109.793 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 25.0 111.52 -177.254 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.239 0.539 0 N-CA-C 111.176 -0.355 . . . . 25.0 111.176 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 25.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 25.0 110.308 176.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 25.0 115.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 25.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 25.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 25.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 25.0 109.437 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 25.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 25.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 25.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 25.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 25.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 25.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 25.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 25.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 25.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 25.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 25.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 8' ' ' VAL . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 25.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 25.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 25.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 25.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 25.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 25.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 25.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 25.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 25.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 25.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 25.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 25.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 25.0 111.573 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 25.0 109.966 -178.067 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 C--O 1.243 0.741 0 N-CA-C 111.408 -0.266 . . . . 25.0 111.408 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 25.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 25.0 110.197 176.245 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 25.0 116.22 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 25.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 25.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 25.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 25.0 109.711 176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 25.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 25.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 25.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 25.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 25.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 25.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 25.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 25.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 25.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 25.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 172.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 25.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 25.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 25.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 25.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 25.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 25.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 25.0 106.95 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 25.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 25.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 25.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 25.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 25.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 25.0 111.264 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 25.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 25.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 25.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.298 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 177.757 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 CA-C-O 120.825 0.26 . . . . 25.0 112.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 25.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 25.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 25.0 109.477 168.586 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.833 0.349 . . . . 25.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 25.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 25.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 25.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 25.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 176.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 25.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 25.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 25.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 25.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 25.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 25.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 25.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 25.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 25.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 25.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 25.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 25.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 25.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 25.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 25.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 25.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 25.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 25.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 25.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 25.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 25.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 25.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 25.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 25.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 25.0 111.433 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 25.0 107.074 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 25.0 111.831 -176.275 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo . . . . . 0 C--O 1.241 0.671 0 CA-C-O 120.704 0.21 . . . . 25.0 112.31 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 25.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 25.0 110.623 175.48 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 25.0 117.773 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 25.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 25.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 25.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 25.0 109.446 175.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 25.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 25.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 25.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 25.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 25.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 25.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 25.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 25.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' HG13 ' A' ' 57' ' ' VAL . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 25.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 25.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 25.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 25.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 25.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 25.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 8' ' ' VAL . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 25.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 25.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 25.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 25.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 25.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 25.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 25.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 25.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 25.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 26' ' ' PHE . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 25.0 111.164 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 25.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 25.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 25.0 110.635 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.427 HG23 HG21 ' A' ' 8' ' ' VAL . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 25.0 108.245 178.592 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 25.0 110.928 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 25.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 25.0 110.384 176.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 25.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 25.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 25.0 108.053 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 25.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 25.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 25.0 109.933 176.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 25.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 25.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 25.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 25.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 25.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 25.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 25.0 107.71 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 25.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 25.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 25.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 25.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 25.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 25.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 25.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 25.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 25.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 25.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 25.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 25.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 25.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 25.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 25.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 25.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 25.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 25.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 25.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 25.0 109.975 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 8' ' ' VAL . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 25.0 109.263 -179.174 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--O 1.242 0.678 0 N-CA-C 112.665 0.217 . . . . 25.0 112.665 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 25.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 25.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 25.0 110.486 172.644 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 25.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 25.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 25.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 25.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 175.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 25.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 173.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 25.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 25.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 25.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 25.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 25.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 25.0 110.8 177.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 25.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 25.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 25.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 25.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 25.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 172.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 25.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 25.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 25.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 25.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 25.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 25.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 25.0 112.115 176.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 25.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 25.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 25.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 25.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 25.0 108.803 173.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 25.0 110.858 179.846 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 C--O 1.245 0.84 0 CA-C-O 120.529 0.137 . . . . 25.0 111.765 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 25.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 25.0 110.805 176.686 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 25.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 HG23 ' A' ' 64' ' ' ILE . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 25.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 25.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 25.0 110.391 175.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 25.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 25.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 25.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 25.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 25.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 25.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 25.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 25.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 25.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 25.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 178.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 25.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 25.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 25.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 25.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 25.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 25.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 25.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 25.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 25.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 25.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 25.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 25.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 25.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 25.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 25.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 25.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 25.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 25.0 112.284 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.429 HG23 HG21 ' A' ' 8' ' ' VAL . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.746 178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt . . . . . 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 25.0 110.896 179.848 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 120.667 0.194 . . . . 25.0 112.499 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 25.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 25.0 109.67 169.334 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 25.0 114.869 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 25.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 25.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 25.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 25.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 25.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 25.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 25.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 25.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 25.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 25.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 25.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 25.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 25.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 25.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 25.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 25.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 25.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 25.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 25.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 25.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 25.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 25.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 25.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 25.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 25.0 111.337 176.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 25.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 25.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 25.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 25.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 25.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 25.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 172.788 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 25.0 111.1 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 25.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 25.0 110.528 176.343 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 25.0 115.93 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 25.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 25.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 25.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 25.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 25.0 110.556 176.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 25.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 25.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 25.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 25.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 25.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 25.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 25.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 25.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 25.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 25.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 25.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 25.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 25.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 25.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 25.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 25.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 25.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 25.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 25.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 25.0 111.699 176.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 25.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 25.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 25.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 25.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 25.0 111.299 174.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 -179.007 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo . . . . . 0 C--O 1.24 0.606 0 N-CA-C 110.802 -0.499 . . . . 25.0 110.802 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 25.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 25.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 25.0 111.331 176.967 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 114.144 1.164 . . . . 25.0 114.144 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 25.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 25.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 179.29 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 25.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 25.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 25.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 25.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 25.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 25.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 25.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 25.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 25.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 25.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 25.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 25.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 25.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 25.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 25.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 25.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 25.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 25.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 25.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 25.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 25.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 25.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 25.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 25.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 25.0 111.091 175.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 25.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 25.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 25.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 25.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 25.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 25.0 111.287 -178.667 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 C--O 1.242 0.692 0 N-CA-C 112.513 0.159 . . . . 25.0 112.513 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 25.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 25.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 25.0 110.019 170.56 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 25.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 25.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 25.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 176.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 25.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 25.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 25.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 25.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 25.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 25.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 25.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 25.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 8' ' ' VAL . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 178.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 25.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 172.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 25.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 25.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 25.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 25.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 25.0 107.154 178.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 25.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 25.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 25.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 25.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 25.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 25.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 25.0 110.156 174.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.488 HG23 HG21 ' A' ' 8' ' ' VAL . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 25.0 109.741 179.685 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo . . . . . 0 C--O 1.243 0.729 0 CA-C-O 120.621 0.175 . . . . 25.0 111.92 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 25.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 25.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 25.0 108.893 167.875 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 113.456 0.909 . . . . 25.0 113.456 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 25.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 25.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.143 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 25.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 25.0 111.467 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 25.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 25.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 -179.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 25.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 25.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 25.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 25.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 25.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -177.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 25.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 25.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 25.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 25.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 25.0 108.445 178.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 25.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 25.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 25.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 25.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 25.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 25.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 25.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 25.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 25.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 25.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 25.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 25.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 25.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 25.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 25.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 25.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 8' ' ' VAL . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 179.057 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.239 0.554 0 CA-C-O 120.666 0.194 . . . . 25.0 112.197 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 25.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 25.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.531 174.931 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 120.704 0.288 . . . . 25.0 110.463 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 25.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 25.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.057 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 25.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 25.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 175.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 25.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 25.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 25.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 25.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 25.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 25.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 25.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 25.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 177.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 25.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 25.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 25.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 25.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 25.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 25.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 25.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 25.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 25.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 25.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 25.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 25.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 25.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 25.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 25.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 25.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 25.0 111.508 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 8' ' ' VAL . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 25.0 108.733 175.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 178.618 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 111.666 -0.167 . . . . 25.0 111.666 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 25.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 25.0 110.695 177.055 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 25.0 114.57 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 25.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 178.315 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 25.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 25.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 174.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 25.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 25.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 25.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 25.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 25.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 25.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 25.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 25.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 25.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 25.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 25.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 8' ' ' VAL . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 25.0 109.706 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 25.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 25.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 25.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 25.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 25.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 25.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 25.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 25.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 25.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 25.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 25.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 25.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 25.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 25.0 110.939 175.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 25.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 25.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 25.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.154 178.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 8' ' ' VAL . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 176.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 178.81 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 25.0 110.955 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 25.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo . . . . . 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 25.0 111.521 178.161 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 25.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 25.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 25.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 25.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 25.0 110.386 177.042 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 25.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 25.0 109.5 174.487 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 25.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 25.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 25.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 25.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 25.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 25.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 15' ' ' ASP . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 25.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 25.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 25.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 25.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 25.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 173.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 25.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 25.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 25.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 25.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 25.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 25.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 25.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 25.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 25.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 25.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 25.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 25.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 25.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 25.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 25.0 111.004 176.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 25.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 25.0 110.797 -178.016 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 C--O 1.243 0.727 0 CA-C-O 120.874 0.281 . . . . 25.0 111.781 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 25.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 25.0 110.657 177.93 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 25.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 178.125 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 25.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 25.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 176.69 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 25.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 25.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 25.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 25.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 25.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 25.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 25.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 25.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 25.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 25.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 25.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 25.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 25.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 25.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 25.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 25.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 25.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 25.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 25.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 25.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 25.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 25.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 25.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 25.0 111.783 179.521 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.402 HG23 HG21 ' A' ' 8' ' ' VAL . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 25.0 109.171 177.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 179.242 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.887 0.286 . . . . 25.0 112.473 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 25.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 25.0 110.702 176.46 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 25.0 117.069 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 25.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 25.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 25.0 108.563 -177.864 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 25.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 25.0 111.838 178.773 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 25.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 25.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 25.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 25.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 25.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 25.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 25.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 25.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 25.0 110.144 -179.812 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 25.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 25.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 11' ' ' LYS . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 178.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 173.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 25.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 25.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 25.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 25.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 25.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 25.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 25.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 25.0 111.633 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 25.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 25.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 25.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 25.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 25.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 25.0 109.702 -179.839 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.242 0.725 0 N-CA-C 111.74 -0.138 . . . . 25.0 111.74 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 25.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 25.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 25.0 110.721 177.263 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 113.077 0.769 . . . . 25.0 113.077 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 25.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 25.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 25.0 108.431 -178.389 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 25.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 176.372 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 25.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 25.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 25.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 25.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 25.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 25.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 25.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 25.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 25.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 25.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 25.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 25.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 8' ' ' VAL . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 178.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 25.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.673 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 25.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 25.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 25.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 25.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 25.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 25.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 25.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 25.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 25.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 25.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 25.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 25.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 25.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 25.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 25.0 111.388 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 8' ' ' VAL . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 25.0 108.918 177.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 25.0 107.657 178.722 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 C--O 1.242 0.679 0 CA-C-O 120.697 0.207 . . . . 25.0 111.768 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 25.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 25.0 110.848 176.989 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.382 1.252 . . . . 25.0 114.382 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 25.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 25.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 25.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 25.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 176.068 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 25.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 25.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 25.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 25.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 25.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 25.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 25.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 25.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 25.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 25.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 25.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 25.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 25.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 25.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 25.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 25.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 173.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 25.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 25.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 25.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 25.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 25.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 25.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 25.0 107.384 179.448 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 25.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 25.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 25.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 25.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 25.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 25.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 25.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 25.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 25.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.294 177.619 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 25.0 108.141 179.713 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 C--O 1.238 0.503 0 N-CA-C 110.929 -0.451 . . . . 25.0 110.929 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 25.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 25.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 25.0 110.959 177.777 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.225 0.536 . . . . 25.0 112.131 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 25.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 25.0 108.747 -178.62 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 25.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 25.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 174.818 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 25.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 25.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 25.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 25.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 25.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 25.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 25.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 25.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 25.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 25.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 25.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 8' ' ' VAL . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.472 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 173.277 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 25.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 25.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 25.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 25.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 25.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 178.103 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 25.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 25.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 25.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 25.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 25.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 25.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 25.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 25.0 109.989 173.815 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.445 HG23 HG21 ' A' ' 8' ' ' VAL . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 176.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt . . . . . 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 177.424 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--O 1.242 0.705 0 N-CA-C 110.948 -0.443 . . . . 25.0 110.948 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 25.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 25.0 110.86 177.626 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 25.0 115.144 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 25.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -178.814 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 25.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 25.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 25.0 110.387 175.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 25.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 25.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 25.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 25.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 25.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 25.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 25.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 25.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 25.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 178.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 25.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 25.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 25.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 25.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 25.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 25.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 25.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 25.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 25.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 25.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 25.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 25.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 25.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 25.0 111.669 178.03 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 25.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -177.2 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 C--O 1.242 0.71 0 CA-C-O 120.727 0.219 . . . . 25.0 111.861 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 25.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 25.0 109.363 170.328 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 25.0 116.014 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 25.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.793 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 25.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 65' ' ' LEU . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 25.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 25.0 110.531 175.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 25.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 25.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 25.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 25.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 25.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 25.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 25.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 25.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 25.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 25.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 25.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 25.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 25.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 179.082 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 25.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 25.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 25.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 25.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 25.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 25.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 25.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 25.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 25.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 25.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 25.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 25.0 110.737 175.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 25.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 25.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 25.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 25.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' HB2' HD21 ' A' ' 13' ' ' LEU . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 25.0 110.544 175.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 11' ' ' LYS . 56.1 mt . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 25.0 109.849 -179.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 C--O 1.245 0.868 0 N-CA-C 111.55 -0.211 . . . . 25.0 111.55 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 25.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 25.0 109.571 169.94 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 25.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 25.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 25.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 25.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 25.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 25.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 25.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 25.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 25.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 25.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 25.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 25.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 25.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 25.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 25.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 25.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 25.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 25.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 25.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 25.0 109.599 172.562 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 25.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 25.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 25.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 25.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 25.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 25.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 25.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 25.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 25.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 25.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 25.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 25.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 25.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 25.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 25.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 25.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 25.0 112.503 178.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 25.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -176.252 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 25.0 110.857 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 25.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 25.0 108.943 173.266 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 25.0 115.742 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 25.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 25.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 25.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 25.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 25.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 25.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 25.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 25.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 25.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 25.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 25.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 25.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 25.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 25.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 25.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 25.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 25.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 25.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 25.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 25.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 25.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 25.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 25.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 25.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 25.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 25.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 25.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 25.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 25.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 25.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 25.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 25.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 25.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 25.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 25.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 25.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 -179.454 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 CA--C 1.537 0.656 0 CA-C-O 120.625 0.177 . . . . 25.0 112.404 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 25.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 25.0 109.538 170.684 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 114.489 1.292 . . . . 25.0 114.489 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 25.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -179.82 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 25.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 25.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 25.0 109.339 174.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 25.0 110.379 173.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 25.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 25.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 25.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 25.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 25.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 25.0 108.754 -176.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 25.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 25.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 25.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 178.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 173.236 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 25.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 25.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 25.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 25.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.616 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 25.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 25.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 25.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 25.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 25.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 25.0 111.131 175.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 25.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 25.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 25.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 25.0 109.893 177.578 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 177.65 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 C--O 1.243 0.739 0 CA-C-O 120.812 0.255 . . . . 25.0 111.757 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 25.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 25.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 25.0 110.092 175.623 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 CA-C-O 123.348 1.527 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -65.99 124.28 22.12 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 120.897 -1.354 . . . . 25.0 109.741 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttp -78.9 79.72 5.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.786 0.803 . . . . 25.0 111.591 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -80.25 -0.97 38.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.735 -0.666 . . . . 25.0 111.238 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.93 163.67 28.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.509 0.559 . . . . 25.0 112.509 -173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.3 mt -65.5 -41.47 93.17 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.334 0.653 . . . . 25.0 111.843 -176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 52.14 53.63 12.15 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.051 0.94 . . . . 25.0 113.417 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.49 160.45 6.69 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.82 141.36 29.36 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.841 -0.537 . . . . 25.0 110.056 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.66 145.31 44.65 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.837 -0.431 . . . . 25.0 109.837 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -104.78 137.19 42.95 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.644 0.377 . . . . 25.0 111.664 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.31 126.61 30.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.227 -0.442 . . . . 25.0 110.019 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -19.6 26.98 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.895 -0.503 . . . . 25.0 110.258 176.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.05 163.88 31.62 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.23 170.82 15.9 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.547 -0.909 . . . . 25.0 108.547 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -146.24 139.57 25.9 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.456 -0.338 . . . . 25.0 110.162 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.9 t -110.23 124.79 67.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 104.943 -2.243 . . . . 25.0 104.943 176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.18 116.99 18.28 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -103.74 -26.91 12.56 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.158 -0.682 . . . . 25.0 109.158 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -99.92 153.35 37.81 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.183 -1.043 . . . . 25.0 108.183 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.04 -14.87 35.74 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.747 0.34 . . . . 25.0 112.687 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.38 -9.82 51.37 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 116.35 -0.387 . . . . 25.0 110.08 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -94.05 151.93 19.16 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 -169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 mt -99.03 140.84 32.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.84 0.828 . . . . 25.0 111.89 174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.77 132.92 52.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.428 -1.693 . . . . 25.0 106.428 175.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.56 170.28 22.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.745 -0.661 . . . . 25.0 110.801 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -102.42 156.36 17.64 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -56.79 132.16 51.43 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.186 -1.042 . . . . 25.0 108.186 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.0 -11.06 64.14 Favored Glycine 0 C--N 1.322 -0.198 0 CA-C-O 119.182 -0.788 . . . . 25.0 113.805 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -70.56 157.09 38.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 117.663 0.731 . . . . 25.0 109.72 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.72 128.31 74.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.151 -1.055 . . . . 25.0 108.151 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.7 ptp -128.51 155.89 44.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.3 m -90.42 112.02 23.48 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.019 -0.991 . . . . 25.0 109.465 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.8 t -78.17 122.13 32.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.1 mt -94.73 -46.73 6.79 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.424 -0.807 . . . . 25.0 109.177 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -152.08 173.45 14.89 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -126.91 151.66 48.16 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 105.378 -2.082 . . . . 25.0 105.378 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 60.3 35.8 20.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.588 1.661 . . . . 25.0 108.246 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -64.49 145.65 55.77 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 112.819 -1.991 . . . . 25.0 110.716 -176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 58.48 11.87 1.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.824 0.85 . . . . 25.0 113.18 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.86 12.79 79.18 Favored Glycine 0 C--O 1.228 -0.241 0 N-CA-C 111.254 -0.739 . . . . 25.0 111.254 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.4 mt -88.64 86.45 7.0 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -55.06 130.52 42.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.777 0.799 . . . . 25.0 110.75 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.56 57.92 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.507 -0.607 . . . . 25.0 114.147 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -92.61 130.11 38.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 118.4 1.1 . . . . 25.0 108.225 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -112.64 127.72 56.18 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.05 -0.722 . . . . 25.0 109.05 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 51.8 tp -75.87 121.93 23.36 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 106.949 -1.5 . . . . 25.0 106.949 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 m -134.34 170.48 15.67 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.043 0.449 . . . . 25.0 110.409 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.56 129.64 46.26 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.51 132.08 22.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.6 m170 56.02 28.15 12.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.224 0.61 . . . . 25.0 112.305 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.85 6.83 88.56 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.985 -0.626 . . . . 25.0 114.049 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -110.65 137.07 48.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 105.326 -2.102 . . . . 25.0 105.326 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.4 148.06 26.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.21 170.59 39.79 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 25.0 113.549 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 pt -82.67 154.07 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.596 0.713 . . . . 25.0 110.059 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.01 140.14 19.18 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -67.93 116.39 4.28 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 118.023 -0.851 . . . . 25.0 110.803 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.02 -25.4 66.09 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.017 -0.538 . . . . 25.0 114.424 -173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -76.09 -3.46 36.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -108.9 5.78 24.73 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.501 -0.555 . . . . 25.0 109.501 172.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.71 154.98 31.87 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.121 0.962 . . . . 25.0 111.943 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HB2' HD21 ' A' ' 13' ' ' LEU . 34.8 ttmt -130.27 119.98 23.7 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 114.809 -1.087 . . . . 25.0 109.858 173.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.412 HG23 HG21 ' A' ' 8' ' ' VAL . 37.9 mm -66.92 127.49 28.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 106.991 -1.485 . . . . 25.0 106.991 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.1 mt -93.93 92.53 7.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.146 -1.798 . . . . 25.0 106.146 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.15 102.78 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.971 -1.013 . . . . 25.0 109.471 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -79.67 27.6 2.54 Favored Glycine 0 C--O 1.218 -0.869 0 N-CA-C 115.099 0.8 . . . . 25.0 115.099 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.6 mtp -85.61 -6.49 59.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -134.22 129.77 36.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.091 -0.504 . . . . 25.0 110.721 -174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -69.0 138.32 54.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.176 0.512 . . . . 25.0 110.424 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -144.72 126.67 15.44 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.168 0.509 . . . . 25.0 110.464 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -85.17 147.91 48.84 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 108.026 -1.102 . . . . 25.0 108.026 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -74.86 160.83 40.06 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 121.975 0.46 . . . . 25.0 113.28 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.96 53.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.143 0.423 . . . . 25.0 112.143 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.45 77.45 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.144 -0.55 . . . . 25.0 114.303 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.1 p -77.69 50.95 0.87 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 114.201 1.186 . . . . 25.0 114.201 -176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.69 -169.09 53.74 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.14 -0.553 . . . . 25.0 112.33 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.5 31.41 0.25 Allowed Glycine 0 C--O 1.218 -0.861 0 C-N-CA 120.654 -0.784 . . . . 25.0 114.704 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 m -68.95 -29.87 68.19 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.376 0.88 . . . . 25.0 113.376 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.46 25.59 68.78 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.181 -0.533 . . . . 25.0 114.322 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.9 m -73.36 114.55 11.7 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.21 0.448 . . . . 25.0 112.21 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.49 98.04 2.06 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.316 -1.914 . . . . 25.0 108.316 174.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.3 mt -90.95 -4.71 56.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.956 0.408 . . . . 25.0 111.507 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.22 164.55 31.94 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.627 -1.249 . . . . 25.0 107.627 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.58 127.93 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.476 0.547 . . . . 25.0 112.476 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -125.87 67.93 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.726 -1.212 . . . . 25.0 107.726 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.85 131.36 49.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.824 -1.08 . . . . 25.0 111.235 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.99 151.92 58.17 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.1 -0.955 . . . . 25.0 111.992 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.08 160.87 48.07 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 117.494 -1.204 . . . . 25.0 111.687 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.17 150.4 59.56 Favored 'Trans proline' 0 C--N 1.344 0.289 0 C-N-CA 117.877 -0.949 . . . . 25.0 112.014 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -77.3 151.84 81.23 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.93 162.73 40.36 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 N-CA-C 110.173 -0.741 . . . . 25.0 110.173 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.57 175.25 10.94 Favored 'Trans proline' 0 C--N 1.346 0.414 0 N-CA-C 113.426 0.51 . . . . 25.0 113.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.5 mt -133.72 155.7 80.18 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.598 -0.728 . . . . 25.0 109.181 178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -76.3 176.79 9.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.961 2.44 . . . . 25.0 113.795 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.56 38.07 0.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.38 -0.827 . . . . 25.0 112.722 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.7 166.84 12.99 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 114.399 0.519 . . . . 25.0 114.399 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.35 126.51 30.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.763 0.792 . . . . 25.0 110.998 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 124.154 1.931 . . . . 25.0 113.084 179.31 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 CA-C-O 122.969 1.316 . . . . 25.0 114.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.7 p -150.34 152.05 33.83 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 120.976 -1.308 . . . . 25.0 107.738 176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -81.56 91.65 6.4 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.592 -0.521 . . . . 25.0 109.592 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -121.14 126.0 48.63 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 105.937 -1.875 . . . . 25.0 105.937 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 60.35 172.35 0.09 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.947 1.462 . . . . 25.0 114.947 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.5 mt -78.15 -31.83 49.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.319 -0.855 . . . . 25.0 111.79 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.8 m120 53.81 43.17 31.36 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 64' ' ' ILE . 1.2 m -103.61 161.73 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.17 -1.048 . . . . 25.0 108.17 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.93 145.2 28.09 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.954 -0.466 . . . . 25.0 109.875 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.51 144.04 37.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.292 -0.255 . . . . 25.0 110.344 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -103.88 138.9 39.8 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.663 0.385 . . . . 25.0 111.324 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.46 125.44 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 25.0 110.363 172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -87.9 -18.3 29.49 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.265 -0.643 . . . . 25.0 109.265 175.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -144.07 158.81 43.49 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -67.76 154.86 40.6 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.324 -0.621 . . . . 25.0 109.324 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -138.51 137.79 37.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.079 0.466 . . . . 25.0 110.466 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.8 125.22 69.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 104.397 -2.445 . . . . 25.0 104.397 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 121.34 21.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -103.01 -20.35 14.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.741 0.781 . . . . 25.0 109.336 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -108.89 151.42 41.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 107.718 -1.215 . . . . 25.0 107.718 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.27 -11.4 28.67 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 O-C-N 121.93 0.437 . . . . 25.0 112.295 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.61 -3.77 54.46 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.762 0.825 . . . . 25.0 109.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -100.59 151.33 21.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.037 0.446 . . . . 25.0 111.384 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.2 mt -95.66 141.24 29.39 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.742 0.782 . . . . 25.0 111.512 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.9 p -106.09 135.61 47.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 105.214 -2.143 . . . . 25.0 105.214 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -156.66 167.85 29.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.333 0.587 . . . . 25.0 111.859 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -97.79 153.76 18.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.307 -0.86 . . . . 25.0 109.531 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -57.06 129.09 40.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.86 -15.3 56.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-O 119.282 -0.732 . . . . 25.0 113.782 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -67.05 154.58 40.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.507 0.653 . . . . 25.0 110.67 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.3 mm -115.88 128.4 73.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.477 -0.934 . . . . 25.0 108.477 178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -126.97 155.16 43.59 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.383 -0.599 . . . . 25.0 109.383 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.1 m -89.78 113.95 25.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.948 -1.024 . . . . 25.0 108.667 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.435 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.4 t -78.67 124.24 36.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -96.42 -46.62 6.3 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.957 -1.02 . . . . 25.0 108.675 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -152.06 172.16 16.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.755 -0.832 . . . . 25.0 108.755 172.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -126.15 149.2 49.14 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.567 -1.642 . . . . 25.0 106.567 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 58.8 38.21 24.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 123.603 1.668 . . . . 25.0 108.178 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -63.89 144.5 57.02 Favored 'General case' 0 C--O 1.212 -0.897 0 CA-C-N 112.905 -1.952 . . . . 25.0 110.485 -176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 59.97 12.18 3.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.845 . . . . 25.0 113.157 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.94 14.06 80.16 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 110.788 -0.925 . . . . 25.0 110.788 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -86.46 90.68 8.29 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -56.7 129.19 40.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.412 0.625 . . . . 25.0 110.82 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.73 -14.68 57.81 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-O 119.365 -0.686 . . . . 25.0 113.928 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -92.76 126.52 37.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.397 1.099 . . . . 25.0 108.936 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -114.54 126.51 55.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -73.89 122.39 22.45 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 107.536 -1.283 . . . . 25.0 107.536 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 m -134.94 169.12 17.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.138 0.494 . . . . 25.0 111.175 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.01 127.49 45.98 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.914 -1.143 . . . . 25.0 107.914 177.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.1 129.67 22.68 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.16 29.94 13.57 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.199 0.6 . . . . 25.0 112.302 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.16 89.32 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 114.48 0.552 . . . . 25.0 114.48 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.2 137.05 48.48 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 104.609 -2.367 . . . . 25.0 104.609 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.78 142.06 36.16 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.57 -0.53 . . . . 25.0 109.57 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.54 171.99 44.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.166 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -82.19 156.98 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.369 0.604 . . . . 25.0 109.502 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.3 t -141.6 139.09 18.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.573 -0.899 . . . . 25.0 108.573 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.27 110.75 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.421 -0.586 . . . . 25.0 111.168 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.08 -22.16 57.47 Favored Glycine 0 C--O 1.218 -0.857 0 CA-C-N 116.346 -0.388 . . . . 25.0 113.071 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.95 -13.67 60.19 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.547 0.573 . . . . 25.0 112.547 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -115.44 9.8 15.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 122.055 -0.403 . . . . 25.0 110.685 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.81 145.02 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.435 0.636 . . . . 25.0 112.385 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HB2' HD21 ' A' ' 13' ' ' LEU . 24.9 ttmm -122.58 120.14 32.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 120.977 0.418 . . . . 25.0 111.348 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 8' ' ' VAL . 50.3 mm -67.55 125.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.162 -1.051 . . . . 25.0 108.162 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -93.94 82.5 4.24 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.678 0.751 . . . . 25.0 109.891 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.33 139.79 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.23 -122.97 0.47 Allowed Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.559 -0.616 . . . . 25.0 111.559 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.1 39.72 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.172 -0.605 . . . . 25.0 109.834 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -162.58 -61.46 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.42 0.45 . . . . 25.0 109.888 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.31 -27.42 47.23 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.736 0.779 . . . . 25.0 112.014 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -132.33 163.85 27.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.906 -0.588 . . . . 25.0 111.09 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -62.71 149.91 88.1 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.518 -0.764 . . . . 25.0 109.801 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.47 161.21 46.22 Favored 'Trans proline' 0 C--N 1.349 0.58 0 N-CA-C 113.58 0.569 . . . . 25.0 113.58 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.99 173.36 16.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.683 -2.339 . . . . 25.0 104.683 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.06 168.38 37.82 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 109.448 -1.461 . . . . 25.0 109.448 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -130.52 -4.68 4.22 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.372 1.249 . . . . 25.0 114.372 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.93 -149.83 40.14 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.449 -0.881 . . . . 25.0 111.426 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.62 160.07 20.12 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.867 -1.693 . . . . 25.0 108.867 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.5 t -150.64 161.93 41.65 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.873 -1.528 . . . . 25.0 106.873 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.22 138.17 10.08 Favored Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 108.973 -1.651 . . . . 25.0 108.973 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -150.2 156.97 42.58 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.83 97.59 2.27 Favored Glycine 0 C--O 1.22 -0.756 0 N-CA-C 109.753 -1.339 . . . . 25.0 109.753 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -106.54 86.8 2.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.621 0.724 . . . . 25.0 109.656 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.8 p -112.7 161.84 16.4 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.62 9.45 5.14 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.357 1.036 . . . . 25.0 112.364 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -86.96 85.9 7.29 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.0 mt -72.61 139.12 47.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 25.0 111.332 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.78 145.93 71.55 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.76 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.26 164.84 33.25 Favored 'Trans proline' 0 C--O 1.241 0.66 0 O-C-N 121.587 0.256 . . . . 25.0 112.111 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.36 159.68 30.31 Favored 'Trans proline' 0 C--N 1.349 0.573 0 N-CA-C 114.558 0.945 . . . . 25.0 114.558 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.34 153.38 37.78 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.879 -1.526 . . . . 25.0 106.879 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -69.39 161.36 46.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 118.385 -0.61 . . . . 25.0 111.462 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.28 174.77 12.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 120.386 0.724 . . . . 25.0 113.445 -178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.0 mt -133.9 156.54 79.22 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.84 171.12 18.56 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.5 1.466 . . . . 25.0 112.6 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -99.53 23.46 9.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.685 . . . . 25.0 111.864 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 159.47 -172.62 36.13 Favored Glycine 0 N--CA 1.456 -0.024 0 C-N-CA 120.943 -0.646 . . . . 25.0 112.117 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.09 105.52 2.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.02 0.914 . . . . 25.0 109.463 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 123.986 1.851 . . . . 25.0 113.804 -175.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 123.098 1.388 . . . . 25.0 115.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 m -144.9 133.4 21.96 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 120.971 -1.311 . . . . 25.0 108.945 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.3 mtp -134.4 154.98 51.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.237 -1.764 . . . . 25.0 106.237 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -103.47 -23.24 13.54 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.324 0.583 . . . . 25.0 110.845 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -146.95 178.96 7.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.455 -1.248 . . . . 25.0 108.821 -173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.5 mt -63.37 -39.55 94.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 m120 51.8 52.92 13.55 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.805 0.842 . . . . 25.0 113.24 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.66 162.28 7.46 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.728 0 N-CA-C 108.002 -1.11 . . . . 25.0 108.002 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.2 mt -96.42 144.63 26.37 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.734 -0.604 . . . . 25.0 110.415 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.68 144.03 39.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.149 -0.315 . . . . 25.0 110.149 175.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -105.51 137.57 43.13 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.794 0.437 . . . . 25.0 111.711 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.61 126.11 29.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.883 -0.599 . . . . 25.0 111.023 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.44 -18.6 27.95 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.036 -0.415 . . . . 25.0 110.187 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -143.26 159.63 41.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 104.254 -2.498 . . . . 25.0 104.254 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -79.69 167.63 20.41 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -143.29 139.61 30.23 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 116.401 -0.363 . . . . 25.0 110.251 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.2 t -111.45 124.93 68.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 104.322 -2.473 . . . . 25.0 104.322 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.18 121.28 22.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.249 -1.019 . . . . 25.0 108.249 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -110.55 -25.4 10.02 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.8 t -93.79 146.87 32.52 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.616 -1.624 . . . . 25.0 106.616 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -67.36 -13.89 40.88 Favored 'Trans proline' 0 C--N 1.343 0.259 0 O-C-N 121.88 0.41 . . . . 25.0 112.385 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -93.67 -2.94 53.28 Favored 'General case' 0 C--O 1.207 -1.159 0 CA-C-N 116.68 -0.236 . . . . 25.0 110.504 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.41 153.37 17.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.304 0.502 . . . . 25.0 112.348 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.35 142.84 29.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.563 0.697 . . . . 25.0 111.916 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -108.48 131.5 54.74 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.891 -1.522 . . . . 25.0 106.891 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -154.91 169.87 23.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.693 . . . . 25.0 111.172 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -102.16 159.05 15.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.393 0.616 . . . . 25.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -60.54 128.3 35.96 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.01 -1.107 . . . . 25.0 108.01 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.31 -15.65 56.05 Favored Glycine 0 CA--C 1.52 0.384 0 CA-C-O 119.141 -0.811 . . . . 25.0 113.433 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -68.17 158.64 32.74 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.59 0.695 . . . . 25.0 110.904 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mm -117.55 129.48 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -127.31 154.36 45.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -89.44 112.4 23.53 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.188 -0.914 . . . . 25.0 109.195 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.1 t -76.34 123.08 31.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.12 -1.067 . . . . 25.0 108.12 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.15 -48.7 5.83 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.711 -0.848 . . . . 25.0 108.711 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.2 pt-20 -150.36 172.71 14.96 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.639 -0.874 . . . . 25.0 108.639 173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 39.7 mtm105 -124.76 152.19 44.15 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.477 -1.675 . . . . 25.0 106.477 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 58.96 36.79 24.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.516 1.627 . . . . 25.0 108.803 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t -64.35 145.97 55.18 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.863 -1.971 . . . . 25.0 110.775 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 58.35 14.54 2.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.873 0.869 . . . . 25.0 113.196 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.11 13.21 81.38 Favored Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.224 -0.75 . . . . 25.0 111.224 -177.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.0 mt -90.01 85.8 6.42 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -55.32 130.23 41.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.568 0.699 . . . . 25.0 110.26 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.17 -15.32 59.97 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-O 119.108 -0.829 . . . . 25.0 114.087 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -93.41 129.63 39.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.552 1.176 . . . . 25.0 107.951 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -113.41 126.74 55.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.86 -0.793 . . . . 25.0 108.86 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.7 tp -74.95 121.13 21.46 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 107.054 -1.462 . . . . 25.0 107.054 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.4 m -133.16 170.66 15.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.21 0.528 . . . . 25.0 110.65 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.49 129.94 46.8 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.49 129.44 19.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.609 -1.256 . . . . 25.0 107.609 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.8 m170 55.57 30.52 15.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.287 0.635 . . . . 25.0 112.091 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 7.93 88.15 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 114.556 0.582 . . . . 25.0 114.556 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -112.93 137.6 51.08 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 105.595 -2.002 . . . . 25.0 105.595 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -103.97 147.93 26.79 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.165 -0.68 . . . . 25.0 109.165 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.7 169.81 38.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.701 -0.762 . . . . 25.0 113.308 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -82.28 155.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.398 0.618 . . . . 25.0 109.69 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -142.11 139.85 18.59 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.39 117.17 4.78 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.776 -1.016 . . . . 25.0 110.925 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.97 66.6 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 116.114 -0.494 . . . . 25.0 114.133 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.28 -2.47 31.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.892 -0.769 . . . . 25.0 112.987 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -109.55 6.66 24.19 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -119.45 153.99 34.42 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.104 0.955 . . . . 25.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttpt -129.9 120.1 24.34 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 114.592 -1.185 . . . . 25.0 109.146 174.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.16 127.85 31.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.837 -1.171 . . . . 25.0 107.837 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.7 mt -94.0 91.44 6.87 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.239 0.542 . . . . 25.0 110.297 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.8 t -84.01 0.61 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.919 0.866 . . . . 25.0 108.815 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.92 -70.44 3.13 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.979 -0.555 . . . . 25.0 112.359 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 50.4 ttp -72.3 -32.91 67.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.183 0.516 . . . . 25.0 110.123 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.59 101.94 13.58 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.989 -0.745 . . . . 25.0 108.989 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -147.43 173.48 12.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.893 -2.632 . . . . 25.0 103.893 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -145.79 132.79 20.26 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.891 -0.781 . . . . 25.0 108.891 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.9 149.1 97.91 Favored Pre-proline 0 C--O 1.241 0.631 0 CA-C-N 115.969 -0.559 . . . . 25.0 109.92 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.47 -179.83 4.84 Favored 'Trans proline' 0 C--N 1.349 0.604 0 O-C-N 122.299 0.631 . . . . 25.0 110.851 175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.49 68.97 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.07 45.58 8.87 Favored Glycine 0 C--O 1.224 -0.501 0 C-N-CA 120.494 -0.86 . . . . 25.0 114.022 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.8 t -59.07 136.81 58.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.846 -0.427 . . . . 25.0 109.846 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.47 25.32 21.36 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 116.518 -0.31 . . . . 25.0 113.439 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.25 128.84 19.64 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.654 -0.978 . . . . 25.0 110.654 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -72.56 -24.18 61.08 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.541 0.686 . . . . 25.0 111.291 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.62 -177.71 40.3 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 107.537 -2.225 . . . . 25.0 107.537 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.7 p -68.56 140.05 55.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.533 0.667 . . . . 25.0 109.507 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.96 72.09 0.18 Allowed Glycine 0 C--O 1.22 -0.756 0 N-CA-C 110.876 -0.89 . . . . 25.0 110.876 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 68.4 mt 56.76 47.27 18.46 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.133 0.968 . . . . 25.0 110.177 -176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -123.16 129.24 51.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.616 -1.174 . . . . 25.0 108.188 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -137.77 150.62 47.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 25.0 111.266 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -127.93 97.71 4.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.339 -1.356 . . . . 25.0 107.339 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.27 132.28 46.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.339 0.59 . . . . 25.0 110.373 -177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.27 149.56 65.95 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.604 -0.725 . . . . 25.0 109.98 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.82 158.98 54.08 Favored 'Trans proline' 0 C--O 1.242 0.715 0 C-N-CA 116.75 -1.7 . . . . 25.0 111.703 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.56 148.88 48.55 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 117.541 -1.173 . . . . 25.0 111.805 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.0 151.12 86.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.395 -1.335 . . . . 25.0 107.395 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.3 161.01 46.55 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 118.035 -0.843 . . . . 25.0 110.294 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.22 175.48 10.49 Favored 'Trans proline' 0 C--N 1.348 0.528 0 N-CA-C 113.207 0.426 . . . . 25.0 113.207 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.9 mt -133.96 155.26 80.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.737 -0.665 . . . . 25.0 109.714 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.0 178.3 7.76 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.997 2.465 . . . . 25.0 112.846 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -78.47 34.04 0.21 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.75 0.82 . . . . 25.0 111.984 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.95 -173.24 27.75 Favored Glycine 0 CA--C 1.521 0.43 0 O-C-N 122.189 -0.32 . . . . 25.0 113.371 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -68.51 130.4 42.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.805 0.812 . . . . 25.0 109.772 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.213 -0.845 0 CA-C-O 125.57 2.605 . . . . 25.0 111.248 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 123.144 1.413 . . . . 25.0 115.588 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -68.43 116.66 9.24 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.173 -1.192 . . . . 25.0 110.908 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -70.89 135.22 47.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.969 0.414 . . . . 25.0 110.083 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -135.25 11.86 3.54 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.01 -0.541 . . . . 25.0 110.822 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -137.03 168.64 19.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.228 -172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.3 mt -65.94 -39.8 90.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.518 -0.764 . . . . 25.0 111.642 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 51.98 50.9 17.57 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -105.47 159.8 5.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.0 143.78 27.52 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.698 -0.626 . . . . 25.0 109.793 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.19 143.22 42.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.608 -0.515 . . . . 25.0 109.608 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -102.85 136.95 41.73 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.328 0.251 . . . . 25.0 110.981 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.29 126.82 31.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.996 -0.547 . . . . 25.0 109.954 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -88.13 -18.45 28.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 109.841 -0.429 . . . . 25.0 109.841 176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -142.39 167.18 22.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 104.825 -2.287 . . . . 25.0 104.825 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -78.8 175.28 10.62 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.887 -1.153 . . . . 25.0 107.887 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -149.88 140.02 22.12 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.875 -0.417 . . . . 25.0 109.875 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -110.16 124.61 67.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.715 -2.328 . . . . 25.0 104.715 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.34 111.64 13.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -98.74 -22.51 15.84 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -101.12 151.06 37.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -71.02 -7.58 21.72 Favored 'Trans proline' 0 C--N 1.341 0.155 0 O-C-N 121.841 0.39 . . . . 25.0 112.214 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -103.58 -1.44 28.27 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 123.28 0.632 . . . . 25.0 110.802 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -98.98 156.02 17.12 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.687 0.395 . . . . 25.0 111.408 -174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -101.42 143.53 31.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.437 0.637 . . . . 25.0 112.069 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.8 p -109.31 131.41 55.09 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.397 -1.335 . . . . 25.0 107.397 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -153.96 173.33 16.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 25.0 111.773 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -106.87 156.52 18.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.426 0.69 . . . . 25.0 109.833 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.68 130.18 45.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.0 -9.37 61.57 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.097 -0.835 . . . . 25.0 113.607 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.93 160.35 32.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.699 0.75 . . . . 25.0 109.678 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mm -118.46 129.95 74.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -128.57 154.55 46.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.649 -0.871 . . . . 25.0 108.649 175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 112.73 24.09 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.088 -0.96 . . . . 25.0 109.142 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 48.0 t -77.58 120.55 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 108.145 -1.057 . . . . 25.0 108.145 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.6 mt -93.75 -45.54 7.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.023 -0.99 . . . . 25.0 109.299 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.2 pt-20 -154.21 172.13 18.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.161 -0.311 . . . . 25.0 110.161 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -129.18 149.13 51.11 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.609 -1.997 . . . . 25.0 105.609 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.1 t0 58.94 41.58 20.9 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 123.816 1.77 . . . . 25.0 106.498 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.2 t -66.66 139.51 57.87 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 113.472 -1.694 . . . . 25.0 109.049 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 57.06 16.86 3.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.497 0.925 . . . . 25.0 113.497 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.59 77.92 Favored Glycine 0 C--N 1.33 0.205 0 N-CA-C 111.647 -0.581 . . . . 25.0 111.647 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.7 mt -94.02 88.2 5.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.524 -1.288 . . . . 25.0 107.524 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -58.58 144.26 43.46 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.201 1.0 . . . . 25.0 108.96 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.95 -26.34 6.81 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 114.897 -1.047 . . . . 25.0 112.365 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -91.91 133.95 35.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 118.074 0.937 . . . . 25.0 110.133 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -117.87 130.62 56.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.0 124.61 28.03 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.143 -1.428 . . . . 25.0 107.143 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.03 169.69 17.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.162 0.505 . . . . 25.0 110.922 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.67 130.73 49.4 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.379 -0.971 . . . . 25.0 108.379 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.33 135.27 17.67 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.629 -1.249 . . . . 25.0 107.629 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 m170 55.67 31.38 17.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.242 0.617 . . . . 25.0 112.48 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.86 14.04 80.32 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.85 -0.691 . . . . 25.0 113.818 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -122.31 145.6 48.09 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.569 -2.012 . . . . 25.0 105.569 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -110.38 148.63 31.62 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.37 170.7 40.83 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.757 -0.735 . . . . 25.0 112.428 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -81.79 155.57 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.531 0.681 . . . . 25.0 109.301 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.37 139.58 17.84 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.76 120.62 7.37 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 117.592 -1.139 . . . . 25.0 111.333 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.05 -24.66 63.28 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 116.212 -0.449 . . . . 25.0 112.419 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -15.59 58.97 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 25.0 112.697 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -111.27 8.37 21.44 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.106 -0.371 . . . . 25.0 111.79 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -120.62 151.68 39.13 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 114.217 1.191 . . . . 25.0 114.217 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.4 ttpt -127.12 120.02 27.91 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.674 -1.148 . . . . 25.0 109.577 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.9 mm -67.27 128.48 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.127 -1.064 . . . . 25.0 108.127 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.74 90.15 6.94 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.449 -1.315 . . . . 25.0 107.449 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.4 t -67.87 -26.08 33.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.261 -0.881 . . . . 25.0 110.578 -175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.21 -101.73 0.84 Allowed Glycine 0 C--O 1.222 -0.601 0 N-CA-C 111.459 -0.657 . . . . 25.0 111.459 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.1 mtp -71.97 -16.4 62.08 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.163 0.431 . . . . 25.0 112.163 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -91.08 116.49 28.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.847 0.356 . . . . 25.0 110.546 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -139.88 157.58 45.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.976 -1.861 . . . . 25.0 105.976 172.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -86.52 3.13 45.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 25.0 111.441 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -122.48 138.61 29.5 Favored Pre-proline 0 C--O 1.222 -0.393 0 N-CA-C 107.506 -1.294 . . . . 25.0 107.506 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.79 -1.82 11.72 Favored 'Trans proline' 0 C--N 1.345 0.371 0 N-CA-C 114.85 1.058 . . . . 25.0 114.85 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.5 25.48 2.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.99 0.424 . . . . 25.0 110.983 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.41 -161.71 54.41 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.488 -0.863 . . . . 25.0 113.428 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.92 130.38 39.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 25.0 112.276 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.37 60.28 4.85 Favored Glycine 0 C--O 1.224 -0.469 0 CA-C-N 116.235 -0.438 . . . . 25.0 112.237 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.44 -155.36 53.4 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.933 -0.651 . . . . 25.0 111.738 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -153.46 149.28 27.57 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.706 -1.22 . . . . 25.0 107.706 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.57 87.57 1.8 Allowed Glycine 0 C--O 1.218 -0.868 0 N-CA-C 111.719 -0.552 . . . . 25.0 111.719 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 m -87.26 11.46 14.18 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 113.724 1.009 . . . . 25.0 113.724 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.52 -26.46 5.16 Favored Glycine 0 C--O 1.222 -0.604 0 C-N-CA 121.355 -0.45 . . . . 25.0 113.451 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.58 -36.57 78.85 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 112.283 0.475 . . . . 25.0 112.283 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.6 m 70.59 -25.45 0.16 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.772 1.229 . . . . 25.0 113.935 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -120.98 155.88 33.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.212 -1.032 . . . . 25.0 108.212 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -157.59 100.23 1.77 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.1 mt -69.02 130.67 43.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.52 0.676 . . . . 25.0 111.111 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.58 150.81 63.9 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.452 -0.795 . . . . 25.0 112.097 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.84 164.06 36.88 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 119.946 0.43 . . . . 25.0 112.588 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.83 167.62 26.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -100.34 151.93 37.68 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 107.666 -1.235 . . . . 25.0 107.666 176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.08 162.76 40.43 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 O-C-N 122.07 0.51 . . . . 25.0 111.143 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.9 172.32 16.56 Favored 'Trans proline' 0 C--N 1.346 0.442 0 N-CA-C 113.619 0.584 . . . . 25.0 113.619 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.1 mt -133.88 156.11 79.65 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.704 -0.68 . . . . 25.0 110.955 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -78.85 169.97 18.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.375 2.05 . . . . 25.0 113.527 176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -86.0 54.44 3.14 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.457 -0.792 . . . . 25.0 110.997 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.66 33.94 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 115.074 0.79 . . . . 25.0 115.074 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.18 143.47 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.671 0.748 . . . . 25.0 111.295 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.215 -0.73 0 CA-C-O 124.377 2.037 . . . . 25.0 111.177 -178.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 122.994 1.33 . . . . 25.0 115.312 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -150.93 157.17 42.56 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.078 -1.453 . . . . 25.0 107.078 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 89.7 mtp -92.45 137.22 32.55 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.158 -1.052 . . . . 25.0 108.158 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -86.97 152.48 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 60.0 166.48 0.07 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 116.518 2.044 . . . . 25.0 116.518 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.69 -41.74 71.59 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.698 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 51.07 52.43 14.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.893 1.071 . . . . 25.0 113.893 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -105.11 159.74 5.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.465 -1.679 . . . . 25.0 106.465 178.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -94.48 145.7 24.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.51 -0.922 . . . . 25.0 108.51 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.06 144.46 38.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.678 -0.49 . . . . 25.0 109.678 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.7 139.5 42.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.054 0.542 . . . . 25.0 111.833 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 126.05 30.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.756 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -90.63 -17.97 25.95 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.776 -0.453 . . . . 25.0 109.776 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -142.34 160.68 39.78 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.73 152.98 39.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.845 -0.616 . . . . 25.0 109.649 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -140.23 131.64 26.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.697 0.999 . . . . 25.0 113.697 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -110.23 126.53 67.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 105.583 -2.006 . . . . 25.0 105.583 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.11 125.5 27.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.215 -1.031 . . . . 25.0 108.215 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -112.8 -19.4 12.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.518 0.675 . . . . 25.0 109.704 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 m -108.98 153.31 42.56 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.41 -15.67 38.55 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 120.301 0.667 . . . . 25.0 113.269 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.24 -10.99 51.05 Favored 'General case' 0 C--O 1.203 -1.347 0 CA-C-N 116.201 -0.454 . . . . 25.0 110.433 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -94.38 147.84 22.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.715 1.005 . . . . 25.0 113.715 -166.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.53 146.4 23.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.941 0.877 . . . . 25.0 111.272 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.9 t -110.72 128.58 55.78 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.12 -1.807 . . . . 25.0 106.12 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -155.82 174.0 15.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.691 -1.226 . . . . 25.0 107.691 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -125.38 167.76 14.51 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.063 -0.398 . . . . 25.0 111.27 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.76 127.34 31.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.282 0.563 . . . . 25.0 111.955 -176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -13.06 59.48 Favored Glycine 0 N--CA 1.453 -0.172 0 CA-C-N 115.751 -0.659 . . . . 25.0 113.848 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -69.66 154.76 41.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 117.578 0.689 . . . . 25.0 110.258 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.2 mm -117.41 130.06 72.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 25.0 109.661 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.2 ptp -128.71 158.63 38.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.692 -0.485 . . . . 25.0 109.692 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.0 m -93.04 115.09 27.78 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 115.381 -0.827 . . . . 25.0 109.492 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.0 t -81.11 123.38 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.894 -0.78 . . . . 25.0 108.894 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -94.92 -45.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.192 -0.913 . . . . 25.0 109.736 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 21.1 pt-20 -153.89 170.88 19.94 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.401 -0.592 . . . . 25.0 109.401 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -126.55 151.44 47.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.962 -1.496 . . . . 25.0 106.962 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 58.69 36.2 24.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 123.663 1.697 . . . . 25.0 107.208 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.42 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.8 t -62.54 144.23 56.31 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 112.539 -2.118 . . . . 25.0 111.329 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 57.93 14.1 2.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.84 13.15 78.49 Favored Glycine 0 C--O 1.228 -0.264 0 N-CA-C 111.44 -0.664 . . . . 25.0 111.44 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.7 mt -90.37 93.88 9.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.592 -0.892 . . . . 25.0 108.592 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.99 128.95 37.75 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.532 0.682 . . . . 25.0 111.024 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.51 -13.68 54.5 Favored Glycine 0 C--O 1.239 0.464 0 N-CA-C 114.733 0.653 . . . . 25.0 114.733 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -92.43 130.01 38.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.295 1.048 . . . . 25.0 108.449 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -115.59 127.73 55.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.723 -0.473 . . . . 25.0 109.723 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.2 tp -74.97 121.61 22.21 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 107.359 -1.348 . . . . 25.0 107.359 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 m -134.27 170.46 15.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.154 0.502 . . . . 25.0 110.795 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.89 129.86 47.59 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.15 135.8 18.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.819 -1.178 . . . . 25.0 107.819 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.8 m170 55.9 30.67 16.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.229 0.611 . . . . 25.0 112.319 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.22 13.64 79.51 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.953 -0.641 . . . . 25.0 113.836 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 148.28 43.55 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.466 -2.049 . . . . 25.0 105.466 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -114.09 146.26 40.49 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.17 172.89 43.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.734 -0.746 . . . . 25.0 112.873 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.1 156.1 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.504 0.669 . . . . 25.0 109.698 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.8 t -141.56 139.48 18.76 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.205 -0.907 . . . . 25.0 108.594 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.18 112.5 3.17 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 118.41 -0.593 . . . . 25.0 111.228 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.54 -22.71 57.14 Favored Glycine 0 C--O 1.223 -0.588 0 O-C-N 122.047 -0.408 . . . . 25.0 112.428 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -65.61 -14.32 60.9 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.003 0.742 . . . . 25.0 113.003 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.58 9.46 14.19 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 122.087 -0.383 . . . . 25.0 110.913 177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 tp -125.62 144.76 50.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.775 0.798 . . . . 25.0 112.619 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttmt -121.48 120.51 35.14 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 115.862 -0.608 . . . . 25.0 110.783 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 8' ' ' VAL . 50.8 mm -67.24 123.39 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.8 mt -92.57 90.77 7.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.697 -1.964 . . . . 25.0 105.697 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 68' ' ' MET . 16.8 m -63.13 -12.32 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 114.805 1.409 . . . . 25.0 114.805 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.34 -7.79 29.11 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 121.635 -0.317 . . . . 25.0 113.765 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.447 ' H ' HG23 ' A' ' 66' ' ' VAL . 91.5 mmm -107.24 -54.25 2.5 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 113.537 0.94 . . . . 25.0 113.537 -175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -139.67 32.31 2.04 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.741 1.015 . . . . 25.0 113.741 -171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.29 138.05 58.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 25.0 110.703 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -74.76 108.41 7.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.819 -0.808 . . . . 25.0 108.819 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.39 143.18 80.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.903 -0.59 . . . . 25.0 110.507 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.48 168.4 23.84 Favored 'Trans proline' 0 C--N 1.347 0.462 0 O-C-N 122.128 0.541 . . . . 25.0 113.065 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.31 33.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.135 -2.172 . . . . 25.0 105.135 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.52 177.1 24.97 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.359 -1.096 . . . . 25.0 110.359 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 m -75.64 133.9 40.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.683 -0.488 . . . . 25.0 109.683 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.38 -28.54 73.21 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.663 -0.78 . . . . 25.0 113.564 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -77.53 -10.0 86.51 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 121.088 -0.577 . . . . 25.0 112.339 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.1 m -105.31 35.36 2.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.294 0.568 . . . . 25.0 110.468 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -8.54 66.08 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 115.273 0.869 . . . . 25.0 115.273 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.8 m -141.21 154.52 45.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.333 0.567 . . . . 25.0 109.731 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.52 179.25 29.67 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 123.524 0.515 . . . . 25.0 113.323 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -141.26 141.38 33.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.554 -2.017 . . . . 25.0 105.554 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.4 p -126.84 98.64 5.43 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.991 -0.744 . . . . 25.0 108.991 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 60.61 13.66 4.4 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.557 1.143 . . . . 25.0 112.907 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.5 78.81 9.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 25.0 110.957 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.22 137.06 41.0 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.42 145.5 79.59 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 25.0 110.726 -177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.88 164.66 34.05 Favored 'Trans proline' 0 C--O 1.24 0.586 0 O-C-N 121.78 0.358 . . . . 25.0 111.926 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.47 160.21 47.3 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 118.222 -0.719 . . . . 25.0 113.865 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -88.2 151.85 49.53 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.087 -1.449 . . . . 25.0 107.087 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.98 162.99 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 122.088 0.52 . . . . 25.0 111.109 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.96 173.92 12.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 O-C-N 122.027 0.488 . . . . 25.0 113.096 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.72 156.97 78.96 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.698 -0.852 . . . . 25.0 108.698 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.38 167.68 26.58 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.836 1.691 . . . . 25.0 112.913 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -117.23 72.11 0.82 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.684 -1.143 . . . . 25.0 110.099 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.53 176.3 47.98 Favored Glycine 0 CA--C 1.511 -0.177 0 C-N-CA 120.756 -0.735 . . . . 25.0 111.426 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -137.7 156.95 47.45 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.215 -0.732 0 CA-C-O 124.312 2.006 . . . . 25.0 113.347 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 122.758 1.199 . . . . 25.0 115.869 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t 58.27 -161.89 0.23 Allowed 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.348 1.059 . . . . 25.0 109.869 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.9 ttp -136.46 65.79 1.51 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt 59.84 -107.64 0.34 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.859 -1.064 . . . . 25.0 112.3 -174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -104.03 169.21 8.63 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt -66.35 -39.97 89.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.405 -0.816 . . . . 25.0 109.833 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 51.39 50.38 19.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.596 0.962 . . . . 25.0 113.596 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -105.24 163.34 4.41 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.65 142.17 32.5 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.853 -0.529 . . . . 25.0 110.183 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.57 144.17 44.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.598 -0.274 . . . . 25.0 110.48 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -104.1 138.91 39.93 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.747 0.419 . . . . 25.0 111.957 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.76 131.26 40.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 25.0 111.039 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -93.52 -17.04 23.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 120.776 0.322 . . . . 25.0 110.438 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.22 165.68 27.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.741 -1.207 . . . . 25.0 107.741 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.61 156.44 39.44 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.729 -1.211 . . . . 25.0 107.729 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -136.59 132.89 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.541 -0.54 . . . . 25.0 109.541 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.2 t -108.65 123.54 64.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.84 125.88 29.92 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 -28.77 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.266 0.555 . . . . 25.0 109.514 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 m -100.66 154.34 37.23 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 25.0 109.624 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.88 -13.89 37.69 Favored 'Trans proline' 0 C--N 1.343 0.284 0 N-CA-C 113.075 0.375 . . . . 25.0 113.075 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -91.46 -6.57 52.49 Favored 'General case' 0 C--O 1.2 -1.534 0 CA-C-O 119.458 -0.306 . . . . 25.0 110.569 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -95.97 150.73 20.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.63 0.65 . . . . 25.0 112.511 -170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.4 144.23 28.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.586 0.708 . . . . 25.0 111.814 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.83 132.57 54.09 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.776 -1.194 . . . . 25.0 107.776 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -153.71 171.22 19.19 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.43 -0.805 . . . . 25.0 112.572 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -105.12 154.27 20.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.839 0.856 . . . . 25.0 109.749 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -56.05 127.82 32.38 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.33 -12.75 58.54 Favored Glycine 0 CA--C 1.519 0.298 0 CA-C-O 118.985 -0.897 . . . . 25.0 114.45 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -69.99 160.2 32.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 117.733 0.767 . . . . 25.0 110.877 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.8 mm -119.79 130.25 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.269 -0.641 . . . . 25.0 109.269 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.7 ptp -128.63 156.13 43.89 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.582 -0.525 . . . . 25.0 109.582 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.09 112.41 23.86 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.205 -0.907 . . . . 25.0 109.362 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.3 t -78.4 124.9 37.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.502 -0.925 . . . . 25.0 108.502 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.19 -48.58 5.3 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.302 -0.863 . . . . 25.0 109.427 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -151.66 171.0 18.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.83 150.57 49.13 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.367 -1.345 . . . . 25.0 107.367 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 59.09 36.1 24.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 123.871 1.796 . . . . 25.0 107.593 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.29 144.43 55.64 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 112.235 -2.257 . . . . 25.0 111.306 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 57.41 14.82 2.37 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.381 0.882 . . . . 25.0 113.381 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.64 12.33 81.79 Favored Glycine 0 C--N 1.33 0.199 0 N-CA-C 111.556 -0.617 . . . . 25.0 111.556 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 mt -89.34 94.97 10.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.975 -1.12 . . . . 25.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.25 131.07 48.9 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.515 0.674 . . . . 25.0 110.964 -176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.7 -15.9 39.29 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.821 -0.704 . . . . 25.0 114.694 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -88.55 129.97 35.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.232 1.016 . . . . 25.0 108.653 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.2 126.15 54.22 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.82 122.88 23.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 m -135.1 172.01 13.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 25.0 110.455 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.83 131.15 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.258 -1.015 . . . . 25.0 108.258 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -148.08 135.0 20.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.193 -1.41 . . . . 25.0 107.193 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.6 m170 55.9 31.0 16.97 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.154 0.582 . . . . 25.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.23 13.39 79.64 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.084 -0.579 . . . . 25.0 113.648 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -119.5 139.14 52.58 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.809 -1.922 . . . . 25.0 105.809 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -103.83 149.36 25.13 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.225 -0.657 . . . . 25.0 109.225 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.27 170.63 39.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.626 -0.797 . . . . 25.0 113.16 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 pt -82.48 154.44 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.777 0.799 . . . . 25.0 109.862 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -140.95 139.77 20.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 -177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 115.28 4.11 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 117.926 -0.916 . . . . 25.0 111.018 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -22.41 58.59 Favored Glycine 0 C--O 1.217 -0.907 0 C-N-CA 121.502 -0.38 . . . . 25.0 112.2 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -64.29 -15.23 59.79 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.865 0.691 . . . . 25.0 112.865 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.61 10.67 14.49 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.017 -0.427 . . . . 25.0 110.688 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.7 tp -126.67 144.17 51.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.926 0.713 . . . . 25.0 112.926 -175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.6 ttpt -123.01 120.03 32.12 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.127 -0.488 . . . . 25.0 111.796 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.406 HG23 HG21 ' A' ' 8' ' ' VAL . 47.6 mm -69.71 127.99 32.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.351 -0.84 . . . . 25.0 109.344 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.7 mt -94.43 72.88 3.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.096 0.474 . . . . 25.0 111.106 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.2 m -72.03 -7.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 112.84 0.681 . . . . 25.0 112.84 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 93.89 -113.57 4.55 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 97.8 mmm -91.96 156.05 17.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.06 0.457 . . . . 25.0 110.244 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -117.17 26.7 9.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.678 -0.692 . . . . 25.0 112.07 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.05 29.72 16.98 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.133 1.445 . . . . 25.0 109.874 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -154.71 152.3 29.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -60.69 151.04 73.55 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.696 -1.224 . . . . 25.0 107.696 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.15 156.24 62.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 115.853 -2.298 . . . . 25.0 112.508 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.4 36.8 1.68 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.497 -0.927 . . . . 25.0 108.497 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.8 -30.7 46.93 Favored Glycine 0 C--O 1.221 -0.676 0 N-CA-C 114.947 0.739 . . . . 25.0 114.947 -174.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.0 m 51.22 30.8 6.11 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.387 1.625 . . . . 25.0 115.387 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.22 161.44 54.33 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 110.742 -0.943 . . . . 25.0 110.742 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 -0.12 71.06 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.233 -0.747 . . . . 25.0 111.233 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 p -82.76 153.56 25.2 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.92 -0.77 . . . . 25.0 108.92 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.38 170.29 12.67 Favored Glycine 0 C--O 1.227 -0.321 0 N-CA-C 109.526 -1.43 . . . . 25.0 109.526 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.9 t -163.75 -58.12 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.44 0.62 . . . . 25.0 109.921 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.07 -166.82 32.94 Favored Glycine 0 N--CA 1.453 -0.18 0 N-CA-C 108.691 -1.764 . . . . 25.0 108.691 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.95 144.11 56.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.979 -0.749 . . . . 25.0 108.979 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.7 p -133.36 144.87 49.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.486 -1.672 . . . . 25.0 106.486 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -131.17 125.11 32.15 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.986 -0.746 . . . . 25.0 108.986 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.29 110.73 10.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.5 mt -76.71 141.73 40.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.238 0.542 . . . . 25.0 109.57 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.49 145.86 72.54 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.803 -0.635 . . . . 25.0 112.039 -175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.62 166.12 30.79 Favored 'Trans proline' 0 C--O 1.24 0.6 0 N-CA-C 110.779 -0.508 . . . . 25.0 110.779 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.12 158.11 52.8 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 117.821 -0.986 . . . . 25.0 114.075 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -88.36 151.29 48.36 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.537 -1.653 . . . . 25.0 106.537 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.02 161.25 46.59 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 117.964 -0.89 . . . . 25.0 110.478 175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.1 172.75 15.74 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.549 0.557 . . . . 25.0 113.549 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.1 mt -133.99 155.46 80.15 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.837 -0.619 . . . . 25.0 111.294 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -79.0 172.25 15.21 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.14 1.893 . . . . 25.0 112.255 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -87.05 48.12 1.6 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.978 -0.555 . . . . 25.0 111.544 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.01 -132.58 11.17 Favored Glycine 0 C--O 1.233 0.085 0 C-N-CA 120.862 -0.685 . . . . 25.0 111.759 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -62.84 114.44 3.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.475 0.655 . . . . 25.0 110.522 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.478 0.958 0 C-N-CA 126.172 1.789 . . . . 25.0 111.726 -177.254 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 123.266 1.481 . . . . 25.0 115.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 t -76.85 129.39 36.16 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 121.144 -1.21 . . . . 25.0 109.089 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.9 mtt -97.32 166.21 11.66 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.49 -0.559 . . . . 25.0 109.49 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -120.69 122.16 39.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 59.18 164.53 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.629 1.714 . . . . 25.0 115.629 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -77.67 -40.37 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.843 -1.071 . . . . 25.0 110.978 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 54.2 51.7 13.98 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.694 0.998 . . . . 25.0 113.694 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.07 161.81 7.19 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 106.99 -1.485 . . . . 25.0 106.99 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.7 mt -97.21 146.23 25.29 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 121.643 -0.661 . . . . 25.0 109.981 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.63 143.44 37.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.131 -0.322 . . . . 25.0 110.131 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -103.25 137.21 41.69 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.631 0.372 . . . . 25.0 111.984 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 126.77 31.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.308 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -90.7 -15.42 30.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -143.41 154.06 43.32 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 9.4 m-20 -66.9 153.7 42.83 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 173.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -138.72 130.5 27.8 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 120.957 0.408 . . . . 25.0 110.622 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.0 t -107.74 125.3 64.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 103.715 -2.698 . . . . 25.0 103.715 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.76 126.94 31.97 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.252 -0.885 . . . . 25.0 108.762 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -107.52 -20.56 13.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.848 0.832 . . . . 25.0 109.092 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -106.23 147.7 35.33 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.677 -1.231 . . . . 25.0 107.677 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.69 -13.22 36.64 Favored 'Trans proline' 0 C--O 1.239 0.561 0 N-CA-C 113.554 0.559 . . . . 25.0 113.554 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.6 -2.34 45.05 Favored 'General case' 0 C--O 1.206 -1.207 0 C-N-CA 122.703 0.401 . . . . 25.0 110.024 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -93.86 146.81 23.62 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.894 -0.504 . . . . 25.0 110.552 -176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -90.46 144.05 26.16 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.533 0.682 . . . . 25.0 111.203 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -109.98 133.76 52.83 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.762 -1.94 . . . . 25.0 105.762 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -155.89 171.73 19.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.501 -0.772 . . . . 25.0 111.721 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 11.1 tpt180 -106.12 150.29 25.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.99 -1.004 . . . . 25.0 109.644 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -58.42 123.99 18.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.588 -0.733 . . . . 25.0 109.762 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.48 -9.91 53.35 Favored Glycine 0 CA--C 1.518 0.234 0 CA-C-O 119.241 -0.755 . . . . 25.0 113.047 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -69.93 159.05 34.44 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.606 0.703 . . . . 25.0 110.181 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.97 128.65 75.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.44 -0.948 . . . . 25.0 108.44 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -126.42 155.78 41.64 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.7 m -90.31 113.09 24.87 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.447 -0.797 . . . . 25.0 109.656 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.9 t -78.41 121.45 31.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.49 -45.72 6.97 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.308 -0.86 . . . . 25.0 109.774 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.0 pt-20 -153.41 173.39 15.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.54 -0.541 . . . . 25.0 109.54 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -128.91 151.54 49.53 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 106.472 -1.677 . . . . 25.0 106.472 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 59.3 35.13 23.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.913 1.816 . . . . 25.0 107.622 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.5 t -63.41 144.28 57.1 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.43 -2.168 . . . . 25.0 111.062 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 57.75 15.2 2.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.944 0.898 . . . . 25.0 113.225 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.95 12.92 80.46 Favored Glycine 0 C--O 1.229 -0.197 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 mt -91.24 87.96 6.71 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.64 130.38 42.85 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.633 0.73 . . . . 25.0 110.544 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.2 57.17 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.371 -0.683 . . . . 25.0 114.039 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -91.38 129.99 37.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.549 1.175 . . . . 25.0 108.607 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -113.39 125.74 54.58 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -73.75 122.49 22.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.053 -1.462 . . . . 25.0 107.053 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 m -134.99 170.05 16.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.101 0.477 . . . . 25.0 110.702 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 130.22 48.14 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.64 132.09 17.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.93 -1.137 . . . . 25.0 107.93 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.7 m170 54.7 31.08 14.61 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.323 0.649 . . . . 25.0 112.587 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.82 11.07 85.78 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 120.917 -0.658 . . . . 25.0 114.426 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 138.01 52.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.897 -2.26 . . . . 25.0 104.897 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -104.67 143.67 32.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.098 -1.075 . . . . 25.0 108.098 177.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.71 171.33 43.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.602 -0.809 . . . . 25.0 112.576 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.75 156.24 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.553 0.692 . . . . 25.0 110.004 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.3 t -142.94 139.85 17.39 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.43 120.96 7.53 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.784 -1.677 . . . . 25.0 111.211 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.22 -23.98 62.76 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 112.224 -0.35 . . . . 25.0 112.224 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.0 -12.85 41.94 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.013 0.746 . . . . 25.0 113.013 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -116.39 9.5 14.41 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.961 -0.462 . . . . 25.0 111.162 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.08 154.14 37.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 113.587 0.958 . . . . 25.0 113.587 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.432 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.9 ttmt -128.19 120.05 26.48 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.819 -1.082 . . . . 25.0 109.976 174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.29 128.3 31.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.412 -0.959 . . . . 25.0 108.412 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.2 mt -103.47 101.12 11.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.502 -1.296 . . . . 25.0 107.502 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.9 m -77.49 151.92 5.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.632 -0.877 . . . . 25.0 108.632 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.04 155.53 27.6 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.497 -1.441 . . . . 25.0 109.497 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 69' ' ' TYR . 9.2 ttp 59.7 -162.56 0.25 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.271 0.628 . . . . 25.0 111.661 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.433 ' H ' ' HG2' ' A' ' 68' ' ' MET . 29.6 m-85 55.66 -149.48 0.45 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.796 0.838 . . . . 25.0 111.444 -176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 40.25 37.98 0.48 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 117.952 2.575 . . . . 25.0 117.952 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -76.94 67.91 3.03 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.841 -0.537 . . . . 25.0 111.951 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -138.1 156.19 74.05 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 107.25 -1.389 . . . . 25.0 107.25 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.01 -11.08 18.01 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 114.728 1.011 . . . . 25.0 114.728 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.51 142.48 30.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.945 -0.391 . . . . 25.0 109.945 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.6 -156.96 16.44 Favored Glycine 0 C--O 1.225 -0.422 0 C-N-CA 121.331 -0.462 . . . . 25.0 112.464 177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 51.0 m 55.41 -92.77 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.948 1.462 . . . . 25.0 114.948 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.85 47.49 3.82 Favored Glycine 0 C--O 1.221 -0.663 0 N-CA-C 114.276 0.471 . . . . 25.0 114.276 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.54 -31.01 79.31 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 114.611 0.604 . . . . 25.0 114.611 -177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.0 t -153.3 142.25 21.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.152 -1.425 . . . . 25.0 107.152 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.5 -34.47 7.42 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.035 -0.602 . . . . 25.0 114.511 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -143.08 8.11 1.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.154 1.168 . . . . 25.0 114.154 -175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.78 -74.64 2.44 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 111.363 -0.695 . . . . 25.0 111.363 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 54.22 38.8 29.98 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.052 0.941 . . . . 25.0 111.55 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.1 t -152.08 167.25 29.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -123.52 120.64 33.49 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 104.886 -2.265 . . . . 25.0 104.886 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -138.77 103.06 4.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.618 -0.882 . . . . 25.0 108.618 -171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.4 mt -64.43 130.72 44.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.738 -0.665 . . . . 25.0 109.276 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.42 147.73 95.13 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.313 -0.858 . . . . 25.0 112.564 -173.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.31 160.56 49.11 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 118.139 -0.774 . . . . 25.0 110.872 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.88 152.52 63.58 Favored 'Trans proline' 0 C--O 1.236 0.408 0 N-CA-C 114.859 1.061 . . . . 25.0 114.859 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -90.58 152.07 44.73 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 105.94 -1.874 . . . . 25.0 105.94 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.42 162.6 39.97 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 117.738 -1.041 . . . . 25.0 109.926 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.79 173.19 14.37 Favored 'Trans proline' 0 C--N 1.346 0.441 0 N-CA-C 113.242 0.439 . . . . 25.0 113.242 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.9 155.69 80.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.591 -0.731 . . . . 25.0 110.101 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 171.89 17.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.605 1.536 . . . . 25.0 112.074 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -90.42 30.36 1.14 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.743 0.782 . . . . 25.0 110.397 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.82 10.67 69.28 Favored Glycine 0 CA--C 1.516 0.132 0 CA-C-N 115.905 -0.588 . . . . 25.0 112.495 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -77.08 178.62 6.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.777 0.799 . . . . 25.0 110.335 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.213 -0.844 0 CA-C-O 125.633 2.635 . . . . 25.0 111.996 177.2 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 123.392 1.551 . . . . 25.0 115.383 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 m -84.61 125.17 32.22 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 120.684 -1.48 . . . . 25.0 111.17 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.3 ptp -101.42 108.31 19.87 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -108.12 16.75 23.03 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.941 -1.133 . . . . 25.0 107.941 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -134.35 164.46 27.36 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.079 -0.964 . . . . 25.0 110.665 -171.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.47 -38.59 81.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.516 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 m120 52.95 49.71 19.6 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.806 0.842 . . . . 25.0 112.825 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HG23 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -105.97 167.9 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.155 -1.424 . . . . 25.0 107.155 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.14 148.27 25.97 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.64 0.655 . . . . 25.0 109.476 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.06 145.54 41.9 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.82 -0.437 . . . . 25.0 109.82 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -105.86 137.83 43.07 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.61 0.364 . . . . 25.0 110.893 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.88 127.46 32.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.658 . . . . 25.0 110.739 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.14 -20.75 26.58 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -142.66 164.91 28.84 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.653 -2.351 . . . . 25.0 104.653 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -79.89 168.9 18.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -143.38 134.89 26.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.8 t -107.71 124.9 64.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 104.029 -2.582 . . . . 25.0 104.029 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.01 124.4 26.91 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.695 -0.854 . . . . 25.0 108.695 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 -20.68 12.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.815 0.817 . . . . 25.0 108.972 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.2 t -100.33 148.08 34.42 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 107.778 -1.193 . . . . 25.0 107.778 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 -13.46 37.57 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 119.889 0.393 . . . . 25.0 112.752 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.8 1.35 45.84 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 122.311 0.244 . . . . 25.0 110.645 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -97.05 147.8 23.66 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.522 -0.736 . . . . 25.0 112.184 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.65 141.94 27.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.903 0.858 . . . . 25.0 111.686 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.4 p -108.55 131.08 55.2 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 25.0 106.812 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -152.18 173.45 14.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.878 -0.601 . . . . 25.0 110.94 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -105.37 161.66 14.12 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.842 -0.429 . . . . 25.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -59.11 133.96 56.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.691 -1.225 . . . . 25.0 107.691 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.38 -9.83 73.87 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 119.085 -0.841 . . . . 25.0 113.789 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -70.22 160.99 31.14 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 117.637 0.719 . . . . 25.0 110.086 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.5 mm -123.55 127.34 74.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.063 0.545 . . . . 25.0 109.62 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.2 ptp -125.56 156.06 39.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.187 0.518 . . . . 25.0 109.665 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -90.48 114.97 27.27 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.41 -0.959 . . . . 25.0 108.41 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -79.88 124.89 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.446 -0.946 . . . . 25.0 108.446 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.46 -49.77 5.02 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.331 -0.849 . . . . 25.0 108.809 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.7 pt-20 -149.38 172.49 14.84 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.33 -0.989 . . . . 25.0 108.33 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.7 mtm180 -124.91 150.15 46.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.137 -1.431 . . . . 25.0 107.137 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 58.76 37.68 24.98 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 123.702 1.715 . . . . 25.0 108.805 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 8.1 t -64.04 147.61 51.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 112.559 -2.11 . . . . 25.0 110.549 -177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.06 14.08 3.25 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.31 13.11 82.33 Favored Glycine 0 CA--C 1.518 0.22 0 N-CA-C 111.187 -0.765 . . . . 25.0 111.187 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.91 88.24 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.58 129.96 43.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.494 0.664 . . . . 25.0 110.565 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.09 -13.87 62.16 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.989 -0.55 . . . . 25.0 113.975 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -96.9 127.26 42.7 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 108.221 -1.029 . . . . 25.0 108.221 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -115.34 127.85 55.69 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.894 -0.504 . . . . 25.0 109.742 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.436 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.4 tp -74.41 122.8 23.55 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.2 m -136.08 172.31 13.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.256 0.55 . . . . 25.0 110.398 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.68 127.89 43.04 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.524 -0.762 . . . . 25.0 109.037 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.54 139.21 25.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 106.768 -1.568 . . . . 25.0 106.768 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m170 56.3 27.75 12.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.144 0.577 . . . . 25.0 111.597 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.84 13.11 75.27 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.972 -0.632 . . . . 25.0 113.462 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.26 141.59 47.95 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 105.206 -2.146 . . . . 25.0 105.206 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.49 142.86 34.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.877 -0.786 . . . . 25.0 108.877 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.48 170.34 42.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.522 -0.847 . . . . 25.0 113.538 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -80.2 156.17 4.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.769 0.795 . . . . 25.0 110.007 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.0 t -142.6 139.69 17.66 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.75 116.14 4.53 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 118.025 -0.85 . . . . 25.0 111.171 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.41 -21.34 59.9 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 112.037 -0.425 . . . . 25.0 112.037 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -64.15 -16.79 62.63 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.589 0.588 . . . . 25.0 112.589 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.79 10.57 15.39 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.951 -0.468 . . . . 25.0 111.12 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -126.82 142.37 51.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.7 1.0 . . . . 25.0 113.7 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -120.51 120.0 34.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.893 -0.594 . . . . 25.0 111.068 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 50.4 mm -66.09 126.68 25.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.203 -0.908 . . . . 25.0 109.092 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.7 mt -97.04 94.84 7.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.674 -1.602 . . . . 25.0 106.674 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.17 133.82 30.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.288 -1.004 . . . . 25.0 108.288 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.8 154.35 26.74 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 109.04 -1.624 . . . . 25.0 109.04 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 19.0 ttt 70.14 160.37 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.411 1.084 . . . . 25.0 110.886 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 59.75 -167.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.705 0.802 . . . . 25.0 113.039 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.6 t0 59.04 177.32 0.07 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.188 1.551 . . . . 25.0 115.188 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.47 113.45 26.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -60.59 145.14 87.96 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.16 150.84 66.38 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 117.785 -1.01 . . . . 25.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.9 139.3 20.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.924 -1.509 . . . . 25.0 106.924 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 159.77 26.36 Favored Glycine 0 C--O 1.226 -0.381 0 N-CA-C 111.112 -0.795 . . . . 25.0 111.112 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 m -106.6 1.67 25.43 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.254 0.465 . . . . 25.0 112.254 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.52 -178.77 42.49 Favored Glycine 0 C--O 1.231 -0.047 0 C-N-CA 121.058 -0.591 . . . . 25.0 113.429 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.1 -93.99 0.79 Allowed Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.365 -0.445 . . . . 25.0 112.618 178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 81.1 p -75.37 -16.51 60.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 122.7 -0.294 . . . . 25.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.52 36.14 3.58 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 111.792 -0.523 . . . . 25.0 111.792 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -69.0 153.68 43.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.64 152.25 51.42 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 109.674 -1.37 . . . . 25.0 109.674 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.93 150.93 51.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.3 m -109.74 -29.5 8.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -139.73 154.42 47.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -157.36 96.88 1.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.719 -1.215 . . . . 25.0 107.719 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.17 118.8 31.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.474 0.654 . . . . 25.0 110.08 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.92 142.15 76.05 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.452 -0.794 . . . . 25.0 111.996 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.74 164.99 32.5 Favored 'Trans proline' 0 C--O 1.241 0.651 0 O-C-N 121.597 0.262 . . . . 25.0 112.474 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.18 158.02 55.87 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 114.068 0.757 . . . . 25.0 114.068 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -90.39 152.81 45.94 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.54 161.95 43.9 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.564 -0.49 . . . . 25.0 111.453 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.64 176.96 9.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 120.219 0.613 . . . . 25.0 113.462 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 mt -133.48 153.77 80.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 25.0 109.843 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -79.5 171.69 15.51 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.204 2.603 . . . . 25.0 113.773 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -91.57 41.78 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.563 -0.744 . . . . 25.0 111.854 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.15 -175.04 31.82 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 114.737 0.655 . . . . 25.0 114.737 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -71.21 124.59 24.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.735 0.778 . . . . 25.0 110.456 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.214 -0.79 0 CA-C-O 124.628 2.156 . . . . 25.0 113.068 179.076 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 115.47 0.948 . . . . 25.0 115.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.11 16.36 4.75 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.137 1.532 . . . . 25.0 115.137 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -108.6 137.4 46.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.741 0.305 . . . . 25.0 110.289 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -146.08 144.29 29.92 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.092 -2.559 . . . . 25.0 104.092 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 56.02 176.7 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.99 1.107 . . . . 25.0 113.99 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.39 -40.55 67.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.133 -0.485 . . . . 25.0 109.938 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 51.73 55.09 9.85 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.461 0.912 . . . . 25.0 113.461 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.76 159.37 12.78 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 N-CA-C 107.66 -1.237 . . . . 25.0 107.66 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.71 146.91 23.84 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.666 -0.646 . . . . 25.0 110.19 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.48 143.76 35.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.213 -0.291 . . . . 25.0 110.213 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -105.47 138.77 41.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.635 0.374 . . . . 25.0 111.159 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.6 129.65 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.971 -0.558 . . . . 25.0 111.216 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.42 -18.64 25.07 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.258 -0.275 . . . . 25.0 110.258 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -144.36 163.51 33.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -71.0 154.06 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -137.96 135.42 36.0 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.901 -0.407 . . . . 25.0 109.901 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -112.25 125.48 69.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 104.282 -2.488 . . . . 25.0 104.282 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.01 128.58 35.32 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.638 -0.875 . . . . 25.0 108.638 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -112.52 -21.31 11.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.06 -0.718 . . . . 25.0 109.06 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.8 t -102.81 147.67 34.42 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.415 -1.328 . . . . 25.0 107.415 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.86 -14.24 40.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 O-C-N 121.772 0.354 . . . . 25.0 112.515 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.9 0.27 56.05 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 123.334 0.654 . . . . 25.0 110.349 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -101.72 149.08 24.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.245 0.545 . . . . 25.0 112.218 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.6 mt -92.7 143.95 25.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.49 0.662 . . . . 25.0 111.609 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.8 p -109.22 137.54 46.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -157.94 171.48 20.18 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.025 0.75 . . . . 25.0 113.025 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -105.04 154.57 19.96 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.436 -0.802 . . . . 25.0 110.206 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -56.86 126.62 27.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.077 -0.712 . . . . 25.0 109.077 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.04 -14.78 57.08 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 118.989 -0.895 . . . . 25.0 114.679 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -66.51 155.21 38.29 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.859 0.83 . . . . 25.0 110.878 -178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.78 125.45 73.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 116.029 -0.532 . . . . 25.0 109.756 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -126.25 156.31 40.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.04 0.448 . . . . 25.0 109.816 177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -91.97 113.59 25.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.454 -0.794 . . . . 25.0 109.731 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.429 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.4 t -78.72 122.94 34.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.962 -0.755 . . . . 25.0 108.962 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -95.22 -46.57 6.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.345 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -153.04 170.02 21.48 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.006 -0.739 . . . . 25.0 109.006 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -127.07 149.91 49.71 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 106.536 -1.653 . . . . 25.0 106.536 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 59.42 37.71 23.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 123.739 1.733 . . . . 25.0 107.689 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.7 t -64.36 145.69 55.64 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 112.713 -2.04 . . . . 25.0 109.975 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 57.77 15.25 2.87 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.737 0.815 . . . . 25.0 113.106 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.06 12.22 83.56 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 111.65 -0.58 . . . . 25.0 111.65 -177.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.9 mt -87.74 89.86 8.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -55.32 127.98 31.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.812 0.815 . . . . 25.0 110.868 -178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.13 -13.78 62.45 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-O 119.227 -0.763 . . . . 25.0 114.279 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -93.42 128.23 39.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 118.546 1.173 . . . . 25.0 108.248 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.0 m0 -115.36 124.1 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.567 -0.531 . . . . 25.0 109.567 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -72.75 121.84 20.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.8 -1.185 . . . . 25.0 107.8 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.4 m -135.15 171.41 14.47 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.948 0.404 . . . . 25.0 110.967 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.82 131.69 47.76 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 tp -149.33 134.85 18.51 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.0 m170 56.19 27.79 12.17 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.355 0.662 . . . . 25.0 112.2 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.16 12.55 84.02 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.06 -0.591 . . . . 25.0 114.016 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.05 138.8 50.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.578 -2.379 . . . . 25.0 104.578 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -105.37 144.21 32.46 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.659 -0.867 . . . . 25.0 108.659 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.24 168.26 39.39 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.605 -0.807 . . . . 25.0 113.024 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.4 pt -80.09 157.68 4.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.429 0.633 . . . . 25.0 109.509 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -143.32 139.69 16.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.59 116.97 4.88 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 117.643 -1.104 . . . . 25.0 111.364 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.78 -21.52 58.48 Favored Glycine 0 C--O 1.219 -0.786 0 O-C-N 121.909 -0.494 . . . . 25.0 112.509 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -17.17 63.98 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.382 -0.481 . . . . 25.0 111.787 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -114.84 9.82 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.194 -0.316 . . . . 25.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -126.95 144.69 50.93 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.328 0.862 . . . . 25.0 113.328 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.8 ttpt -125.38 119.91 29.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 116.089 -0.505 . . . . 25.0 112.251 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.95 126.34 25.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.281 -0.872 . . . . 25.0 109.618 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.4 mt -96.85 92.8 6.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.94 5.68 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.104 0.779 . . . . 25.0 113.104 -176.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.65 -12.61 27.41 Favored Glycine 0 C--O 1.222 -0.607 0 N-CA-C 114.732 0.653 . . . . 25.0 114.732 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 74.1 mtm -81.35 -5.33 57.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.186 0.81 . . . . 25.0 113.186 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -142.34 151.72 42.21 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.977 -0.452 . . . . 25.0 112.156 -175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -139.17 157.5 45.82 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 172.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -160.37 106.61 1.53 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.349 -0.611 . . . . 25.0 109.349 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.63 140.92 68.37 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.26 108.94 2.71 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 118.269 -0.687 . . . . 25.0 112.648 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.07 154.62 31.25 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.792 -1.188 . . . . 25.0 107.792 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.35 174.22 20.62 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 112.032 -0.427 . . . . 25.0 112.032 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.2 p -80.0 164.99 23.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.97 3.13 Favored Glycine 0 C--O 1.227 -0.303 0 C-N-CA 121.33 -0.462 . . . . 25.0 112.704 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.59 10.3 8.94 Favored Glycine 0 C--O 1.219 -0.839 0 CA-C-O 121.439 0.466 . . . . 25.0 112.939 177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m -88.6 -9.47 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.07 0.548 . . . . 25.0 110.415 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.26 157.92 24.33 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.544 -1.022 . . . . 25.0 110.544 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.2 m -68.79 -26.58 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.227 0.513 . . . . 25.0 111.815 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.69 151.96 9.1 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 106.889 -2.485 . . . . 25.0 106.889 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.9 mt -153.36 -47.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.799 0.799 . . . . 25.0 110.609 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -136.99 165.97 24.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.611 -1.625 . . . . 25.0 106.611 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.26 156.39 44.72 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 123.502 0.501 . . . . 25.0 109.798 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -121.07 93.62 4.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.35 135.66 53.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.487 0.661 . . . . 25.0 109.272 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.82 149.13 87.78 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.472 -0.785 . . . . 25.0 112.749 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -69.56 164.97 32.32 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 121.761 0.348 . . . . 25.0 111.335 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -69.93 163.16 39.42 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 117.792 -1.006 . . . . 25.0 113.028 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -97.64 149.84 36.14 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.259 -1.756 . . . . 25.0 106.259 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.35 161.34 45.19 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 117.295 -1.337 . . . . 25.0 110.468 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -74.03 174.9 11.62 Favored 'Trans proline' 0 C--N 1.346 0.413 0 N-CA-C 113.328 0.472 . . . . 25.0 113.328 -177.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.8 mt -133.92 153.46 79.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.882 -0.599 . . . . 25.0 111.025 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.49 177.37 8.2 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.957 2.438 . . . . 25.0 111.293 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -91.3 27.02 2.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.427 0.632 . . . . 25.0 110.622 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 118.44 177.54 16.92 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 111.423 -0.671 . . . . 25.0 111.423 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.44 142.25 51.15 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 124.159 1.933 . . . . 25.0 113.057 -176.407 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 CA-C-O 123.243 1.468 . . . . 25.0 115.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 p -65.06 129.1 38.46 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.071 -1.252 . . . . 25.0 111.149 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ttt 52.54 52.76 13.46 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.007 0.817 . . . . 25.0 112.735 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -116.55 140.55 49.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.635 -0.876 . . . . 25.0 108.635 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 61.38 168.44 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 115.209 1.559 . . . . 25.0 115.209 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.37 -32.66 55.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.133 -0.939 . . . . 25.0 112.188 -174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.6 m120 51.46 45.65 27.68 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.34 1.237 . . . . 25.0 114.34 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -103.41 161.97 4.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 N-CA-C 107.621 -1.251 . . . . 25.0 107.621 -179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -101.12 142.37 32.67 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.76 143.46 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.922 -0.399 . . . . 25.0 109.922 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' HD11 ' A' ' 31' ' ' ILE . 3.2 ttmm -104.34 137.56 42.06 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.651 0.381 . . . . 25.0 110.992 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.05 129.96 39.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.03 -0.532 . . . . 25.0 110.647 174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -89.94 -20.12 23.71 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.318 -0.238 . . . . 25.0 110.588 175.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -141.14 162.45 35.46 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 -177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -67.92 153.16 44.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.61 -1.256 . . . . 25.0 107.61 171.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -136.75 134.23 36.89 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 120.954 0.407 . . . . 25.0 109.915 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.28 125.41 67.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 104.954 -2.239 . . . . 25.0 104.954 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.14 122.54 22.9 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.267 -1.012 . . . . 25.0 108.267 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -107.05 -18.91 13.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.116 0.96 . . . . 25.0 108.536 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -108.77 146.81 34.52 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 114.296 -1.32 . . . . 25.0 107.518 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.99 -8.7 24.25 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 O-C-N 121.759 0.347 . . . . 25.0 112.704 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.2 -1.33 51.94 Favored 'General case' 0 C--O 1.204 -1.31 0 N-CA-C 109.977 -0.379 . . . . 25.0 109.977 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -101.26 150.84 22.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.199 0.523 . . . . 25.0 111.977 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.55 142.7 27.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.744 0.783 . . . . 25.0 111.69 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -109.72 130.23 55.54 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.886 -1.524 . . . . 25.0 106.886 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -152.65 169.09 23.56 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.362 0.875 . . . . 25.0 113.362 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -98.38 154.65 17.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.822 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.09 131.77 48.45 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.22 . . . . 25.0 107.707 170.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.71 -9.41 68.66 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.701 -1.055 . . . . 25.0 113.825 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -71.27 159.55 34.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 118.224 1.012 . . . . 25.0 109.772 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD11 ' HE2' ' A' ' 11' ' ' LYS . 49.7 mm -119.54 130.16 74.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.303 -0.999 . . . . 25.0 108.303 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -128.16 155.02 45.12 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.761 -0.829 . . . . 25.0 108.761 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.6 m -89.8 113.23 24.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.914 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.2 t -78.32 124.58 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 N-CA-C 108.392 -0.966 . . . . 25.0 108.392 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.0 mt -96.49 -48.11 5.68 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.105 -0.952 . . . . 25.0 109.165 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.1 pt-20 -151.61 171.76 17.11 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.292 -0.633 . . . . 25.0 109.292 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.6 mtm-85 -123.88 151.6 43.3 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 106.35 -1.722 . . . . 25.0 106.35 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 58.85 36.62 24.75 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.621 1.677 . . . . 25.0 108.029 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -64.24 146.9 53.57 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 112.692 -2.049 . . . . 25.0 110.454 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 58.6 12.99 2.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.891 0.877 . . . . 25.0 113.306 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 12.74 80.83 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 111.202 -0.759 . . . . 25.0 111.202 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.8 mt -88.68 88.91 7.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.323 -0.991 . . . . 25.0 108.323 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -56.54 129.53 41.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.59 0.709 . . . . 25.0 110.72 -178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.03 -15.09 58.85 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.816 -0.629 . . . . 25.0 113.993 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -93.43 128.6 39.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -115.85 126.68 54.29 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.83 -0.544 . . . . 25.0 109.575 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.1 tp -73.39 122.8 22.65 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.942 -1.133 . . . . 25.0 107.942 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.1 m -135.75 170.72 15.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.124 0.488 . . . . 25.0 110.795 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.49 130.55 50.85 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.525 -0.917 . . . . 25.0 108.525 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -154.93 139.49 16.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.622 -1.251 . . . . 25.0 107.622 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 56.11 29.81 15.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.371 0.668 . . . . 25.0 112.299 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.97 16.12 76.49 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.763 -0.732 . . . . 25.0 113.79 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.61 154.17 39.69 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -114.44 147.18 39.66 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.58 -1.267 . . . . 25.0 107.58 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.55 169.23 39.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.76 -0.733 . . . . 25.0 112.409 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.48 157.58 4.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.423 0.63 . . . . 25.0 109.648 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.63 139.62 17.53 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 108.519 -0.919 . . . . 25.0 108.519 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.61 109.5 2.3 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 CA-C-O 121.782 0.659 . . . . 25.0 110.886 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.54 -23.71 60.91 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -76.48 -2.64 33.15 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.856 -0.791 . . . . 25.0 112.946 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -112.52 8.0 19.13 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 172.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -123.85 147.31 47.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.449 0.642 . . . . 25.0 112.178 -175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.8 ttmm -122.62 119.95 32.3 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.727 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 8' ' ' VAL . 51.2 mm -70.74 125.46 29.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.31 75.25 3.94 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.31 -26.9 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.407 0.623 . . . . 25.0 110.142 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.66 -28.03 6.13 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.145 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 24.5 ttm -74.33 30.64 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.612 1.165 . . . . 25.0 113.479 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -140.26 127.18 20.71 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.851 -0.531 . . . . 25.0 109.977 -175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -71.45 -29.56 65.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.945 0.402 . . . . 25.0 111.96 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -76.16 59.52 1.36 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.196 0.998 . . . . 25.0 112.002 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -78.15 147.25 72.7 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 106.788 -1.56 . . . . 25.0 106.788 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.21 -15.34 35.37 Favored 'Trans proline' 0 C--O 1.217 -0.533 0 C-N-CA 118.103 -0.798 . . . . 25.0 113.976 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.89 -24.33 67.7 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.21 -0.306 . . . . 25.0 111.194 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.28 -1.86 90.23 Favored Glycine 0 C--O 1.219 -0.785 0 C-N-CA 121.008 -0.615 . . . . 25.0 113.284 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.3 t -86.67 -11.54 50.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.251 0.525 . . . . 25.0 110.747 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.79 -155.07 52.72 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.195 -0.762 . . . . 25.0 111.195 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -138.64 148.9 20.28 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 106.141 -2.783 . . . . 25.0 106.141 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.5 t -158.62 170.58 21.86 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.916 -1.142 . . . . 25.0 107.916 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.22 151.54 8.44 Favored Glycine 0 C--O 1.227 -0.341 0 N-CA-C 110.66 -0.976 . . . . 25.0 110.66 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.04 29.36 0.41 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.863 0.84 . . . . 25.0 109.661 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.81 -176.93 39.34 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 106.782 -2.527 . . . . 25.0 106.782 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.77 -45.2 90.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.911 0.855 . . . . 25.0 110.871 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.17 171.23 0.15 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.101 0.96 . . . . 25.0 111.501 -178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -130.64 139.1 50.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.984 -0.746 . . . . 25.0 108.984 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -150.16 91.39 1.76 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.874 -1.158 . . . . 25.0 107.874 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.346 0.593 . . . . 25.0 110.419 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.67 149.53 80.94 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.351 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.95 161.66 45.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 117.166 -1.422 . . . . 25.0 111.403 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 150.06 61.4 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 117.702 -1.065 . . . . 25.0 111.897 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -81.63 154.44 71.03 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.717 -0.845 . . . . 25.0 108.717 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.68 160.59 49.17 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 118.495 -0.537 . . . . 25.0 111.019 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.41 175.28 11.48 Favored 'Trans proline' 0 C--N 1.348 0.532 0 N-CA-C 113.672 0.605 . . . . 25.0 113.672 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.1 mt -133.88 155.47 80.24 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.001 -0.545 . . . . 25.0 110.724 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.03 168.36 23.49 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.272 1.981 . . . . 25.0 113.323 177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.22 43.24 1.07 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.97 -1.014 . . . . 25.0 112.11 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.54 -159.3 14.97 Favored Glycine 0 CA--C 1.517 0.165 0 C-N-CA 121.274 -0.489 . . . . 25.0 113.324 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.11 115.16 6.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.008 0.909 . . . . 25.0 110.093 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 CA--C 1.557 1.246 0 CA-C-O 124.57 2.128 . . . . 25.0 114.513 -176.759 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 CA-C-O 124.58 2.211 . . . . 25.0 113.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -67.95 150.45 48.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.975 -1.612 . . . . 25.0 110.171 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpt 52.96 38.62 27.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.026 0.75 . . . . 25.0 113.026 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -89.51 14.67 10.88 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.635 -0.666 . . . . 25.0 110.981 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.0 161.14 35.63 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.454 -0.943 . . . . 25.0 108.454 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.99 -42.8 89.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.888 -0.596 . . . . 25.0 112.294 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.2 53.99 11.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 25.0 113.614 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -108.3 162.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 107.564 -1.273 . . . . 25.0 107.564 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.56 143.38 27.61 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.857 -0.527 . . . . 25.0 110.082 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.82 144.52 41.53 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.925 -0.398 . . . . 25.0 109.925 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -105.27 138.72 41.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.531 0.332 . . . . 25.0 111.746 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 125.41 28.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 25.0 109.778 175.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.1 -18.92 29.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.598 -0.519 . . . . 25.0 109.598 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -141.27 162.74 34.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.138 -1.06 . . . . 25.0 108.138 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -73.25 155.6 39.36 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -139.73 126.23 20.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.361 0.6 . . . . 25.0 112.105 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.7 t -104.54 124.95 59.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 103.166 -2.901 . . . . 25.0 103.166 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.1 126.38 29.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -105.86 -25.09 12.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -104.22 152.09 39.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.707 -0.849 . . . . 25.0 108.707 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.85 -13.24 34.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 O-C-N 121.881 0.411 . . . . 25.0 113.099 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.12 -4.55 42.58 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-N 116.539 -0.301 . . . . 25.0 110.56 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -92.89 152.38 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.035 0.445 . . . . 25.0 111.861 -174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.04 143.6 27.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.732 0.777 . . . . 25.0 112.344 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.4 p -105.51 128.67 53.7 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.911 -1.144 . . . . 25.0 107.911 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -153.92 176.11 12.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.99 171.71 8.05 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.404 -0.591 . . . . 25.0 109.404 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.04 135.13 57.62 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.877 0.846 . . . . 25.0 110.516 178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.73 76.93 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.285 -0.87 . . . . 25.0 113.624 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 158.92 35.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 117.688 0.744 . . . . 25.0 109.281 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -122.72 125.99 73.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -127.38 155.74 43.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.084 0.469 . . . . 25.0 110.157 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.4 m -90.6 111.88 23.37 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.227 -0.897 . . . . 25.0 109.628 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.2 t -78.55 120.11 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.57 -44.64 8.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.484 -0.78 . . . . 25.0 109.049 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.63 170.06 21.75 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.704 -0.851 . . . . 25.0 108.704 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.4 mtm105 -123.77 151.78 42.92 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.163 -1.421 . . . . 25.0 107.163 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 59.23 36.94 23.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.724 1.726 . . . . 25.0 108.15 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.56 145.2 56.51 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 112.583 -2.099 . . . . 25.0 111.471 -175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 58.72 13.25 2.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.714 1.005 . . . . 25.0 113.714 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.29 13.56 78.55 Favored Glycine 0 C--O 1.229 -0.208 0 N-CA-C 111.048 -0.821 . . . . 25.0 111.048 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.3 mt -89.45 89.49 7.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.47 129.99 43.05 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.563 0.697 . . . . 25.0 110.668 -176.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.04 52.16 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-O 119.136 -0.813 . . . . 25.0 114.447 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -91.01 129.09 37.04 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 118.848 1.324 . . . . 25.0 108.832 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -113.34 126.2 55.11 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.11 119.55 19.41 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -131.83 170.98 14.09 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.101 0.477 . . . . 25.0 110.549 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.13 130.58 46.61 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.852 -1.166 . . . . 25.0 107.852 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.85 133.46 19.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.673 -1.232 . . . . 25.0 107.673 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.3 m170 55.89 28.36 12.41 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.105 0.562 . . . . 25.0 112.18 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.76 9.62 86.78 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.097 -0.573 . . . . 25.0 114.123 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -114.95 137.95 51.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.489 -2.041 . . . . 25.0 105.489 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.43 147.83 26.66 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.39 171.22 41.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.763 . . . . 25.0 113.018 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -81.5 156.17 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -143.65 140.13 17.05 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 106.992 -1.485 . . . . 25.0 106.992 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.53 119.43 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 117.322 -1.319 . . . . 25.0 110.661 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.76 -22.49 64.3 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 112.043 -0.423 . . . . 25.0 112.043 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -63.59 -14.25 49.64 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.902 0.704 . . . . 25.0 112.902 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -115.56 9.91 15.49 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 122.039 -0.413 . . . . 25.0 111.602 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.66 153.31 37.05 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 122.057 0.932 . . . . 25.0 113.453 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 13' ' ' LEU . 23.4 ttmm -127.89 120.0 26.8 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 114.583 -1.19 . . . . 25.0 109.725 173.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.8 mm -68.65 127.11 29.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.364 -1.347 . . . . 25.0 107.364 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.23 91.65 7.35 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.5 -0.926 . . . . 25.0 108.5 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.4 130.13 36.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.994 -0.743 . . . . 25.0 108.994 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.2 173.05 43.42 Favored Glycine 0 C--O 1.227 -0.338 0 C-N-CA 120.895 -0.669 . . . . 25.0 112.066 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 74.23 -44.4 0.56 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.253 1.421 . . . . 25.0 112.474 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -80.3 -179.32 7.05 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.269 0.628 . . . . 25.0 110.159 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 53.91 33.79 18.05 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.67 1.224 . . . . 25.0 112.708 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -73.4 99.75 3.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.929 -1.032 . . . . 25.0 110.088 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 74.26 158.08 0.16 Allowed Pre-proline 0 N--CA 1.49 1.545 0 C-N-CA 125.715 1.606 . . . . 25.0 108.311 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.46 48.0 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 N-CA-C 115.188 1.188 . . . . 25.0 115.188 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.44 137.73 52.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.23 -49.14 3.94 Favored Glycine 0 C--O 1.221 -0.712 0 C-N-CA 121.201 -0.523 . . . . 25.0 113.546 -178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -75.08 -24.37 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.704 0.752 . . . . 25.0 111.578 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.74 -40.6 2.78 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 113.886 0.314 . . . . 25.0 113.886 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 177.62 -131.32 1.76 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.207 -1.157 . . . . 25.0 110.207 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.9 m -142.34 146.43 34.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.89 151.49 16.97 Favored Glycine 0 C--O 1.23 -0.126 0 C-N-CA 121.149 -0.548 . . . . 25.0 111.889 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -150.57 64.84 0.94 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.06 -0.719 . . . . 25.0 109.06 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.21 -40.83 94.98 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 120.744 -0.741 . . . . 25.0 113.035 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.8 mt 52.3 35.9 18.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.366 0.876 . . . . 25.0 113.366 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -104.44 -60.67 1.56 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.812 0.339 . . . . 25.0 110.449 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -158.5 149.02 20.13 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.728 -2.323 . . . . 25.0 104.728 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.69 111.99 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.609 -0.515 . . . . 25.0 109.609 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -91.19 119.76 31.55 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.166 0.507 . . . . 25.0 110.452 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.19 145.63 86.03 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.089 -0.505 . . . . 25.0 109.994 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.73 160.98 40.21 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 118.662 -0.426 . . . . 25.0 112.67 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.83 157.85 40.96 Favored 'Trans proline' 0 C--N 1.35 0.615 0 N-CA-C 114.442 0.901 . . . . 25.0 114.442 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -86.47 153.19 55.81 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.14 161.52 45.53 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 N-CA-C 109.612 -0.957 . . . . 25.0 109.612 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.91 174.79 11.35 Favored 'Trans proline' 0 C--N 1.35 0.632 0 N-CA-C 113.524 0.548 . . . . 25.0 113.524 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.96 156.69 79.03 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.613 -0.721 . . . . 25.0 109.267 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.04 -163.19 0.17 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.561 2.84 . . . . 25.0 113.37 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 75.98 -1.62 2.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.293 1.837 . . . . 25.0 113.669 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.72 85.17 0.07 OUTLIER Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.545 -1.207 . . . . 25.0 115.912 171.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.35 129.25 37.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.752 0.787 . . . . 25.0 109.587 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.213 -0.862 0 CA-C-O 124.478 2.085 . . . . 25.0 113.201 -179.334 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 CA-C-O 124.868 2.371 . . . . 25.0 113.246 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -77.34 166.49 23.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.725 -1.738 . . . . 25.0 109.98 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.2 tpp 58.06 48.46 13.09 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.452 0.908 . . . . 25.0 113.452 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -65.63 134.64 53.7 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.232 -1.395 . . . . 25.0 107.232 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 63.26 161.22 0.09 Allowed 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 115.276 1.584 . . . . 25.0 115.276 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.61 -42.26 82.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.221 -0.899 . . . . 25.0 112.264 -176.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 50.18 50.91 17.73 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 25.0 113.896 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.8 158.84 4.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 106.262 -1.755 . . . . 25.0 106.262 177.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -95.97 142.3 28.36 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.58 140.43 46.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.921 -0.77 . . . . 25.0 108.921 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 26.7 ttmt -103.18 136.34 43.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 123.347 0.404 . . . . 25.0 110.681 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.52 130.6 41.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.187 -0.46 . . . . 25.0 110.209 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.41 -18.96 24.51 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 109.406 -0.59 . . . . 25.0 109.406 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -143.1 164.09 31.08 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.773 -0.825 . . . . 25.0 108.773 -175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -70.42 156.75 38.93 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -139.24 131.6 28.45 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.976 -0.75 . . . . 25.0 108.976 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.1 t -107.91 124.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 103.422 -2.807 . . . . 25.0 103.422 174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.4 125.16 26.71 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -106.91 -19.83 13.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.79 -0.818 . . . . 25.0 108.79 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 m -108.58 152.51 42.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.977 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.24 -13.72 33.78 Favored 'Trans proline' 0 C--N 1.344 0.313 0 O-C-N 121.89 0.416 . . . . 25.0 112.526 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.03 -2.96 42.33 Favored 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 116.21 -0.45 . . . . 25.0 111.024 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -97.51 149.39 22.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 25.0 112.199 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -95.41 144.89 25.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.744 0.783 . . . . 25.0 112.055 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 p -110.04 133.16 53.49 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.345 -1.354 . . . . 25.0 107.345 176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -156.58 172.3 18.8 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.514 -0.766 . . . . 25.0 112.529 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -103.54 157.33 17.12 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.794 0.838 . . . . 25.0 109.4 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -55.36 132.22 47.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.305 -0.998 . . . . 25.0 108.305 169.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.22 -8.91 69.84 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-O 119.221 -0.766 . . . . 25.0 113.989 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -72.61 160.49 32.17 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.925 0.862 . . . . 25.0 109.852 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 49.4 mm -121.8 123.92 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 122.84 0.456 . . . . 25.0 110.396 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.89 152.06 41.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.538 0.685 . . . . 25.0 109.817 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.0 m -88.54 112.85 23.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.885 -1.052 . . . . 25.0 109.514 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.8 t -79.63 121.45 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -93.63 -42.53 9.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.874 -0.603 . . . . 25.0 109.826 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.7 pt-20 -154.88 171.01 20.35 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.612 -1.255 . . . . 25.0 107.612 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.6 mtm105 -124.45 152.94 42.69 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.225 -1.398 . . . . 25.0 107.225 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 58.56 36.68 25.3 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 123.5 1.619 . . . . 25.0 108.406 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 7.2 t -64.13 147.56 51.95 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 112.692 -2.049 . . . . 25.0 111.171 -175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 55.75 21.62 4.83 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.421 0.688 . . . . 25.0 112.2 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.65 13.91 74.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.149 -0.548 . . . . 25.0 112.568 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 47.3 mt -87.27 91.82 8.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.546 -1.65 . . . . 25.0 106.546 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -59.05 134.77 57.28 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.454 -0.573 . . . . 25.0 109.454 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -15.12 47.33 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-O 119.002 -0.888 . . . . 25.0 114.365 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -95.28 129.72 42.31 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 118.612 1.206 . . . . 25.0 109.713 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -113.71 128.31 56.37 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.688 -0.632 . . . . 25.0 110.315 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 51.2 tp -75.9 121.25 22.39 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.773 -1.195 . . . . 25.0 107.773 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.6 m -134.61 170.54 15.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.953 0.406 . . . . 25.0 110.773 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.88 129.19 46.49 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.009 -1.108 . . . . 25.0 108.009 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -140.51 129.43 23.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.26 -1.385 . . . . 25.0 107.26 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 52.9 31.54 10.97 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.038 0.755 . . . . 25.0 113.038 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.26 6.59 87.79 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.86 -0.686 . . . . 25.0 114.142 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -108.73 136.62 48.0 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 104.852 -2.277 . . . . 25.0 104.852 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -105.0 146.55 28.89 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 170.47 41.02 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.103 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -82.76 154.61 3.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.195 0.521 . . . . 25.0 109.738 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -141.71 139.57 18.7 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 107.961 -1.126 . . . . 25.0 107.961 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.35 120.8 7.42 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 117.211 -1.392 . . . . 25.0 111.771 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.63 -25.62 63.61 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.533 -0.365 . . . . 25.0 113.032 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.17 -15.43 56.84 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.105 0.78 . . . . 25.0 113.105 178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.37 9.67 16.91 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.922 -0.487 . . . . 25.0 111.704 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -118.85 151.25 38.43 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.079 0.942 . . . . 25.0 112.832 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -125.97 119.45 27.75 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.806 -1.088 . . . . 25.0 109.128 173.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 8' ' ' VAL . 48.3 mm -68.56 128.21 31.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.235 -1.395 . . . . 25.0 107.235 176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.39 88.54 7.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -76.0 114.12 15.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.282 -0.872 . . . . 25.0 109.179 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.96 -175.31 46.77 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 110.07 -1.212 . . . . 25.0 110.07 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ptp 65.37 -6.22 0.4 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 115.765 1.765 . . . . 25.0 115.765 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -105.32 -4.91 20.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.365 0.602 . . . . 25.0 109.873 174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -81.85 154.86 25.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.49 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -144.08 -33.35 0.41 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.337 1.236 . . . . 25.0 114.337 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.73 145.79 32.71 Favored Pre-proline 0 C--O 1.22 -0.494 0 N-CA-C 107.508 -1.293 . . . . 25.0 107.508 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.96 7.51 3.94 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 N-CA-C 113.941 0.708 . . . . 25.0 113.941 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.14 132.47 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.053 -0.351 . . . . 25.0 110.053 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.13 164.83 37.2 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 121.036 -0.602 . . . . 25.0 112.191 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -70.2 -24.79 63.17 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.919 0.711 . . . . 25.0 112.919 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.04 -171.27 50.43 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 120.894 -0.669 . . . . 25.0 112.974 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.49 146.25 5.61 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 109.493 -1.443 . . . . 25.0 109.493 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 m -73.61 -42.68 61.18 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 113.602 0.964 . . . . 25.0 113.602 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.3 3.92 27.36 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.958 1.143 . . . . 25.0 115.958 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -84.95 3.96 35.87 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.89 1.441 . . . . 25.0 114.89 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.18 23.29 71.69 Favored Glycine 0 C--O 1.226 -0.374 0 C-N-CA 120.892 -0.671 . . . . 25.0 113.657 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.7 124.03 19.95 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.583 -0.525 . . . . 25.0 109.583 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.32 11.13 5.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.212 1.19 . . . . 25.0 114.212 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.88 -178.01 0.08 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.953 0.901 . . . . 25.0 111.568 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -152.87 99.92 2.47 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.362 -0.836 . . . . 25.0 111.591 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.58 142.82 44.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.287 0.565 . . . . 25.0 110.517 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.61 148.21 41.36 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 113.528 0.936 . . . . 25.0 113.528 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.59 167.12 27.84 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 121.175 1.25 . . . . 25.0 112.214 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.66 169.08 21.93 Favored 'Trans proline' 0 C--O 1.239 0.55 0 N-CA-C 113.346 0.479 . . . . 25.0 113.346 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -109.17 152.59 42.64 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 107.513 -1.291 . . . . 25.0 107.513 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.95 162.27 42.81 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 O-C-N 122.084 0.518 . . . . 25.0 111.332 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.23 174.59 12.54 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 120.341 0.694 . . . . 25.0 113.66 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.3 mt -134.01 155.84 79.77 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 123.07 0.548 . . . . 25.0 111.081 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.66 177.15 8.36 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.1 2.534 . . . . 25.0 112.043 174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -104.08 32.89 3.71 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.798 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.55 171.08 44.26 Favored Glycine 0 C--O 1.229 -0.218 0 C-N-CA 120.511 -0.852 . . . . 25.0 113.798 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -75.82 106.81 7.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.454 0.645 . . . . 25.0 109.346 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.213 -0.866 0 CA-C-O 123.404 1.573 . . . . 25.0 112.042 -178.571 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 CA-C-O 122.775 1.208 . . . . 25.0 115.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.1 p -135.77 162.05 33.86 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.492 -1.005 . . . . 25.0 108.667 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.2 ttt -172.27 -31.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.549 0.69 . . . . 25.0 110.25 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -82.84 136.22 34.7 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 102.541 -3.133 . . . . 25.0 102.541 173.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 62.54 161.37 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 125.428 1.705 . . . . 25.0 112.578 -169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.23 -38.28 66.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.166 -0.925 . . . . 25.0 111.649 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.8 m120 52.85 46.33 26.98 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.802 1.038 . . . . 25.0 113.802 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER -101.93 162.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -98.45 141.8 30.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.848 -0.797 . . . . 25.0 108.848 175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.01 142.2 44.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -103.88 137.29 42.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.893 0.378 . . . . 25.0 111.28 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.74 123.28 22.26 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.485 -0.78 . . . . 25.0 110.818 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -84.18 -20.05 33.03 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 176.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.23 167.59 22.05 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 105.437 -2.06 . . . . 25.0 105.437 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -78.03 171.24 15.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.458 -0.941 . . . . 25.0 108.458 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -146.36 138.59 25.08 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 25.0 109.849 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.52 123.08 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 105.299 -2.111 . . . . 25.0 105.299 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.75 117.69 18.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -106.11 -24.78 12.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 t -95.66 146.69 31.76 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.33 -10.76 29.93 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 O-C-N 121.803 0.37 . . . . 25.0 113.041 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.5 -2.62 41.55 Favored 'General case' 0 C--O 1.207 -1.162 0 O-C-N 122.385 -0.197 . . . . 25.0 110.987 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -92.84 151.17 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.158 0.504 . . . . 25.0 111.69 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.27 143.12 28.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.635 0.731 . . . . 25.0 111.519 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -109.92 134.62 51.89 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.925 -1.509 . . . . 25.0 106.925 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -155.07 172.78 17.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.327 -0.851 . . . . 25.0 110.64 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -108.54 159.03 17.03 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.669 -0.863 . . . . 25.0 108.669 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -53.52 133.14 41.07 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.045 -0.724 . . . . 25.0 109.045 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.71 -15.81 59.32 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 118.982 -0.899 . . . . 25.0 114.069 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.1 155.07 40.36 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 117.937 0.869 . . . . 25.0 110.816 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.1 mm -116.62 126.45 74.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -123.8 155.03 38.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.338 -0.616 . . . . 25.0 109.338 176.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.225 -0.898 . . . . 25.0 109.111 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.7 t -79.76 125.23 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.6 mt -97.85 -46.12 6.06 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.25 -0.886 . . . . 25.0 109.457 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -152.87 171.03 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.444 -0.576 . . . . 25.0 109.444 173.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -126.77 150.53 49.06 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.584 -1.635 . . . . 25.0 106.584 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.72 35.64 22.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 123.736 1.732 . . . . 25.0 108.101 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.71 145.29 55.07 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 112.669 -2.06 . . . . 25.0 110.891 -177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 58.55 10.75 1.48 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.447 1.099 . . . . 25.0 113.505 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 15.64 71.67 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.932 -0.867 . . . . 25.0 110.932 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.24 90.04 7.91 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.244 -1.391 . . . . 25.0 107.244 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -56.49 129.75 42.06 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.421 0.629 . . . . 25.0 110.573 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.69 -14.58 57.98 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-O 119.599 -0.556 . . . . 25.0 114.296 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -92.77 130.03 38.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 118.263 1.031 . . . . 25.0 108.754 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.09 126.51 54.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.364 -0.606 . . . . 25.0 109.364 -176.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.17 120.23 19.46 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.388 -1.338 . . . . 25.0 107.388 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -133.91 170.59 15.38 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.147 0.499 . . . . 25.0 110.44 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 128.98 45.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 tp -142.11 128.52 20.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.198 -1.408 . . . . 25.0 107.198 -176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 54.03 30.16 11.38 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.266 0.627 . . . . 25.0 112.196 -175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.15 5.69 87.31 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.063 -0.589 . . . . 25.0 114.292 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -106.66 137.02 45.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -103.08 148.17 26.06 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.125 -0.694 . . . . 25.0 109.125 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.95 171.37 40.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.662 -0.78 . . . . 25.0 113.288 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.9 pt -81.91 154.77 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.554 0.692 . . . . 25.0 110.052 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -141.84 139.35 18.19 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 25.0 108.665 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.77 115.59 4.3 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 118.155 -0.764 . . . . 25.0 111.54 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.02 -22.16 57.32 Favored Glycine 0 C--O 1.22 -0.741 0 O-C-N 122.084 -0.385 . . . . 25.0 113.023 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.41 64.44 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.191 -0.594 . . . . 25.0 112.102 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -112.66 9.72 19.32 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.212 -0.305 . . . . 25.0 110.791 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -126.62 142.55 51.5 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.606 0.965 . . . . 25.0 113.606 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.4 ttpt -121.56 120.24 34.25 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.759 -0.655 . . . . 25.0 111.422 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.519 HG23 HG21 ' A' ' 8' ' ' VAL . 50.6 mm -68.04 124.65 24.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.74 176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.2 mt -92.44 94.55 9.16 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.762 -0.829 . . . . 25.0 108.762 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -81.37 4.88 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.424 -0.807 . . . . 25.0 112.283 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.8 -40.8 2.81 Favored Glycine 0 N--CA 1.46 0.296 0 CA-C-O 121.585 0.547 . . . . 25.0 112.133 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 95.6 mmm -75.3 164.49 26.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.217 -0.66 . . . . 25.0 109.217 175.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 62.93 -166.91 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.035 0.934 . . . . 25.0 111.596 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 59.39 -9.56 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -73.97 90.83 1.98 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -138.27 153.8 73.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 104.88 -2.267 . . . . 25.0 104.88 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.9 -23.04 22.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 116.899 -1.601 . . . . 25.0 113.01 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -156.53 156.89 34.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.433 -2.062 . . . . 25.0 105.433 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.87 -26.87 43.67 Favored Glycine 0 CA--C 1.517 0.181 0 C-N-CA 120.552 -0.832 . . . . 25.0 111.952 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.4 t 65.36 175.68 0.21 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.446 1.099 . . . . 25.0 110.332 -174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 61.8 31.62 78.86 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 121.092 -0.575 . . . . 25.0 113.126 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.69 -155.21 11.51 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.803 -1.319 . . . . 25.0 109.803 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.9 m 59.47 31.61 21.15 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.466 0.706 . . . . 25.0 112.063 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -130.4 -127.14 2.87 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 108.421 -1.871 . . . . 25.0 108.421 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.9 m -143.61 160.44 40.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.23 -1.026 . . . . 25.0 108.23 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.68 168.71 38.39 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 107.813 -2.115 . . . . 25.0 107.813 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.91 -23.48 16.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 117.548 0.674 . . . . 25.0 111.844 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.0 p -88.5 125.26 34.68 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -79.98 154.95 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.25 67.64 9.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.2 1.0 . . . . 25.0 109.144 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.88 138.53 58.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.604 -1.18 . . . . 25.0 111.182 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.16 150.51 68.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.265 1.209 . . . . 25.0 114.265 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.65 166.61 28.91 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 120.24 0.626 . . . . 25.0 111.874 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.99 165.94 30.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 117.864 -0.957 . . . . 25.0 113.6 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.43 156.29 37.76 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 105.739 -1.948 . . . . 25.0 105.739 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -63.99 164.22 22.84 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 O-C-N 122.196 0.577 . . . . 25.0 110.617 175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.76 171.83 15.68 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 117.37 -1.287 . . . . 25.0 111.72 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -133.98 156.51 79.18 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.645 -0.707 . . . . 25.0 110.813 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.04 -175.22 2.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.434 2.09 . . . . 25.0 112.686 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 66.37 8.91 6.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.394 1.478 . . . . 25.0 113.353 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.58 161.73 27.5 Favored Glycine 0 C--N 1.32 -0.327 0 N-CA-C 107.957 -2.057 . . . . 25.0 107.957 169.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -68.75 136.13 52.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 122.774 1.273 . . . . 25.0 111.045 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.217 -0.62 0 CA-C-O 125.209 2.433 . . . . 25.0 110.519 -178.358 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 CA-C-O 123.363 1.535 . . . . 25.0 115.656 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -90.0 146.28 24.47 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.037 -1.272 . . . . 25.0 109.227 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -77.12 88.45 3.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.506 0.67 . . . . 25.0 110.311 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.71 140.07 53.01 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 105.405 -2.072 . . . . 25.0 105.405 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 60.63 165.63 0.08 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.134 1.901 . . . . 25.0 116.134 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.34 -41.15 57.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.306 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 54.33 50.29 16.62 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 161.64 5.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 N-CA-C 107.389 -1.338 . . . . 25.0 107.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.85 141.56 29.91 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.893 -0.504 . . . . 25.0 109.826 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.41 144.94 44.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -104.49 136.94 43.11 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.607 0.363 . . . . 25.0 111.689 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.0 128.17 34.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.791 -0.641 . . . . 25.0 110.086 173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.82 -16.47 30.1 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.035 0.445 . . . . 25.0 110.055 176.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -143.28 165.81 26.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.648 -1.241 . . . . 25.0 107.648 -177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -78.13 163.08 26.16 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.853 -1.165 . . . . 25.0 107.853 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -144.72 133.76 22.69 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.97 -0.752 . . . . 25.0 108.97 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.0 123.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 104.548 -2.39 . . . . 25.0 104.548 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.75 126.03 29.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.635 -0.711 . . . . 25.0 109.219 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -111.22 -33.53 6.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.449 0.642 . . . . 25.0 109.41 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -86.42 147.56 44.7 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.096 -1.446 . . . . 25.0 107.096 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.94 -12.66 36.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 O-C-N 121.843 0.391 . . . . 25.0 112.861 176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -99.24 -1.49 39.01 Favored 'General case' 0 C--O 1.207 -1.159 0 C-N-CA 122.003 0.121 . . . . 25.0 110.801 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -91.21 152.52 20.51 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.756 -0.59 . . . . 25.0 111.406 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.56 143.72 30.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.732 0.777 . . . . 25.0 111.97 175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.84 131.9 54.54 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 176.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -157.03 175.88 13.5 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.077 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -114.72 160.05 19.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.166 0.508 . . . . 25.0 110.964 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.89 128.89 28.5 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.5 -14.48 57.89 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 119.055 -0.858 . . . . 25.0 114.051 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.99 155.64 40.58 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 118.01 0.905 . . . . 25.0 110.401 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mm -117.1 128.65 74.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.919 -1.141 . . . . 25.0 107.919 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -127.18 156.53 41.66 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.233 -0.654 . . . . 25.0 109.233 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -90.48 112.25 23.82 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.282 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -78.21 120.54 29.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.711 0 N-CA-C 108.722 -0.844 . . . . 25.0 108.722 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.2 mt -93.17 -45.19 7.99 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.319 -0.855 . . . . 25.0 109.014 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.12 170.87 20.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.644 -0.502 . . . . 25.0 109.644 172.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.3 mtm105 -123.04 152.23 41.17 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 58.75 36.79 25.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 123.564 1.65 . . . . 25.0 108.066 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.82 145.73 55.85 Favored 'General case' 0 C--O 1.212 -0.887 0 CA-C-N 112.822 -1.99 . . . . 25.0 111.457 -176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 58.08 14.68 2.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.086 0.954 . . . . 25.0 113.367 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.66 13.17 80.5 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 111.211 -0.756 . . . . 25.0 111.211 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -91.21 89.18 7.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.253 -1.388 . . . . 25.0 107.253 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.59 130.8 46.72 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.642 0.734 . . . . 25.0 110.375 -177.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.95 56.4 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-O 119.059 -0.856 . . . . 25.0 114.103 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -92.69 130.02 38.44 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.024 1.412 . . . . 25.0 108.349 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.7 127.67 56.13 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.105 -0.702 . . . . 25.0 109.105 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 tp -75.04 121.69 22.39 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.033 -1.469 . . . . 25.0 107.033 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.9 m -134.82 169.36 17.48 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.204 0.526 . . . . 25.0 110.767 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.72 129.75 49.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.261 -0.881 . . . . 25.0 108.692 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.2 139.08 19.89 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 56.17 27.14 11.15 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.3 14.84 79.03 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.848 -0.691 . . . . 25.0 112.937 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -120.3 150.35 40.86 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -113.58 147.28 38.31 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.64 171.75 42.24 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.379 -0.915 . . . . 25.0 112.916 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.0 pt -83.89 153.16 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.789 0.804 . . . . 25.0 109.818 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.96 139.01 20.42 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.27 116.35 4.47 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 117.667 -1.089 . . . . 25.0 111.105 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.56 63.45 Favored Glycine 0 C--O 1.221 -0.69 0 CA-C-N 116.127 -0.488 . . . . 25.0 112.965 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -65.81 -10.53 38.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.59 0.589 . . . . 25.0 112.59 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.13 10.59 15.01 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.037 -0.414 . . . . 25.0 110.872 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.48 153.3 38.11 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.918 0.866 . . . . 25.0 113.226 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -129.08 120.0 25.17 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.92 -1.036 . . . . 25.0 110.242 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 mm -68.0 126.56 28.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.5 mt -94.71 89.75 5.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.23 -35.36 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.209 -0.905 . . . . 25.0 111.383 -174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.9 2.39 70.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.047 -0.597 . . . . 25.0 114.03 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -97.53 -48.18 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.409 -0.589 . . . . 25.0 109.409 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -72.97 -38.85 66.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.617 0.722 . . . . 25.0 109.217 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -83.95 112.03 19.79 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.652 -1.24 . . . . 25.0 107.652 177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -66.77 -13.74 61.79 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.686 1.365 . . . . 25.0 114.686 -176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -161.1 156.21 20.61 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 108.849 -0.797 . . . . 25.0 108.849 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.53 163.88 37.25 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.092 -1.472 . . . . 25.0 111.142 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.81 74.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.742 0.645 . . . . 25.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.07 75.98 Favored Glycine 0 C--O 1.221 -0.657 0 N-CA-C 115.641 1.016 . . . . 25.0 115.641 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.2 p -114.67 -94.96 0.47 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.699 0.75 . . . . 25.0 112.451 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.29 -171.92 37.4 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 109.751 -1.34 . . . . 25.0 109.751 -176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.86 -172.51 51.8 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 121.11 -0.567 . . . . 25.0 111.851 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.1 m -150.63 165.89 31.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.808 -1.182 . . . . 25.0 107.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.54 -1.56 32.49 Favored Glycine 0 C--O 1.224 -0.481 0 CA-C-O 121.377 0.432 . . . . 25.0 112.559 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 62.7 m -145.73 163.73 34.03 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.856 -1.905 . . . . 25.0 105.856 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.82 41.95 2.38 Favored Glycine 0 N--CA 1.461 0.352 0 C-N-CA 121.03 -0.605 . . . . 25.0 112.176 -177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.59 175.31 0.07 Allowed 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.026 1.491 . . . . 25.0 115.026 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.9 p -133.86 174.88 9.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 106.653 -1.61 . . . . 25.0 106.653 -175.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 61.74 15.42 6.97 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.687 1.736 . . . . 25.0 115.687 170.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -84.96 89.47 7.6 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.11 -1.441 . . . . 25.0 107.11 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.68 144.71 50.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.939 -1.028 . . . . 25.0 112.198 -171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.35 144.8 50.61 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 113.652 0.982 . . . . 25.0 113.652 -175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -76.5 167.7 25.12 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 120.248 0.632 . . . . 25.0 111.507 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.58 159.48 27.87 Favored 'Trans proline' 0 C--N 1.348 0.538 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -102.23 152.28 38.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.899 -1.519 . . . . 25.0 106.899 175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.32 159.97 51.02 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 O-C-N 122.289 0.626 . . . . 25.0 111.134 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.37 177.55 7.77 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 120.241 0.627 . . . . 25.0 112.857 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.94 156.3 79.41 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.574 -1.269 . . . . 25.0 107.574 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.2 -170.97 0.71 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.352 2.035 . . . . 25.0 114.076 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 76.91 -5.16 2.23 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.73 2.012 . . . . 25.0 112.973 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.86 140.65 6.35 Favored Glycine 0 C--N 1.309 -0.949 0 N-CA-C 107.868 -2.093 . . . . 25.0 107.868 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.16 147.79 24.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.191 -1.781 . . . . 25.0 106.191 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.215 -0.762 0 CA-C-O 124.255 1.979 . . . . 25.0 112.609 -178.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 CA-C-O 125.135 2.52 . . . . 25.0 112.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.4 t -71.19 -29.59 65.36 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 112.327 -1.937 . . . . 25.0 110.567 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtt 55.79 47.87 19.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.755 0.822 . . . . 25.0 112.066 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -113.57 24.2 12.4 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.709 0.766 . . . . 25.0 109.269 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -135.29 165.58 25.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.8 -1.091 . . . . 25.0 110.669 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 70.7 mt -67.6 -39.12 84.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.455 -0.793 . . . . 25.0 110.149 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m120 52.71 51.44 16.0 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.277 0.843 . . . . 25.0 113.277 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -108.84 162.34 6.73 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.9 mt -98.24 141.65 30.89 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 121.761 -0.587 . . . . 25.0 110.847 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.96 144.53 45.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.04 -0.356 . . . . 25.0 110.04 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 ttmt -104.56 137.41 42.44 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.58 0.352 . . . . 25.0 111.535 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.13 129.11 37.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.916 -0.584 . . . . 25.0 110.45 174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -91.28 -17.39 26.04 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 122.141 -0.349 . . . . 25.0 110.504 175.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -143.26 164.85 29.09 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -70.99 155.64 40.59 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.183 -1.414 . . . . 25.0 107.183 173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -137.49 128.86 28.07 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 109.368 -0.605 . . . . 25.0 109.368 173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.1 t -105.68 124.81 60.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 103.542 -2.762 . . . . 25.0 103.542 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.89 122.9 23.25 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.968 -1.123 . . . . 25.0 107.968 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -110.73 -18.6 13.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.662 0.744 . . . . 25.0 109.016 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t -103.1 148.56 35.81 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.303 -1.369 . . . . 25.0 107.303 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.02 -12.97 35.62 Favored 'Trans proline' 0 C--O 1.239 0.536 0 N-CA-C 113.64 0.592 . . . . 25.0 113.64 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.57 -6.24 33.89 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-O 120.943 0.402 . . . . 25.0 110.624 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -88.09 148.25 24.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.395 0.617 . . . . 25.0 111.54 -173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.73 143.68 26.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.627 0.727 . . . . 25.0 112.14 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 p -109.44 131.25 55.24 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.79 -1.189 . . . . 25.0 107.79 176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.37 171.35 19.44 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.262 -0.881 . . . . 25.0 112.618 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -105.59 154.24 20.69 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.725 0.81 . . . . 25.0 109.224 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -53.6 130.66 36.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.332 -0.618 . . . . 25.0 109.332 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.88 -11.63 62.48 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.85 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.66 155.05 41.24 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 117.856 0.828 . . . . 25.0 109.846 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.06 127.48 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -125.18 154.74 41.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.299 -0.63 . . . . 25.0 109.299 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.5 m -89.24 113.2 24.4 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.03 -0.987 . . . . 25.0 108.818 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.7 t -77.65 121.62 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.203 -1.036 . . . . 25.0 108.203 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -94.83 -47.69 6.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -151.67 173.09 15.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.971 -0.751 . . . . 25.0 108.971 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -128.4 150.34 50.16 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.89 36.24 21.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 123.663 1.697 . . . . 25.0 108.049 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -64.33 145.97 55.17 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 112.69 -2.05 . . . . 25.0 111.381 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.59 13.89 2.8 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.913 0.885 . . . . 25.0 113.264 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 12.42 81.51 Favored Glycine 0 C--O 1.229 -0.212 0 N-CA-C 111.143 -0.783 . . . . 25.0 111.143 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.3 mt -89.64 91.65 8.75 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -56.5 129.59 41.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.536 0.684 . . . . 25.0 110.647 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.23 -14.86 56.56 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-O 119.289 -0.729 . . . . 25.0 114.49 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -90.15 130.04 36.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.652 1.226 . . . . 25.0 108.681 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -113.48 124.29 52.05 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.696 -0.854 . . . . 25.0 108.696 -177.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.4 tp -72.63 122.46 21.44 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.954 -1.498 . . . . 25.0 106.954 178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.9 m -134.25 170.24 16.0 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.169 0.509 . . . . 25.0 110.547 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.1 129.31 46.4 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.04 -1.096 . . . . 25.0 108.04 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.55 133.61 20.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.5 m170 55.3 28.91 12.0 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.241 0.616 . . . . 25.0 112.175 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.87 8.83 86.73 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.04 -0.6 . . . . 25.0 114.496 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 137.07 52.04 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 104.806 -2.294 . . . . 25.0 104.806 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -102.77 142.76 33.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.705 -0.85 . . . . 25.0 108.705 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.07 169.56 40.93 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.547 -0.835 . . . . 25.0 113.538 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 pt -79.27 154.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.702 0.763 . . . . 25.0 110.375 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -142.94 139.62 17.11 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.077 -1.082 . . . . 25.0 108.077 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.59 121.36 7.87 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 117.255 -1.363 . . . . 25.0 111.851 176.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -25.01 62.38 Favored Glycine 0 C--O 1.225 -0.433 0 CA-C-N 116.385 -0.371 . . . . 25.0 112.807 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -14.77 55.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.989 0.737 . . . . 25.0 112.989 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.34 9.05 16.83 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.204 -0.31 . . . . 25.0 111.283 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.02 152.91 38.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 113.737 1.014 . . . . 25.0 113.737 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -127.84 119.97 26.79 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.891 -1.049 . . . . 25.0 109.793 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.3 126.56 29.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.932 -1.507 . . . . 25.0 106.932 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -89.3 70.7 8.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.497 0.665 . . . . 25.0 111.52 -177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.38 -24.16 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 173.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.82 -81.23 1.11 Allowed Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 114.975 -1.012 . . . . 25.0 111.43 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.86 163.0 39.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -159.6 45.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.134 -1.062 . . . . 25.0 108.134 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 57.48 6.39 0.4 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 117.888 2.551 . . . . 25.0 117.888 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -69.43 111.72 5.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.352 -0.842 . . . . 25.0 110.175 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -63.13 149.42 90.94 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.144 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.94 152.98 63.7 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 118.256 -0.696 . . . . 25.0 112.851 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -114.75 -9.3 12.56 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 112.661 0.615 . . . . 25.0 112.661 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.6 10.8 71.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 115.351 0.9 . . . . 25.0 115.351 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 t -77.23 67.2 3.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.83 -40.81 2.1 Favored Glycine 0 C--O 1.218 -0.846 0 N-CA-C 116.874 1.51 . . . . 25.0 116.874 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.25 0.84 79.7 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 117.466 0.633 . . . . 25.0 113.48 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m 57.25 36.83 27.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.75 153.48 23.75 Favored Glycine 0 C--O 1.23 -0.1 0 N-CA-C 109.105 -1.598 . . . . 25.0 109.105 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 m -152.93 -28.32 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.754 1.39 . . . . 25.0 114.754 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.02 24.48 77.08 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.874 -0.679 . . . . 25.0 114.151 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.56 115.83 21.71 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 p 46.62 70.81 0.35 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 124.262 0.977 . . . . 25.0 113.273 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t0 69.01 175.27 0.28 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.921 -1.49 . . . . 25.0 111.458 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.43 63.0 1.11 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.006 -1.109 . . . . 25.0 108.006 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.96 133.98 55.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.55 -1.204 . . . . 25.0 109.895 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.21 149.67 69.81 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 113.61 0.967 . . . . 25.0 113.61 -172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -69.78 165.57 30.55 Favored 'Trans proline' 0 C--N 1.35 0.619 0 O-C-N 121.831 0.385 . . . . 25.0 111.176 174.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.89 162.6 41.5 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 117.972 -0.885 . . . . 25.0 113.473 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -95.83 152.32 38.97 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 106.838 -1.542 . . . . 25.0 106.838 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.96 162.7 38.68 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.107 -0.795 . . . . 25.0 110.308 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.16 171.98 16.49 Favored 'Trans proline' 0 C--N 1.346 0.443 0 N-CA-C 113.52 0.546 . . . . 25.0 113.52 -176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.5 mt -133.93 158.42 75.46 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.337 -0.847 . . . . 25.0 110.737 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -78.36 -160.25 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.565 2.843 . . . . 25.0 109.973 171.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 66.94 20.7 10.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.45 1.1 . . . . 25.0 111.449 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -149.91 156.21 26.64 Favored Glycine 0 N--CA 1.45 -0.396 0 N-CA-C 108.073 -2.011 . . . . 25.0 108.073 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.3 mm-40 -80.07 135.45 36.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.666 0.746 . . . . 25.0 110.617 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.1 t . . . . . 0 C--O 1.214 -0.803 0 CA-C-O 125.474 2.559 . . . . 25.0 110.978 179.332 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.012 0 CA-C-O 124.941 2.412 . . . . 25.0 113.409 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -84.78 -21.04 30.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 112.825 -1.687 . . . . 25.0 109.695 178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.8 ttt -86.92 148.95 25.13 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.412 -0.958 . . . . 25.0 108.412 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -77.55 122.97 25.99 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 103.313 -2.847 . . . . 25.0 103.313 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 61.25 165.01 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.186 1.551 . . . . 25.0 115.186 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.59 -41.28 65.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.124 -0.944 . . . . 25.0 112.282 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 53.47 51.54 15.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -106.19 159.61 6.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 N-CA-C 106.632 -1.618 . . . . 25.0 106.632 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.85 144.99 25.72 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.651 -0.656 . . . . 25.0 109.9 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.78 142.89 36.7 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.329 -0.249 . . . . 25.0 110.329 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -104.79 138.8 40.52 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.72 0.408 . . . . 25.0 111.835 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.83 122.97 24.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.686 -0.688 . . . . 25.0 110.817 174.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.509 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.4 mm? -87.46 -17.57 31.88 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 109.437 -0.579 . . . . 25.0 109.437 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -143.6 159.49 42.36 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.158 -2.164 . . . . 25.0 105.158 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -78.51 164.97 24.27 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.294 -1.002 . . . . 25.0 108.294 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -141.3 133.31 27.68 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.0 t -106.13 124.72 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 103.867 -2.642 . . . . 25.0 103.867 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.49 123.3 25.22 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.326 -0.99 . . . . 25.0 108.326 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -110.48 -24.76 10.4 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.6 t -97.17 147.91 33.63 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 107.857 -1.164 . . . . 25.0 107.857 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -67.69 -11.75 33.16 Favored 'Trans proline' 0 CA--C 1.532 0.391 0 N-CA-C 113.493 0.536 . . . . 25.0 113.493 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.49 -3.75 42.75 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 122.215 0.206 . . . . 25.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -93.06 147.33 22.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.628 -0.67 . . . . 25.0 112.576 -172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -92.18 142.95 26.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.698 0.761 . . . . 25.0 111.393 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.83 131.53 54.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.84 -1.541 . . . . 25.0 106.84 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -153.48 170.47 20.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.182 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -106.1 156.18 18.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.383 0.611 . . . . 25.0 109.373 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -56.04 130.62 44.72 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.54 -11.58 61.35 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-O 119.259 -0.745 . . . . 25.0 113.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -72.18 157.95 36.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.692 0.746 . . . . 25.0 110.343 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.6 mm -119.0 129.44 75.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.259 -0.645 . . . . 25.0 109.259 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -127.07 156.64 41.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 25.0 109.701 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.3 m -91.57 112.79 24.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.142 -0.936 . . . . 25.0 109.606 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 8' ' ' VAL . 37.1 t -78.69 124.74 37.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.7 mt -98.59 -44.73 6.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.307 -0.86 . . . . 25.0 110.474 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -153.26 171.91 17.81 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.399 -0.593 . . . . 25.0 109.399 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mtm180 -126.45 150.83 48.43 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 106.897 -1.52 . . . . 25.0 106.897 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 58.85 35.28 24.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.666 1.698 . . . . 25.0 107.919 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -62.54 145.04 55.32 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 112.55 -2.113 . . . . 25.0 111.26 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 57.64 14.94 2.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.12 0.968 . . . . 25.0 113.561 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.78 13.57 79.47 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 111.177 -0.769 . . . . 25.0 111.177 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.35 92.11 8.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -57.33 129.51 42.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.414 0.626 . . . . 25.0 110.894 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.94 -14.56 56.62 Favored Glycine 0 C--O 1.238 0.355 0 C-N-CA 121.087 -0.578 . . . . 25.0 114.228 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -90.87 129.96 36.86 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 118.081 0.94 . . . . 25.0 108.573 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -116.07 126.09 53.29 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.931 -0.766 . . . . 25.0 108.931 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.44 122.86 22.79 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.064 -1.458 . . . . 25.0 107.064 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.4 m -134.64 171.59 14.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.032 0.444 . . . . 25.0 109.914 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.24 130.32 46.1 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.835 -1.172 . . . . 25.0 107.835 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.27 130.39 19.58 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.527 -1.286 . . . . 25.0 107.527 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m170 54.64 30.74 13.85 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.251 0.621 . . . . 25.0 112.102 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.21 7.15 88.8 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 114.986 0.754 . . . . 25.0 114.986 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.03 137.0 52.08 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.28 143.69 32.33 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.474 -0.935 . . . . 25.0 108.474 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.84 170.34 41.35 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.661 -0.78 . . . . 25.0 112.815 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.8 pt -81.48 155.85 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.608 0.718 . . . . 25.0 110.296 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.5 t -141.82 140.04 19.31 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.92 113.45 3.57 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 118.114 -0.79 . . . . 25.0 111.061 175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.18 -23.15 57.12 Favored Glycine 0 C--O 1.219 -0.831 0 O-C-N 122.098 -0.376 . . . . 25.0 112.649 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -64.95 -12.87 54.64 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.091 0.775 . . . . 25.0 113.091 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.03 9.99 13.82 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.0 -0.438 . . . . 25.0 110.876 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 tp -127.2 144.78 50.97 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.978 0.732 . . . . 25.0 112.978 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.509 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.2 ttpt -121.05 120.92 36.74 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 116.091 -0.504 . . . . 25.0 111.573 176.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.31 124.35 23.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.338 -0.846 . . . . 25.0 108.831 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.3 mt -91.48 79.21 5.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.607 0.718 . . . . 25.0 109.966 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.5 t -67.59 129.92 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.492 -1.67 . . . . 25.0 106.492 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.32 41.29 1.12 Allowed Glycine 0 C--O 1.221 -0.667 0 CA-C-O 121.621 0.567 . . . . 25.0 114.391 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 27.6 ttt -153.33 -37.58 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.947 0.899 . . . . 25.0 108.726 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -114.67 -0.24 13.67 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 116.673 2.101 . . . . 25.0 116.673 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.36 -47.97 83.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.41 1.005 . . . . 25.0 111.491 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -166.91 -58.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.82 -0.627 . . . . 25.0 111.447 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -151.64 157.4 34.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 106.212 -1.773 . . . . 25.0 106.212 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.61 -7.06 19.07 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 117.929 -0.914 . . . . 25.0 112.898 173.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.05 110.2 20.08 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.691 0.281 . . . . 25.0 110.304 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.0 162.85 11.49 Favored Glycine 0 C--O 1.219 -0.813 0 N-CA-C 110.642 -0.983 . . . . 25.0 110.642 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 p -116.3 -45.11 2.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.217 0.508 . . . . 25.0 112.055 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.2 93.56 0.55 Allowed Glycine 0 C--O 1.224 -0.478 0 C-N-CA 121.0 -0.619 . . . . 25.0 112.229 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.34 -164.76 31.13 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.943 -0.646 . . . . 25.0 113.016 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.0 p -92.33 -178.92 5.08 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.95 -1.13 . . . . 25.0 107.95 176.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.24 171.33 38.95 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.456 -1.857 . . . . 25.0 108.456 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.3 t -79.06 147.72 32.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.652 0.726 . . . . 25.0 109.33 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.27 156.22 23.33 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 107.897 -2.081 . . . . 25.0 107.897 173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.6 mt -126.05 -7.19 6.59 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.421 0.611 . . . . 25.0 111.1 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.8 p -142.6 161.25 38.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -80.62 153.6 27.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.601 -0.888 . . . . 25.0 108.601 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -146.65 118.37 8.07 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.912 -1.514 . . . . 25.0 106.912 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.4 mt -79.17 131.63 36.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.252 0.549 . . . . 25.0 111.225 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.62 146.07 56.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.706 -0.679 . . . . 25.0 111.825 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.89 166.04 31.1 Favored 'Trans proline' 0 C--O 1.243 0.741 0 O-C-N 121.736 0.335 . . . . 25.0 111.408 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.71 156.29 57.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 117.532 -1.178 . . . . 25.0 113.685 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -87.63 152.25 51.52 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.45 162.95 38.56 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 118.166 -0.756 . . . . 25.0 110.197 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.73 170.11 20.79 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 118.245 -0.703 . . . . 25.0 113.366 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.5 mt -133.95 159.14 73.56 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.235 -0.893 . . . . 25.0 110.665 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.82 177.31 8.26 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 109.783 -0.891 . . . . 25.0 109.783 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 63.62 5.99 2.42 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.624 1.342 . . . . 25.0 114.624 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -93.7 -8.18 60.97 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 114.878 -1.056 . . . . 25.0 111.427 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 27.66 58.14 0.1 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.906 1.817 . . . . 25.0 115.906 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.563 1.48 0 CA-C-O 125.945 2.783 . . . . 25.0 113.389 -176.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.844 0 CA-C-O 124.562 2.201 . . . . 25.0 112.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t 58.05 14.41 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 111.161 -2.519 . . . . 25.0 114.122 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.9 ttt -81.66 64.24 6.28 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.719 1.007 . . . . 25.0 113.719 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -80.66 133.3 35.69 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.57 -1.27 . . . . 25.0 107.57 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 63.57 163.81 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 116.22 1.934 . . . . 25.0 116.22 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -72.77 -41.31 65.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.973 -1.012 . . . . 25.0 111.498 -175.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 53.17 49.83 19.09 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.781 1.03 . . . . 25.0 113.781 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -104.49 158.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.9 mt -95.92 145.85 25.06 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 121.678 -0.639 . . . . 25.0 110.458 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.41 37.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.132 -0.355 . . . . 25.0 110.336 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -102.22 137.19 40.81 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.828 0.451 . . . . 25.0 110.897 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.64 129.29 37.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.948 -0.569 . . . . 25.0 109.765 175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -90.32 -17.55 27.14 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.124 0.488 . . . . 25.0 109.711 176.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -142.62 166.14 25.48 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.042 -1.836 . . . . 25.0 106.042 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.88 170.47 16.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 173.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -147.37 130.44 16.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.8 -0.815 . . . . 25.0 108.8 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -104.17 122.73 57.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 103.794 -2.669 . . . . 25.0 103.794 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.08 122.92 21.76 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.719 -0.845 . . . . 25.0 108.719 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -108.09 -21.14 12.92 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 25.0 109.445 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.8 t -106.19 146.45 32.98 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 106.701 -1.592 . . . . 25.0 106.701 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.45 -11.05 30.84 Favored 'Trans proline' 0 C--N 1.343 0.274 0 N-CA-C 113.576 0.568 . . . . 25.0 113.576 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -92.29 -6.22 50.79 Favored 'General case' 0 C--O 1.2 -1.527 0 O-C-N 122.136 -0.352 . . . . 25.0 110.622 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -93.17 151.99 19.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.126 0.489 . . . . 25.0 112.163 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -96.86 143.93 27.29 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.648 0.737 . . . . 25.0 112.099 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 p -107.11 133.55 51.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.799 -1.556 . . . . 25.0 106.799 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -156.1 171.06 20.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.763 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -104.06 157.05 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.488 -0.778 . . . . 25.0 109.725 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -57.03 132.44 52.89 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.088 -1.079 . . . . 25.0 108.088 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 -11.24 65.79 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 119.186 -0.786 . . . . 25.0 114.23 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -72.03 158.77 35.36 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 117.665 0.733 . . . . 25.0 110.037 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.7 129.53 73.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.0 ptp -128.07 154.23 45.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.323 -0.621 . . . . 25.0 109.323 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -90.53 112.99 24.87 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.029 -0.987 . . . . 25.0 109.198 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.9 t -78.31 118.78 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.633 -0.877 . . . . 25.0 108.633 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 84.4 mt -91.25 -44.95 8.9 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.783 -0.644 . . . . 25.0 109.297 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 14.6 pt-20 -153.93 171.98 18.15 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.173 -0.677 . . . . 25.0 109.173 172.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 78.0 mtm-85 -124.63 152.33 43.74 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 105.984 -1.858 . . . . 25.0 105.984 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 58.59 37.52 25.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 123.851 1.786 . . . . 25.0 107.918 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -66.22 146.31 54.77 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 112.504 -2.134 . . . . 25.0 110.836 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 56.62 20.34 4.9 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.967 0.729 . . . . 25.0 112.967 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.15 11.17 85.62 Favored Glycine 0 C--O 1.228 -0.237 0 C-N-CA 121.021 -0.609 . . . . 25.0 112.058 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.14 86.72 6.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.119 -1.067 . . . . 25.0 108.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.11 130.86 43.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.744 0.783 . . . . 25.0 110.328 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.5 -15.21 57.56 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-O 119.164 -0.798 . . . . 25.0 114.248 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -94.22 129.95 40.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 118.703 1.251 . . . . 25.0 108.815 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -113.93 127.37 55.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.243 -0.651 . . . . 25.0 109.243 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 50.0 tp -74.93 120.44 20.47 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 106.95 -1.5 . . . . 25.0 106.95 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 m -133.45 169.59 16.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.282 0.563 . . . . 25.0 110.772 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.47 129.0 46.67 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.08 130.19 20.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.09 -1.078 . . . . 25.0 108.09 -176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.7 m170 56.23 28.19 12.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.34 0.656 . . . . 25.0 111.882 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.16 8.31 87.91 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 114.511 0.564 . . . . 25.0 114.511 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -113.58 137.69 51.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 105.634 -1.987 . . . . 25.0 105.634 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.75 150.19 24.3 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.99 170.74 38.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.609 -0.805 . . . . 25.0 113.7 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -79.72 154.51 4.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.495 0.664 . . . . 25.0 109.511 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.6 t -142.97 139.65 17.11 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.38 119.01 6.03 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 117.742 -1.039 . . . . 25.0 111.264 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.83 -22.87 62.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 111.686 -0.566 . . . . 25.0 111.686 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -62.75 -14.92 50.44 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.049 0.759 . . . . 25.0 113.049 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -115.74 9.67 15.22 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.862 -0.524 . . . . 25.0 111.876 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -120.03 151.16 39.41 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HB2' HD21 ' A' ' 13' ' ' LEU . 31.5 ttpt -125.22 119.87 29.69 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.817 -1.083 . . . . 25.0 109.298 172.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mm -68.23 128.83 32.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.1 mt -93.87 84.57 4.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.175 -1.417 . . . . 25.0 107.175 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -68.49 -36.74 76.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.656 -0.702 . . . . 25.0 110.321 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.08 -40.27 2.81 Favored Glycine 0 C--O 1.222 -0.654 0 CA-C-N 116.435 -0.348 . . . . 25.0 112.612 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mtp -69.78 -24.97 63.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.977 0.418 . . . . 25.0 111.112 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -159.11 164.97 34.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -142.28 164.43 30.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.298 -1.371 . . . . 25.0 107.298 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -113.97 25.69 10.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -136.41 147.87 61.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 173.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.06 -10.99 19.65 Favored 'Trans proline' 0 C--O 1.22 -0.412 0 N-CA-C 114.242 0.824 . . . . 25.0 114.242 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.899 -0.778 . . . . 25.0 108.899 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.15 -157.67 11.58 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 108.288 -1.925 . . . . 25.0 108.288 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 p -74.26 146.98 42.81 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.28 -48.5 0.39 Allowed Glycine 0 C--O 1.222 -0.624 0 N-CA-C 109.685 -1.366 . . . . 25.0 109.685 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.74 -176.84 49.39 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 108.436 -1.865 . . . . 25.0 108.436 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.3 m -60.13 140.49 56.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.891 0.346 . . . . 25.0 110.637 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.91 15.28 59.69 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.416 -0.421 . . . . 25.0 112.275 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.7 p -85.61 150.78 24.4 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.805 0.442 . . . . 25.0 109.894 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.38 -164.19 23.49 Favored Glycine 0 CA--C 1.508 -0.378 0 N-CA-C 108.72 -1.752 . . . . 25.0 108.72 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 98.8 mt -133.12 148.21 52.13 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.349 -1.722 . . . . 25.0 106.349 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 149.87 38.28 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -99.37 109.67 22.24 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.347 -0.612 . . . . 25.0 109.347 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -144.01 98.71 3.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.3 140.95 58.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.409 -0.589 . . . . 25.0 109.409 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.55 148.67 42.59 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 114.085 1.142 . . . . 25.0 114.085 -172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.71 165.84 31.27 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 O-C-N 121.751 0.342 . . . . 25.0 112.128 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.42 162.06 43.78 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 114.69 0.996 . . . . 25.0 114.69 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -85.69 153.72 58.33 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.133 -0.94 . . . . 25.0 108.675 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.59 160.49 49.57 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 117.775 -1.016 . . . . 25.0 109.477 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.54 175.77 10.21 Favored 'Trans proline' 0 C--N 1.347 0.449 0 N-CA-C 113.222 0.432 . . . . 25.0 113.222 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -132.8 153.61 81.12 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -80.2 179.32 6.28 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.826 2.351 . . . . 25.0 112.339 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -88.55 11.25 17.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.668 0.747 . . . . 25.0 111.021 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.09 176.81 25.51 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.285 -0.871 . . . . 25.0 112.59 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -137.83 165.43 26.48 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.61 -0.885 . . . . 25.0 108.61 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.213 -0.857 0 CA-C-O 124.233 1.968 . . . . 25.0 112.667 176.648 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.888 0 CA-C-O 125.245 2.581 . . . . 25.0 113.23 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -88.04 57.13 4.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 112.626 -1.787 . . . . 25.0 111.629 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -74.45 82.63 1.96 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.574 0.702 . . . . 25.0 109.598 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -105.81 7.07 32.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.656 -0.702 . . . . 25.0 109.144 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.94 171.51 14.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.936 -1.029 . . . . 25.0 111.061 -173.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.77 -39.7 91.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 25.0 110.381 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 m120 52.86 52.45 13.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.77 0.828 . . . . 25.0 113.167 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG21 HG23 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -109.53 164.57 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.472 -0.936 . . . . 25.0 108.472 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.2 mt -100.66 141.21 33.84 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.94 -0.475 . . . . 25.0 110.29 176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.03 146.69 47.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.444 -0.344 . . . . 25.0 110.083 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -107.06 138.73 42.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.804 0.442 . . . . 25.0 111.576 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.55 123.94 24.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.868 -0.605 . . . . 25.0 110.178 173.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -87.1 -19.22 28.86 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 109.426 -0.583 . . . . 25.0 109.426 176.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -143.29 162.09 36.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 -177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.84 169.04 18.85 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.388 -0.967 . . . . 25.0 108.388 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -145.5 136.35 24.53 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.5 t -109.27 125.11 66.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 104.259 -2.497 . . . . 25.0 104.259 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.6 124.78 27.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.183 -0.917 . . . . 25.0 108.553 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -107.22 -24.18 12.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.414 0.626 . . . . 25.0 109.83 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.9 m -107.45 153.63 41.17 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.619 -0.719 . . . . 25.0 109.082 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.4 -13.82 36.21 Favored 'Trans proline' 0 C--N 1.342 0.226 0 N-CA-C 113.356 0.483 . . . . 25.0 113.356 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.6 -4.97 49.84 Favored 'General case' 0 C--O 1.202 -1.398 0 N-CA-C 110.405 -0.22 . . . . 25.0 110.405 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -95.08 148.64 22.14 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.888 0.699 . . . . 25.0 112.888 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.8 144.96 25.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 25.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.378 -1.341 . . . . 25.0 107.378 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -152.03 171.71 17.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.46 -0.791 . . . . 25.0 111.945 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -103.37 155.56 18.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.199 0.6 . . . . 25.0 109.673 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.04 131.61 47.9 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.546 -0.909 . . . . 25.0 108.546 172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.17 -13.83 60.05 Favored Glycine 0 N--CA 1.452 -0.289 0 CA-C-O 119.265 -0.742 . . . . 25.0 114.047 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -70.68 156.07 39.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.676 0.738 . . . . 25.0 110.435 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.85 130.34 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.655 -0.869 . . . . 25.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -127.31 157.68 39.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.193 -0.669 . . . . 25.0 109.193 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.2 m -90.99 114.77 27.37 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.7 t -80.95 124.85 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.7 mt -95.44 -48.78 5.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.523 -0.917 . . . . 25.0 108.523 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.0 pt-20 -150.57 171.93 16.3 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -124.03 151.33 43.88 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 59.12 36.38 24.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.388 1.566 . . . . 25.0 108.613 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -64.18 146.7 53.83 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 112.87 -1.968 . . . . 25.0 111.387 -176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 58.19 13.58 2.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.072 0.949 . . . . 25.0 113.455 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.58 82.46 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 111.058 -0.817 . . . . 25.0 111.058 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -88.17 87.15 7.23 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.522 -1.658 . . . . 25.0 106.522 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 133.95 56.55 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.437 0.637 . . . . 25.0 109.799 -176.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.4 -16.63 48.1 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.852 -0.689 . . . . 25.0 113.762 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -93.68 129.88 39.83 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 118.283 1.041 . . . . 25.0 108.464 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -116.8 127.76 54.63 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.861 -0.525 . . . . 25.0 109.669 -175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 57.3 tp -74.13 121.57 21.36 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.94 -1.133 . . . . 25.0 107.94 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.4 m -134.98 170.19 16.27 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.184 0.516 . . . . 25.0 110.569 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.12 127.78 45.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 177.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.8 137.01 22.29 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 -176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.9 m170 56.0 30.6 16.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.193 0.597 . . . . 25.0 112.157 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.58 13.48 77.82 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.97 -0.633 . . . . 25.0 113.682 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -120.38 139.52 52.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.118 -1.808 . . . . 25.0 106.118 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.03 149.95 24.7 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.62 172.0 40.05 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.62 -0.8 . . . . 25.0 112.574 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.5 pt -82.6 156.39 3.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.722 0.772 . . . . 25.0 109.865 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -141.79 140.07 19.39 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.117 -1.068 . . . . 25.0 108.117 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.19 111.92 3.02 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 117.901 -0.933 . . . . 25.0 110.856 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.22 -22.22 57.95 Favored Glycine 0 C--O 1.221 -0.666 0 CA-C-O 121.213 0.34 . . . . 25.0 112.47 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -64.76 -15.07 61.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -114.68 9.81 16.54 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.996 -0.44 . . . . 25.0 111.042 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 tp -124.75 144.08 50.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.479 0.657 . . . . 25.0 112.642 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.0 ttmt -120.97 120.01 34.21 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-N 116.013 -0.539 . . . . 25.0 111.433 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 66' ' ' VAL . 48.3 mm -69.45 126.97 30.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 107.074 -1.454 . . . . 25.0 107.074 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -94.4 17.52 12.82 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.755 0.312 . . . . 25.0 111.831 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.536 ' H ' HG22 ' A' ' 64' ' ' ILE . 9.8 t 68.05 -44.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.653 1.581 . . . . 25.0 115.015 177.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.53 -129.04 6.1 Favored Glycine 0 C--O 1.219 -0.787 0 N-CA-C 111.308 -0.717 . . . . 25.0 111.308 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 28.8 ptm -75.13 3.12 9.18 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -94.64 117.44 30.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.19 0.441 . . . . 25.0 112.19 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.39 169.7 17.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -136.11 -27.03 1.12 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.391 0.515 . . . . 25.0 112.391 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -158.61 144.92 12.59 Favored Pre-proline 0 N--CA 1.472 0.675 0 N-CA-C 109.099 -0.704 . . . . 25.0 109.099 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.34 8.55 4.1 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 120.91 1.073 . . . . 25.0 114.146 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.94 149.99 35.24 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.209 -0.663 . . . . 25.0 109.209 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.53 -171.37 39.37 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 115.908 -0.587 . . . . 25.0 111.681 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.6 m -147.08 158.62 43.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.73 -3.74 86.78 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 121.171 -0.537 . . . . 25.0 114.182 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 51.5 4.31 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 114.302 0.481 . . . . 25.0 114.302 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -79.46 152.94 29.98 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.94 -152.54 27.24 Favored Glycine 0 C--O 1.228 -0.253 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 55.8 m -148.74 158.59 44.26 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.85 -178.86 39.14 Favored Glycine 0 C--O 1.229 -0.182 0 N-CA-C 110.292 -1.123 . . . . 25.0 110.292 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.9 mt -119.63 163.7 16.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.771 -0.826 . . . . 25.0 108.771 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.2 m -72.8 -28.06 62.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.876 -1.157 . . . . 25.0 107.876 174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.57 90.31 3.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.588 -1.187 . . . . 25.0 110.835 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -133.89 111.13 10.21 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.8 126.32 33.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.089 0.471 . . . . 25.0 110.208 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.17 144.5 78.9 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.892 -0.595 . . . . 25.0 110.26 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.14 165.04 32.9 Favored 'Trans proline' 0 C--O 1.241 0.671 0 CA-C-N 117.917 0.292 . . . . 25.0 112.31 178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.92 158.17 53.28 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 118.247 -0.702 . . . . 25.0 113.557 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -92.36 151.94 41.88 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 107.424 -1.325 . . . . 25.0 107.424 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.28 161.19 46.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 118.208 -0.728 . . . . 25.0 110.623 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.74 173.38 14.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 N-CA-C 113.693 0.613 . . . . 25.0 113.693 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 mt -133.84 155.86 79.91 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.787 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -79.76 171.4 15.63 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.182 2.588 . . . . 25.0 114.091 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -86.94 30.78 0.73 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.479 0.918 . . . . 25.0 113.479 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.14 158.96 17.5 Favored Glycine 0 C--O 1.227 -0.327 0 N-CA-C 117.455 1.742 . . . . 25.0 117.455 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -96.84 46.71 1.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 122.226 1.012 . . . . 25.0 109.836 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 124.495 2.093 . . . . 25.0 113.397 -176.322 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.118 0 CA-C-O 123.486 1.603 . . . . 25.0 113.334 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 t 75.05 147.85 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 111.061 -2.57 . . . . 25.0 111.713 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.7 mmt -120.23 24.41 10.44 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.935 -1.505 . . . . 25.0 106.935 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -146.32 150.06 35.02 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.392 -1.336 . . . . 25.0 107.392 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 62.89 166.24 0.12 Allowed 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 117.773 2.509 . . . . 25.0 117.773 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -75.32 -34.97 61.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.291 -1.322 . . . . 25.0 112.169 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 54.22 43.16 31.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -102.45 163.26 3.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.41 145.85 27.72 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.03 -0.419 . . . . 25.0 109.932 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.11 145.97 40.11 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.019 -0.363 . . . . 25.0 110.019 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -103.42 137.61 41.29 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.594 0.358 . . . . 25.0 111.416 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.42 128.81 36.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.5 mm? -92.71 -14.15 28.39 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.446 -0.575 . . . . 25.0 109.446 175.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -144.37 160.92 40.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.637 -0.71 . . . . 25.0 109.699 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -71.47 156.38 39.52 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -141.03 137.27 32.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.847 0.356 . . . . 25.0 110.408 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -112.53 127.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.944 -2.613 . . . . 25.0 103.944 176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.36 123.47 26.01 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -106.5 -33.94 7.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.896 -0.779 . . . . 25.0 108.896 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 t -89.89 148.06 38.85 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 107.754 -1.202 . . . . 25.0 107.754 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -67.31 -13.05 38.08 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 O-C-N 121.821 0.379 . . . . 25.0 112.514 175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -5.5 53.25 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-O 119.532 -0.27 . . . . 25.0 110.596 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -94.35 153.64 17.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.779 0.718 . . . . 25.0 112.717 -172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.7 mt -99.27 144.35 28.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.532 0.682 . . . . 25.0 111.701 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.5 p -108.31 133.3 52.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.03 -1.47 . . . . 25.0 107.03 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' HG13 ' A' ' 57' ' ' VAL . 21.8 p90 -155.36 171.8 19.27 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.944 0.72 . . . . 25.0 112.944 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.7 tpt85 -105.83 151.07 24.97 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.829 0.851 . . . . 25.0 109.541 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.01 126.02 22.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.223 -0.899 . . . . 25.0 109.187 172.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.99 -11.55 55.91 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-O 119.176 -0.791 . . . . 25.0 113.726 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -70.86 157.44 38.13 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.829 0.814 . . . . 25.0 110.596 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.5 mm -116.82 127.07 74.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.585 -0.894 . . . . 25.0 108.585 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.4 ptp -126.85 156.3 41.56 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.366 -0.605 . . . . 25.0 109.366 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -90.36 113.49 25.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.366 -0.834 . . . . 25.0 109.061 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HB ' HG22 ' A' ' 8' ' ' VAL . 43.4 t -77.51 124.74 36.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 N-CA-C 108.244 -1.021 . . . . 25.0 108.244 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.4 mt -98.79 -45.73 5.91 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.876 -1.056 . . . . 25.0 109.287 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -154.64 173.83 15.82 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 77.6 mtm-85 -126.35 151.88 47.0 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.144 -1.798 . . . . 25.0 106.144 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.1 35.95 23.96 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.874 1.797 . . . . 25.0 108.086 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.69 145.78 55.69 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.477 -2.147 . . . . 25.0 111.39 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 57.86 14.6 2.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.043 0.937 . . . . 25.0 112.819 -178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.26 81.97 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.397 -0.681 . . . . 25.0 111.397 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.45 92.6 9.19 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.07 -1.085 . . . . 25.0 108.07 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.6 130.75 46.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.642 0.734 . . . . 25.0 110.896 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.33 -14.31 54.87 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.786 -0.643 . . . . 25.0 114.358 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -90.92 130.02 36.89 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 118.457 1.129 . . . . 25.0 109.012 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -111.81 127.36 55.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.0 tp -74.86 122.74 23.85 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.9 m -134.22 169.78 16.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.153 0.501 . . . . 25.0 110.352 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.3 130.93 50.42 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.066 -1.087 . . . . 25.0 108.066 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.09 135.75 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.772 -1.566 . . . . 25.0 106.772 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.0 m170 56.15 29.98 15.63 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 25.0 112.471 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.74 12.94 80.75 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.014 -0.612 . . . . 25.0 113.668 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -118.43 141.66 48.33 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.355 -2.091 . . . . 25.0 105.355 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -106.79 147.79 29.26 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.82 170.49 40.89 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.405 -0.902 . . . . 25.0 113.186 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.3 pt -81.15 155.06 4.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.65 0.738 . . . . 25.0 109.389 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 26' ' ' PHE . 85.4 t -142.77 140.17 18.02 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 107.654 -1.239 . . . . 25.0 107.654 -178.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.83 118.4 5.64 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 117.125 -1.45 . . . . 25.0 111.164 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.83 -23.26 65.31 Favored Glycine 0 C--O 1.222 -0.611 0 N-CA-C 112.001 -0.44 . . . . 25.0 112.001 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -63.99 -11.02 25.06 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.834 0.679 . . . . 25.0 112.834 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -117.8 10.41 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 121.995 -0.441 . . . . 25.0 111.824 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.32 154.87 35.84 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.7 ttpt -129.7 120.2 24.75 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.876 -1.056 . . . . 25.0 110.635 171.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.427 HG23 HG21 ' A' ' 8' ' ' VAL . 39.9 mm -64.99 127.13 25.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.1 98.55 10.14 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.245 -1.02 . . . . 25.0 108.245 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.65 -31.24 51.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.33 -0.85 . . . . 25.0 110.784 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.22 166.33 41.93 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 109.073 -1.611 . . . . 25.0 109.073 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 6.5 tmm? 69.36 -54.26 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.254 1.422 . . . . 25.0 111.082 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -74.93 170.3 16.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.014 -1.476 . . . . 25.0 107.014 170.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 56.4 34.08 23.57 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.825 0.821 . . . . 25.0 112.158 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -65.42 -23.35 66.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.299 0.571 . . . . 25.0 110.728 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -89.92 146.7 35.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.069 -1.456 . . . . 25.0 107.069 175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.01 153.57 63.11 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 116.766 -1.689 . . . . 25.0 110.969 176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.54 141.99 33.27 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.932 -0.766 . . . . 25.0 108.932 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.68 -171.76 54.2 Favored Glycine 0 C--O 1.23 -0.132 0 N-CA-C 111.741 -0.544 . . . . 25.0 111.741 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.9 p -138.25 112.18 8.43 Favored 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 108.853 -0.795 . . . . 25.0 108.853 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.61 -12.73 60.43 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.247 -0.501 . . . . 25.0 113.693 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.87 -168.43 37.54 Favored Glycine 0 C--O 1.219 -0.781 0 N-CA-C 110.347 -1.101 . . . . 25.0 110.347 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 78.9 p -89.05 -4.96 58.21 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.32 -168.37 54.42 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.446 -0.883 . . . . 25.0 111.611 -175.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.2 m -126.99 22.14 6.74 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.337 0.589 . . . . 25.0 110.796 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.13 174.36 41.02 Favored Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 103.489 -3.844 . . . . 25.0 103.489 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.2 mt 52.14 51.95 15.33 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.695 1.248 . . . . 25.0 109.608 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.9 p -66.26 123.3 19.56 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.549 -0.908 . . . . 25.0 108.549 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -140.96 -178.16 5.43 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.425 -0.583 . . . . 25.0 109.425 -174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 68.89 82.31 0.17 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.637 1.575 . . . . 25.0 110.274 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.8 mt -66.63 147.28 53.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.012 -1.449 . . . . 25.0 111.771 -175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.94 53.41 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 114.024 1.12 . . . . 25.0 114.024 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.82 166.71 29.04 Favored 'Trans proline' 0 C--O 1.242 0.696 0 N-CA-C 110.928 -0.451 . . . . 25.0 110.928 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.66 157.1 56.46 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 117.808 -0.995 . . . . 25.0 113.866 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -86.4 151.89 54.23 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 106.774 -1.565 . . . . 25.0 106.774 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.93 163.26 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 N-CA-C 110.384 -0.66 . . . . 25.0 110.384 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.26 174.72 11.61 Favored 'Trans proline' 0 C--N 1.347 0.451 0 CA-C-O 121.255 0.44 . . . . 25.0 113.214 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.7 mt -133.99 159.61 71.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.475 -0.784 . . . . 25.0 109.198 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 97' ' ' GLY . 85.7 Cg_endo -71.79 -176.78 2.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 120.822 1.014 . . . . 25.0 111.36 175.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 72.23 -11.3 0.81 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.594 1.558 . . . . 25.0 114.251 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -105.63 6.43 41.43 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 113.195 -1.82 . . . . 25.0 109.982 172.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.89 134.2 44.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.056 0.932 . . . . 25.0 110.191 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 125.114 2.388 . . . . 25.0 111.182 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.926 0 CA-C-O 124.392 2.107 . . . . 25.0 114.015 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -62.2 119.57 9.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 113.036 -1.582 . . . . 25.0 110.796 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.71 -8.04 38.91 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.944 0.402 . . . . 25.0 111.788 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -146.01 129.41 16.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 103.599 -2.741 . . . . 25.0 103.599 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 56.48 179.81 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 O-C-N 124.268 0.98 . . . . 25.0 113.422 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.05 -37.59 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.023 -0.423 . . . . 25.0 111.561 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 54.59 50.19 16.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.206 1.003 . . . . 25.0 113.549 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.96 160.44 8.99 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.569 0 N-CA-C 108.053 -1.092 . . . . 25.0 108.053 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -99.14 141.06 32.38 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.99 -0.444 . . . . 25.0 110.013 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.97 143.01 46.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.987 -0.375 . . . . 25.0 109.987 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.394 0.278 . . . . 25.0 111.369 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.81 31.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.941 -0.572 . . . . 25.0 109.891 174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -87.99 -18.67 28.52 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.931 -0.481 . . . . 25.0 109.933 176.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -142.44 166.03 25.78 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.751 -2.314 . . . . 25.0 104.751 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -78.24 172.64 13.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 174.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -147.29 137.2 23.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.049 -0.723 . . . . 25.0 109.049 175.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.56 124.51 63.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.757 -2.683 . . . . 25.0 103.757 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -77.66 112.35 14.39 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.53 -1.285 . . . . 25.0 107.53 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -105.92 -18.61 13.99 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.604 0.716 . . . . 25.0 109.3 -176.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.2 m -105.35 150.92 39.48 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 107.634 -1.247 . . . . 25.0 107.634 176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -69.36 -12.75 34.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 N-CA-C 113.848 0.672 . . . . 25.0 113.848 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.0 -3.26 35.3 Favored 'General case' 0 C--O 1.205 -1.237 0 O-C-N 122.473 -0.142 . . . . 25.0 111.101 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -91.89 154.16 19.04 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.579 0.585 . . . . 25.0 112.579 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 mt -100.72 144.73 29.34 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.457 0.646 . . . . 25.0 112.186 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 1.7 p -110.42 133.75 52.98 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.71 -1.218 . . . . 25.0 107.71 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -155.78 173.04 17.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.407 -0.815 . . . . 25.0 110.493 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -107.54 158.32 17.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.882 -0.785 . . . . 25.0 108.882 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -55.23 132.34 47.53 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.87 -6.15 66.87 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-O 119.09 -0.839 . . . . 25.0 113.808 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -75.82 162.76 27.88 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 117.552 0.676 . . . . 25.0 109.18 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.31 126.14 73.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -122.7 154.97 37.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.247 0.546 . . . . 25.0 109.57 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.5 m -89.74 112.47 23.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.121 -0.945 . . . . 25.0 108.878 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 8' ' ' VAL . 38.6 t -77.77 124.39 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 108.322 -0.992 . . . . 25.0 108.322 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.43 -47.49 5.95 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.942 -1.026 . . . . 25.0 108.777 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.26 173.49 15.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.3 mtm180 -125.82 152.78 45.01 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.997 -1.853 . . . . 25.0 105.997 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 58.8 35.29 24.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.609 1.671 . . . . 25.0 108.054 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.41 145.33 56.24 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 112.682 -2.053 . . . . 25.0 110.956 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 58.02 14.42 2.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.986 0.914 . . . . 25.0 113.299 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.53 12.37 80.4 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.7 mt -90.06 87.68 6.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.287 -1.375 . . . . 25.0 107.287 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.48 130.77 46.36 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.554 0.693 . . . . 25.0 110.389 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.39 -15.39 56.71 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 119.279 -0.734 . . . . 25.0 114.156 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.26 130.05 37.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.566 1.183 . . . . 25.0 108.643 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -113.11 125.56 54.5 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.908 -0.775 . . . . 25.0 108.908 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.2 tp -74.49 121.5 21.59 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 106.992 -1.484 . . . . 25.0 106.992 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 m -134.93 171.63 14.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.109 0.48 . . . . 25.0 110.526 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.7 130.14 45.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.402 -0.817 . . . . 25.0 108.848 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.95 134.83 22.48 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.52 -1.289 . . . . 25.0 107.52 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m170 54.45 31.95 15.73 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.96 0.504 . . . . 25.0 111.983 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.64 11.9 77.52 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.932 -0.651 . . . . 25.0 113.759 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -114.53 138.45 50.61 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.08 -2.193 . . . . 25.0 105.08 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -104.48 148.21 26.72 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.775 -0.824 . . . . 25.0 108.775 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.49 171.0 40.52 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.429 -0.891 . . . . 25.0 113.418 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -82.22 155.07 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.613 0.72 . . . . 25.0 109.696 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.3 t -141.73 140.03 19.43 Favored Pre-proline 0 C--N 1.32 -0.708 0 N-CA-C 108.034 -1.098 . . . . 25.0 108.034 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.47 119.74 6.66 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.344 -1.304 . . . . 25.0 110.913 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.47 -24.53 61.8 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-N 116.447 -0.342 . . . . 25.0 112.597 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -17.79 61.45 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.774 0.657 . . . . 25.0 112.774 178.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.33 8.85 23.57 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 122.163 -0.336 . . . . 25.0 111.771 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -120.21 152.22 38.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 114.004 1.113 . . . . 25.0 114.004 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.1 ttmt -127.95 120.0 26.71 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 114.681 -1.145 . . . . 25.0 109.975 174.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.4 HG23 HG21 ' A' ' 8' ' ' VAL . 40.4 mm -70.14 127.74 32.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.54 81.31 3.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.606 0.717 . . . . 25.0 109.263 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.09 105.67 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.591 -0.731 . . . . 25.0 109.401 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.04 31.22 2.58 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 114.972 0.749 . . . . 25.0 114.972 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.9 ttm -80.29 -22.07 41.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.503 0.668 . . . . 25.0 109.307 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -128.25 145.85 50.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.289 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 71' ' ' LYS . 23.1 t0 -103.5 -163.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.537 ' H ' ' CG ' ' A' ' 70' ' ' ASP . 69.3 tttt 57.31 38.93 28.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.297 1.046 . . . . 25.0 110.357 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -60.71 144.13 89.9 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.5 -18.48 25.85 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 114.957 1.099 . . . . 25.0 114.957 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 54.72 -149.48 0.44 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.076 0.55 . . . . 25.0 111.571 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.54 174.33 45.45 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 106.708 -2.557 . . . . 25.0 106.708 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 t -156.46 174.71 15.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.509 -1.663 . . . . 25.0 106.509 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.64 -39.62 2.01 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 113.941 0.336 . . . . 25.0 113.941 176.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 175.08 179.42 45.64 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.403 -0.904 . . . . 25.0 112.365 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.7 p -128.43 59.6 1.52 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.778 0.431 . . . . 25.0 111.179 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.97 9.41 32.37 Favored Glycine 0 N--CA 1.46 0.238 0 C-N-CA 121.009 -0.615 . . . . 25.0 114.304 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.9 t -80.67 150.87 29.22 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.389 -1.708 . . . . 25.0 106.389 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.31 134.93 8.71 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 110.92 -0.872 . . . . 25.0 110.92 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.2 mt -150.98 167.56 27.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.09 28.06 14.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.098 1.147 . . . . 25.0 114.098 173.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -151.57 170.29 20.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.288 -1.745 . . . . 25.0 106.288 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 55.12 63.78 2.0 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.481 1.134 . . . . 25.0 112.08 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.17 137.17 58.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.753 -1.112 . . . . 25.0 111.21 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.36 149.55 65.58 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.28 -0.873 . . . . 25.0 113.151 -174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.87 163.95 36.94 Favored 'Trans proline' 0 C--O 1.242 0.678 0 C-N-CA 120.608 0.872 . . . . 25.0 112.665 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.05 168.19 25.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 N-CA-C 114.509 0.927 . . . . 25.0 114.509 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.88 146.34 36.57 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 107.803 -1.184 . . . . 25.0 107.803 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.41 159.5 52.71 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 117.093 -1.471 . . . . 25.0 110.486 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -57.96 161.48 13.04 Favored 'Trans proline' 0 CA--C 1.509 -0.774 0 N-CA-C 115.434 1.282 . . . . 25.0 115.434 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.0 mt -133.79 156.39 79.45 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 113.103 -1.862 . . . . 25.0 110.536 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.94 -167.06 0.42 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.479 2.786 . . . . 25.0 110.945 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 64.89 14.33 9.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.599 1.159 . . . . 25.0 112.067 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -144.88 152.14 24.2 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 106.337 -2.705 . . . . 25.0 106.337 173.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -81.77 83.2 7.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 122.19 0.995 . . . . 25.0 110.192 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.213 -0.854 0 CA-C-O 125.313 2.482 . . . . 25.0 110.865 -179.485 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 115.469 0.947 . . . . 25.0 115.469 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m 60.7 -168.63 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.809 1.244 . . . . 25.0 110.906 -177.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -135.35 89.98 2.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.685 0.755 . . . . 25.0 110.131 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -134.87 132.45 38.57 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 105.787 -1.931 . . . . 25.0 105.787 177.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 58.17 167.37 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.464 1.653 . . . . 25.0 115.464 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.95 -41.04 60.38 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 115.364 -0.834 . . . . 25.0 111.214 -176.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 51.63 53.11 13.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.015 0.926 . . . . 25.0 113.496 -179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.36 159.71 6.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.698 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.5 mt -94.72 146.27 24.28 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.715 -0.616 . . . . 25.0 109.579 178.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.52 141.6 37.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.859 -0.423 . . . . 25.0 109.859 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -102.43 137.87 40.1 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.306 0.379 . . . . 25.0 111.86 179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.91 125.47 29.17 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 176.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -87.65 -14.94 38.62 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 109.057 -0.72 . . . . 25.0 109.057 175.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -144.02 166.53 24.73 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.892 -1.151 . . . . 25.0 107.892 -177.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 8.2 p-10 -77.23 166.22 23.49 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.063 -1.088 . . . . 25.0 108.063 173.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.17 131.64 20.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.23 0.538 . . . . 25.0 111.251 173.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.52 123.37 57.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 104.24 -2.504 . . . . 25.0 104.24 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.87 115.12 14.11 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.837 -1.172 . . . . 25.0 107.837 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -102.02 -20.53 14.75 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 -178.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.3 m -108.87 151.91 42.07 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.926 -0.768 . . . . 25.0 108.926 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.62 -13.24 32.34 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 N-CA-C 113.67 0.604 . . . . 25.0 113.67 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -89.0 -10.94 45.69 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 108.938 -0.764 . . . . 25.0 108.938 178.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -90.75 149.97 21.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.016 0.747 . . . . 25.0 113.016 -171.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.0 mt -95.52 142.87 27.36 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.642 0.734 . . . . 25.0 112.1 175.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.0 p -107.29 132.77 52.74 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.372 -1.344 . . . . 25.0 107.372 176.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -156.64 176.96 12.03 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.174 -0.921 . . . . 25.0 108.622 -178.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -121.8 167.49 12.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.852 0.358 . . . . 25.0 110.8 177.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -55.83 129.68 40.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.239 0.543 . . . . 25.0 110.442 178.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.22 -5.86 61.3 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 118.913 -0.937 . . . . 25.0 114.131 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.19 159.72 32.48 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.122 0.961 . . . . 25.0 110.316 179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -123.41 126.13 72.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.7 ptp -126.4 154.83 43.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.374 0.607 . . . . 25.0 109.543 176.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.4 m -91.25 112.41 24.31 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 115.039 -0.982 . . . . 25.0 109.061 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -77.48 119.35 25.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.87 -0.789 . . . . 25.0 108.87 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.45 -44.4 9.14 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.365 -0.834 . . . . 25.0 108.888 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.1 pt-20 -154.43 168.94 24.99 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 172.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -121.63 151.42 40.44 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 58.46 37.78 25.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.622 1.677 . . . . 25.0 108.063 177.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.9 t -64.61 146.92 53.94 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 112.723 -2.035 . . . . 25.0 111.398 -175.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 57.73 14.58 2.51 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.95 81.22 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.382 -0.687 . . . . 25.0 111.382 -177.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.4 mt -90.43 87.19 6.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -56.76 130.96 47.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.568 0.699 . . . . 25.0 110.219 -178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.43 -15.07 59.48 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.196 -0.78 . . . . 25.0 113.905 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -94.79 129.58 41.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 118.635 1.218 . . . . 25.0 108.413 176.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -115.16 125.28 53.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.363 -0.606 . . . . 25.0 109.363 -176.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.9 tp -73.13 122.07 21.25 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 27.3 m -134.63 171.05 14.88 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.229 0.538 . . . . 25.0 110.328 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.11 130.29 46.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.59 130.25 20.23 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 -176.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 53.79 29.47 9.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.442 0.534 . . . . 25.0 112.442 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.59 7.43 88.49 Favored Glycine 0 C--O 1.224 -0.475 0 C-N-CA 121.042 -0.599 . . . . 25.0 114.212 179.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.31 137.29 48.23 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 105.009 -2.219 . . . . 25.0 105.009 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -104.1 147.77 27.03 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.913 -0.773 . . . . 25.0 108.913 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.43 170.64 39.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 25.0 113.022 176.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.0 pt -80.29 155.11 4.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.762 0.792 . . . . 25.0 109.788 179.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -142.32 139.73 18.12 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 -178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.71 119.85 6.74 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.69 -1.073 . . . . 25.0 112.115 176.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -24.45 64.93 Favored Glycine 0 C--O 1.222 -0.598 0 CA-C-N 116.302 -0.408 . . . . 25.0 112.246 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.16 -15.24 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.716 0.636 . . . . 25.0 112.716 177.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -113.51 9.35 18.0 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.003 -0.436 . . . . 25.0 112.095 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mt -120.33 151.96 38.52 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 114.173 1.175 . . . . 25.0 114.173 -178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HB2' HD21 ' A' ' 13' ' ' LEU . 13.2 ttpt -125.73 120.01 29.5 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.65 -1.159 . . . . 25.0 108.803 173.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 44.2 mm -70.34 127.16 31.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.565 -0.902 . . . . 25.0 108.565 177.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.3 mt -90.85 65.42 5.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.114 0.483 . . . . 25.0 110.858 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -72.96 -9.11 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-O 121.379 0.609 . . . . 25.0 110.733 176.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.66 176.61 46.68 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 106.876 -2.489 . . . . 25.0 106.876 178.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 9.0 tpt -80.56 78.55 7.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.767 0.784 . . . . 25.0 109.572 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -135.1 148.19 49.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 25.0 108.608 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -140.64 152.74 45.65 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.815 -1.18 . . . . 25.0 107.815 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 10.81 71.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 116.218 1.932 . . . . 25.0 116.218 -178.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.01 149.63 85.58 Favored Pre-proline 0 N--CA 1.47 0.537 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.46 139.96 55.88 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 116.63 -1.78 . . . . 25.0 114.666 -172.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -160.32 -50.58 0.05 Allowed 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 114.438 -1.256 . . . . 25.0 108.286 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.3 -10.76 84.43 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 114.752 0.661 . . . . 25.0 114.752 -179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m 55.41 19.54 3.15 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 116.051 1.871 . . . . 25.0 116.051 176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.38 179.49 43.13 Favored Glycine 0 CA--C 1.508 -0.353 0 N-CA-C 107.685 -2.166 . . . . 25.0 107.685 178.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.84 39.47 96.59 Favored Glycine 0 C--O 1.223 -0.552 0 CA-C-N 118.006 0.903 . . . . 25.0 113.769 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.4 t -54.29 -45.93 72.63 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.53 0.937 . . . . 25.0 113.53 -175.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.47 88.23 0.43 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.058 -0.591 . . . . 25.0 114.043 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.7 t -127.06 80.82 1.98 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 122.35 -0.5 . . . . 25.0 110.11 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 175.49 178.95 45.72 Favored Glycine 0 CA--C 1.509 -0.322 0 N-CA-C 108.41 -1.876 . . . . 25.0 108.41 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -123.37 106.97 11.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.629 -0.878 . . . . 25.0 108.629 178.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.9 p -142.46 168.75 18.98 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.98 -1.859 . . . . 25.0 105.98 178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.93 146.06 55.48 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.179 -1.045 . . . . 25.0 108.179 174.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -138.88 105.13 5.24 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.019 -1.474 . . . . 25.0 107.019 -176.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.8 mt -67.09 140.55 57.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.431 0.634 . . . . 25.0 110.439 -175.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.4 146.69 70.71 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 113.366 0.876 . . . . 25.0 113.366 -174.21 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.69 164.77 33.0 Favored 'Trans proline' 0 C--O 1.245 0.84 0 O-C-N 121.895 0.419 . . . . 25.0 111.765 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -61.08 161.63 21.97 Favored 'Trans proline' 0 C--N 1.346 0.436 0 N-CA-C 113.821 0.662 . . . . 25.0 113.821 177.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -98.61 152.36 37.85 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 173.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.46 160.92 47.14 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 117.351 -1.299 . . . . 25.0 110.805 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.46 176.11 10.13 Favored 'Trans proline' 0 C--N 1.347 0.476 0 N-CA-C 113.249 0.442 . . . . 25.0 113.249 -177.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.8 156.17 79.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.58 -0.526 . . . . 25.0 109.58 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.89 170.94 18.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.201 1.934 . . . . 25.0 113.392 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.42 46.23 0.95 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.13 -0.941 . . . . 25.0 110.612 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.7 145.6 10.64 Favored Glycine 0 C--O 1.225 -0.444 0 N-CA-C 111.171 -0.771 . . . . 25.0 111.171 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -138.39 30.2 2.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.485 1.135 . . . . 25.0 111.947 -175.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.214 -0.765 0 CA-C-O 125.554 2.597 . . . . 25.0 112.891 -177.662 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 CA-C-O 124.271 2.039 . . . . 25.0 115.454 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -77.48 148.7 35.23 Favored 'General case' 0 C--O 1.226 -0.174 0 O-C-N 121.431 -1.041 . . . . 25.0 108.623 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -131.38 163.9 26.87 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.549 -0.537 . . . . 25.0 109.549 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -140.34 130.97 25.61 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.077 -2.564 . . . . 25.0 104.077 173.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 59.91 173.83 0.09 Allowed 'General case' 0 CA--C 1.544 0.725 0 O-C-N 124.573 1.171 . . . . 25.0 113.482 -177.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.03 -32.62 59.44 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.404 0.52 . . . . 25.0 112.404 -174.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.2 m120 53.31 45.16 29.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.566 1.321 . . . . 25.0 114.566 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.429 HG21 HG23 ' A' ' 64' ' ' ILE . 1.1 m -105.41 157.33 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.729 -0.841 . . . . 25.0 108.729 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.66 142.18 27.75 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 122.026 -0.421 . . . . 25.0 110.112 177.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.5 145.81 41.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 122.411 -0.181 . . . . 25.0 111.138 177.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -106.07 139.51 40.48 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.833 0.453 . . . . 25.0 111.187 178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.48 127.99 34.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.212 -0.449 . . . . 25.0 111.163 173.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.88 -20.99 25.23 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.246 -0.284 . . . . 25.0 110.391 175.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -142.58 162.26 35.94 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 103.68 -2.711 . . . . 25.0 103.68 -178.217 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.4 166.72 20.16 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.754 -0.832 . . . . 25.0 108.754 176.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -141.58 137.53 31.99 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.8 t -110.71 125.17 68.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 103.809 -2.663 . . . . 25.0 103.809 176.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.38 117.7 18.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -104.58 -24.78 12.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.0 m -100.99 151.94 37.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 176.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.12 -12.24 31.85 Favored 'Trans proline' 0 C--N 1.342 0.21 0 N-CA-C 113.535 0.552 . . . . 25.0 113.535 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.01 -10.89 34.63 Favored 'General case' 0 C--O 1.197 -1.691 0 CA-C-O 121.303 0.573 . . . . 25.0 110.011 178.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -88.52 151.08 22.75 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 121.502 -0.748 . . . . 25.0 112.637 -170.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.8 mt -97.14 145.04 26.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.614 0.721 . . . . 25.0 111.548 174.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.4 p -109.92 137.06 48.23 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -157.21 169.17 25.39 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 25.0 110.187 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.56 157.12 17.39 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.4 129.58 39.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.084 -1.08 . . . . 25.0 108.084 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.07 -9.53 61.51 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-O 118.507 -1.163 . . . . 25.0 114.471 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.43 160.1 28.16 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 118.262 1.031 . . . . 25.0 110.657 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.9 mm -121.45 127.47 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.759 -0.83 . . . . 25.0 108.759 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.8 ptp -126.0 158.37 35.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.28 -0.637 . . . . 25.0 109.28 175.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 99.1 m -91.72 114.0 26.42 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.95 -1.023 . . . . 25.0 108.469 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 8' ' ' VAL . 46.7 t -78.87 124.86 37.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 178.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -95.71 -48.25 5.85 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.971 -1.013 . . . . 25.0 108.607 -179.216 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.62 173.97 14.54 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.231 -0.588 . . . . 25.0 110.494 174.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.2 mtm105 -124.5 153.59 41.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 106.162 -1.792 . . . . 25.0 106.162 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 57.44 37.26 27.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.541 1.638 . . . . 25.0 107.857 177.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -65.05 144.43 57.28 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 112.854 -1.975 . . . . 25.0 111.076 -175.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 57.27 16.64 3.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.624 0.769 . . . . 25.0 112.707 -178.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.29 11.17 83.75 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.708 -0.557 . . . . 25.0 111.708 -177.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -89.67 91.52 8.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.2 -1.037 . . . . 25.0 108.2 -178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.76 129.48 39.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.67 0.747 . . . . 25.0 111.178 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.96 51.7 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-O 119.395 -0.67 . . . . 25.0 114.342 178.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -88.09 129.99 35.14 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.81 -1.182 . . . . 25.0 107.81 176.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -114.41 125.41 53.81 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.152 -1.055 . . . . 25.0 108.152 -178.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.4 tp -74.54 123.5 24.88 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.262 -1.385 . . . . 25.0 107.262 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.2 m -135.25 170.41 15.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.167 0.508 . . . . 25.0 110.648 178.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.15 129.22 46.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 176.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 127.12 18.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.342 -1.355 . . . . 25.0 107.342 -177.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 53.76 31.95 13.92 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.152 0.797 . . . . 25.0 113.152 -177.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.47 7.72 87.87 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.936 -0.65 . . . . 25.0 113.871 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -109.54 137.04 47.97 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 178.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.22 147.69 29.84 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.238 -1.023 . . . . 25.0 108.238 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.1 170.37 38.74 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.395 -0.907 . . . . 25.0 113.941 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.9 pt -79.41 154.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.824 0.821 . . . . 25.0 109.926 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.6 t -141.35 139.97 19.9 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.952 -1.022 . . . . 25.0 108.422 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.67 111.92 2.92 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.56 174.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -20.96 56.64 Favored Glycine 0 C--O 1.221 -0.683 0 O-C-N 122.013 -0.429 . . . . 25.0 112.281 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -60.63 -19.75 58.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.28 0.632 . . . . 25.0 112.37 176.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -114.16 10.77 17.4 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 122.032 -0.417 . . . . 25.0 111.484 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -124.55 142.88 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.531 0.937 . . . . 25.0 113.531 -174.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.469 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.8 ttpt -123.75 119.98 31.35 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-N 115.867 -0.606 . . . . 25.0 112.284 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.429 HG23 HG21 ' A' ' 8' ' ' VAL . 49.8 mm -66.91 128.29 29.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.896 -1.047 . . . . 25.0 109.746 178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.8 mt -107.09 0.8 23.77 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.259 0.552 . . . . 25.0 110.896 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t 64.86 -87.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.567 -1.651 . . . . 25.0 110.127 -172.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.68 174.03 13.19 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 106.103 -2.799 . . . . 25.0 106.103 -177.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 29.3 ttp 52.41 42.95 31.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.281 1.041 . . . . 25.0 110.374 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.82 90.32 3.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.154 -0.93 . . . . 25.0 111.346 -173.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.98 36.6 0.41 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.167 0.984 . . . . 25.0 110.387 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -67.45 -21.35 65.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 25.0 112.598 -173.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -151.89 147.47 20.0 Favored Pre-proline 0 N--CA 1.469 0.479 0 N-CA-C 105.097 -2.186 . . . . 25.0 105.097 172.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -79.68 -6.0 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 N-CA-C 115.124 1.163 . . . . 25.0 115.124 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.47 -51.67 0.58 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.063 0.764 . . . . 25.0 113.063 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.23 -148.38 20.07 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 120.306 -0.949 . . . . 25.0 113.119 -179.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.0 p -100.88 -2.08 32.96 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.668 0.618 . . . . 25.0 112.668 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 110.73 -171.19 14.39 Favored Glycine 0 CA--C 1.516 0.142 0 N-CA-C 109.599 -1.4 . . . . 25.0 109.599 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -177.86 -157.63 19.08 Favored Glycine 0 C--O 1.227 -0.314 0 N-CA-C 109.125 -1.59 . . . . 25.0 109.125 -177.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m 57.34 33.96 24.03 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.792 1.404 . . . . 25.0 114.792 177.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.78 134.04 9.41 Favored Glycine 0 N--CA 1.454 -0.136 0 N-CA-C 110.23 -1.148 . . . . 25.0 110.23 176.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.5 p -156.77 163.49 39.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.555 -1.646 . . . . 25.0 106.555 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 158.64 -169.24 35.02 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 107.54 -2.224 . . . . 25.0 107.54 -178.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.24 128.35 33.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.104 -1.814 . . . . 25.0 106.104 175.264 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.6 p -134.31 123.51 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.83 -0.804 . . . . 25.0 108.83 179.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.0 88.98 7.84 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 178.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -137.17 113.26 9.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.945 -1.025 . . . . 25.0 109.028 -177.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -90.12 123.42 33.95 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.23 0.538 . . . . 25.0 109.97 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.4 147.66 68.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.771 -0.649 . . . . 25.0 109.879 179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.96 162.6 41.39 Favored 'Trans proline' 0 C--O 1.244 0.807 0 CA-C-N 117.991 0.318 . . . . 25.0 112.499 179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.23 160.55 46.89 Favored 'Trans proline' 0 C--N 1.346 0.43 0 N-CA-C 114.661 0.985 . . . . 25.0 114.661 -176.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -82.31 148.41 59.32 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.187 -1.042 . . . . 25.0 108.187 176.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.5 160.96 47.02 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 117.4 -1.266 . . . . 25.0 109.67 169.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.59 172.03 16.99 Favored 'Trans proline' 0 C--N 1.348 0.52 0 N-CA-C 113.577 0.568 . . . . 25.0 113.577 -176.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 mt -134.02 155.78 79.83 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.661 -0.7 . . . . 25.0 111.084 178.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -77.75 176.21 10.3 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.913 2.409 . . . . 25.0 112.081 174.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -80.18 35.83 0.34 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.169 0.803 . . . . 25.0 113.169 -179.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.66 -177.06 21.11 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 111.738 -0.545 . . . . 25.0 111.738 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -116.62 149.66 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.823 0.82 . . . . 25.0 111.54 -178.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 123.719 1.723 . . . . 25.0 112.732 -179.399 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.576 0 CA-C-O 124.611 2.228 . . . . 25.0 113.223 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -149.61 153.95 37.88 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 113.056 -1.572 . . . . 25.0 107.399 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 54.5 mtt 59.26 15.97 4.63 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -178.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 tttp 67.19 167.33 0.23 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.781 1.232 . . . . 25.0 109.872 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 57.15 178.01 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.869 1.433 . . . . 25.0 114.869 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.35 -38.91 29.58 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.726 -176.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 50.04 52.54 14.5 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.107 1.151 . . . . 25.0 114.107 -178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.58 162.91 5.68 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 105.695 -1.965 . . . . 25.0 105.695 177.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -100.53 149.16 24.0 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 108.955 -0.757 . . . . 25.0 108.955 177.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.34 141.24 37.67 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.892 -0.505 . . . . 25.0 109.877 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -99.85 136.59 39.54 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 123.076 0.235 . . . . 25.0 110.638 178.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.22 130.26 39.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.694 -0.484 . . . . 25.0 109.694 174.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.04 -15.85 28.88 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -144.49 161.52 38.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.863 -176.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.51 150.43 48.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.111 -1.44 . . . . 25.0 107.111 172.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -137.08 132.38 34.05 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 174.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -109.92 126.32 67.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 103.532 -2.766 . . . . 25.0 103.532 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.96 115.84 12.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.05 -28.09 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.317 -0.994 . . . . 25.0 108.317 -177.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -91.33 147.48 35.55 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 107.341 -1.355 . . . . 25.0 107.341 173.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.45 -9.29 25.55 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 N-CA-C 113.9 0.692 . . . . 25.0 113.9 178.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -100.72 -10.99 20.3 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 121.483 0.659 . . . . 25.0 111.653 177.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -79.38 154.15 29.22 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.681 0.753 . . . . 25.0 111.747 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.9 144.59 27.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.604 0.716 . . . . 25.0 112.8 176.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.4 m -104.28 131.58 51.45 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.204 -1.406 . . . . 25.0 107.204 175.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -155.65 169.09 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.639 -0.709 . . . . 25.0 112.707 178.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.43 154.91 18.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.569 0.747 . . . . 25.0 110.102 -178.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -55.32 128.83 35.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.367 -0.975 . . . . 25.0 108.367 171.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.91 -8.73 63.51 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 118.669 -1.073 . . . . 25.0 114.342 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.4 156.85 35.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 118.24 1.02 . . . . 25.0 109.736 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.61 122.65 69.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.976 -1.12 . . . . 25.0 107.976 175.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -123.27 154.31 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 177.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.7 m -89.12 115.19 26.47 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.221 -0.9 . . . . 25.0 109.315 -178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -80.82 121.74 34.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.584 -0.895 . . . . 25.0 108.584 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -95.87 -46.84 6.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.357 -0.838 . . . . 25.0 109.355 -177.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.1 171.48 17.81 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 173.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 65.4 mtm-85 -124.82 153.37 42.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.92 -1.881 . . . . 25.0 105.92 178.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 59.26 33.98 22.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.684 1.707 . . . . 25.0 108.193 175.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 t -62.87 144.98 56.14 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-N 112.777 -2.01 . . . . 25.0 110.268 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.2 9.87 1.5 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 25.0 113.605 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.57 15.86 69.96 Favored Glycine 0 CA--C 1.517 0.162 0 N-CA-C 110.825 -0.91 . . . . 25.0 110.825 -176.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.1 mt -91.19 86.24 6.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.581 -1.637 . . . . 25.0 106.581 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 130.7 46.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.624 0.726 . . . . 25.0 110.016 -177.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.65 -15.18 57.94 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-O 119.193 -0.782 . . . . 25.0 113.97 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -92.58 129.98 38.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.634 1.217 . . . . 25.0 108.235 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -114.38 126.77 55.37 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -176.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.89 120.78 19.95 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.6 m -135.76 171.82 13.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.13 0.491 . . . . 25.0 110.871 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.99 124.27 41.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.334 -0.848 . . . . 25.0 109.042 176.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -149.71 145.58 26.76 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 105.867 -1.901 . . . . 25.0 105.867 -177.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 58.97 27.07 15.83 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.832 0.679 . . . . 25.0 112.832 176.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.92 18.75 76.47 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.959 -0.639 . . . . 25.0 112.537 -179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.74 148.12 51.59 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.352 -1.721 . . . . 25.0 106.352 -176.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -110.26 144.27 39.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.625 -1.25 . . . . 25.0 107.625 178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 177.03 47.27 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.397 -0.906 . . . . 25.0 112.657 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -85.24 154.64 3.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.757 0.789 . . . . 25.0 110.367 -178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -141.98 139.61 18.41 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 -178.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.26 119.62 6.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 117.384 -1.278 . . . . 25.0 111.337 176.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.29 -23.91 62.82 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 112.158 -0.377 . . . . 25.0 112.158 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -65.22 -10.8 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.269 0.841 . . . . 25.0 113.269 178.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -117.42 10.38 13.59 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.942 -0.474 . . . . 25.0 110.898 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -121.64 153.02 38.67 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 122.08 0.943 . . . . 25.0 113.49 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -128.98 120.03 25.34 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.67 -1.15 . . . . 25.0 109.888 173.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.8 mm -67.54 128.28 30.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.587 -0.733 . . . . 25.0 109.44 178.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.7 mt -103.68 107.89 18.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 103.0 -2.963 . . . . 25.0 103.0 172.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -56.18 117.5 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.407 0.622 . . . . 25.0 110.905 -171.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.1 178.5 50.88 Favored Glycine 0 C--O 1.225 -0.441 0 CA-C-N 115.582 -0.735 . . . . 25.0 111.952 -176.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 5.3 mpp? 62.59 5.81 1.81 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.504 1.668 . . . . 25.0 115.504 177.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -87.55 -67.34 0.83 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.642 -0.503 . . . . 25.0 109.642 173.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.91 -174.99 4.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 178.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -145.6 34.51 1.05 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.703 0.631 . . . . 25.0 112.703 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -80.25 146.97 63.6 Favored Pre-proline 0 N--CA 1.471 0.596 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.9 133.56 20.18 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 116.27 -2.02 . . . . 25.0 111.638 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -157.03 141.39 16.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.317 -0.623 . . . . 25.0 109.317 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.29 -139.29 45.79 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 120.759 -0.734 . . . . 25.0 112.793 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t 57.32 28.95 16.04 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.686 1.365 . . . . 25.0 114.686 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 166.12 51.2 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.13 -1.188 . . . . 25.0 110.13 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.28 175.83 45.73 Favored Glycine 0 N--CA 1.453 -0.21 0 N-CA-C 108.29 -1.924 . . . . 25.0 108.29 179.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.5 m -102.13 130.17 48.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 117.643 0.722 . . . . 25.0 110.85 -178.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.75 43.05 3.19 Favored Glycine 0 C--O 1.221 -0.699 0 C-N-CA 121.643 -0.313 . . . . 25.0 112.979 179.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 m -65.54 -27.33 68.38 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -175.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.08 -7.85 58.98 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.351 -0.452 . . . . 25.0 113.826 179.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.41 157.39 34.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.836 0.351 . . . . 25.0 110.604 -178.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -95.65 124.57 39.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.743 -1.577 . . . . 25.0 106.743 173.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -155.57 169.37 24.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 -177.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 60.62 85.88 0.11 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.093 1.357 . . . . 25.0 112.789 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.56 142.41 58.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.962 -1.017 . . . . 25.0 111.071 -177.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.91 148.35 56.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 113.758 1.021 . . . . 25.0 113.758 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.26 167.18 27.98 Favored 'Trans proline' 0 C--O 1.241 0.637 0 N-CA-C 111.1 -0.385 . . . . 25.0 111.1 173.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.84 163.27 39.39 Favored 'Trans proline' 0 C--N 1.345 0.38 0 N-CA-C 114.015 0.737 . . . . 25.0 114.015 -177.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -94.92 154.51 39.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 176.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.69 162.28 42.66 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 118.176 -0.749 . . . . 25.0 110.528 176.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.16 174.43 12.06 Favored 'Trans proline' 0 C--N 1.348 0.533 0 N-CA-C 113.326 0.471 . . . . 25.0 113.326 -177.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -133.86 162.03 60.17 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.551 -0.75 . . . . 25.0 110.866 -179.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.82 178.68 5.53 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.114 1.209 . . . . 25.0 111.454 175.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 68.75 7.85 6.39 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.332 1.453 . . . . 25.0 111.429 -174.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.16 -169.09 51.28 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 114.113 -1.403 . . . . 25.0 111.926 175.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -85.64 57.14 4.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.368 1.08 . . . . 25.0 108.468 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 C--O 1.211 -0.974 0 CA-C-O 125.283 2.468 . . . . 25.0 110.541 -176.16 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 CA-C-O 124.709 2.283 . . . . 25.0 113.281 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 m -139.0 8.15 2.49 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 112.851 -1.675 . . . . 25.0 112.327 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.33 -24.03 27.81 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.98 1.104 . . . . 25.0 113.98 -176.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -145.59 136.6 24.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 106.678 -1.601 . . . . 25.0 106.678 178.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 59.5 167.38 0.06 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.93 1.826 . . . . 25.0 115.93 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.2 mt -74.0 -40.93 62.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.415 -0.811 . . . . 25.0 111.612 -175.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 53.53 48.1 22.49 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.686 0.995 . . . . 25.0 113.686 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.26 155.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 107.687 -1.227 . . . . 25.0 107.687 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.0 mt -90.95 140.68 29.6 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.899 -0.501 . . . . 25.0 110.009 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.48 143.09 41.56 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.814 -0.439 . . . . 25.0 109.814 176.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -103.91 136.82 42.87 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.39 0.431 . . . . 25.0 110.965 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.38 131.91 41.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.983 -0.553 . . . . 25.0 109.905 174.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -94.0 -15.67 24.63 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 120.743 0.306 . . . . 25.0 110.556 176.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -143.79 161.98 37.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.657 -0.868 . . . . 25.0 108.657 -178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -69.45 154.32 42.2 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.788 -1.19 . . . . 25.0 107.788 173.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -139.48 132.91 30.16 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 174.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.99 125.77 68.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 103.878 -2.638 . . . . 25.0 103.878 175.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.41 126.21 30.21 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.393 -0.821 . . . . 25.0 109.166 -177.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.88 -32.88 9.55 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.964 -0.754 . . . . 25.0 108.964 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -94.72 151.3 39.01 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.602 179.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.45 -11.47 31.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 O-C-N 121.687 0.309 . . . . 25.0 112.32 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.95 -6.09 46.29 Favored 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 122.822 0.449 . . . . 25.0 110.383 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -97.83 151.94 19.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.562 0.619 . . . . 25.0 112.606 -172.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 mt -97.14 144.41 27.01 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.275 0.56 . . . . 25.0 112.476 175.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -107.36 136.72 46.69 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.149 -1.426 . . . . 25.0 107.149 174.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -159.4 172.47 17.87 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.555 0.693 . . . . 25.0 112.103 -179.356 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -103.11 154.75 18.97 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.14 0.976 . . . . 25.0 110.033 -178.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -55.33 130.08 41.03 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 169.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.4 -12.01 63.31 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 118.765 -1.02 . . . . 25.0 113.719 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.94 155.6 39.08 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 118.194 0.997 . . . . 25.0 109.765 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -115.86 127.78 73.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 107.182 -1.414 . . . . 25.0 107.182 176.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.0 ptp -126.88 156.14 41.87 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 177.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -90.59 112.51 24.24 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 115.134 -0.939 . . . . 25.0 109.037 -177.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.5 t -79.09 120.53 30.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.23 -45.59 7.78 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.277 -0.874 . . . . 25.0 109.167 -177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 15.4 pt-20 -154.19 172.19 17.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.875 -1.158 . . . . 25.0 107.875 173.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -129.48 150.73 50.7 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 105.798 -1.927 . . . . 25.0 105.798 178.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 62.35 36.2 14.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.648 1.69 . . . . 25.0 108.133 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 10.1 t -65.26 145.48 56.17 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 112.481 -2.145 . . . . 25.0 111.61 -176.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 60.04 7.85 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.206 1.003 . . . . 25.0 112.794 -178.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.85 71.11 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.663 -0.975 . . . . 25.0 110.663 -176.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.75 97.59 11.28 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.879 -1.156 . . . . 25.0 107.879 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.26 138.31 58.13 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.346 1.07 . . . . 25.0 111.11 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.52 -15.4 30.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.438 -0.801 . . . . 25.0 113.714 -177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -91.68 129.99 37.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 118.345 1.073 . . . . 25.0 109.505 176.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.94 125.04 53.59 Favored 'General case' 0 C--O 1.215 -0.72 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 -177.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.2 tp -74.82 121.07 21.24 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.33 -1.359 . . . . 25.0 107.33 177.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.0 m -133.27 171.72 13.65 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.09 0.471 . . . . 25.0 110.043 179.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.31 131.45 45.41 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.578 -0.737 . . . . 25.0 109.083 177.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.56 135.66 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 -177.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.1 m170 56.38 30.93 17.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.349 0.659 . . . . 25.0 112.466 179.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.48 14.01 81.33 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.523 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -120.01 142.9 48.39 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.338 -1.727 . . . . 25.0 106.338 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.77 147.11 33.81 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.55 -0.908 . . . . 25.0 108.55 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.68 170.58 40.89 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.506 -0.854 . . . . 25.0 113.759 176.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.8 pt -79.39 154.63 4.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.925 -0.768 . . . . 25.0 108.925 178.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 96.6 t -142.09 139.92 18.71 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.1 119.69 6.57 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 116.597 -1.802 . . . . 25.0 111.699 176.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.49 -24.86 62.26 Favored Glycine 0 N--CA 1.459 0.206 0 O-C-N 121.941 -0.474 . . . . 25.0 112.06 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -14.91 44.06 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.777 0.658 . . . . 25.0 112.777 178.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.0 9.42 14.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 122.212 -0.305 . . . . 25.0 111.709 -179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.17 154.44 34.78 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 113.769 1.025 . . . . 25.0 113.769 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.0 ttmt -131.42 119.7 22.0 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.462 -0.79 . . . . 25.0 111.299 174.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.8 128.84 31.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.4 mt -100.09 74.4 1.78 Allowed 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 109.684 -0.488 . . . . 25.0 109.684 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -70.89 -12.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.408 1.262 . . . . 25.0 114.408 -177.697 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.71 2.33 Favored Glycine 0 C--O 1.22 -0.722 0 C-N-CA 121.297 -0.478 . . . . 25.0 113.753 -177.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -51.61 -30.7 22.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.925 0.89 . . . . 25.0 113.335 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -100.46 75.35 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.189 0.44 . . . . 25.0 112.189 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -110.93 99.11 8.06 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.872 0.844 . . . . 25.0 110.034 175.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -139.16 1.73 2.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.583 0.706 . . . . 25.0 111.359 -177.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -133.12 148.73 70.42 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 102.344 -3.206 . . . . 25.0 102.344 175.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.12 152.54 80.98 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.361 -1.959 . . . . 25.0 111.514 -175.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 38.06 0.12 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.618 0.969 . . . . 25.0 113.618 -177.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.7 129.31 4.49 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 109.724 -1.35 . . . . 25.0 109.724 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.4 m -157.28 150.73 24.01 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 179.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.61 -165.6 54.77 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.882 -0.675 . . . . 25.0 112.367 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.04 152.65 22.41 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 109.176 -1.569 . . . . 25.0 109.176 178.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 t -68.74 -21.88 64.35 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.341 0.497 . . . . 25.0 112.341 -178.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 164.99 -175.67 40.87 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 110.952 -0.859 . . . . 25.0 110.952 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.0 t -153.91 149.81 27.7 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 177.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.04 -149.68 49.45 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.142 -1.028 . . . . 25.0 110.954 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 82.7 mt -86.54 -5.35 59.17 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 -178.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.5 p 42.88 72.07 0.2 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.22 1.193 . . . . 25.0 114.22 -178.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.25 97.31 0.12 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.026 -0.988 . . . . 25.0 113.175 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -141.13 115.77 9.6 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.32 139.28 31.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.474 0.654 . . . . 25.0 111.981 -176.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 148.45 54.64 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.628 -0.715 . . . . 25.0 111.028 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.92 163.9 37.07 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 118.497 -0.535 . . . . 25.0 110.802 175.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -61.11 160.71 25.18 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.172 0.797 . . . . 25.0 114.172 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -93.51 152.68 41.12 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 105.684 -1.969 . . . . 25.0 105.684 171.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.61 164.15 35.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 O-C-N 122.331 0.648 . . . . 25.0 111.331 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.23 179.2 6.04 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 120.421 0.748 . . . . 25.0 113.542 -178.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.6 mt -133.73 157.76 77.11 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.985 -0.552 . . . . 25.0 109.631 179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.21 -171.7 0.75 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.943 3.095 . . . . 25.0 114.09 -178.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 68.53 8.06 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.401 1.48 . . . . 25.0 111.454 -177.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.65 99.58 2.3 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.116 -1.402 . . . . 25.0 110.378 175.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -76.01 64.25 1.88 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.527 1.156 . . . . 25.0 111.164 177.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.553 1.073 0 CA-C-O 123.548 1.642 . . . . 25.0 113.048 -179.92 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.145 0 CA-C-O 124.453 2.14 . . . . 25.0 115.505 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -87.89 120.8 29.58 Favored 'General case' 0 C--O 1.232 0.149 0 O-C-N 120.885 -1.362 . . . . 25.0 110.58 -179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -71.39 103.31 2.86 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.574 -0.528 . . . . 25.0 109.574 177.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -113.21 139.06 49.1 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 104.109 -2.552 . . . . 25.0 104.109 176.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 61.73 164.71 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 124.961 1.413 . . . . 25.0 114.144 -174.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -41.74 65.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.395 -0.82 . . . . 25.0 111.812 -175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 52.79 52.36 14.13 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.825 1.046 . . . . 25.0 113.825 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.38 159.48 6.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.65 0 N-CA-C 107.352 -1.351 . . . . 25.0 107.352 179.29 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -95.22 142.23 27.89 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.865 -0.522 . . . . 25.0 109.885 177.709 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.4 144.61 44.6 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.635 -0.505 . . . . 25.0 109.635 177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -105.26 137.52 42.92 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.118 0.261 . . . . 25.0 111.121 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 127.78 33.64 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.574 0.546 . . . . 25.0 109.813 175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.93 -19.65 28.5 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -142.75 165.93 26.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.864 -0.607 . . . . 25.0 110.004 -175.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.32 161.9 28.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 171.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -153.32 105.1 2.83 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.194 -0.669 . . . . 25.0 109.194 178.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.45 123.32 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.16 -2.904 . . . . 25.0 103.16 174.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 131.72 43.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.981 -1.009 . . . . 25.0 108.416 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -119.48 -24.17 6.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.624 -0.717 . . . . 25.0 109.927 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 t -95.56 146.47 31.37 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 106.429 -1.693 . . . . 25.0 106.429 174.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.72 -12.39 35.33 Favored 'Trans proline' 0 CA--C 1.531 0.347 0 N-CA-C 113.738 0.63 . . . . 25.0 113.738 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -99.89 -3.4 32.52 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 122.822 0.449 . . . . 25.0 110.42 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -91.73 145.22 24.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 25.0 112.22 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.1 mt -89.37 143.81 26.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.592 0.71 . . . . 25.0 111.415 176.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.47 124.96 50.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.909 -1.042 . . . . 25.0 108.837 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -151.45 168.36 25.1 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.465 0.913 . . . . 25.0 113.465 -178.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -101.21 155.24 18.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.326 1.051 . . . . 25.0 109.587 -178.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -56.32 130.33 44.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.637 -0.875 . . . . 25.0 108.637 172.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.99 -12.16 60.64 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-O 119.144 -0.809 . . . . 25.0 113.668 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -70.17 157.69 37.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.742 0.771 . . . . 25.0 110.08 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.7 mm -116.93 128.54 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.014 -0.736 . . . . 25.0 109.014 179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.5 ptp -127.46 154.37 45.16 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.316 -0.624 . . . . 25.0 109.316 175.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.6 m -90.02 112.49 23.93 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.03 -0.986 . . . . 25.0 109.32 -179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 39.0 t -78.79 121.9 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 108.576 -0.898 . . . . 25.0 108.576 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.5 mt -95.45 -43.18 8.1 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.643 -0.708 . . . . 25.0 109.389 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.81 172.46 17.94 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 172.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.6 mtm-85 -123.91 154.07 40.25 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 105.768 -1.938 . . . . 25.0 105.768 178.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.31 36.49 25.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.541 1.639 . . . . 25.0 107.725 173.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 t -64.97 145.78 55.87 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 112.864 -1.971 . . . . 25.0 110.607 -175.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 59.29 10.99 1.95 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.842 0.857 . . . . 25.0 113.112 -178.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.09 14.15 77.65 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.178 -0.769 . . . . 25.0 111.178 -176.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 mt -88.17 88.76 7.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.162 -1.422 . . . . 25.0 107.162 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -55.17 128.66 34.93 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.562 0.696 . . . . 25.0 110.877 -177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.51 -15.27 57.37 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 119.112 -0.827 . . . . 25.0 114.231 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -90.9 129.99 36.88 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.755 1.277 . . . . 25.0 108.0 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -113.16 127.61 56.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 tp -75.37 119.15 19.07 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.911 -1.514 . . . . 25.0 106.911 178.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.2 m -132.53 169.93 15.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.959 0.409 . . . . 25.0 109.97 178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.62 129.34 47.09 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 176.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.02 132.66 23.77 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.739 -1.578 . . . . 25.0 106.739 -177.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 27.9 m170 56.01 27.18 10.9 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.019 0.528 . . . . 25.0 112.033 -178.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.76 7.16 88.37 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.021 -0.609 . . . . 25.0 114.314 -179.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 137.04 49.74 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 105.728 -1.953 . . . . 25.0 105.728 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -101.12 147.15 26.56 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 25.0 109.362 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.77 174.08 45.38 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.331 -0.708 . . . . 25.0 111.331 177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.2 pt -85.87 155.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.611 0.72 . . . . 25.0 110.009 -179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.6 t -141.83 139.53 18.47 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.293 -1.003 . . . . 25.0 108.293 -178.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.25 119.37 6.35 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 117.408 -1.262 . . . . 25.0 111.091 175.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.87 -21.71 61.39 Favored Glycine 0 C--O 1.224 -0.474 0 CA-C-O 121.436 0.465 . . . . 25.0 112.07 -179.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -61.55 -17.99 57.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.092 0.557 . . . . 25.0 112.439 176.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -114.82 10.54 16.51 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.92 -0.488 . . . . 25.0 111.808 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -121.79 151.53 40.48 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 113.637 0.977 . . . . 25.0 113.637 -179.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -129.27 119.94 24.84 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.709 -1.132 . . . . 25.0 110.303 174.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.29 126.84 28.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 177.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.82 70.05 4.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 25.0 111.287 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.93 -33.44 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.43 -0.952 . . . . 25.0 108.43 176.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.15 -3.55 61.54 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 115.838 -0.619 . . . . 25.0 113.825 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 48.0 ttp -134.74 75.58 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.591 0.71 . . . . 25.0 111.04 -176.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -161.12 145.99 13.83 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.521 -1.289 . . . . 25.0 107.521 176.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -162.52 -54.11 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.651 -0.5 . . . . 25.0 109.651 178.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 91.0 mttt 55.88 40.13 30.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.085 -0.961 . . . . 25.0 113.222 176.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -111.51 146.55 34.87 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 107.117 -1.438 . . . . 25.0 107.117 176.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.16 124.06 9.72 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 116.232 -2.045 . . . . 25.0 112.685 -178.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 49.6 34.22 6.86 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.318 1.229 . . . . 25.0 114.318 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.15 176.53 41.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.384 -0.913 . . . . 25.0 112.989 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.7 p -144.45 162.63 36.03 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.06 -1.459 . . . . 25.0 107.06 -178.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.48 153.32 13.23 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 119.642 -1.266 . . . . 25.0 115.55 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.0 -153.76 24.39 Favored Glycine 0 C--O 1.227 -0.32 0 N-CA-C 110.594 -1.002 . . . . 25.0 110.594 178.525 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 80.0 p -135.34 154.54 51.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.613 -0.884 . . . . 25.0 108.613 177.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.52 -166.55 37.84 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 110.826 -0.909 . . . . 25.0 110.826 177.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.7 p -148.96 159.61 44.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 177.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.03 171.9 41.26 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 107.621 -2.191 . . . . 25.0 107.621 178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.2 mt 59.64 176.58 0.08 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.116 0.966 . . . . 25.0 112.361 -175.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 t -123.05 -12.43 7.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.906 -0.775 . . . . 25.0 108.906 177.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -99.67 116.99 33.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -145.68 126.69 14.59 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.712 -1.958 . . . . 25.0 105.712 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.3 mt -106.26 142.15 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 25.0 110.895 -176.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.3 146.18 39.41 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 115.735 -0.666 . . . . 25.0 111.625 -177.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.82 165.39 31.55 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 119.859 0.373 . . . . 25.0 112.513 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.75 161.17 45.96 Favored 'Trans proline' 0 C--N 1.347 0.473 0 N-CA-C 115.16 1.177 . . . . 25.0 115.16 -176.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -84.35 149.88 56.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.875 -1.057 . . . . 25.0 108.959 177.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.85 162.57 41.63 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 117.761 -1.026 . . . . 25.0 110.019 170.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.77 172.22 16.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 N-CA-C 113.85 0.673 . . . . 25.0 113.85 -176.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.97 153.36 79.75 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.776 -0.647 . . . . 25.0 110.743 177.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.64 173.29 11.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.608 2.872 . . . . 25.0 113.933 176.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.75 57.64 4.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.402 175.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.33 -161.97 47.38 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.599 0.599 . . . . 25.0 114.599 178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -123.09 141.69 51.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 -179.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 C--O 1.212 -0.875 0 CA-C-O 125.348 2.499 . . . . 25.0 110.644 178.103 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.912 0 CA-C-O 124.033 1.907 . . . . 25.0 115.46 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -73.97 30.23 0.08 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.146 1.378 . . . . 25.0 114.149 -179.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.36 9.41 20.63 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 25.0 111.096 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -125.17 130.38 52.04 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 178.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 58.78 172.94 0.07 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 125.212 1.57 . . . . 25.0 115.072 176.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.16 -39.25 89.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.08 -0.711 . . . . 25.0 109.08 179.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.26 51.96 15.71 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 122.123 0.963 . . . . 25.0 113.133 177.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.58 163.97 5.18 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.734 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 -179.205 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -98.1 143.27 28.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.378 -0.601 . . . . 25.0 109.378 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.58 143.89 41.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 177.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -102.93 137.2 41.43 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.344 0.257 . . . . 25.0 111.5 179.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.54 125.65 28.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.977 -0.556 . . . . 25.0 109.886 175.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -88.29 -17.91 29.68 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 176.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -143.14 163.26 33.38 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 105.782 -1.933 . . . . 25.0 105.782 -178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -80.21 166.73 21.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 175.569 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -143.89 131.47 21.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.257 -0.646 . . . . 25.0 109.257 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -105.85 123.62 60.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.316 -2.846 . . . . 25.0 103.316 175.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.39 118.99 17.98 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.13 -24.64 13.92 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.073 -0.714 . . . . 25.0 109.073 -178.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.8 m -106.47 152.74 40.73 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 178.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.04 -14.71 35.54 Favored 'Trans proline' 0 C--N 1.341 0.169 0 O-C-N 121.94 0.442 . . . . 25.0 113.023 -179.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.82 -7.15 53.14 Favored 'General case' 0 C--O 1.198 -1.625 0 N-CA-C 110.162 -0.31 . . . . 25.0 110.162 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -94.2 150.21 20.52 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.444 0.535 . . . . 25.0 112.444 -172.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.9 mt -96.59 144.35 26.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.593 0.711 . . . . 25.0 112.374 176.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.54 129.64 55.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 177.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.34 172.58 17.46 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.443 -0.799 . . . . 25.0 110.764 -177.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -108.0 159.55 16.47 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -55.89 132.72 50.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 173.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.72 -8.72 63.89 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 119.138 -0.812 . . . . 25.0 113.762 178.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 161.33 30.5 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 117.621 0.711 . . . . 25.0 110.286 -179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.8 mm -121.4 125.58 73.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.8 ptp -126.08 154.06 43.61 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.6 m -88.19 113.5 23.87 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.873 -1.058 . . . . 25.0 109.5 -179.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 8' ' ' VAL . 34.1 t -80.82 121.13 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 N-CA-C 108.459 -0.941 . . . . 25.0 108.459 178.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.8 mt -93.25 -45.57 7.79 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.813 -1.085 . . . . 25.0 109.12 -177.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.2 pt-20 -153.06 171.04 19.02 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 172.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 mtm105 -124.45 153.38 42.04 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.174 -1.787 . . . . 25.0 106.174 177.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 59.85 35.82 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.581 1.658 . . . . 25.0 107.961 176.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 t -65.39 147.06 54.09 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 112.836 -1.984 . . . . 25.0 111.538 -175.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 57.77 14.51 2.51 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.482 0.919 . . . . 25.0 113.482 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.46 10.55 83.31 Favored Glycine 0 N--CA 1.454 -0.146 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -90.43 87.72 6.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.485 -1.672 . . . . 25.0 106.485 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.67 138.08 57.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.568 0.699 . . . . 25.0 109.213 -177.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.95 38.06 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.519 -0.848 . . . . 25.0 113.485 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -92.83 129.92 38.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.305 1.053 . . . . 25.0 108.185 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -113.13 127.15 56.11 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 25.0 109.2 -177.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 56.0 tp -75.24 120.43 20.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.154 -1.424 . . . . 25.0 107.154 178.141 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.7 m -133.21 171.1 14.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.093 0.473 . . . . 25.0 110.435 178.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.8 128.35 42.16 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 176.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -140.77 133.15 28.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -179.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.2 m170 55.88 29.11 13.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.154 0.581 . . . . 25.0 112.075 -178.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.19 7.18 86.79 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.106 -0.568 . . . . 25.0 114.047 -179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.78 137.0 48.21 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 105.425 -2.065 . . . . 25.0 105.425 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -102.69 149.27 24.62 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.188 -0.671 . . . . 25.0 109.188 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.78 171.11 40.09 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.866 -0.683 . . . . 25.0 112.514 177.3 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.6 pt -83.95 155.17 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.661 0.743 . . . . 25.0 109.712 -179.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.71 140.03 17.93 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.166 -1.05 . . . . 25.0 108.166 -178.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.26 120.49 7.34 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 117.9 -0.933 . . . . 25.0 111.408 177.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.01 -26.27 63.07 Favored Glycine 0 C--O 1.224 -0.504 0 CA-C-N 116.358 -0.383 . . . . 25.0 113.696 -177.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.32 -14.97 59.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 178.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -110.29 8.68 23.57 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.984 -0.448 . . . . 25.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.81 152.0 40.0 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -179.012 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.1 ttmt -128.5 119.82 25.6 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.736 -1.12 . . . . 25.0 110.156 174.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.488 HG23 HG21 ' A' ' 8' ' ' VAL . 33.6 mm -69.72 128.32 32.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.515 -0.92 . . . . 25.0 108.515 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.0 mt -100.5 85.77 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.308 0.575 . . . . 25.0 109.741 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.39 107.33 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.745 -0.465 . . . . 25.0 109.745 -178.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.32 47.53 1.02 Allowed Glycine 0 C--O 1.215 -1.055 0 CA-C-N 116.427 -0.351 . . . . 25.0 113.217 -178.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.0 ptp -130.86 18.82 5.07 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -177.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -132.17 94.78 3.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.04 6.42 1.6 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.74 0.816 . . . . 25.0 112.98 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -63.36 -16.8 61.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.13 0.789 . . . . 25.0 113.13 -176.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -159.08 157.67 28.12 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 107.692 -1.225 . . . . 25.0 107.692 175.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.34 160.83 47.61 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 116.612 -1.792 . . . . 25.0 112.379 175.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.55 24.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.463 -0.569 . . . . 25.0 109.463 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -175.62 145.97 7.99 Favored Glycine 0 N--CA 1.453 -0.194 0 N-CA-C 109.199 -1.56 . . . . 25.0 109.199 176.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 t -163.45 150.38 12.39 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.49 174.07 46.61 Favored Glycine 0 C--O 1.226 -0.358 0 N-CA-C 107.984 -2.046 . . . . 25.0 107.984 178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.31 18.5 0.1 Allowed Glycine 0 C--O 1.221 -0.712 0 CA-C-N 117.944 0.872 . . . . 25.0 115.262 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.2 m 52.46 27.86 5.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.24 1.941 . . . . 25.0 116.24 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -68.76 138.81 32.12 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.425 -0.893 . . . . 25.0 111.005 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -99.69 -11.45 20.87 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.453 1.279 . . . . 25.0 114.453 -174.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.48 -174.15 44.47 Favored Glycine 0 C--O 1.228 -0.25 0 N-CA-C 109.735 -1.346 . . . . 25.0 109.735 -177.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.6 mp -122.0 93.25 3.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.4 t -155.23 155.29 33.58 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.565 -1.272 . . . . 25.0 107.565 178.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 50.85 34.11 9.77 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.202 1.927 . . . . 25.0 116.202 171.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -105.74 81.87 1.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.817 0.818 . . . . 25.0 110.617 -178.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.5 mt -76.93 151.89 35.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.543 -0.753 . . . . 25.0 111.903 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 148.73 52.92 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 113.593 0.96 . . . . 25.0 113.593 -175.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.19 165.1 33.57 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 120.512 0.808 . . . . 25.0 111.92 175.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.25 167.31 27.21 Favored 'Trans proline' 0 C--N 1.345 0.36 0 N-CA-C 113.691 0.612 . . . . 25.0 113.691 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -91.63 150.43 41.0 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 107.608 -1.256 . . . . 25.0 107.608 176.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.85 159.37 54.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 116.851 -1.633 . . . . 25.0 108.893 167.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.57 174.99 11.68 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 118.586 -0.476 . . . . 25.0 113.062 -177.064 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.91 152.66 79.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.111 -0.7 . . . . 25.0 109.111 176.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.57 171.44 9.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.68 2.253 . . . . 25.0 113.739 175.471 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 mp0 -92.75 86.83 5.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.031 173.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.4 169.02 36.12 Favored Glycine 0 C--O 1.225 -0.407 0 C-N-CA 120.92 -0.657 . . . . 25.0 111.931 178.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 162.89 40.69 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.819 -1.549 . . . . 25.0 106.819 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.212 -0.887 0 CA-C-O 126.324 2.964 . . . . 25.0 112.587 -179.042 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.967 0 CA-C-O 124.123 1.957 . . . . 25.0 113.251 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m 56.89 26.52 11.78 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 112.118 -2.041 . . . . 25.0 112.604 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.3 tpt -81.42 47.82 1.09 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.887 0.475 . . . . 25.0 112.196 -177.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp 63.56 105.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.135 1.374 . . . . 25.0 113.267 -179.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 61.11 174.76 0.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.023 -0.99 . . . . 25.0 113.456 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 86.8 mt -72.66 -39.61 66.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 25.0 111.549 -176.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.87 52.88 11.24 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.831 0.853 . . . . 25.0 112.218 178.452 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -112.17 162.41 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.143 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -100.16 144.04 29.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.41 -0.589 . . . . 25.0 109.41 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.21 142.96 44.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 177.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.8 ttmt -103.81 137.16 42.22 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.66 0.384 . . . . 25.0 111.467 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 127.1 31.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.896 -0.593 . . . . 25.0 110.535 175.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -89.43 -20.14 24.29 Favored 'General case' 0 C--O 1.218 -0.588 0 O-C-N 122.013 -0.429 . . . . 25.0 110.363 174.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -144.1 166.28 25.45 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 -176.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -70.26 160.76 31.6 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.605 0.717 . . . . 25.0 111.473 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -141.19 126.21 18.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 -179.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -116.94 125.15 73.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.125 -2.546 . . . . 25.0 104.125 176.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.32 118.67 19.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.485 -0.779 . . . . 25.0 109.864 -176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -107.0 -17.75 14.1 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.854 0.835 . . . . 25.0 109.08 179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.17 151.45 40.77 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 114.968 -1.015 . . . . 25.0 108.475 -179.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.34 -15.79 38.87 Favored 'Trans proline' 0 C--N 1.343 0.263 0 CA-C-O 120.906 0.294 . . . . 25.0 112.769 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.81 -0.71 47.52 Favored 'General case' 0 C--O 1.206 -1.186 0 CA-C-N 116.294 -0.412 . . . . 25.0 110.243 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -97.06 150.4 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.125 0.488 . . . . 25.0 111.677 -171.718 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.81 171.52 9.88 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 174.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -137.79 134.95 35.83 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.855 -1.906 . . . . 25.0 105.855 173.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -158.66 171.96 19.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -177.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 tpt85 -106.99 150.52 26.4 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.985 0.914 . . . . 25.0 108.953 -179.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -51.58 128.53 23.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.111 -0.495 . . . . 25.0 109.925 173.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.74 -13.47 57.84 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-O 119.29 -0.728 . . . . 25.0 113.978 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.54 156.59 38.66 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.616 0.708 . . . . 25.0 109.953 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.42 HD11 ' HE3' ' A' ' 11' ' ' LYS . 47.0 mm -116.05 129.06 73.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.6 ptp -126.52 154.55 43.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 176.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.9 114.29 26.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.963 -1.017 . . . . 25.0 109.077 -179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 8' ' ' VAL . 25.8 t -79.45 124.35 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 108.445 -0.946 . . . . 25.0 108.445 178.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.3 mt -95.43 -47.83 6.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.023 -0.99 . . . . 25.0 108.423 -179.118 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.6 pt-20 -152.6 174.65 13.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -128.45 151.49 49.33 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 106.329 -1.73 . . . . 25.0 106.329 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 59.34 37.5 23.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 123.772 1.748 . . . . 25.0 107.92 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.423 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.9 t -66.23 147.5 53.24 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 112.507 -2.133 . . . . 25.0 111.45 -176.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 57.65 15.5 2.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.63 0.772 . . . . 25.0 112.893 -178.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.3 12.92 82.6 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.461 -0.656 . . . . 25.0 111.461 -177.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.16 91.06 8.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.374 -0.972 . . . . 25.0 108.374 -179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.08 129.97 44.06 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.578 0.704 . . . . 25.0 110.67 -178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.19 -13.71 60.99 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-O 119.393 -0.671 . . . . 25.0 114.257 179.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -94.3 129.93 40.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.161 0.981 . . . . 25.0 108.723 177.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -113.86 127.81 56.14 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.565 -0.709 . . . . 25.0 110.12 -177.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.8 tp -76.82 119.1 20.13 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 107.907 -1.145 . . . . 25.0 107.907 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.8 m -132.92 169.5 16.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.305 0.574 . . . . 25.0 110.379 179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.17 48.51 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.655 -1.239 . . . . 25.0 107.655 176.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.1 128.68 18.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.2 m170 55.52 31.13 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.807 0.669 . . . . 25.0 112.807 177.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.04 8.88 87.25 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.991 -0.624 . . . . 25.0 114.301 179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -114.69 139.43 49.67 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 104.612 -2.366 . . . . 25.0 104.612 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -109.78 145.34 36.84 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.0 171.65 42.43 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.408 -0.901 . . . . 25.0 113.529 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -82.59 154.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.569 0.699 . . . . 25.0 109.464 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.5 t -142.5 141.14 19.93 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.062 -1.088 . . . . 25.0 108.062 -178.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.95 117.91 5.24 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 118.26 -0.694 . . . . 25.0 111.19 176.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.67 -24.26 66.06 Favored Glycine 0 C--O 1.223 -0.563 0 N-CA-C 114.496 0.558 . . . . 25.0 114.496 -174.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -76.66 -3.21 36.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.974 -0.721 . . . . 25.0 112.727 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -110.87 6.26 21.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.963 -0.384 . . . . 25.0 109.963 172.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -119.24 153.14 35.46 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.906 0.86 . . . . 25.0 112.375 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -126.32 119.85 28.4 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.973 -1.012 . . . . 25.0 109.392 173.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.435 HG23 HG21 ' A' ' 8' ' ' VAL . 43.6 mm -69.26 127.17 30.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.17 85.68 4.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.503 -1.295 . . . . 25.0 107.503 179.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.8 130.13 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 -178.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -82.92 146.33 24.1 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 109.761 -1.336 . . . . 25.0 109.761 177.451 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.4 ttt 62.33 -174.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.756 0.822 . . . . 25.0 112.205 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 67.23 -38.42 0.34 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 117.098 2.258 . . . . 25.0 117.098 178.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -66.65 135.08 53.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -142.86 33.13 1.39 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.802 0.81 . . . . 25.0 109.517 -176.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -83.45 158.99 62.51 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.482 -0.932 . . . . 25.0 108.482 179.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.95 154.4 72.89 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 115.702 -2.399 . . . . 25.0 111.261 174.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -142.21 166.88 23.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.307 -1.368 . . . . 25.0 107.307 -179.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.37 -170.74 37.27 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.445 -1.462 . . . . 25.0 109.445 -179.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.3 m -65.91 153.16 42.78 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.641 0.608 . . . . 25.0 112.641 -179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.22 -146.62 21.18 Favored Glycine 0 C--O 1.221 -0.677 0 N-CA-C 110.151 -1.18 . . . . 25.0 110.151 175.487 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.4 22.07 17.9 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.969 -0.634 . . . . 25.0 114.134 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.0 t -70.28 159.0 34.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 176.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.59 -143.92 5.62 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 116.25 -0.432 . . . . 25.0 113.236 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 m 57.93 31.32 20.42 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.197 0.814 . . . . 25.0 113.197 -179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.41 -11.79 84.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.761 -0.733 . . . . 25.0 113.129 178.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.9 mt -129.87 79.78 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.307 -0.627 . . . . 25.0 109.307 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.1 t -152.35 168.97 23.71 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.06 -2.2 . . . . 25.0 105.06 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -77.5 141.08 39.84 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 176.087 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -145.56 97.39 2.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 177.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.9 mt -80.44 130.52 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.569 0.699 . . . . 25.0 110.855 -177.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.48 151.46 59.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.362 -0.836 . . . . 25.0 110.984 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.91 159.51 53.03 Favored 'Trans proline' 0 C--O 1.239 0.554 0 C-N-CA 117.213 -1.391 . . . . 25.0 112.197 176.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.71 153.87 59.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 117.977 -0.882 . . . . 25.0 112.506 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -77.73 152.68 80.57 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.111 -1.07 . . . . 25.0 108.111 177.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.06 162.67 40.77 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 118.13 -0.78 . . . . 25.0 110.531 174.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.15 175.51 10.42 Favored 'Trans proline' 0 C--N 1.347 0.48 0 O-C-N 121.921 0.432 . . . . 25.0 112.981 -177.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.1 mt -133.91 157.67 77.23 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.235 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.26 172.68 15.88 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.203 1.935 . . . . 25.0 113.208 178.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.3 56.77 1.77 Allowed 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.976 0.894 . . . . 25.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.57 -116.49 4.31 Favored Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.852 -0.69 . . . . 25.0 112.974 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.6 123.69 18.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.212 1.006 . . . . 25.0 110.414 -177.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.549 0.912 0 CA-C-O 125.798 2.713 . . . . 25.0 111.946 -175.173 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.805 0 CA-C-O 124.458 2.143 . . . . 25.0 114.162 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -146.72 158.1 43.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.833 -1.183 . . . . 25.0 109.258 179.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -75.49 165.14 25.57 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 177.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -84.23 20.64 1.56 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 120.799 0.333 . . . . 25.0 111.773 176.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -134.89 158.6 43.83 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.955 -0.566 . . . . 25.0 110.463 -178.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 73.7 mt -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.428 -0.805 . . . . 25.0 112.126 -176.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 52.04 53.43 12.54 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.489 0.922 . . . . 25.0 113.489 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -107.1 160.65 6.32 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 N-CA-C 106.705 -1.591 . . . . 25.0 106.705 179.057 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -95.3 143.85 26.35 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.208 -0.664 . . . . 25.0 109.208 177.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.5 142.93 41.48 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.679 -0.489 . . . . 25.0 109.679 176.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -103.76 138.65 40.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.305 0.378 . . . . 25.0 111.176 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.69 127.55 33.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.153 -0.476 . . . . 25.0 110.118 174.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.23 -18.54 26.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 175.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -144.69 161.01 40.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.807 -1.183 . . . . 25.0 107.807 -176.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -70.26 157.09 38.32 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.878 -0.416 . . . . 25.0 109.878 174.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -138.54 136.57 36.19 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.999 0.428 . . . . 25.0 110.221 173.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.07 125.41 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 104.03 -2.581 . . . . 25.0 104.03 177.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -76.55 113.5 14.24 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -102.89 -18.68 14.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.725 -0.843 . . . . 25.0 108.725 -179.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -103.58 152.2 38.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.938 -1.028 . . . . 25.0 108.537 179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.47 -13.71 35.82 Favored 'Trans proline' 0 C--N 1.343 0.266 0 N-CA-C 113.384 0.494 . . . . 25.0 113.384 -178.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -107.46 5.16 26.96 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 122.666 0.386 . . . . 25.0 111.617 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -95.67 152.58 18.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.978 0.418 . . . . 25.0 111.37 -176.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.0 mt -98.6 142.1 30.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.7 0.762 . . . . 25.0 111.946 175.798 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -107.99 129.99 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 177.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.63 168.03 27.56 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.861 -0.608 . . . . 25.0 112.442 -179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 tpt85 -99.46 152.68 19.72 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.515 -0.766 . . . . 25.0 109.485 -179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -55.29 127.87 31.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.503 -0.925 . . . . 25.0 108.503 172.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.53 -13.82 58.05 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-O 119.128 -0.818 . . . . 25.0 114.508 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.77 159.62 33.24 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 117.964 0.882 . . . . 25.0 110.704 -178.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.8 mm -118.42 129.81 74.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.148 -0.686 . . . . 25.0 109.148 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.1 ptp -127.83 157.57 40.08 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 175.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.7 m -92.53 113.34 25.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.291 -0.868 . . . . 25.0 109.048 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HB ' HG22 ' A' ' 8' ' ' VAL . 42.1 t -79.76 122.42 34.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.801 -0.814 . . . . 25.0 108.801 179.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -94.86 -43.63 8.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.477 -0.783 . . . . 25.0 109.726 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -154.14 173.17 16.43 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 173.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -126.95 151.98 47.78 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 106.038 -1.838 . . . . 25.0 106.038 178.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 59.44 36.62 23.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 123.429 1.585 . . . . 25.0 108.307 178.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 t -64.85 143.55 57.86 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 112.771 -2.013 . . . . 25.0 111.085 -175.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 59.59 11.65 2.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.943 0.897 . . . . 25.0 112.741 -178.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.23 82.02 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 111.384 -0.686 . . . . 25.0 111.384 -176.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.58 96.23 10.33 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 107.09 -1.448 . . . . 25.0 107.09 -179.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -66.47 139.78 57.98 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.077 0.942 . . . . 25.0 110.971 -175.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 -16.4 18.39 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.496 -0.775 . . . . 25.0 113.184 -177.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.17 130.02 37.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 118.573 1.187 . . . . 25.0 108.692 176.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -115.42 128.72 56.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.171 -0.677 . . . . 25.0 109.171 -177.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.0 tp -75.76 121.36 22.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.217 -1.401 . . . . 25.0 107.217 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 m -134.35 169.3 17.43 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.14 0.495 . . . . 25.0 110.536 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.2 129.04 47.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.11 -1.07 . . . . 25.0 108.11 178.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.33 134.71 19.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.356 -1.35 . . . . 25.0 107.356 -176.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 40.1 m170 56.05 29.37 14.36 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.265 0.626 . . . . 25.0 112.059 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.99 10.85 85.09 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 120.9 -0.667 . . . . 25.0 113.948 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -117.85 139.51 51.0 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 105.907 -1.886 . . . . 25.0 105.907 -178.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -104.41 147.83 27.11 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.78 -0.822 . . . . 25.0 108.78 178.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.7 171.8 42.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.694 -0.765 . . . . 25.0 112.576 178.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.0 pt -83.02 154.47 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.863 0.839 . . . . 25.0 109.613 -179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.32 139.2 18.56 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.9 -1.045 . . . . 25.0 108.37 -177.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.42 116.61 4.7 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 118.522 -0.518 . . . . 25.0 111.309 175.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.03 -21.25 58.91 Favored Glycine 0 C--O 1.223 -0.56 0 O-C-N 122.028 -0.42 . . . . 25.0 112.941 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -16.51 63.69 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.263 -0.551 . . . . 25.0 111.703 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -113.8 9.07 17.57 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.132 -0.355 . . . . 25.0 111.173 179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -126.86 141.1 51.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -174.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.6 ttpt -120.81 120.05 34.47 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 115.561 -0.745 . . . . 25.0 111.508 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 HG21 ' A' ' 8' ' ' VAL . 50.2 mm -67.55 126.26 26.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.23 -0.895 . . . . 25.0 108.733 175.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.7 mt -90.09 85.45 6.3 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.222 -1.029 . . . . 25.0 108.222 178.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.83 162.3 4.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.86 -1.064 . . . . 25.0 110.153 -179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.8 170.94 35.49 Favored Glycine 0 CA--C 1.517 0.175 0 C-N-CA 120.786 -0.721 . . . . 25.0 111.393 177.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.6 ttm 71.79 -39.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.317 1.447 . . . . 25.0 113.903 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -86.69 68.91 10.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.05 1.13 . . . . 25.0 114.05 -177.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -93.8 -72.86 0.59 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.493 -0.776 . . . . 25.0 109.201 173.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt 54.32 64.99 1.63 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.098 0.777 . . . . 25.0 113.098 177.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -59.24 145.6 80.73 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-N 115.545 -0.752 . . . . 25.0 110.469 177.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -78.74 175.43 11.01 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 120.661 0.908 . . . . 25.0 114.216 -177.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.79 168.13 22.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.572 -2.381 . . . . 25.0 104.572 175.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 34.87 9.9 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.691 -0.766 . . . . 25.0 112.308 -179.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m 60.79 -161.71 0.28 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.626 0.77 . . . . 25.0 111.651 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 166.71 -176.89 41.71 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 108.681 -1.768 . . . . 25.0 108.681 -177.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -179.14 -179.07 48.66 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 109.134 -1.586 . . . . 25.0 109.134 178.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.7 m -107.17 123.84 48.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 178.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.86 52.09 0.32 Allowed Glycine 0 C--O 1.217 -0.925 0 N-CA-C 111.361 -0.696 . . . . 25.0 111.361 -177.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -65.06 -22.51 66.98 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 114.614 1.338 . . . . 25.0 114.614 -175.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.31 -153.69 29.31 Favored Glycine 0 CA--C 1.516 0.103 0 C-N-CA 120.609 -0.805 . . . . 25.0 111.93 -178.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.4 mp -82.63 170.27 15.33 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.7 p -66.67 128.76 37.49 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.294 -0.632 . . . . 25.0 109.294 176.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.27 -172.95 4.3 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.195 -0.668 . . . . 25.0 109.195 -176.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 59.19 95.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.141 1.534 . . . . 25.0 115.141 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.84 129.5 40.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.655 -0.702 . . . . 25.0 109.265 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -76.76 153.03 83.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.512 -0.767 . . . . 25.0 112.344 -175.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -68.43 164.41 32.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 O-C-N 121.801 0.369 . . . . 25.0 111.666 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.18 160.95 47.82 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 118.212 -0.725 . . . . 25.0 113.284 -177.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -94.1 150.08 37.86 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 106.188 -1.782 . . . . 25.0 106.188 174.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.17 163.37 36.36 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 117.985 -0.877 . . . . 25.0 110.695 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.09 174.43 12.44 Favored 'Trans proline' 0 C--N 1.347 0.482 0 N-CA-C 113.438 0.515 . . . . 25.0 113.438 -176.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.7 mt -133.97 157.25 78.16 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.67 -0.695 . . . . 25.0 110.337 179.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 97' ' ' GLY . 67.5 Cg_endo -74.99 -177.96 3.83 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.59 1.527 . . . . 25.0 110.636 174.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 68.88 -6.7 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.364 1.465 . . . . 25.0 114.204 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 95' ' ' PRO . . . -98.86 14.9 61.33 Favored Glycine 0 C--N 1.313 -0.703 0 CA-C-N 113.587 -1.642 . . . . 25.0 109.421 172.223 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -137.57 147.21 44.92 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.434 -1.321 . . . . 25.0 107.434 -178.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.483 1.211 0 C-N-CA 125.346 1.459 . . . . 25.0 113.646 179.555 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.931 0 CA-C-O 124.568 2.204 . . . . 25.0 113.707 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.2 t -68.47 -19.03 64.53 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.276 -1.132 . . . . 25.0 111.86 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ptm -147.59 28.28 0.97 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.557 0.694 . . . . 25.0 110.536 -179.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -143.4 153.32 42.56 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 105.131 -2.174 . . . . 25.0 105.131 179.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 59.74 168.06 0.07 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.57 1.322 . . . . 25.0 114.57 179.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.99 -41.98 70.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.639 -0.709 . . . . 25.0 111.663 -176.55 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 49.27 56.11 8.32 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -108.59 164.42 5.46 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 178.315 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.0 mt -100.1 145.92 27.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 118.931 0.787 . . . . 25.0 109.698 177.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.14 144.44 40.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.25 -0.278 . . . . 25.0 110.25 178.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -105.47 139.54 39.94 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.697 0.399 . . . . 25.0 111.017 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.65 130.91 39.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.435 . . . . 25.0 110.497 175.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.2 mm? -91.05 -17.67 25.84 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 174.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.19 154.8 42.18 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -177.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.23 155.03 38.26 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.583 0.552 . . . . 25.0 109.637 175.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -138.62 136.98 36.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.309 -0.405 . . . . 25.0 110.011 175.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.1 t -115.19 126.1 72.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 104.067 -2.568 . . . . 25.0 104.067 175.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.38 127.37 32.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.657 -0.701 . . . . 25.0 109.289 -177.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -108.6 -20.17 13.18 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.872 -0.788 . . . . 25.0 108.872 179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.51 147.38 33.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 175.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -7.93 22.23 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 120.132 0.554 . . . . 25.0 112.782 177.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -106.38 4.45 28.52 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 122.806 0.443 . . . . 25.0 110.602 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -100.62 153.25 19.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.834 0.349 . . . . 25.0 110.288 -178.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.98 144.82 27.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.821 0.82 . . . . 25.0 112.381 177.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.1 m -104.72 130.47 52.78 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 176.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -153.02 166.94 30.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.541 0.941 . . . . 25.0 113.541 178.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.2 tpt85 -93.55 156.71 16.58 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.156 -0.929 . . . . 25.0 110.396 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -60.26 127.63 32.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.199 -1.408 . . . . 25.0 107.199 169.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.26 -10.53 65.42 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-O 119.376 -0.68 . . . . 25.0 114.476 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.87 160.22 33.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 117.336 0.568 . . . . 25.0 110.459 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.43 125.99 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 122.869 0.467 . . . . 25.0 110.164 -178.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 ptp -126.46 155.02 42.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.207 0.527 . . . . 25.0 110.415 176.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -89.49 112.46 23.64 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.26 -0.882 . . . . 25.0 109.565 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 8' ' ' VAL . 31.8 t -80.58 123.36 37.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 CA-C-O 121.213 0.53 . . . . 25.0 109.706 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -96.57 -44.22 7.25 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.285 -0.871 . . . . 25.0 110.383 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.16 173.17 16.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.551 -0.536 . . . . 25.0 109.551 173.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -127.89 150.02 50.05 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.62 -1.622 . . . . 25.0 106.62 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 59.53 36.09 22.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.644 1.688 . . . . 25.0 107.945 178.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -64.21 145.44 55.97 Favored 'General case' 0 C--O 1.211 -0.921 0 CA-C-N 112.494 -2.139 . . . . 25.0 111.581 -176.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 57.91 16.31 3.6 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.996 0.918 . . . . 25.0 113.142 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.76 12.13 83.15 Favored Glycine 0 C--O 1.226 -0.38 0 N-CA-C 111.511 -0.636 . . . . 25.0 111.511 -177.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 mt -90.56 89.57 7.61 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.575 -1.269 . . . . 25.0 107.575 -179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.65 130.33 44.84 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.496 0.665 . . . . 25.0 110.604 -178.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.26 -14.87 56.6 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.071 -0.585 . . . . 25.0 114.266 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -92.73 130.02 38.48 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.158 0.979 . . . . 25.0 108.369 177.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -115.06 128.11 56.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.058 -0.719 . . . . 25.0 109.058 -177.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 52.2 tp -74.81 121.81 22.37 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.181 -1.415 . . . . 25.0 107.181 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -134.74 172.49 12.88 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.944 -0.391 . . . . 25.0 109.944 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.86 130.53 45.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.946 -1.131 . . . . 25.0 107.946 176.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.8 tp -143.4 133.97 24.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.0 m170 55.29 28.96 12.06 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.296 0.639 . . . . 25.0 111.626 -178.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.73 5.66 89.32 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 115.112 0.805 . . . . 25.0 115.112 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -113.59 136.91 52.3 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 106.301 -1.74 . . . . 25.0 106.301 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -96.05 147.8 23.34 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.597 -0.52 . . . . 25.0 109.597 178.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.96 168.52 38.84 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.989 -0.624 . . . . 25.0 111.545 177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.12 156.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.615 0.722 . . . . 25.0 109.641 -179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.2 t -142.4 139.66 17.9 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 107.974 -1.121 . . . . 25.0 107.974 -177.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.39 113.11 3.37 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 118.222 -0.718 . . . . 25.0 110.939 175.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.68 -21.74 58.51 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-O 121.284 0.38 . . . . 25.0 112.437 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -64.19 -15.38 59.79 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.643 0.608 . . . . 25.0 112.643 177.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.27 9.91 14.67 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 122.001 -0.437 . . . . 25.0 110.949 178.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 tp -125.34 142.43 51.5 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -174.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.5 ttmt -119.06 119.97 35.82 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 115.822 -0.626 . . . . 25.0 111.154 178.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 HG21 ' A' ' 8' ' ' VAL . 49.3 mm -70.1 125.92 29.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.562 -0.903 . . . . 25.0 108.562 176.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.5 mt -94.38 89.7 5.98 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.296 -1.372 . . . . 25.0 107.296 178.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.19 108.82 9.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.428 -0.805 . . . . 25.0 109.642 -176.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.38 46.24 3.63 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 112.013 -0.435 . . . . 25.0 112.013 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.51 151.03 32.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.863 -1.162 . . . . 25.0 107.863 -175.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 63.43 10.22 4.68 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.858 1.799 . . . . 25.0 115.858 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -81.62 125.55 30.68 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.592 -0.693 . . . . 25.0 111.705 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -150.04 29.44 0.73 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.91 -1.144 . . . . 25.0 107.91 175.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -78.17 155.74 79.51 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.428 -0.805 . . . . 25.0 111.191 -174.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.51 160.21 44.81 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 117.692 -1.072 . . . . 25.0 112.324 178.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.05 -170.71 0.16 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.307 1.043 . . . . 25.0 112.2 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.52 166.15 20.58 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 111.074 -0.81 . . . . 25.0 111.074 -178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.0 p -66.13 -23.71 66.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 179.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.46 167.43 43.24 Favored Glycine 0 CA--C 1.517 0.199 0 CA-C-O 121.493 0.496 . . . . 25.0 113.625 177.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.28 130.22 10.18 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 110.035 -1.226 . . . . 25.0 110.035 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.6 p -152.38 152.86 32.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.955 -1.128 . . . . 25.0 107.955 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.52 -2.67 30.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 121.47 -0.395 . . . . 25.0 113.543 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.2 m -65.09 153.08 41.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.823 -0.806 . . . . 25.0 108.823 175.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.77 60.23 3.38 Favored Glycine 0 C--O 1.218 -0.9 0 CA-C-N 116.647 -0.251 . . . . 25.0 113.601 179.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.8 mt -73.47 -17.04 61.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.893 0.477 . . . . 25.0 111.362 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.0 -163.57 0.24 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.103 0.877 . . . . 25.0 109.497 -177.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 55.49 -176.69 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.98 1.474 . . . . 25.0 114.98 -179.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.7 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.713 1.605 . . . . 25.0 112.156 -173.576 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.59 130.5 34.56 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.739 . . . . 25.0 111.573 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.57 140.96 72.18 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.383 -0.826 . . . . 25.0 112.033 -177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.74 165.95 30.97 Favored 'Trans proline' 0 C--O 1.24 0.616 0 N-CA-C 110.955 -0.441 . . . . 25.0 110.955 175.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -71.48 157.43 56.36 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 117.558 -1.161 . . . . 25.0 113.787 -177.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -88.18 150.34 46.99 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 175.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.64 159.44 52.74 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 117.847 -0.969 . . . . 25.0 111.521 178.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -61.75 169.01 7.66 Favored 'Trans proline' 0 CA--C 1.51 -0.722 0 N-CA-C 114.768 1.026 . . . . 25.0 114.768 -179.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.2 mt -133.95 154.62 80.41 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 113.275 -1.784 . . . . 25.0 110.274 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.89 169.81 20.99 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.143 1.895 . . . . 25.0 112.892 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -93.67 34.06 1.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.437 -0.801 . . . . 25.0 111.927 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.49 -171.16 20.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.449 -0.405 . . . . 25.0 113.825 178.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -103.78 149.06 25.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 122.021 0.915 . . . . 25.0 111.76 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 124.061 1.886 . . . . 25.0 112.503 177.151 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.258 0 CA-C-O 123.46 1.589 . . . . 25.0 114.949 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 54.76 22.02 3.9 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 113.245 -1.478 . . . . 25.0 114.567 177.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -63.95 126.8 28.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.988 -0.745 . . . . 25.0 108.988 -178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -125.36 3.11 7.75 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.606 -0.725 . . . . 25.0 110.003 -179.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -137.81 168.96 18.61 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.767 -1.106 . . . . 25.0 109.121 -176.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 66.4 mt -66.27 -39.35 89.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.807 -0.633 . . . . 25.0 110.945 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.1 m120 53.28 47.79 23.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.047 0.939 . . . . 25.0 112.895 178.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.57 162.47 4.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 108.072 -1.084 . . . . 25.0 108.072 -178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.0 mt -97.75 143.61 28.21 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.491 -0.756 . . . . 25.0 110.895 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.52 145.41 42.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.889 -0.411 . . . . 25.0 109.889 176.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -105.44 138.39 41.72 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.392 0.277 . . . . 25.0 111.253 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.21 129.03 37.03 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.767 0.667 . . . . 25.0 110.085 176.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -89.92 -18.69 25.65 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 120.671 0.272 . . . . 25.0 110.386 177.042 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -143.55 163.95 31.74 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.181 -2.155 . . . . 25.0 105.181 -178.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -81.24 170.05 16.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.525 0.679 . . . . 25.0 109.5 174.487 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -149.27 141.09 23.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.923 -0.58 . . . . 25.0 110.091 -179.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.31 129.26 70.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 103.924 -2.621 . . . . 25.0 103.924 174.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.39 109.72 9.16 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.12 -0.696 . . . . 25.0 109.12 -178.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.86 -23.14 15.99 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.356 -0.979 . . . . 25.0 108.356 -179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.64 149.34 35.68 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.229 -1.397 . . . . 25.0 107.229 178.312 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.21 -15.04 38.85 Favored 'Trans proline' 0 C--O 1.232 0.199 0 O-C-N 122.084 0.518 . . . . 25.0 111.949 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -94.98 -3.3 48.74 Favored 'General case' 0 C--O 1.206 -1.209 0 CA-C-N 116.299 -0.409 . . . . 25.0 111.53 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -94.95 155.79 16.6 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.042 0.756 . . . . 25.0 113.042 -170.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.6 mt -99.44 144.31 28.7 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.296 0.57 . . . . 25.0 112.013 176.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.2 m -104.98 131.65 52.22 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.043 -1.465 . . . . 25.0 107.043 174.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -156.38 172.79 17.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.273 -0.421 . . . . 25.0 112.009 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HB3' ' A' ' 15' ' ' ASP . 12.3 tpt180 -109.09 156.58 19.63 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.901 0.481 . . . . 25.0 110.142 -179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -54.62 130.56 40.65 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.346 -0.983 . . . . 25.0 108.346 173.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.06 -14.73 59.8 Favored Glycine 0 C--O 1.239 0.432 0 CA-C-O 118.98 -0.9 . . . . 25.0 114.211 -179.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -70.27 156.01 39.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.047 0.924 . . . . 25.0 110.89 -177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.0 mm -114.33 129.7 69.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 108.82 -0.807 . . . . 25.0 108.82 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.1 ptp -128.37 154.55 45.87 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.7 m -89.6 112.35 23.55 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 114.835 -1.075 . . . . 25.0 109.309 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.96 122.48 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 179.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.85 -47.27 6.82 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.727 -1.124 . . . . 25.0 109.39 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.404 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 16.0 pt-20 -152.96 172.02 17.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.437 -0.949 . . . . 25.0 108.437 173.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.58 151.23 49.7 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 106.111 -1.811 . . . . 25.0 106.111 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 60.09 36.72 21.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 123.835 1.779 . . . . 25.0 106.792 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.1 t -64.55 144.61 57.08 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 112.595 -2.093 . . . . 25.0 111.728 -174.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 57.64 14.19 2.28 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.875 0.87 . . . . 25.0 113.129 -178.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.88 11.94 80.63 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.355 -0.698 . . . . 25.0 111.355 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 mt -89.8 90.77 8.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -58.43 135.89 57.35 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.544 0.688 . . . . 25.0 109.454 -177.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.89 -17.82 34.3 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-O 118.96 -0.911 . . . . 25.0 114.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -91.65 130.56 37.43 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 118.837 1.318 . . . . 25.0 109.21 178.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -111.49 126.91 55.46 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.56 -0.712 . . . . 25.0 109.541 -178.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.9 tp -76.13 122.34 24.16 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 107.039 -1.467 . . . . 25.0 107.039 178.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.8 m -133.87 171.88 13.57 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.035 0.445 . . . . 25.0 110.832 178.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.06 131.78 45.92 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.886 -1.153 . . . . 25.0 107.886 175.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.86 132.06 19.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.43 -1.322 . . . . 25.0 107.43 -177.34 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 46.8 m170 55.79 29.46 13.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.871 0.693 . . . . 25.0 112.871 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.12 9.32 87.18 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.966 -0.635 . . . . 25.0 114.155 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.9 136.76 52.74 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 105.877 -1.897 . . . . 25.0 105.877 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -102.62 146.16 28.59 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.81 170.63 41.07 Favored Glycine 0 C--O 1.224 -0.495 0 C-N-CA 120.49 -0.862 . . . . 25.0 113.668 178.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.78 154.86 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.66 . . . . 25.0 109.707 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 88.8 t -142.94 140.31 17.92 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 107.425 -1.324 . . . . 25.0 107.425 -178.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.93 122.36 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 117.313 -1.325 . . . . 25.0 111.525 176.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.79 61.79 Favored Glycine 0 C--O 1.223 -0.542 0 O-C-N 122.126 -0.359 . . . . 25.0 113.693 -178.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.64 -15.09 57.33 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.803 0.441 . . . . 25.0 112.174 177.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -112.55 9.99 19.54 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.733 -0.604 . . . . 25.0 112.088 179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mt -124.82 151.47 45.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 114.236 1.199 . . . . 25.0 114.236 -178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.3 ttmt -128.35 118.54 23.37 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.56 -1.2 . . . . 25.0 111.004 176.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.9 mm -69.01 125.46 26.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 108.292 -1.003 . . . . 25.0 108.292 178.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 72.8 mt -93.84 74.19 4.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.395 0.617 . . . . 25.0 110.797 -178.016 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.53 -31.78 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.342 -0.845 . . . . 25.0 110.278 178.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.24 115.95 0.68 Allowed Glycine 0 C--O 1.221 -0.716 0 CA-C-N 116.278 -0.419 . . . . 25.0 113.333 178.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 66.8 mtm 62.07 -49.54 0.16 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.622 2.453 . . . . 25.0 117.622 178.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -53.34 144.6 16.03 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.04 0.536 . . . . 25.0 111.035 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.5 t0 56.16 69.69 0.71 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.681 0.993 . . . . 25.0 113.681 177.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm 54.2 29.2 10.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.909 1.818 . . . . 25.0 115.909 168.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -85.01 143.34 39.76 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.38 149.16 50.15 Favored 'Trans proline' 0 C--N 1.344 0.33 0 N-CA-C 114.553 0.944 . . . . 25.0 114.553 -172.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.92 161.15 27.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.523 -0.762 . . . . 25.0 109.254 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.36 -87.7 1.01 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.251 -0.74 . . . . 25.0 111.251 -179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.2 m 52.6 31.44 10.09 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.933 1.457 . . . . 25.0 114.933 177.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.72 87.0 Favored Glycine 0 C--O 1.223 -0.575 0 C-N-CA 120.673 -0.775 . . . . 25.0 112.549 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.39 152.99 8.65 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 109.967 -1.253 . . . . 25.0 109.967 176.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.2 t -167.0 153.66 8.49 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.14 -1.8 . . . . 25.0 106.14 178.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.74 154.95 12.0 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 109.235 -1.546 . . . . 25.0 109.235 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 16.5 m -131.22 19.36 4.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.407 0.604 . . . . 25.0 109.959 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 121.43 -173.95 15.79 Favored Glycine 0 CA--C 1.51 -0.28 0 N-CA-C 107.361 -2.296 . . . . 25.0 107.361 -174.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.32 -41.77 47.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.56 0.68 . . . . 25.0 110.187 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 70.15 139.13 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 125.155 1.535 . . . . 25.0 112.367 -177.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -80.78 121.8 26.37 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.769 -1.937 . . . . 25.0 105.769 175.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -147.81 117.37 7.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.314 -0.624 . . . . 25.0 109.314 -173.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.51 111.54 19.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.672 0.749 . . . . 25.0 109.381 178.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.54 148.28 98.64 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 25.0 111.324 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.92 160.58 49.14 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 117.868 -0.955 . . . . 25.0 111.781 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.82 153.8 63.86 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 118.089 -0.807 . . . . 25.0 113.065 -176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -81.14 148.87 64.92 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 106.065 -1.828 . . . . 25.0 106.065 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.17 163.29 38.36 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 118.239 -0.707 . . . . 25.0 110.657 177.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -71.28 176.47 7.86 Favored 'Trans proline' 0 C--N 1.347 0.46 0 CA-C-O 121.335 0.473 . . . . 25.0 112.88 -178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.0 mt -133.99 159.63 71.64 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 -179.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.29 -175.96 2.24 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.605 1.537 . . . . 25.0 111.349 178.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 57.3 14.95 2.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 115.403 1.631 . . . . 25.0 115.403 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.59 12.63 67.89 Favored Glycine 0 C--O 1.229 -0.169 0 N-CA-C 110.47 -1.052 . . . . 25.0 110.47 172.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.09 118.75 14.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.034 0.921 . . . . 25.0 109.037 -177.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.209 -1.04 0 CA-C-O 124.512 2.101 . . . . 25.0 112.712 -177.126 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.956 0 CA-C-O 124.615 2.231 . . . . 25.0 113.628 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.2 t -75.31 128.04 34.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 113.149 -1.526 . . . . 25.0 108.993 178.337 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.7 tpt -144.59 122.3 11.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 178.747 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 67.1 158.75 0.13 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 124.727 1.267 . . . . 25.0 108.417 -171.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 58.76 179.61 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.049 1.5 . . . . 25.0 115.049 176.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.8 mt -81.12 -40.39 24.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.675 -0.693 . . . . 25.0 111.146 -178.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 49.45 55.84 8.75 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.707 1.003 . . . . 25.0 113.707 -177.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -107.89 160.74 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.633 -1.617 . . . . 25.0 106.633 178.125 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.8 mt -97.85 143.14 28.77 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 121.686 -0.634 . . . . 25.0 109.526 178.138 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.56 143.91 43.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.294 -0.261 . . . . 25.0 110.294 177.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -103.61 137.15 42.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 122.653 0.381 . . . . 25.0 110.968 178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.73 125.22 26.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.85 -0.614 . . . . 25.0 110.665 173.641 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -84.73 -22.27 29.76 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 110.158 -0.312 . . . . 25.0 110.158 176.69 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -142.44 168.76 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 104.351 -2.463 . . . . 25.0 104.351 -177.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -79.78 171.36 15.23 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 174.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -145.75 136.13 24.01 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.797 -0.446 . . . . 25.0 109.797 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.7 t -108.11 123.62 63.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 104.611 -2.366 . . . . 25.0 104.611 176.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 117.61 18.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.554 -0.906 . . . . 25.0 108.554 -179.023 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -101.38 -21.56 14.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 25.0 109.063 -179.27 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -108.93 152.8 42.59 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.163 178.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 -13.31 32.09 Favored 'Trans proline' 0 C--N 1.344 0.321 0 O-C-N 121.843 0.391 . . . . 25.0 113.061 -179.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -6.36 52.95 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 109.953 -0.388 . . . . 25.0 109.953 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -97.38 148.72 22.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.194 0.521 . . . . 25.0 112.226 -170.846 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.5 mt -94.11 142.99 26.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.51 0.672 . . . . 25.0 111.314 175.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -110.53 133.27 53.45 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 106.702 -1.592 . . . . 25.0 106.702 175.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -154.88 171.75 19.15 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.521 -0.763 . . . . 25.0 111.872 -178.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -104.61 156.37 18.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 -179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -56.17 133.63 52.42 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 173.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.81 -10.88 66.39 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 118.881 -0.955 . . . . 25.0 114.087 177.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -70.6 158.57 35.93 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 117.763 0.782 . . . . 25.0 109.715 -179.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.8 130.59 73.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 178.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.0 ptp -128.6 156.49 43.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.123 -0.695 . . . . 25.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -89.96 113.56 25.23 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.117 -0.947 . . . . 25.0 109.029 -179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 8' ' ' VAL . 44.7 t -80.3 121.42 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.54 -46.32 7.35 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.204 -0.907 . . . . 25.0 109.188 -178.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.29 168.92 24.39 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 173.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 mtm105 -121.4 151.2 40.45 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 107.14 -1.429 . . . . 25.0 107.14 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 58.36 36.9 25.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 123.633 1.682 . . . . 25.0 108.258 176.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 t -64.23 147.44 52.39 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 112.752 -2.022 . . . . 25.0 111.382 -176.539 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 57.8 15.07 2.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.343 0.868 . . . . 25.0 113.343 -179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.44 11.95 82.56 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 111.368 -0.693 . . . . 25.0 111.368 -177.425 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.1 mt -90.26 89.72 7.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 -179.07 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.85 129.47 41.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.635 0.731 . . . . 25.0 110.742 -178.282 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.3 -14.61 58.9 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-O 119.473 -0.626 . . . . 25.0 113.952 179.453 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -93.18 129.73 39.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.997 -1.112 . . . . 25.0 107.997 176.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -116.14 128.1 55.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 -177.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.1 tp -74.82 121.38 21.72 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.8 m -135.42 169.65 17.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.1 0.476 . . . . 25.0 110.773 178.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.02 128.69 47.83 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.56 -0.904 . . . . 25.0 108.56 177.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.98 136.58 19.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.171 -1.048 . . . . 25.0 108.171 -176.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.5 m170 55.26 31.95 17.61 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.306 0.642 . . . . 25.0 112.219 178.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.82 13.41 82.38 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.926 -0.654 . . . . 25.0 114.268 179.445 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.08 146.16 47.47 Favored 'General case' 0 CA--C 1.505 -0.755 0 N-CA-C 106.247 -1.76 . . . . 25.0 106.247 179.176 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -107.56 146.35 32.01 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.018 -1.475 . . . . 25.0 107.018 177.157 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.64 170.55 41.98 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.533 -0.841 . . . . 25.0 112.736 179.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -82.96 155.1 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.714 0.769 . . . . 25.0 109.777 -179.563 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -141.01 139.55 19.61 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.377 -0.971 . . . . 25.0 108.377 -177.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.21 117.0 4.86 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 117.499 -1.201 . . . . 25.0 111.007 174.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.82 -19.8 61.31 Favored Glycine 0 C--O 1.219 -0.79 0 N-CA-C 111.689 -0.565 . . . . 25.0 111.689 179.054 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -63.58 -18.4 63.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.143 0.496 . . . . 25.0 111.957 176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -115.71 10.58 15.48 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 122.048 -0.407 . . . . 25.0 111.252 178.118 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 tp -126.56 140.71 52.23 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -175.429 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 13' ' ' LEU . 37.9 ttpt -120.7 120.01 34.47 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.718 -0.674 . . . . 25.0 111.783 179.521 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.402 HG23 HG21 ' A' ' 8' ' ' VAL . 50.5 mm -68.26 126.55 28.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.145 -0.934 . . . . 25.0 109.171 177.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.77 85.86 4.95 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.606 -0.887 . . . . 25.0 108.606 179.242 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.97 -27.51 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.693 -179.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.44 -52.81 4.78 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.473 -1.051 . . . . 25.0 110.473 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 76.6 mtm -72.13 157.48 37.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.102 -0.703 . . . . 25.0 109.102 175.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.25 11.16 6.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.864 1.431 . . . . 25.0 114.864 175.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.36 164.73 26.25 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 177.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -139.59 43.11 2.0 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.396 0.517 . . . . 25.0 112.396 -173.606 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -65.7 152.0 93.69 Favored Pre-proline 0 N--CA 1.469 0.48 0 N-CA-C 109.291 -0.633 . . . . 25.0 109.291 176.219 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.86 -15.15 16.92 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 118.267 -0.689 . . . . 25.0 112.553 173.874 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -158.28 -105.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.828 -0.804 . . . . 25.0 108.828 -179.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.5 -52.0 0.01 OUTLIER Glycine 0 C--O 1.235 0.162 0 N-CA-C 111.194 -0.762 . . . . 25.0 111.194 178.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 p -90.67 -179.85 5.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.372 -0.973 . . . . 25.0 108.372 176.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.08 -48.79 4.11 Favored Glycine 0 CA--C 1.518 0.261 0 N-CA-C 114.65 0.62 . . . . 25.0 114.65 176.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.18 40.41 1.48 Allowed Glycine 0 CA--C 1.521 0.465 0 N-CA-C 115.537 0.975 . . . . 25.0 115.537 -178.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 m -96.0 -37.78 10.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.233 0.517 . . . . 25.0 111.412 179.15 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.63 173.68 37.73 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.923 -0.871 . . . . 25.0 110.923 -175.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -122.3 -1.13 9.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.69 0.626 . . . . 25.0 112.69 -179.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 97.9 -21.55 45.48 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 119.329 -0.706 . . . . 25.0 113.937 -179.354 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.5 mt 54.97 -147.34 0.52 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.356 0.662 . . . . 25.0 109.731 -179.334 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.5 p -135.27 166.23 23.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.128 -1.805 . . . . 25.0 106.128 179.142 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 59.19 15.53 4.25 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.421 1.638 . . . . 25.0 115.421 171.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.23 88.51 6.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.953 0.883 . . . . 25.0 109.644 179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.3 mt -76.4 123.5 26.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.607 0.717 . . . . 25.0 110.101 -178.263 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.96 149.59 85.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 115.284 -0.871 . . . . 25.0 112.195 -176.375 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.45 163.99 36.95 Favored 'Trans proline' 0 C--O 1.241 0.65 0 O-C-N 121.758 0.347 . . . . 25.0 112.473 178.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.18 156.62 59.09 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 114.233 0.82 . . . . 25.0 114.233 -176.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -87.04 151.56 51.96 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.457 -1.312 . . . . 25.0 107.457 176.214 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.94 162.69 38.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 118.143 -0.772 . . . . 25.0 110.702 176.46 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.23 172.47 15.95 Favored 'Trans proline' 0 C--N 1.349 0.565 0 N-CA-C 113.467 0.526 . . . . 25.0 113.467 -176.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.5 mt -133.97 154.84 80.51 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 25.0 110.854 178.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.19 174.7 12.07 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.53 2.153 . . . . 25.0 112.468 176.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -82.4 38.33 0.55 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.013 -0.539 . . . . 25.0 112.143 179.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.34 -146.86 19.22 Favored Glycine 0 CA--C 1.516 0.155 0 C-N-CA 121.144 -0.551 . . . . 25.0 111.802 -178.626 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -77.15 87.05 3.61 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 122.183 0.992 . . . . 25.0 109.996 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 125.662 2.649 . . . . 25.0 111.812 -179.651 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 CA-C-O 122.582 1.101 . . . . 25.0 115.221 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p -68.28 141.11 55.96 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.403 -1.057 . . . . 25.0 108.351 177.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -111.45 159.07 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 25.0 112.39 -175.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -147.73 148.08 30.61 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 103.659 -2.719 . . . . 25.0 103.659 172.423 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 58.35 167.48 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 117.069 2.248 . . . . 25.0 117.069 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.3 mt -80.85 -40.93 24.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.718 -1.128 . . . . 25.0 111.019 -178.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 55.54 52.26 11.43 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.682 0.993 . . . . 25.0 113.682 177.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -111.41 159.98 11.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.891 0 N-CA-C 108.563 -0.903 . . . . 25.0 108.563 -177.864 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.7 mt -94.24 143.9 25.99 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 121.482 -0.761 . . . . 25.0 111.192 178.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.84 146.21 40.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.711 -0.222 . . . . 25.0 110.471 177.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' HE3' HD11 ' A' ' 31' ' ' ILE . 30.6 ttmt -106.42 139.17 41.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.597 0.359 . . . . 25.0 111.838 178.773 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.37 128.75 36.33 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.249 -0.649 . . . . 25.0 109.249 175.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.23 -16.81 28.66 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.535 -0.542 . . . . 25.0 109.535 174.842 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -143.27 158.42 43.64 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -176.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.96 155.33 40.47 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.584 -1.265 . . . . 25.0 107.584 176.361 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -138.25 128.76 26.34 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.845 0.355 . . . . 25.0 111.321 178.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.41 125.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 104.218 -2.512 . . . . 25.0 104.218 175.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.48 127.54 32.92 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.389 -0.823 . . . . 25.0 108.974 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -112.62 -19.31 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 t -102.86 146.91 33.28 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.248 -1.39 . . . . 25.0 107.248 174.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.34 -13.18 37.05 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 113.069 0.373 . . . . 25.0 113.069 177.546 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -0.81 45.43 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 120.527 0.203 . . . . 25.0 110.899 179.068 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -93.94 148.25 22.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.333 0.587 . . . . 25.0 111.998 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -90.36 144.65 25.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.641 0.734 . . . . 25.0 112.002 176.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.5 t -109.41 127.61 54.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.194 -1.41 . . . . 25.0 107.194 177.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -152.62 174.74 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.303 -0.629 . . . . 25.0 109.303 -178.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -115.02 169.69 8.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 25.0 110.144 -179.812 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -61.98 134.36 56.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.562 0.696 . . . . 25.0 109.667 179.428 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.77 -3.83 81.47 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-O 118.752 -1.027 . . . . 25.0 114.32 179.119 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.03 162.11 29.93 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 118.152 0.976 . . . . 25.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' A' ' 11' ' ' LYS . 50.3 mm -122.81 126.68 74.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -127.26 155.33 43.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.158 -0.474 . . . . 25.0 110.09 177.319 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.9 m -90.11 112.7 24.26 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 115.379 -0.828 . . . . 25.0 109.587 179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 ' HB ' HG22 ' A' ' 8' ' ' VAL . 45.3 t -78.3 117.74 24.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 25.0 108.815 178.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.3 mt -90.63 -44.87 9.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.37 -0.832 . . . . 25.0 109.369 -179.257 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 17.4 pt-20 -153.98 174.28 14.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.59 -0.522 . . . . 25.0 109.59 173.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -128.12 151.88 48.67 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 58.57 37.63 25.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 123.643 1.687 . . . . 25.0 107.271 178.574 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.3 t -65.11 145.17 56.65 Favored 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 112.706 -2.043 . . . . 25.0 111.254 -175.516 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 57.21 15.05 2.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.344 0.868 . . . . 25.0 113.344 -178.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.72 78.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 111.519 -0.632 . . . . 25.0 111.519 -177.422 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.2 mt -91.41 92.28 8.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.8 128.94 35.25 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.498 0.666 . . . . 25.0 110.953 -178.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.56 -14.81 57.21 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.199 -0.778 . . . . 25.0 114.316 178.329 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -90.99 129.89 36.96 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.877 1.339 . . . . 25.0 108.949 177.809 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -113.05 125.89 54.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 -178.14 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.2 tp -74.12 121.77 21.68 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 178.243 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 22.0 m -134.58 170.45 15.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.311 0.577 . . . . 25.0 111.041 179.317 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.74 129.78 47.66 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.337 -0.986 . . . . 25.0 108.337 177.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.11 133.17 20.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 -177.451 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.4 m170 54.55 30.48 13.15 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.63 0.604 . . . . 25.0 112.63 178.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.82 86.13 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 121.003 -0.618 . . . . 25.0 114.51 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -119.2 138.16 53.14 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 -179.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -103.5 147.27 27.37 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 178.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.28 170.89 41.0 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.583 -0.818 . . . . 25.0 112.516 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -80.66 155.92 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.6 0.714 . . . . 25.0 109.176 179.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.2 t -142.9 139.36 16.85 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -178.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.4 118.39 5.65 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 117.345 -1.304 . . . . 25.0 111.633 176.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.74 -21.51 65.26 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-N 116.201 -0.454 . . . . 25.0 112.003 -178.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.33 -16.1 59.37 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.534 0.568 . . . . 25.0 112.534 176.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -114.9 9.68 16.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.47 0.308 . . . . 25.0 111.577 179.2 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -119.74 151.96 37.95 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.193 1.183 . . . . 25.0 114.193 -179.271 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -128.2 119.74 25.84 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.854 -1.066 . . . . 25.0 109.987 173.509 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.38 127.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.845 -1.169 . . . . 25.0 107.845 176.5 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -90.13 73.59 7.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.497 0.665 . . . . 25.0 109.702 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.02 -33.78 64.42 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.527 -0.76 . . . . 25.0 110.202 -179.149 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.6 -1.8 56.24 Favored Glycine 0 C--O 1.218 -0.862 0 N-CA-C 115.032 0.773 . . . . 25.0 115.032 178.189 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.3 ttp -132.27 -36.83 1.12 Allowed 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 -176.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.54 -5.92 49.66 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 117.067 2.247 . . . . 25.0 117.067 -172.294 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.2 t0 13.34 73.22 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 117.573 2.434 . . . . 25.0 117.573 -172.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -65.87 -26.66 67.74 Favored 'General case' 0 C--O 1.239 0.537 0 O-C-N 121.586 -0.696 . . . . 25.0 110.138 179.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.3 133.64 0.76 Allowed Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 174.379 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.79 -14.38 17.41 Favored 'Trans proline' 0 C--N 1.344 0.317 0 N-CA-C 114.338 0.861 . . . . 25.0 114.338 -174.532 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 61.24 -96.96 0.06 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.045 0.938 . . . . 25.0 110.84 -176.508 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.98 -161.38 45.59 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.407 -0.677 . . . . 25.0 111.407 -179.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.9 p -94.7 155.67 16.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 179.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.69 173.93 40.64 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.174 -1.571 . . . . 25.0 109.174 176.629 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.48 87.77 0.23 Allowed Glycine 0 C--O 1.223 -0.532 0 N-CA-C 111.179 -0.768 . . . . 25.0 111.179 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.8 m -125.34 21.14 7.98 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.345 0.498 . . . . 25.0 112.345 -175.829 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.69 38.13 1.25 Allowed Glycine 0 C--O 1.223 -0.569 0 N-CA-C 115.45 0.94 . . . . 25.0 115.45 -177.321 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 m -64.73 -25.18 67.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.203 0.501 . . . . 25.0 111.631 -179.576 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.84 46.34 3.59 Favored Glycine 0 C--O 1.22 -0.779 0 N-CA-C 111.894 -0.482 . . . . 25.0 111.894 176.127 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 53.63 32.91 15.36 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.748 0.785 . . . . 25.0 112.021 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.48 17.49 9.59 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 179.104 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -73.87 127.31 32.52 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 122.104 -0.373 . . . . 25.0 110.539 176.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -122.41 75.49 1.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.795 0.807 . . . . 25.0 110.466 177.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.73 141.89 56.46 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.898 -1.046 . . . . 25.0 110.803 179.433 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.46 149.0 60.26 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 115.757 -0.656 . . . . 25.0 111.398 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.45 163.22 39.22 Favored 'Trans proline' 0 C--O 1.242 0.725 0 O-C-N 121.637 0.283 . . . . 25.0 111.74 176.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -61.04 161.11 23.45 Favored 'Trans proline' 0 C--N 1.348 0.535 0 N-CA-C 113.704 0.617 . . . . 25.0 113.704 178.52 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -100.08 153.09 37.95 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 106.128 -1.804 . . . . 25.0 106.128 174.153 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.49 161.22 45.91 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 117.754 -1.031 . . . . 25.0 110.721 177.263 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.59 174.74 12.11 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 120.167 0.578 . . . . 25.0 113.397 -177.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 156.21 79.52 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.756 -0.656 . . . . 25.0 109.9 179.016 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.89 173.37 14.58 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 121.988 1.792 . . . . 25.0 112.357 176.51 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.52 52.26 2.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.488 0.661 . . . . 25.0 111.163 178.682 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.57 173.6 32.28 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 121.788 0.66 . . . . 25.0 114.194 178.426 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.1 mp0 -106.56 122.55 46.53 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 122.145 0.974 . . . . 25.0 111.345 -174.057 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 124.087 1.899 . . . . 25.0 113.536 179.603 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.008 0 CA-C-O 124.383 2.102 . . . . 25.0 115.161 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -77.96 140.08 39.21 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 121.356 -1.085 . . . . 25.0 110.039 179.228 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.4 ttm -63.42 142.83 58.24 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 176.297 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -135.66 145.19 46.52 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 103.563 -2.755 . . . . 25.0 103.563 175.786 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 61.49 169.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 124.892 1.37 . . . . 25.0 113.077 -174.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -75.08 -32.19 61.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.722 -0.672 . . . . 25.0 112.262 -175.319 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 53.87 39.99 31.04 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.906 1.446 . . . . 25.0 114.906 178.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -100.4 163.53 2.95 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.431 -0.952 . . . . 25.0 108.431 -178.389 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.9 144.54 30.4 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 175.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 143.99 41.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.976 -0.379 . . . . 25.0 109.976 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -103.56 138.56 40.07 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.574 0.35 . . . . 25.0 111.669 178.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.87 125.81 29.62 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.936 0.494 . . . . 25.0 110.531 175.232 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -89.72 -17.21 28.73 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.758 -0.46 . . . . 25.0 109.758 176.372 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -144.98 163.58 33.77 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.505 -2.405 . . . . 25.0 104.505 -178.755 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.08 172.42 13.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.54 -1.282 . . . . 25.0 107.54 175.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -148.01 140.67 24.61 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.68 -0.489 . . . . 25.0 109.68 177.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.51 127.23 67.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 104.5 -2.407 . . . . 25.0 104.5 176.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.64 110.24 13.59 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 179.842 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -99.39 -29.64 12.65 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.739 -0.838 . . . . 25.0 108.739 -179.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.5 t -90.66 146.95 35.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.247 -1.39 . . . . 25.0 107.247 174.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.27 -10.08 27.85 Favored 'Trans proline' 0 C--N 1.345 0.366 0 N-CA-C 112.999 0.346 . . . . 25.0 112.999 176.895 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.27 -7.92 34.19 Favored 'General case' 0 C--O 1.202 -1.398 0 CA-C-O 121.02 0.438 . . . . 25.0 111.135 177.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -86.85 152.9 22.06 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.361 0.6 . . . . 25.0 112.454 -173.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 mt -98.96 140.27 33.37 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 25.0 111.611 174.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.7 p -105.19 134.15 48.78 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.511 -1.662 . . . . 25.0 106.511 175.458 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -154.93 171.39 19.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -107.37 150.07 27.15 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.658 0.742 . . . . 25.0 109.535 -177.059 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -55.05 123.04 12.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.964 -0.562 . . . . 25.0 110.133 175.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.09 -12.18 40.74 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.488 -0.778 . . . . 25.0 113.629 -178.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.83 160.72 32.24 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.431 0.616 . . . . 25.0 110.76 -177.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.5 mm -119.62 129.41 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.836 -0.801 . . . . 25.0 108.836 178.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.4 ptp -128.04 156.46 42.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.449 -0.574 . . . . 25.0 109.449 175.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -90.89 114.07 26.42 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.195 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 8' ' ' VAL . 36.9 t -79.62 125.63 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 N-CA-C 108.869 -0.789 . . . . 25.0 108.869 178.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.62 -46.97 5.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.072 -0.967 . . . . 25.0 109.446 -178.21 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 18.7 pt-20 -152.95 169.82 21.92 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.945 -0.761 . . . . 25.0 108.945 173.673 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -126.56 150.23 48.96 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.495 -1.669 . . . . 25.0 106.495 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 59.37 37.32 23.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.877 1.799 . . . . 25.0 107.467 178.932 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 4.4 t -63.46 145.18 56.15 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 112.474 -2.148 . . . . 25.0 110.66 -177.088 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 59.53 9.14 1.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.354 1.062 . . . . 25.0 113.013 -177.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.55 14.78 69.94 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.966 -0.854 . . . . 25.0 110.966 -176.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.9 mt -89.68 93.38 9.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.469 -0.937 . . . . 25.0 108.469 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -55.48 128.69 35.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.626 0.726 . . . . 25.0 111.137 -177.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.22 54.25 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.799 -0.637 . . . . 25.0 114.538 178.35 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -89.51 129.62 35.97 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 176.569 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.8 m0 -116.85 124.87 50.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.251 -0.648 . . . . 25.0 109.251 -177.482 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.8 tp -73.31 121.29 20.17 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.459 -1.312 . . . . 25.0 107.459 178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.0 m -134.24 171.65 13.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.112 0.482 . . . . 25.0 110.329 178.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.64 127.76 41.24 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 178.064 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.3 131.65 25.14 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.596 -1.261 . . . . 25.0 107.596 -179.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.5 m170 55.43 30.49 15.11 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.401 0.68 . . . . 25.0 112.155 -178.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 7.85 86.9 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.015 -0.612 . . . . 25.0 114.111 -179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -109.91 137.03 48.26 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 104.67 -2.345 . . . . 25.0 104.67 179.094 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -105.34 148.43 27.07 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.548 -0.908 . . . . 25.0 108.548 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.63 169.94 37.89 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.529 -0.843 . . . . 25.0 114.349 177.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -78.79 154.6 4.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.572 0.701 . . . . 25.0 110.342 -179.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 70.4 t -142.67 139.53 17.38 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.363 -0.835 . . . . 25.0 108.879 -177.279 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.37 113.79 3.59 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 118.371 -0.619 . . . . 25.0 111.548 174.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -21.77 56.67 Favored Glycine 0 C--O 1.221 -0.688 0 O-C-N 122.118 -0.363 . . . . 25.0 113.08 179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -17.28 64.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 122.136 -0.626 . . . . 25.0 112.0 177.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -112.16 9.41 20.15 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 122.049 -0.407 . . . . 25.0 110.748 178.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -126.75 142.46 51.54 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' HB2' HD21 ' A' ' 13' ' ' LEU . 36.4 ttpt -121.79 119.96 33.2 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.85 -0.614 . . . . 25.0 111.388 178.023 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 8' ' ' VAL . 48.6 mm -67.93 126.24 27.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.014 -0.994 . . . . 25.0 108.918 177.249 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.28 79.55 5.04 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.657 -1.238 . . . . 25.0 107.657 178.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -64.4 120.91 12.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 25.0 111.27 -177.14 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.35 6.95 74.34 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 114.436 0.534 . . . . 25.0 114.436 -178.223 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.2 ptp -80.54 0.76 32.41 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.303 -0.528 . . . . 25.0 111.733 -179.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -122.26 104.06 9.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.957 0.408 . . . . 25.0 110.882 179.351 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -74.82 -33.02 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 122.031 0.92 . . . . 25.0 109.022 175.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -106.34 135.31 48.06 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.804 -1.089 . . . . 25.0 112.586 -171.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -158.26 158.28 29.68 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 103.887 -2.634 . . . . 25.0 103.887 176.098 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -73.59 144.84 36.41 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 114.567 -3.155 . . . . 25.0 111.372 174.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 55.29 -170.6 0.07 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 176.254 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.33 177.89 47.35 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 107.639 -2.185 . . . . 25.0 107.639 -178.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 56.44 17.4 2.93 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.193 1.924 . . . . 25.0 116.193 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.79 159.21 34.31 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.567 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.72 175.25 41.41 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 106.262 -2.735 . . . . 25.0 106.262 178.452 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m -149.73 -87.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.467 1.133 . . . . 25.0 111.765 -179.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.99 157.08 48.22 Favored Glycine 0 N--CA 1.455 -0.077 0 C-N-CA 120.753 -0.737 . . . . 25.0 111.543 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 46.6 t -147.06 -79.19 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.581 0.215 . . . . 25.0 111.581 178.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.23 2.12 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 115.088 0.795 . . . . 25.0 115.088 -177.747 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.54 152.03 27.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.019 0.409 . . . . 25.0 109.949 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.2 p -116.73 87.01 2.61 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.652 -0.87 . . . . 25.0 108.652 -179.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -154.14 -174.4 4.95 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 103.484 -2.784 . . . . 25.0 103.484 -177.723 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 68.26 86.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.595 1.158 . . . . 25.0 111.332 179.227 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.55 130.7 47.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.191 -0.913 . . . . 25.0 111.269 -177.278 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.74 148.38 68.91 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.247 -0.888 . . . . 25.0 110.929 -178.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.29 164.52 35.46 Favored 'Trans proline' 0 C--O 1.242 0.679 0 O-C-N 121.681 0.306 . . . . 25.0 111.768 176.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.62 164.37 35.93 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 118.133 -0.778 . . . . 25.0 113.255 -178.154 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -95.31 150.94 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.479 -1.675 . . . . 25.0 106.479 174.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.58 161.16 46.33 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 117.502 -1.199 . . . . 25.0 110.848 176.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.75 177.66 7.78 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 120.125 0.55 . . . . 25.0 113.338 -177.444 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 mt -132.68 156.52 79.99 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 115.907 -0.588 . . . . 25.0 109.482 178.558 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.9 -169.82 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.331 3.354 . . . . 25.0 113.544 179.401 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 63.69 26.09 14.42 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.933 1.293 . . . . 25.0 109.207 -174.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.26 131.77 3.71 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.232 -1.547 . . . . 25.0 109.232 173.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -114.02 150.39 33.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.962 0.887 . . . . 25.0 110.282 -178.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--O 1.214 -0.77 0 CA-C-O 125.468 2.556 . . . . 25.0 111.828 178.629 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 CA-C-O 123.047 1.359 . . . . 25.0 115.555 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -79.0 136.6 37.25 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 121.22 -1.165 . . . . 25.0 110.494 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.6 mtt -106.91 -3.09 20.61 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.505 0.669 . . . . 25.0 111.545 177.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -97.2 135.24 39.42 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 104.054 -2.573 . . . . 25.0 104.054 172.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 63.82 162.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.321 1.638 . . . . 25.0 114.382 -177.381 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 80.2 mt -71.67 -39.63 70.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.405 -0.816 . . . . 25.0 111.583 -175.302 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 52.42 50.36 18.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 25.0 113.422 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.96 160.59 6.24 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 179.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.7 142.67 27.72 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.444 -0.502 . . . . 25.0 110.325 178.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.87 145.76 44.77 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.968 -0.382 . . . . 25.0 109.968 176.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -105.92 140.14 39.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.422 0.289 . . . . 25.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.04 126.69 31.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.887 -0.412 . . . . 25.0 109.887 173.224 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -88.37 -15.88 34.43 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 176.068 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -145.48 164.01 32.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.456 -0.942 . . . . 25.0 108.456 -176.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.38 156.14 39.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.295 -1.002 . . . . 25.0 108.295 174.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -138.11 133.09 32.99 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.042 -0.355 . . . . 25.0 110.042 174.427 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.96 123.36 63.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 104.795 -2.298 . . . . 25.0 104.795 177.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.34 126.26 30.64 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 -179.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.7 -30.82 6.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.676 0.75 . . . . 25.0 109.228 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.19 151.8 47.12 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 109.103 -0.703 . . . . 25.0 109.103 177.244 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.32 -13.11 35.22 Favored 'Trans proline' 0 C--N 1.343 0.24 0 O-C-N 121.921 0.432 . . . . 25.0 112.475 176.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.87 -7.18 43.93 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-N 116.024 -0.535 . . . . 25.0 111.495 178.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -94.48 149.48 21.19 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.388 0.885 . . . . 25.0 113.388 -170.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.1 mt -94.26 144.84 25.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.687 0.756 . . . . 25.0 112.06 175.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 131.02 55.4 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.782 -1.192 . . . . 25.0 107.782 176.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -154.85 172.35 18.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.44 0.904 . . . . 25.0 113.44 -178.651 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -105.33 154.15 20.66 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.214 1.006 . . . . 25.0 110.386 -176.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -55.52 126.17 24.11 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.605 -1.257 . . . . 25.0 107.605 173.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.73 -16.27 51.6 Favored Glycine 0 CA--C 1.518 0.274 0 CA-C-O 118.517 -1.157 . . . . 25.0 114.763 -178.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -64.9 152.39 43.2 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.594 1.197 . . . . 25.0 110.97 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.9 127.86 72.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.271 -1.011 . . . . 25.0 108.271 177.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.9 ptp -127.86 155.32 44.33 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.322 -0.622 . . . . 25.0 109.322 177.598 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.3 m -89.45 112.31 23.43 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 114.789 -1.096 . . . . 25.0 109.18 -179.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.7 t -79.4 123.05 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 109.001 -0.74 . . . . 25.0 109.001 179.32 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -95.44 -45.02 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.324 -0.853 . . . . 25.0 110.029 -178.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 11.2 pt-20 -153.7 174.29 14.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 173.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.6 mtm-85 -126.32 151.35 47.67 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 178.174 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 58.31 37.87 25.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.864 1.793 . . . . 25.0 107.879 177.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 t -63.86 144.6 56.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 112.912 -1.949 . . . . 25.0 110.901 -176.2 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 59.79 9.08 1.53 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.003 0.921 . . . . 25.0 113.024 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.95 14.41 72.46 Favored Glycine 0 C--O 1.229 -0.207 0 N-CA-C 110.87 -0.892 . . . . 25.0 110.87 -175.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.8 mt -87.8 94.79 9.86 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.78 -1.192 . . . . 25.0 107.78 -179.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -55.48 128.99 37.03 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.545 0.688 . . . . 25.0 111.29 -177.605 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.16 -14.89 56.38 Favored Glycine 0 C--O 1.238 0.384 0 CA-C-O 119.487 -0.619 . . . . 25.0 114.613 178.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -91.52 129.09 37.55 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 118.204 1.002 . . . . 25.0 109.067 178.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -114.52 127.88 56.04 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.924 -0.769 . . . . 25.0 108.924 -177.235 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 62.4 tp -75.45 122.82 24.4 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.384 -1.339 . . . . 25.0 107.384 179.448 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.3 m -134.74 171.57 14.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.305 0.574 . . . . 25.0 110.743 177.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.73 131.44 49.7 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.926 -1.138 . . . . 25.0 107.926 176.393 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 tp -149.68 136.78 19.69 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.042 -1.466 . . . . 25.0 107.042 -177.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.6 m170 56.66 27.48 12.64 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.345 0.658 . . . . 25.0 112.301 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.02 12.88 83.12 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.88 -0.676 . . . . 25.0 113.419 -178.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -118.27 139.47 51.27 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.526 -2.028 . . . . 25.0 105.526 -178.434 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -103.99 148.34 26.31 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.75 -0.833 . . . . 25.0 108.75 178.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.61 171.48 41.11 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.436 -0.888 . . . . 25.0 113.133 177.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.3 pt -81.97 154.25 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.476 0.655 . . . . 25.0 109.821 -179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.83 138.78 18.64 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 108.194 -1.039 . . . . 25.0 108.194 -177.644 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.4 114.24 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 118.488 -0.541 . . . . 25.0 111.688 176.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.64 -22.4 56.75 Favored Glycine 0 C--O 1.216 -0.997 0 O-C-N 121.947 -0.47 . . . . 25.0 113.06 -179.443 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -18.41 63.36 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.255 -0.556 . . . . 25.0 112.432 178.166 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.01 9.64 16.06 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 122.579 0.352 . . . . 25.0 110.827 -178.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -125.25 145.61 49.91 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 112.737 0.644 . . . . 25.0 112.737 -175.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HB2' HD21 ' A' ' 13' ' ' LEU . 35.9 ttmt -124.23 120.13 31.36 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.294 177.619 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -67.24 126.53 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 107.698 -1.223 . . . . 25.0 107.698 176.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.6 mt -97.7 72.03 2.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.141 -1.059 . . . . 25.0 108.141 179.713 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.3 143.99 7.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 CA-C-N 115.063 -0.971 . . . . 25.0 112.903 -176.245 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.7 -175.32 50.69 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 108.408 -1.877 . . . . 25.0 108.408 174.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 2.2 tmm? 55.39 45.38 25.49 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.315 1.055 . . . . 25.0 109.902 -178.553 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.97 138.06 48.15 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.187 -1.412 . . . . 25.0 107.187 -179.596 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -64.15 118.72 8.97 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.835 0.826 . . . . 25.0 110.365 178.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -143.74 160.98 39.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.385 -2.08 . . . . 25.0 105.385 -177.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -133.91 156.4 79.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.422 -0.955 . . . . 25.0 108.422 178.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.51 170.44 19.3 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 117.2 -1.4 . . . . 25.0 112.245 175.153 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 59.67 178.22 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.491 1.663 . . . . 25.0 115.491 173.634 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.25 -177.73 22.41 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 108.885 -1.686 . . . . 25.0 108.885 -175.183 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.1 t 59.8 -166.88 0.18 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.299 0.64 . . . . 25.0 110.223 -176.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.25 -37.63 2.57 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 115.604 1.002 . . . . 25.0 115.604 178.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.94 -33.75 88.0 Favored Glycine 0 C--O 1.225 -0.435 0 CA-C-N 117.492 0.646 . . . . 25.0 114.413 -176.889 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.3 p -157.61 167.91 28.76 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.232 -1.396 . . . . 25.0 107.232 178.426 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.33 154.81 29.07 Favored Glycine 0 C--O 1.221 -0.707 0 N-CA-C 109.297 -1.521 . . . . 25.0 109.297 175.005 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.5 p -89.72 8.61 30.82 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.093 0.473 . . . . 25.0 110.417 179.311 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.86 156.01 8.61 Favored Glycine 0 C--O 1.236 0.24 0 N-CA-C 107.595 -2.202 . . . . 25.0 107.595 -176.127 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.96 141.22 32.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.526 -1.657 . . . . 25.0 106.526 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 13.1 p 46.8 -156.32 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 124.364 1.04 . . . . 25.0 111.916 -178.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 54.19 18.42 1.79 Allowed 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.896 1.813 . . . . 25.0 115.896 177.069 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -128.38 103.46 7.16 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.04 -0.726 . . . . 25.0 109.04 -179.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.78 147.37 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.43 -0.805 . . . . 25.0 111.707 -175.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.33 146.39 61.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 113.184 0.809 . . . . 25.0 113.184 -177.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.79 168.73 22.99 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 120.149 0.566 . . . . 25.0 110.929 172.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.78 164.63 33.84 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 118.134 -0.777 . . . . 25.0 113.279 -179.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.43 151.77 37.84 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 105.891 -1.892 . . . . 25.0 105.891 175.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.67 162.66 40.17 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 118.54 -0.506 . . . . 25.0 110.959 177.777 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.97 173.13 15.02 Favored 'Trans proline' 0 C--N 1.351 0.688 0 N-CA-C 113.158 0.407 . . . . 25.0 113.158 -177.063 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.9 mt -133.9 154.84 80.58 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.567 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.42 169.63 18.43 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 120.839 1.026 . . . . 25.0 112.938 175.28 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -98.46 65.73 1.66 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.249 -0.887 . . . . 25.0 108.779 175.66 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -95.29 174.79 32.72 Favored Glycine 0 C--O 1.229 -0.172 0 CA-C-N 115.766 -0.652 . . . . 25.0 112.358 -178.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -68.65 137.16 53.97 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 176.526 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 126.259 2.933 . . . . 25.0 111.959 -177.499 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 122.463 1.035 . . . . 25.0 114.577 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.0 p 61.12 -19.68 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 118.092 2.627 . . . . 25.0 118.092 179.323 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -45.76 -63.43 0.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.834 1.79 . . . . 25.0 115.834 -176.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 55.86 19.34 3.46 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.738 1.755 . . . . 25.0 115.738 -178.749 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -135.93 169.91 16.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.225 0.536 . . . . 25.0 112.131 -177.525 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.06 -40.63 87.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.212 -0.904 . . . . 25.0 110.102 178.077 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 m120 52.66 52.86 13.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.927 0.891 . . . . 25.0 113.348 178.676 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -109.45 162.77 6.96 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 N-CA-C 108.747 -0.834 . . . . 25.0 108.747 -178.62 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.49 146.18 24.63 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.626 -0.672 . . . . 25.0 110.357 176.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.76 147.4 39.06 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 176.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -107.38 138.25 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.627 0.371 . . . . 25.0 111.685 178.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.44 125.7 28.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 175.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -86.37 -20.23 28.57 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.192 -0.669 . . . . 25.0 109.192 174.818 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -143.25 158.61 43.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.157 -1.053 . . . . 25.0 108.157 -176.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.09 157.82 37.53 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.62 0.575 . . . . 25.0 109.571 177.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -140.73 129.87 23.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.181 0.515 . . . . 25.0 111.901 176.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -106.12 123.77 60.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 104.017 -2.586 . . . . 25.0 104.017 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.76 130.6 40.86 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.162 -0.681 . . . . 25.0 109.162 -178.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -110.83 -37.45 5.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.433 0.635 . . . . 25.0 109.372 177.953 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 t -85.94 147.28 45.24 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 106.786 -1.561 . . . . 25.0 106.786 174.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.57 -14.65 42.85 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 118.533 -0.511 . . . . 25.0 111.896 176.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -90.73 -6.19 54.75 Favored 'General case' 0 C--O 1.205 -1.237 0 C-N-CA 122.934 0.494 . . . . 25.0 109.994 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -91.8 149.02 21.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.361 0.6 . . . . 25.0 111.754 -175.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -93.49 143.45 26.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.578 0.704 . . . . 25.0 112.026 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 p -107.37 130.22 54.82 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.265 -1.013 . . . . 25.0 108.265 176.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -154.7 175.3 13.86 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 -179.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.33 170.59 8.43 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 179.476 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.22 136.97 58.19 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.587 0.708 . . . . 25.0 109.799 177.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.03 -4.27 77.89 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.475 -0.784 . . . . 25.0 113.516 175.511 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.03 158.02 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 179.008 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.9 mm -119.98 126.25 75.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 178.842 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.1 ptp -128.33 155.5 44.55 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.097 0.475 . . . . 25.0 109.813 177.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -89.71 112.2 23.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.387 -0.824 . . . . 25.0 109.461 -179.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 8' ' ' VAL . 47.8 t -78.39 124.1 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 178.472 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.1 mt -96.83 -46.11 6.38 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.339 -0.846 . . . . 25.0 109.022 -177.858 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 12.4 pt-20 -151.83 172.87 15.51 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 173.277 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -124.48 153.48 41.95 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 106.346 -1.724 . . . . 25.0 106.346 177.82 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 58.77 35.82 24.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 123.738 1.732 . . . . 25.0 108.065 174.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -64.01 145.11 56.47 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 112.652 -2.067 . . . . 25.0 110.733 -175.378 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 60.6 10.71 2.69 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.764 0.826 . . . . 25.0 112.836 -178.551 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.33 11.43 78.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.235 -0.746 . . . . 25.0 111.235 -176.713 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.99 90.65 8.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.229 -1.026 . . . . 25.0 108.229 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.09 129.33 37.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.69 0.757 . . . . 25.0 110.622 -177.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.21 55.9 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-O 119.269 -0.739 . . . . 25.0 114.288 178.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -91.51 129.13 37.54 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 118.887 1.343 . . . . 25.0 107.707 177.138 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -112.74 129.35 56.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.852 -0.795 . . . . 25.0 108.852 -178.58 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 59.0 tp -76.1 122.43 24.27 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 106.733 -1.581 . . . . 25.0 106.733 178.103 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.1 m -134.4 170.32 15.92 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.99 0.424 . . . . 25.0 110.219 178.19 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.37 129.91 48.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 176.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -149.94 135.46 18.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 -177.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 37.9 m170 55.59 27.71 10.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.33 0.652 . . . . 25.0 112.74 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.33 10.38 86.28 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.034 -0.603 . . . . 25.0 114.37 -179.388 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 137.29 51.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.669 -2.345 . . . . 25.0 104.669 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.42 137.21 43.6 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 177.368 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.61 173.94 46.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.574 -0.822 . . . . 25.0 113.87 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.78 154.3 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.875 0.845 . . . . 25.0 110.183 -178.237 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.2 t -142.9 139.6 17.15 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -178.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.31 116.64 4.61 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 117.547 -1.169 . . . . 25.0 111.667 176.072 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.35 -23.8 62.79 Favored Glycine 0 C--O 1.22 -0.77 0 CA-C-N 116.073 -0.512 . . . . 25.0 113.268 -177.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.62 -16.33 60.63 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.242 0.46 . . . . 25.0 112.242 177.327 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -110.34 8.4 23.36 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.138 -0.352 . . . . 25.0 111.257 178.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.95 153.39 34.69 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 113.613 0.968 . . . . 25.0 113.613 -179.575 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.4 ttmt -129.26 119.59 24.24 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.621 -1.172 . . . . 25.0 109.989 173.815 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.445 HG23 HG21 ' A' ' 8' ' ' VAL . 38.9 mm -67.21 124.96 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.264 -1.013 . . . . 25.0 108.264 176.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -95.78 94.14 7.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.398 -2.075 . . . . 25.0 105.398 177.424 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.96 123.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -175.478 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.61 163.62 53.23 Favored Glycine 0 C--O 1.228 -0.267 0 N-CA-C 111.038 -0.825 . . . . 25.0 111.038 -178.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 ttp 69.87 -38.19 0.4 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.112 1.365 . . . . 25.0 114.347 -178.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -90.33 119.85 30.98 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.582 0.956 . . . . 25.0 113.582 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.93 155.43 22.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 165.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -135.78 38.04 2.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.64 -0.504 . . . . 25.0 109.64 -178.489 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt 77.33 151.12 0.13 Allowed Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 126.773 2.029 . . . . 25.0 110.014 -178.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.86 140.81 62.5 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 116.403 -1.931 . . . . 25.0 112.266 -178.537 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -155.81 141.06 17.55 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.702 -1.222 . . . . 25.0 107.702 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.73 174.29 46.92 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 107.882 -2.087 . . . . 25.0 107.882 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.3 t -161.36 163.8 30.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 105.051 -2.203 . . . . 25.0 105.051 179.055 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.78 169.07 41.06 Favored Glycine 0 C--O 1.221 -0.691 0 N-CA-C 107.98 -2.048 . . . . 25.0 107.98 177.829 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.44 -67.84 0.3 Allowed Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.516 -1.034 . . . . 25.0 110.516 178.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m 53.53 28.57 7.89 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.491 0.923 . . . . 25.0 113.491 176.859 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.62 -169.12 37.59 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.513 -1.835 . . . . 25.0 108.513 -177.249 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 m -76.62 60.87 1.72 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.881 1.067 . . . . 25.0 113.881 -177.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -66.9 -46.01 78.01 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.915 -0.66 . . . . 25.0 111.476 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.3 mt 49.49 37.22 11.66 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.066 1.135 . . . . 25.0 114.066 173.749 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.0 m -100.55 -47.71 4.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.957 0.408 . . . . 25.0 111.364 -178.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 57.29 179.82 0.05 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -1.151 . . . . 25.0 112.648 -176.698 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.97 134.5 8.61 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.437 -1.32 . . . . 25.0 107.437 -176.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.37 130.61 36.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.425 0.631 . . . . 25.0 109.634 -178.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.33 148.15 77.08 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 25.0 112.074 -177.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.48 162.81 41.1 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 118.136 -0.776 . . . . 25.0 110.948 174.607 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 159.38 50.92 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 117.55 -1.167 . . . . 25.0 112.557 -177.881 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -86.39 150.01 50.62 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 106.257 -1.757 . . . . 25.0 106.257 175.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.13 160.06 51.41 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 117.531 -1.179 . . . . 25.0 110.86 177.626 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.86 179.8 5.33 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 119.926 0.417 . . . . 25.0 112.675 -178.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.6 mt -127.88 155.83 76.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.94 -0.573 . . . . 25.0 109.628 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.1 -173.4 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.343 2.695 . . . . 25.0 112.865 179.366 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.75 11.31 1.3 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 118.187 2.662 . . . . 25.0 118.187 173.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.38 -155.55 16.27 Favored Glycine 0 C--O 1.222 -0.621 0 CA-C-N 115.801 -0.636 . . . . 25.0 112.796 176.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 50.41 38.54 18.39 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 123.836 1.779 . . . . 25.0 113.049 -177.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 125.308 2.48 . . . . 25.0 111.138 177.784 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 122.632 1.129 . . . . 25.0 115.192 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -67.01 112.03 4.15 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.458 -1.025 . . . . 25.0 110.288 179.596 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -81.19 72.29 8.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.69 -0.855 . . . . 25.0 108.69 178.522 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 tptm 65.41 -177.09 0.18 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.103 -1.073 . . . . 25.0 108.103 -172.101 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 54.79 -174.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.144 1.535 . . . . 25.0 115.144 175.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.75 -41.14 68.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 177.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 52.94 55.44 8.96 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.271 -0.877 . . . . 25.0 113.35 177.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.7 OUTLIER -114.02 161.34 12.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.673 0 N-CA-C 108.167 -1.049 . . . . 25.0 108.167 -178.814 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.7 mt -97.82 142.9 29.01 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.77 -0.581 . . . . 25.0 110.663 177.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.43 145.89 43.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.051 -0.351 . . . . 25.0 110.051 177.793 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -105.51 138.2 42.09 Favored 'General case' 0 CA--C 1.517 -0.295 0 O-C-N 123.337 0.398 . . . . 25.0 111.231 178.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 130.86 41.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.634 -0.712 . . . . 25.0 110.937 173.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -92.27 -18.16 23.79 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 110.387 -0.227 . . . . 25.0 110.387 175.13 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -143.32 161.49 38.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.22 -0.446 . . . . 25.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -68.5 151.76 46.35 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.285 -1.005 . . . . 25.0 108.285 174.096 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 128.03 18.36 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.072 -0.714 . . . . 25.0 109.072 -176.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.7 t -116.85 128.67 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 N-CA-C 104.251 -2.5 . . . . 25.0 104.251 178.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.84 123.66 24.63 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.891 0.744 . . . . 25.0 109.084 -178.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -108.44 -19.23 13.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.589 0.709 . . . . 25.0 109.12 179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.0 m -109.03 151.79 42.11 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 176.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.89 -13.49 34.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 N-CA-C 113.53 0.55 . . . . 25.0 113.53 -178.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -99.17 -0.48 41.47 Favored 'General case' 0 C--O 1.211 -0.943 0 C-N-CA 122.409 0.283 . . . . 25.0 110.413 -179.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -94.63 150.94 19.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.961 0.41 . . . . 25.0 110.617 -176.638 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.03 165.02 13.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.61 -0.515 . . . . 25.0 109.61 175.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -129.84 116.75 19.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 176.607 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -140.12 172.12 13.2 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.142 1.164 . . . . 25.0 114.142 -178.746 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -105.14 154.88 19.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.525 -0.761 . . . . 25.0 110.199 -178.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -55.15 128.67 34.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 172.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.41 -13.08 61.61 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-O 118.95 -0.917 . . . . 25.0 114.191 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.95 158.5 36.37 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 118.008 0.904 . . . . 25.0 110.439 -178.597 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.56 130.11 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 178.785 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.9 ptp -127.85 156.58 42.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.2 m -90.46 112.96 24.8 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.073 -0.967 . . . . 25.0 109.075 179.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -79.76 124.05 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 108.399 -0.963 . . . . 25.0 108.399 178.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.1 mt -98.9 -45.68 5.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.07 -0.968 . . . . 25.0 109.891 -176.389 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -152.24 171.72 17.52 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.482 -0.933 . . . . 25.0 108.482 173.034 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -127.9 150.72 49.75 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 179.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 60.26 35.91 20.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.715 1.722 . . . . 25.0 108.415 178.878 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -63.82 145.04 56.54 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 112.79 -2.005 . . . . 25.0 111.167 -177.037 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 59.63 11.52 2.43 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.996 0.918 . . . . 25.0 113.044 -178.901 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.77 12.15 80.42 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 111.05 -0.82 . . . . 25.0 111.05 -176.748 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.7 mt -88.83 91.37 8.79 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.51 137.98 57.84 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.562 0.696 . . . . 25.0 109.6 -176.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.38 -18.91 26.28 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.777 -0.725 . . . . 25.0 113.803 179.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -90.13 129.98 36.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 118.024 0.912 . . . . 25.0 108.934 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -113.66 126.9 55.77 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.933 -0.766 . . . . 25.0 108.933 -177.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 63.2 tp -74.48 121.78 22.01 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 106.762 -1.57 . . . . 25.0 106.762 178.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.9 m -134.09 169.25 17.42 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.01 0.433 . . . . 25.0 110.071 177.808 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.01 129.54 49.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.963 -1.125 . . . . 25.0 107.963 177.055 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.03 133.66 19.89 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.048 -1.464 . . . . 25.0 107.048 -176.49 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 35.6 m170 56.11 29.56 14.81 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.216 0.606 . . . . 25.0 112.0 -178.893 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.85 9.5 85.09 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 121.137 -0.554 . . . . 25.0 114.073 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.38 139.03 50.37 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.947 -1.872 . . . . 25.0 105.947 -179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -103.81 146.92 27.92 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.167 -0.679 . . . . 25.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.66 172.23 43.96 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.822 . . . . 25.0 112.477 177.896 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.25 155.07 3.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.093 -0.706 . . . . 25.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -141.25 139.5 19.2 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -177.716 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.32 109.98 2.35 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 CA-C-N 118.34 0.443 . . . . 25.0 111.006 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.85 -22.84 55.23 Favored Glycine 0 C--O 1.221 -0.699 0 O-C-N 122.181 -0.324 . . . . 25.0 113.895 -178.418 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -14.54 61.51 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 122.052 -0.675 . . . . 25.0 112.065 178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -112.61 10.85 19.53 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 122.088 -0.383 . . . . 25.0 110.561 178.669 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -126.75 144.27 50.99 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.26 0.837 . . . . 25.0 113.26 -176.076 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HB2' HD21 ' A' ' 13' ' ' LEU . 39.0 ttpt -125.18 120.08 30.34 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.869 -0.605 . . . . 25.0 111.669 178.03 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.9 mm -68.59 127.86 31.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.429 -0.805 . . . . 25.0 109.022 178.014 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.99 72.06 3.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.221 0.452 . . . . 25.0 112.221 -177.2 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.2 m -75.26 -11.22 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.073 0.463 . . . . 25.0 110.984 176.071 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.22 177.59 48.27 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 110.585 -1.006 . . . . 25.0 110.585 -178.137 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.5 mtm 55.02 15.29 1.14 Allowed 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.793 1.775 . . . . 25.0 115.793 177.418 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -131.94 172.27 12.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.483 -1.303 . . . . 25.0 107.483 -178.387 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t0 60.4 43.31 13.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.789 0.836 . . . . 25.0 112.126 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -77.23 60.71 1.99 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.686 0.755 . . . . 25.0 111.536 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -70.08 154.55 94.52 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.661 -0.699 . . . . 25.0 110.228 -179.971 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.59 -16.64 18.84 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 N-CA-C 114.599 0.961 . . . . 25.0 114.599 179.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.93 98.64 9.32 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.911 -0.493 . . . . 25.0 110.894 -179.098 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.17 -14.64 58.7 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.871 1.108 . . . . 25.0 115.871 -178.626 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -93.14 149.22 21.38 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 117.935 0.867 . . . . 25.0 111.175 -177.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 126.73 -170.7 18.48 Favored Glycine 0 C--N 1.329 0.169 0 CA-C-N 116.724 -0.216 . . . . 25.0 112.917 177.253 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 -59.03 3.27 Favored Glycine 0 C--O 1.226 -0.376 0 CA-C-O 120.085 -0.286 . . . . 25.0 113.745 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 58.2 m -134.46 146.5 49.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.401 -0.963 . . . . 25.0 108.401 178.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.87 9.14 86.72 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.885 -0.674 . . . . 25.0 112.225 -178.295 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 78.7 p -120.01 160.63 22.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 25.0 109.112 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.26 174.88 49.31 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.418 -1.073 . . . . 25.0 110.418 176.182 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.4 mt -126.55 160.18 31.35 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.251 -1.018 . . . . 25.0 108.251 179.53 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 t -139.66 163.58 32.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.023 -2.214 . . . . 25.0 105.023 177.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.74 151.21 42.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.679 -0.86 . . . . 25.0 108.679 176.962 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -153.59 99.79 2.35 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.02 -1.474 . . . . 25.0 107.02 179.962 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.55 139.18 58.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.501 0.667 . . . . 25.0 111.367 -173.825 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.16 148.96 40.52 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.23 -0.895 . . . . 25.0 113.283 -174.212 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.84 164.76 34.65 Favored 'Trans proline' 0 C--O 1.242 0.71 0 O-C-N 121.836 0.387 . . . . 25.0 111.861 175.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.03 165.24 33.01 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 118.391 -0.606 . . . . 25.0 113.3 -178.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -84.95 152.76 59.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.877 -1.157 . . . . 25.0 107.877 177.182 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.51 159.72 51.18 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 117.627 -1.116 . . . . 25.0 109.363 170.328 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.8 170.85 19.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 118.402 -0.599 . . . . 25.0 113.482 -175.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.1 mt -133.94 155.94 79.75 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.51 -0.768 . . . . 25.0 108.943 178.297 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.6 167.68 25.05 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 121.222 1.282 . . . . 25.0 113.156 176.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.02 28.48 4.37 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 25.0 110.401 -178.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 88.96 -157.8 27.55 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.144 -0.782 . . . . 25.0 111.144 -176.009 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -74.13 149.88 40.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.265 1.031 . . . . 25.0 110.797 -179.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.211 -0.926 0 CA-C-O 124.785 2.231 . . . . 25.0 111.504 178.99 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.098 0 CA-C-O 122.348 0.971 . . . . 25.0 114.379 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t 54.82 37.2 28.12 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.887 0.875 . . . . 25.0 111.702 -178.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.6 ttt 54.29 64.75 1.71 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.899 0.857 . . . . 25.0 112.484 -178.613 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -134.27 148.31 50.78 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.507 -2.034 . . . . 25.0 105.507 176.292 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 56.93 170.94 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.014 1.857 . . . . 25.0 116.014 179.482 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.5 mt -72.54 -41.05 66.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 25.0 110.965 -178.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 50.64 57.25 6.83 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.423 0.897 . . . . 25.0 113.423 -179.544 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -112.28 158.76 12.59 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.718 0 N-CA-C 106.97 -1.493 . . . . 25.0 106.97 178.793 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -96.38 144.37 26.58 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.582 -0.699 . . . . 25.0 110.245 178.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.23 145.69 39.56 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.429 -0.211 . . . . 25.0 110.429 178.44 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HB2' HD11 ' A' ' 65' ' ' LEU . 6.2 ttmt -103.99 137.56 41.79 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.892 0.477 . . . . 25.0 111.846 179.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.6 132.16 41.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.699 -0.482 . . . . 25.0 109.699 173.544 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.3 mm? -94.43 -15.03 24.62 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.736 0.303 . . . . 25.0 110.531 175.777 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -145.25 160.6 41.24 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.828 -0.805 . . . . 25.0 108.828 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.54 154.02 42.66 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.566 -1.272 . . . . 25.0 107.566 174.514 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -137.4 128.46 27.58 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 109.414 -0.588 . . . . 25.0 109.414 174.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.21 124.84 60.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 102.99 -2.966 . . . . 25.0 102.99 175.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.3 123.86 23.88 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 -179.413 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -109.76 -27.39 9.34 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.614 -0.884 . . . . 25.0 108.614 -177.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 t -95.07 146.12 30.74 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 106.371 -1.714 . . . . 25.0 106.371 173.488 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.31 -13.15 37.01 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 118.658 -0.428 . . . . 25.0 112.599 177.582 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -6.97 50.85 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 120.556 0.217 . . . . 25.0 110.57 178.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -90.23 153.18 20.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.276 0.56 . . . . 25.0 112.255 -173.493 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -95.97 144.72 26.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.586 0.708 . . . . 25.0 111.881 174.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.6 p -108.39 133.82 52.06 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.055 -1.461 . . . . 25.0 107.055 175.414 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -157.24 172.1 19.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.316 -0.857 . . . . 25.0 112.525 -178.444 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 33.1 tpt85 -105.53 151.49 24.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.259 1.023 . . . . 25.0 110.32 -177.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -54.28 125.34 18.88 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.489 0.716 . . . . 25.0 109.322 172.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.17 -11.44 57.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 118.828 -0.985 . . . . 25.0 113.943 -179.064 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.81 158.52 36.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 117.879 0.839 . . . . 25.0 110.14 -177.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 50.2 mm -117.87 127.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 178.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 4.2 ptp -127.07 156.55 41.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 175.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.7 m -90.75 112.28 24.0 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.418 -0.81 . . . . 25.0 109.681 -179.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 8' ' ' VAL . 41.5 t -78.13 120.99 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 N-CA-C 108.575 -0.898 . . . . 25.0 108.575 179.082 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.9 mt -94.0 -45.63 7.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.33 -0.85 . . . . 25.0 109.605 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -153.28 171.68 18.17 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.655 -0.418 . . . . 25.0 110.324 173.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -128.44 146.97 50.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 105.761 -1.94 . . . . 25.0 105.761 179.338 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t0 60.42 42.64 14.3 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 123.905 1.812 . . . . 25.0 106.784 -175.072 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -67.86 142.09 56.23 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 113.323 -1.762 . . . . 25.0 108.859 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.61 11.8 1.9 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.037 0.935 . . . . 25.0 113.51 -177.726 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.87 16.16 70.91 Favored Glycine 0 CA--C 1.518 0.226 0 N-CA-C 110.953 -0.859 . . . . 25.0 110.953 -176.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.2 mt -93.86 90.14 6.4 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.058 -1.09 . . . . 25.0 108.058 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.18 145.18 27.08 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.459 1.123 . . . . 25.0 111.398 178.488 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.29 -26.37 2.58 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.651 -1.159 . . . . 25.0 113.016 -176.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -86.54 131.3 34.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.73 1.265 . . . . 25.0 110.109 179.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -116.55 128.38 55.37 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.784 -1.191 . . . . 25.0 107.784 -179.37 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.58 123.89 25.64 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 106.603 -1.628 . . . . 25.0 106.603 177.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.6 m -134.98 169.55 17.24 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.114 0.483 . . . . 25.0 110.475 177.917 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.42 130.21 48.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.846 -1.168 . . . . 25.0 107.846 177.052 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.24 132.09 20.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 -178.001 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.2 m170 55.37 30.13 14.33 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.389 0.676 . . . . 25.0 112.186 -178.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.59 8.34 87.16 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.986 -0.626 . . . . 25.0 114.372 -179.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -113.49 139.2 49.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 105.922 -1.881 . . . . 25.0 105.922 179.47 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -105.95 146.99 29.31 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 -179.675 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.92 171.35 42.03 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.629 -0.796 . . . . 25.0 113.324 177.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.2 pt -79.87 155.54 4.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.65 0.738 . . . . 25.0 109.063 179.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.99 139.34 16.72 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.071 -1.085 . . . . 25.0 108.071 -179.272 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.28 114.76 3.73 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 117.949 -0.901 . . . . 25.0 110.737 175.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.9 -21.17 60.81 Favored Glycine 0 C--O 1.222 -0.609 0 N-CA-C 112.21 -0.356 . . . . 25.0 112.21 -178.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -62.12 -16.99 56.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.03 0.532 . . . . 25.0 112.427 176.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -114.89 11.24 16.58 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.053 -0.404 . . . . 25.0 111.358 179.291 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -119.87 153.78 35.33 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 122.114 0.959 . . . . 25.0 113.248 -179.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' HB2' HD21 ' A' ' 13' ' ' LEU . 33.1 ttmt -129.86 120.06 24.32 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.776 -1.102 . . . . 25.0 110.544 175.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 mm -70.43 128.69 34.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.316 -0.994 . . . . 25.0 108.316 179.345 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 11' ' ' LYS . 56.1 mt -106.55 83.17 1.83 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.266 0.555 . . . . 25.0 109.849 -179.55 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.3 m -70.84 146.87 11.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.208 0.528 . . . . 25.0 111.283 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -93.21 -171.8 40.01 Favored Glycine 0 C--O 1.217 -0.919 0 N-CA-C 109.451 -1.46 . . . . 25.0 109.451 176.709 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.9 mtm 62.23 8.82 2.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 115.607 1.706 . . . . 25.0 115.607 178.04 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -127.9 26.66 5.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 110.219 -0.289 . . . . 25.0 110.219 177.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 47.09 50.3 14.2 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.73 0.776 . . . . 25.0 111.82 -179.147 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -70.89 83.43 0.66 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.188 0.994 . . . . 25.0 113.283 -174.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -75.23 151.38 85.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.341 -0.845 . . . . 25.0 109.353 176.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.62 -15.73 21.61 Favored 'Trans proline' 0 C--N 1.35 0.638 0 N-CA-C 115.219 1.2 . . . . 25.0 115.219 -176.503 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 62.22 22.77 13.4 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.939 1.089 . . . . 25.0 113.939 -179.476 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.56 178.0 15.34 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.493 -0.384 . . . . 25.0 112.307 176.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 p -161.24 167.55 25.79 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 104.417 -2.438 . . . . 25.0 104.417 177.536 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.7 -152.62 19.66 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 111.595 -0.602 . . . . 25.0 111.595 179.422 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.1 -41.31 1.17 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 179.44 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.5 t 54.59 24.08 5.15 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.104 1.89 . . . . 25.0 116.104 174.451 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.3 153.43 22.41 Favored Glycine 0 CA--C 1.512 -0.099 0 N-CA-C 111.565 -0.614 . . . . 25.0 111.565 179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 44.8 m -97.01 177.22 5.68 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.644 0.377 . . . . 25.0 110.203 -178.775 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.99 -125.56 15.89 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 109.057 -1.617 . . . . 25.0 109.057 -179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.55 -20.71 58.48 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.157 0.428 . . . . 25.0 112.157 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.5 m 62.21 36.84 14.66 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 -169.618 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 50.78 -159.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 112.878 -1.965 . . . . 25.0 115.549 173.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 67.01 97.38 0.05 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.769 1.228 . . . . 25.0 109.98 -173.39 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.69 135.34 56.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.697 -0.683 . . . . 25.0 111.479 -173.422 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.7 146.66 53.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.019 -0.992 . . . . 25.0 112.511 -175.334 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.25 165.58 31.54 Favored 'Trans proline' 0 C--O 1.245 0.868 0 O-C-N 121.793 0.365 . . . . 25.0 111.55 174.464 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.72 164.54 35.31 Favored 'Trans proline' 0 C--N 1.346 0.402 0 N-CA-C 113.793 0.651 . . . . 25.0 113.793 -177.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.88 152.65 59.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.041 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.06 162.91 39.76 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 N-CA-C 109.571 -0.973 . . . . 25.0 109.571 169.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.93 172.4 16.41 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 113.813 0.659 . . . . 25.0 113.813 -175.634 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.9 mt -133.87 156.48 79.31 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 25.0 110.251 177.799 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.24 -162.04 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.963 3.109 . . . . 25.0 112.41 177.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 67.51 13.36 9.28 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.065 1.346 . . . . 25.0 113.129 178.532 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.41 -85.47 1.37 Allowed Glycine 0 C--O 1.226 -0.385 0 N-CA-C 110.347 -1.101 . . . . 25.0 110.347 172.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -113.24 124.09 51.7 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.914 -0.773 . . . . 25.0 108.914 177.072 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 126.257 2.932 . . . . 25.0 111.683 -178.507 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 CA-C-O 124.84 2.355 . . . . 25.0 113.452 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m -147.38 162.8 38.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.223 -1.489 . . . . 25.0 109.357 -179.35 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.3 ttp -132.67 153.26 51.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.441 -0.948 . . . . 25.0 108.441 -179.045 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -121.83 142.4 50.27 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 103.555 -2.757 . . . . 25.0 103.555 174.101 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.53 165.67 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 -176.392 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -73.33 -43.03 61.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.558 -0.746 . . . . 25.0 111.833 -176.166 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 54.98 56.74 6.27 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.927 0.891 . . . . 25.0 113.194 -179.688 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.92 160.55 12.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 N-CA-C 107.263 -1.384 . . . . 25.0 107.263 178.968 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -97.15 142.76 28.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 118.396 0.544 . . . . 25.0 110.401 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.97 145.77 44.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.991 -0.374 . . . . 25.0 109.991 176.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -108.23 140.02 42.08 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.727 0.411 . . . . 25.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.69 128.42 35.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.997 -0.547 . . . . 25.0 110.633 175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -88.92 -17.1 30.24 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.715 -0.476 . . . . 25.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -146.78 167.45 23.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 -176.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.18 158.0 37.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.011 -1.107 . . . . 25.0 108.011 173.679 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -138.44 134.25 33.82 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.231 -0.655 . . . . 25.0 109.231 171.311 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.52 126.49 66.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 103.769 -2.678 . . . . 25.0 103.769 176.402 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.91 116.75 17.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.46 -1.311 . . . . 25.0 107.46 -179.705 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -104.77 -19.27 13.97 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.573 0.701 . . . . 25.0 109.464 -177.379 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.2 m -108.9 151.84 42.06 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 108.226 -1.027 . . . . 25.0 108.226 175.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.44 -13.87 36.18 Favored 'Trans proline' 0 C--N 1.34 0.117 0 N-CA-C 113.837 0.668 . . . . 25.0 113.837 -177.709 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.24 1.1 49.27 Favored 'General case' 0 C--O 1.208 -1.13 0 N-CA-C 110.276 -0.268 . . . . 25.0 110.276 179.318 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -95.66 154.95 16.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.994 -0.441 . . . . 25.0 111.489 -175.457 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 69.5 mt -100.26 144.73 28.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 25.0 111.69 175.044 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 p -109.48 135.4 50.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.293 -1.373 . . . . 25.0 107.293 175.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.08 170.08 23.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.271 -0.877 . . . . 25.0 112.683 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -104.44 154.14 20.24 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.946 0.898 . . . . 25.0 109.081 -178.246 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -54.72 128.22 31.74 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.241 -0.651 . . . . 25.0 109.241 174.526 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.86 -11.6 60.8 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.249 -0.751 . . . . 25.0 114.646 -179.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.73 156.71 38.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.021 0.91 . . . . 25.0 110.579 -178.47 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.9 mm -116.64 128.65 73.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 25.0 109.468 179.27 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.6 ptp -125.51 155.91 39.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.347 0.594 . . . . 25.0 109.596 175.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.8 m -90.97 113.38 25.61 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.022 -0.99 . . . . 25.0 108.963 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.1 123.5 34.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.825 -0.806 . . . . 25.0 108.825 179.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.4 mt -96.74 -46.41 6.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.453 -0.794 . . . . 25.0 109.527 -177.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 39' ' ' THR . 19.1 pt-20 -152.95 172.51 16.69 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.599 -0.519 . . . . 25.0 109.599 172.562 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -128.02 150.18 50.04 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.829 -1.545 . . . . 25.0 106.829 -179.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 58.93 36.51 24.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 123.793 1.759 . . . . 25.0 107.742 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.425 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 5.7 t -63.49 145.02 56.48 Favored 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 112.541 -2.118 . . . . 25.0 111.506 -176.332 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 57.89 14.38 2.54 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.013 0.925 . . . . 25.0 113.355 -179.078 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.2 13.66 78.51 Favored Glycine 0 C--O 1.228 -0.229 0 N-CA-C 111.19 -0.764 . . . . 25.0 111.19 -177.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 mt -91.57 93.33 8.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.734 -1.21 . . . . 25.0 107.734 -179.424 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -57.18 129.55 42.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.49 0.662 . . . . 25.0 110.685 -177.015 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.35 -15.38 50.48 Favored Glycine 0 C--O 1.235 0.207 0 CA-C-O 119.445 -0.642 . . . . 25.0 114.283 178.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -89.66 129.96 36.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.483 1.142 . . . . 25.0 108.371 177.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.6 m0 -116.13 124.82 51.31 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.125 -0.695 . . . . 25.0 109.125 -177.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.7 tp -72.89 122.09 21.07 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.471 -1.307 . . . . 25.0 107.471 179.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.2 m -135.16 169.98 16.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.318 0.58 . . . . 25.0 110.661 179.062 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.59 129.57 47.52 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.936 -1.135 . . . . 25.0 107.936 177.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 130.77 19.63 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.21 -1.033 . . . . 25.0 108.21 -176.645 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.7 m170 54.35 31.99 15.51 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.232 0.613 . . . . 25.0 112.648 178.405 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.69 10.48 85.72 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.953 -0.641 . . . . 25.0 114.681 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -119.37 146.22 45.52 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 105.845 -1.909 . . . . 25.0 105.845 179.366 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.18 148.05 34.86 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.961 -0.755 . . . . 25.0 108.961 179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 177.07 171.86 41.07 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.671 -0.776 . . . . 25.0 112.426 177.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.6 pt -81.93 156.17 4.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 25.0 109.589 179.93 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.3 t -142.21 139.32 17.68 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -177.669 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.97 116.68 4.79 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 117.982 -0.879 . . . . 25.0 111.158 175.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.57 -22.15 58.81 Favored Glycine 0 C--O 1.22 -0.727 0 O-C-N 122.026 -0.421 . . . . 25.0 112.244 179.421 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -16.36 62.28 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.578 0.584 . . . . 25.0 112.578 178.013 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -115.49 10.16 15.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.325 0.25 . . . . 25.0 110.48 179.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 tp -127.22 143.94 51.14 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.814 1.042 . . . . 25.0 113.814 -175.157 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' HD21 ' A' ' 13' ' ' LEU . 38.5 ttpt -123.18 120.0 31.9 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 112.503 0.557 . . . . 25.0 112.503 178.401 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.26 126.06 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.327 -0.851 . . . . 25.0 109.204 177.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -96.49 41.35 1.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -176.252 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 72.6 t -106.61 -57.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.014 0.376 . . . . 25.0 112.014 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.42 -97.95 1.61 Allowed Glycine 0 C--O 1.225 -0.407 0 N-CA-C 106.909 -2.476 . . . . 25.0 106.909 -170.726 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.33 108.92 3.82 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.655 0.727 . . . . 25.0 110.478 176.236 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -146.83 149.24 32.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.906 -0.776 . . . . 25.0 108.906 176.132 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -87.19 -25.64 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.971 0.891 . . . . 25.0 109.464 172.01 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -109.84 160.23 16.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.83 -0.623 . . . . 25.0 110.759 -176.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -80.06 157.85 73.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.89 -13.7 37.3 Favored 'Trans proline' 0 C--N 1.35 0.651 0 N-CA-C 114.713 1.005 . . . . 25.0 114.713 179.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 53.33 35.97 21.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.433 0.901 . . . . 25.0 113.433 176.703 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.3 -178.06 36.73 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 108.704 -1.758 . . . . 25.0 108.704 179.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.6 m -145.58 165.53 28.4 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.254 -0.647 . . . . 25.0 109.254 -178.503 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 172.75 40.55 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 107.827 -2.109 . . . . 25.0 107.827 178.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.18 -151.02 7.44 Favored Glycine 0 C--O 1.239 0.431 0 CA-C-N 117.79 0.795 . . . . 25.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 64.8 m -143.42 162.34 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.236 -1.024 . . . . 25.0 108.236 177.67 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -139.57 109.09 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 109.282 -1.527 . . . . 25.0 109.282 175.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.3 p -155.27 141.64 18.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.1 -3.64 19.3 Favored Glycine 0 C--O 1.222 -0.608 0 C-N-CA 121.293 -0.48 . . . . 25.0 113.324 -179.427 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.73 150.48 51.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.493 -0.929 . . . . 25.0 108.493 -177.661 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 22.5 p -141.52 67.47 1.34 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.749 0.785 . . . . 25.0 110.062 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -88.6 53.46 2.72 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.007 -0.997 . . . . 25.0 112.299 -174.725 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 140.38 15.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 106.125 -1.805 . . . . 25.0 106.125 -179.28 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.48 146.16 23.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.284 -0.871 . . . . 25.0 110.424 -177.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.67 146.23 46.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.107 -0.497 . . . . 25.0 112.141 -177.2 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.57 167.15 26.33 Favored 'Trans proline' 0 C--O 1.241 0.657 0 N-CA-C 110.857 -0.478 . . . . 25.0 110.857 174.358 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.56 161.77 44.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 117.487 -1.208 . . . . 25.0 112.881 -178.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -94.48 152.98 40.41 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 175.413 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.51 155.88 67.5 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 116.602 -1.799 . . . . 25.0 108.943 173.266 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.65 174.76 12.11 Favored 'Trans proline' 0 C--O 1.239 0.572 0 O-C-N 121.878 0.409 . . . . 25.0 112.907 -176.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.3 mt -130.61 161.55 60.21 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 25.0 111.659 -179.37 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.4 -164.01 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.06 1.84 . . . . 25.0 112.692 177.16 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 62.57 12.26 5.35 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.024 1.329 . . . . 25.0 114.412 178.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.78 6.91 48.87 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.601 -0.727 . . . . 25.0 113.689 176.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.64 143.68 57.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.604 -1.628 . . . . 25.0 106.604 173.825 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 116.549 2.055 . . . . 25.0 116.549 -170.847 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.839 0 CA-C-O 124.34 2.078 . . . . 25.0 115.075 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -148.19 150.03 33.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.514 -1.661 . . . . 25.0 106.514 176.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.5 mtt -136.34 136.27 39.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.975 -0.38 . . . . 25.0 109.975 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -158.11 140.7 14.57 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 103.421 -2.807 . . . . 25.0 103.421 175.82 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 58.42 175.33 0.06 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.742 1.756 . . . . 25.0 115.742 177.711 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.1 mt -85.54 -37.67 19.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.016 -0.993 . . . . 25.0 110.946 -177.311 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 51.99 50.73 17.93 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.101 1.148 . . . . 25.0 114.101 -179.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.58 160.0 7.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 107.607 -1.257 . . . . 25.0 107.607 -179.49 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.41 144.73 26.86 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.344 0.592 . . . . 25.0 110.914 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.64 147.33 46.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.715 -0.675 . . . . 25.0 110.531 177.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -107.38 140.23 40.63 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.338 0.399 . . . . 25.0 111.074 177.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.49 127.77 33.9 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 122.53 0.332 . . . . 25.0 110.822 174.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -20.85 27.07 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.919 -0.4 . . . . 25.0 109.919 175.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -143.97 167.45 22.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 -176.592 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.84 160.37 30.73 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.858 -0.793 . . . . 25.0 108.858 171.829 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -146.53 129.44 16.33 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.949 -0.569 . . . . 25.0 109.839 172.471 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -106.25 124.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 104.536 -2.394 . . . . 25.0 104.536 175.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . -72.68 127.34 32.26 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.875 -0.787 . . . . 25.0 108.875 -178.276 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -109.15 -29.68 8.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.66 0.743 . . . . 25.0 109.507 178.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.3 t -91.24 147.1 34.81 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.83 -1.544 . . . . 25.0 106.83 174.94 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.56 -11.65 32.53 Favored 'Trans proline' 0 C--O 1.237 0.442 0 O-C-N 122.116 0.534 . . . . 25.0 111.885 176.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -98.07 1.62 47.88 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-O 119.541 -0.266 . . . . 25.0 110.775 178.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -96.91 151.18 19.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.432 0.56 . . . . 25.0 111.506 -177.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -96.01 141.61 29.21 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 121.806 0.813 . . . . 25.0 111.919 174.497 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -106.41 134.97 48.71 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.503 -1.665 . . . . 25.0 106.503 175.62 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -157.68 167.73 29.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.776 -0.647 . . . . 25.0 112.706 -179.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -99.03 158.09 15.9 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.154 0.582 . . . . 25.0 109.83 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -57.05 131.6 50.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.125 -1.065 . . . . 25.0 108.125 172.209 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.51 -13.41 61.26 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 118.804 -0.998 . . . . 25.0 114.462 178.696 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.66 154.8 37.84 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 117.782 0.791 . . . . 25.0 110.942 -179.715 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.9 mm -116.81 129.17 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.276 -1.009 . . . . 25.0 108.276 178.014 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 5.2 ptp -130.13 155.27 46.48 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.419 0.628 . . . . 25.0 109.972 177.737 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.1 m -90.37 112.52 24.14 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 114.85 -1.068 . . . . 25.0 109.613 -179.292 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -79.75 119.52 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 179.415 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.6 mt -90.77 -46.66 8.1 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.064 -0.971 . . . . 25.0 109.011 -179.171 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -155.15 169.38 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.569 -0.53 . . . . 25.0 109.569 174.146 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -123.94 150.64 44.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.7 -1.593 . . . . 25.0 106.7 179.832 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 59.11 37.99 23.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 124.06 1.886 . . . . 25.0 108.28 -179.339 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t -64.7 145.34 56.34 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 112.799 -2.0 . . . . 25.0 110.889 -176.233 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 58.02 13.24 2.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.793 0.837 . . . . 25.0 113.076 -178.167 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.26 13.09 79.62 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.261 -0.736 . . . . 25.0 111.261 -177.221 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.2 mt -87.88 95.24 10.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -179.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -56.88 129.07 39.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.692 0.758 . . . . 25.0 110.827 -177.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.85 -13.3 57.02 Favored Glycine 0 C--O 1.238 0.363 0 CA-C-N 115.884 -0.598 . . . . 25.0 114.307 178.139 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -93.19 129.78 39.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 1.0 . . . . 25.0 109.601 178.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -114.85 126.52 54.91 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.127 -0.358 . . . . 25.0 110.047 -176.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 tp -75.41 119.08 19.01 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.488 -1.301 . . . . 25.0 107.488 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.3 m -132.47 171.46 13.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.231 0.539 . . . . 25.0 110.623 178.137 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.47 129.06 44.13 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 177.655 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.91 133.39 23.42 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.123 -1.436 . . . . 25.0 107.123 -177.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.8 m170 55.96 28.76 13.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.291 0.636 . . . . 25.0 112.098 -177.525 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.65 9.15 86.37 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.086 -0.578 . . . . 25.0 114.238 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -112.82 138.53 49.52 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 105.747 -1.946 . . . . 25.0 105.747 179.615 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -102.74 148.66 25.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.638 -0.505 . . . . 25.0 109.638 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.97 170.9 41.56 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.84 -0.695 . . . . 25.0 113.728 175.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.6 pt -80.37 156.76 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 179.256 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -143.0 138.79 16.13 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.147 -1.057 . . . . 25.0 108.147 -177.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.56 110.15 2.44 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 CA-C-N 118.594 0.534 . . . . 25.0 110.868 175.062 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.69 -22.07 52.2 Favored Glycine 0 C--O 1.222 -0.647 0 O-C-N 122.06 -0.4 . . . . 25.0 114.022 -177.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -16.23 63.41 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 122.076 -0.661 . . . . 25.0 112.22 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -111.67 9.57 21.0 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.19 -0.319 . . . . 25.0 110.618 178.737 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.5 tp -124.76 144.94 49.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.985 0.735 . . . . 25.0 112.985 -176.312 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -122.97 119.1 29.41 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 116.104 -0.498 . . . . 25.0 111.521 178.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.13 126.02 28.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 106.978 -1.49 . . . . 25.0 106.978 175.716 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -91.56 68.84 5.73 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 -179.454 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -27.88 43.31 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.621 0 N-CA-C 115.089 1.515 . . . . 25.0 115.089 -173.167 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.1 2.99 67.67 Favored Glycine 0 C--O 1.218 -0.873 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.879 -177.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 98.8 mmm -88.57 -9.58 51.78 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.133 1.16 . . . . 25.0 114.133 -176.275 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.59 133.22 25.25 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.351 -0.218 . . . . 25.0 110.747 -175.823 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -120.74 179.09 4.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 114.147 1.166 . . . . 25.0 114.147 -173.789 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 55.08 42.37 30.9 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.408 1.632 . . . . 25.0 115.408 171.062 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.68 149.31 50.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 105.465 -2.05 . . . . 25.0 105.465 171.038 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.89 151.79 73.8 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.225 -178.767 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.75 -30.71 0.16 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -176.513 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.28 134.25 12.28 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 120.305 -0.95 . . . . 25.0 111.588 -178.011 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.6 m -100.35 -15.47 17.98 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 117.347 0.573 . . . . 25.0 111.803 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 152.83 -146.2 14.49 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.565 -1.414 . . . . 25.0 109.565 -175.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.46 175.03 40.88 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 121.697 0.609 . . . . 25.0 114.006 179.099 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -94.4 152.93 18.24 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 122.659 -0.318 . . . . 25.0 110.232 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.72 9.35 86.89 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 114.845 0.698 . . . . 25.0 114.845 176.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -58.17 150.99 20.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.802 0.667 . . . . 25.0 112.802 -178.003 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.97 48.86 0.54 Allowed Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.706 -0.958 . . . . 25.0 110.706 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.41 -174.42 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.637 -0.505 . . . . 25.0 109.637 -178.533 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.2 p -74.15 -178.77 3.51 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.42 0.688 . . . . 25.0 109.923 177.099 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 62.12 -158.57 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.009 0.924 . . . . 25.0 112.251 175.178 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 48.5 42.22 18.32 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.837 0.827 . . . . 25.0 111.755 -176.819 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.09 134.86 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.324 -0.853 . . . . 25.0 111.226 -175.324 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.93 148.27 67.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.101 -0.954 . . . . 25.0 112.35 -175.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.05 164.1 36.71 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 O-C-N 121.902 0.422 . . . . 25.0 112.404 175.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.16 164.11 36.86 Favored 'Trans proline' 0 C--N 1.347 0.474 0 CA-C-O 121.435 0.515 . . . . 25.0 112.689 -179.287 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -81.97 152.19 68.26 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.152 -0.685 . . . . 25.0 109.152 177.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.65 162.21 42.9 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 N-CA-C 109.538 -0.986 . . . . 25.0 109.538 170.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.51 172.77 15.03 Favored 'Trans proline' 0 C--N 1.345 0.351 0 N-CA-C 113.566 0.564 . . . . 25.0 113.566 -175.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.3 mt -133.09 156.59 79.84 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 178.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -75.49 -176.59 3.03 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.622 2.214 . . . . 25.0 112.581 179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.54 11.91 6.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.835 1.254 . . . . 25.0 113.136 179.631 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.78 160.55 41.29 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.427 -1.069 . . . . 25.0 110.427 175.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.79 161.86 18.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.645 0.736 . . . . 25.0 110.982 -178.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.215 -0.72 0 CA-C-O 126.171 2.891 . . . . 25.0 112.204 -179.836 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.607 0 CA-C-O 122.895 1.275 . . . . 25.0 115.84 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t 59.2 -155.02 0.36 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.726 1.21 . . . . 25.0 108.902 -175.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 42.75 55.23 4.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.456 1.102 . . . . 25.0 113.748 177.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -73.55 132.63 43.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.151 -1.796 . . . . 25.0 106.151 175.038 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 62.63 161.38 0.08 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.919 1.387 . . . . 25.0 114.489 -176.401 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 67.7 mt -77.71 -35.21 52.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.721 -1.127 . . . . 25.0 112.323 -174.089 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.9 49.02 21.15 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.189 1.181 . . . . 25.0 114.189 179.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 34' ' ' VAL . 0.8 OUTLIER -107.43 161.1 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -179.82 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.9 mt -98.26 145.76 26.33 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.765 -0.585 . . . . 25.0 110.345 178.268 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.09 142.57 36.09 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.264 -0.272 . . . . 25.0 110.791 178.29 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -103.89 138.95 39.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.339 0.256 . . . . 25.0 111.318 178.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.84 126.81 30.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.722 173.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 63' ' ' LYS . 1.1 mm? -87.54 -19.13 28.31 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.339 -0.615 . . . . 25.0 109.339 174.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -145.56 159.36 43.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.163 -0.68 . . . . 25.0 109.163 -176.593 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 10.7 m-20 -67.66 156.6 36.48 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 123.662 0.601 . . . . 25.0 110.379 173.846 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 132.64 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.459 -174.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.45 128.12 74.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 105.153 -2.166 . . . . 25.0 105.153 179.111 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -73.91 121.53 21.11 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.498 -0.774 . . . . 25.0 109.277 -179.392 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -107.2 -19.44 13.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.797 0.808 . . . . 25.0 108.823 178.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 t -108.21 147.49 35.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 176.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -14.3 39.65 Favored 'Trans proline' 0 C--N 1.346 0.42 0 O-C-N 121.887 0.414 . . . . 25.0 112.838 177.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 -9.19 56.14 Favored 'General case' 0 C--O 1.205 -1.25 0 C-N-CA 122.63 0.372 . . . . 25.0 110.184 177.436 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -94.03 148.88 21.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.237 0.541 . . . . 25.0 111.308 -171.163 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.0 mt -86.85 162.64 17.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 25.0 109.577 174.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 107.23 9.54 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 177.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -132.64 168.48 18.2 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.569 1.322 . . . . 25.0 114.569 -177.288 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' OD1' ' A' ' 15' ' ' ASP . 6.2 tpt180 -104.24 151.38 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.476 -1.238 . . . . 25.0 108.754 -176.206 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.06 127.58 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 25.0 110.32 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.44 -12.7 56.9 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.953 -0.915 . . . . 25.0 113.617 -179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.84 157.63 36.1 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 117.905 0.852 . . . . 25.0 110.848 -178.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.92 130.27 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 109.222 -0.659 . . . . 25.0 109.222 178.402 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 3.3 ptp -128.82 156.93 42.83 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.319 -0.623 . . . . 25.0 109.319 176.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.1 m -92.42 114.28 26.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.112 -0.949 . . . . 25.0 109.038 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 8' ' ' VAL . 40.1 t -78.59 124.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.63 -0.878 . . . . 25.0 108.63 178.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.6 mt -97.67 -46.1 6.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.414 -0.812 . . . . 25.0 109.488 -178.73 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' LEU . 13.3 pt-20 -151.79 172.33 16.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.436 -0.95 . . . . 25.0 108.436 173.236 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.4 mtm180 -127.63 150.99 49.49 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.403 -1.703 . . . . 25.0 106.403 178.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 60.59 36.01 19.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 123.705 1.716 . . . . 25.0 107.934 177.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 t -64.2 146.28 54.56 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 112.6 -2.091 . . . . 25.0 111.434 -176.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 58.16 14.18 2.64 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.134 0.974 . . . . 25.0 112.995 -178.216 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.18 12.73 81.98 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 111.283 -0.727 . . . . 25.0 111.283 -176.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -89.52 88.91 7.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.985 -1.117 . . . . 25.0 107.985 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.41 130.51 45.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.501 0.667 . . . . 25.0 110.208 -177.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.25 -14.69 58.63 Favored Glycine 0 C--O 1.237 0.327 0 N-CA-C 114.493 0.557 . . . . 25.0 114.493 179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -93.67 129.58 39.92 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.463 -0.94 . . . . 25.0 108.463 177.122 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -115.53 127.3 55.18 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.683 -0.636 . . . . 25.0 109.417 -176.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 58.5 tp -74.41 121.05 20.81 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.083 -1.451 . . . . 25.0 107.083 178.616 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.3 m -133.48 168.48 18.55 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.028 0.442 . . . . 25.0 109.936 178.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.11 128.89 48.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.812 -1.181 . . . . 25.0 107.812 177.519 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.37 130.55 20.79 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.607 -1.627 . . . . 25.0 106.607 -176.571 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m170 56.35 27.17 11.56 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.182 0.593 . . . . 25.0 111.595 -178.783 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.74 4.5 89.42 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 119.711 -0.494 . . . . 25.0 114.128 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 136.61 46.39 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 104.828 -2.286 . . . . 25.0 104.828 179.376 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -104.14 141.15 36.75 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.386 -0.598 . . . . 25.0 109.386 178.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.97 171.95 44.97 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.82 -0.705 . . . . 25.0 112.761 178.066 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 pt -79.9 154.77 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.711 0.767 . . . . 25.0 109.44 -179.692 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.1 t -140.17 139.11 20.31 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.15 -0.932 . . . . 25.0 108.586 -178.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.33 110.49 2.68 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 118.645 -0.437 . . . . 25.0 111.131 175.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.35 -22.12 55.39 Favored Glycine 0 C--O 1.222 -0.64 0 O-C-N 122.194 -0.316 . . . . 25.0 112.482 -179.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.92 -16.02 60.5 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.617 0.599 . . . . 25.0 112.617 177.545 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -114.37 10.06 17.0 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.834 -0.541 . . . . 25.0 111.263 178.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 tp -123.89 145.02 49.41 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.243 0.831 . . . . 25.0 113.243 -175.244 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' HB2' HD21 ' A' ' 13' ' ' LEU . 40.2 ttpt -121.95 119.91 32.87 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 116.176 -0.466 . . . . 25.0 109.893 177.578 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.2 mm -68.1 127.7 30.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.027 -1.101 . . . . 25.0 108.027 176.026 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -93.98 97.22 10.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.193 -1.78 . . . . 25.0 106.193 177.65 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.81 -38.24 18.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.899 -0.408 . . . . 25.0 109.899 -174.659 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.91 31.17 62.43 Favored Glycine 0 C--O 1.228 -0.23 0 N-CA-C 110.01 -1.236 . . . . 25.0 110.01 -179.374 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 55.5 ttm -139.46 -85.24 0.24 Allowed 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.095 0.406 . . . . 25.0 112.095 -176.569 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -90.19 -17.2 27.98 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 121.666 -0.646 . . . . 25.0 111.392 -177.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 15.93 59.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.657 2.465 . . . . 25.0 117.657 179.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -74.54 -6.88 50.97 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.115 0.783 . . . . 25.0 113.115 -176.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -89.33 137.13 29.3 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 104.973 -2.232 . . . . 25.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.33 161.43 44.42 Favored 'Trans proline' 0 C--O 1.237 0.459 0 N-CA-C 115.682 1.378 . . . . 25.0 115.682 -169.214 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.3 161.68 41.04 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 102.658 -3.09 . . . . 25.0 102.658 175.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.51 -151.28 22.89 Favored Glycine 0 CA--C 1.508 -0.379 0 N-CA-C 107.311 -2.316 . . . . 25.0 107.311 -175.534 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -19.09 64.92 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 112.904 0.705 . . . . 25.0 112.904 178.133 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.61 -43.05 2.5 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 112.179 -0.368 . . . . 25.0 112.179 178.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.64 -173.05 22.52 Favored Glycine 0 C--O 1.225 -0.423 0 N-CA-C 106.84 -2.504 . . . . 25.0 106.84 179.502 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.7 t -158.56 144.81 17.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.741 -1.948 . . . . 25.0 105.741 176.072 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.4 69.05 1.47 Allowed Glycine 0 CA--C 1.524 0.612 0 N-CA-C 115.062 0.785 . . . . 25.0 115.062 178.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.3 t -143.06 151.63 40.99 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.219 -0.66 . . . . 25.0 109.219 178.267 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.47 28.17 43.56 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.5 1.36 . . . . 25.0 116.5 176.272 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 64.5 mt 55.91 34.59 23.87 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.102 0.561 . . . . 25.0 110.85 -176.187 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 88.12 -6.71 0.55 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.994 2.118 . . . . 25.0 112.852 177.142 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -100.41 153.34 19.42 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 174.045 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.59 72.48 1.48 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.953 0.882 . . . . 25.0 108.656 179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.99 142.8 56.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.25 -1.341 . . . . 25.0 111.222 -177.005 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.81 150.04 43.15 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 114.593 -1.185 . . . . 25.0 113.658 -173.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.53 166.29 30.25 Favored 'Trans proline' 0 C--O 1.243 0.739 0 O-C-N 121.696 0.314 . . . . 25.0 111.757 174.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.7 157.19 61.36 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 117.319 -1.321 . . . . 25.0 113.62 -177.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -84.84 154.93 61.57 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 106.365 -1.717 . . . . 25.0 106.365 175.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.21 161.84 42.85 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.684 -1.077 . . . . 25.0 110.092 175.623 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.31 175.68 9.66 Favored 'Trans proline' 0 C--N 1.344 0.31 0 CA-C-O 121.075 0.365 . . . . 25.0 112.514 -178.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 16.6 mt -131.33 153.42 81.64 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.6 -1.259 . . . . 25.0 107.6 176.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.44 167.67 22.53 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 121.97 1.78 . . . . 25.0 114.273 -178.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -97.89 90.42 4.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.441 -1.254 . . . . 25.0 107.767 178.393 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.76 -173.3 39.16 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.23 -0.51 . . . . 25.0 111.869 -177.783 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.92 30.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.405 -1.332 . . . . 25.0 107.405 178.955 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 124.638 2.161 . . . . 25.0 111.253 179.701 . . . . . . . . 0 0 . 1 stop_ save_